AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

The Phoenix Holdings Ltd.

Quarterly Report Sep 7, 2023

6983_rns_2023-09-07_ecbd6955-ce1a-44dc-a9dc-64a9f4e65a99.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

The Phoenix Holdings Ltd. Consolidated Interim Financial Statements as of June 30, 2023 (Unaudited)

השקעות, ביטוח ופיננסים

Members of the Board

Benjamin Gabbay - Chairman Ben Langworthy Dr. Ehud Shapira (Independent Director) Eliezer Yones Rachel Levine (External Director) Richard Kaplan (External Director) Roger Abravanel Stella Amar Cohen Itzhak Shukri Cohen

Table of Contents

Part 1 Report of the Board of Directors on the State of the Corporation's Affairs
Part 2 Consolidated Interim Financial Statements
Part 3 Standalone Financial Data from the Consolidated Interim Financial Statements
Attributed to the Company
Part 4 Report on the Effectiveness of Internal Control over Financial Reporting and Disclosure
Part 5 Statements Regarding Controls and Procedures in respect of Disclosure
in the Financial Statements of The Phoenix Insurance Company Ltd.

Part 1

Report of the Board of Directors on the State of the Corporation's Affairs

Table of Contents

1. THE GROUP'S STRUCTURE, ITS AREAS OF ACTIVITY, AND DEVELOPMENTS
THEREIN………………………………………………………………………………………….2
2. DESCRIPTION OF THE BUSINESS ENVIRONMENT 12
3. DEVELOPMENTS IN THE MACROECONOMIC ENVIRONMENT 22
4. BUSINESS TARGETS AND STRATEGY 25
5. THE
BOARD
OF
DIRECTORS'
EXPLANATIONS
FOR
THE
STATE
OF
THE
CORPORATION'S BUSINESS……………………………………………………………26
6. DISCLOSURE ON EXPOSURE TO, AND MANAGEMENT OF, MARKET RISKS 54
7. LINKAGE BALANCE 55
8. CORPORATE GOVERNANCE ASPECTS 58
9. DISCLOSURE PROVISIONS RELATING TO THE CORPORATION'S FINANCIAL
REPORTING…………………………………………………………………………………….60

Report of the Board of Directors on the State of the Corporation's Affairs as of June 30, 2023

The Report of the Board of Directors of The Phoenix Holdings Ltd. (hereinafter, "The Phoenix Holdings" or the "Company" or the Corporation") as of June 30, 2023, outlines the principal changes in the Company's operations in the period from January through June 2023 (hereinafter - the "Reporting Period").

The report was prepared in accordance with the Securities Regulations (Periodic and Immediate Reports), 1970. With regard to the insurance, pension, and provident fund operations of the Group, the Report was prepared pursuant to the Supervision of Insurance Business Regulations (Reporting), 1998, and in accordance with the directives issued by the Commissioner of the Capital Market, Insurance and Savings Authority (hereinafter - the "Supervisor" or the "Commissioner"). The report was prepared assuming that the reader also has at his/her disposal the Company's report for first quarter of 2023 as well as the full 2022 periodic report (hereinafter - the "Periodic Report").

The Report of the Board of Directors is an integral part of the quarterly report, and the quarterly report should be read in its entirety, as a single unit (hereinafter - the "Financial Report" or the "Financial Statements").

1. The Group's Structure, its Areas of Activity, and Developments Therein

1.1. Group structure

The Company's shareholders

The controlling shareholder of the Company is Belenus Lux S.à.r.l. (hereinafter - "Belenus"), which is held indirectly, through a number of companies, by two global funds - Centerbridge Partners LP and Gallatin Point Capital LLC. Centerbridge Partners LP is controlled by CCP III Cayman GP Ltd. and Gallatin Point Capital LLC is controlled by Matthew Botein, Lewis (Lee) Sachs.

In December 2022, the Company reported that a consortium of investors from the United Arab Emirates alongside other international investors are assessing the option of acquiring the control core in the Company from Belenus, and the parties' signing a memorandum of understanding. In July 2023, the Company reported that the parties reached a mutual understanding regarding the cancellation of the memorandum of understanding, and a concurrent execution of a transaction for the sale of shares by Belenus to the consortium, while retaining a stake of at least 30% of its shares on a fully diluted basis.

On August 14, 2023, a transaction for the sale of 2% of the Company's shares to a company controlled by an investor from the United Arab Emirates was completed, and as of the report's publication date Belenus holds 31.15% of the Company's shares.

For further details, please see reports dated December 13, 2022, July 23, 2023 and August 15, 2023 (Ref. Nos.: 2022-01-150541, 2023-01-068953 and 2023-01-075799, respectively).

1.2. Areas of activity

  • 1.2.1. For a description of the group's areas of activity and its holding structure, please see Section 1.2 in the chapter entitled Description of the Corporation's Business in the 2022 Periodic Report.
  • 1.2.2. The Company has various sources of income from the activities of its subsidiaries, as outlined in the sections dealing with the various operating segments. Set forth below is the pre-tax comprehensive income attributed to the shareholders in the reporting period; for further details, please see Note 3 to the Financial Report:

* In order to separate the financial results between profits attributed to insurance and profits arising from other core activities, the Company splits the "other" segment. The split is made for convenience purposes and the Company views the capital and unattributed segment as a single operating segment.

The Group is engaged in four core areas of activity: insurance, asset management, credit and distribution, which are divided into seven reporting segments in the financial statements (property and casualty insurance, health insurance, life insurance and savings, asset management - pension and provident, asset management - financial services, insurance agencies and credit). As of the report date, the Group has NIS 406 billion in assets under management. In the insurance business, the Company operates through The Phoenix Insurance Company Ltd; in the asset management business, the Company operates through The Phoenix Pension and Provident Ltd., The Phoenix Investment House Ltd.,1 and The Phoenix Advanced Investments Ltd.; in its credit business, the Company operates mainly through Gama Management and Clearing Ltd. a publicly-traded company, whose controlling shareholder is the Company.2 In its distribution activity through The Phoenix Agencies 1989 Ltd., and the agencies owned and held by The Phoenix Agencies.3

1.3. Developments in the Group in the reporting period and thereafter

1.3.1. Interest rates, the capital market and inflation

Changes in the risk-free interest rate curve and capital market affect The Phoenix Insurance's assets, liabilities, financial performance, and solvency ratio. The Company manages the interest risks of all of its assets and liabilities.

Interest rates - during the reporting period, the Bank of Israel increased its interest rate from 3.25% to 4.75%. Furthermore, in the reporting period, the shekel yield curve increased, and on the other hand the illiquidity premium decreased by 0.16%, which led to a decrease in the discount rate and a negative effect on the financial statements. Changes in the shekel interest rate curve affect both the Company's financial results and The Phoenix Insurance's solvency ratio; in accordance with the provisions for calculating the solvency ratio, the illiquidity premium is not used.

1 Formerly Excellence Investment House.

2 For information about the tender offer for the acquisition of the entire stake in Gama, see Section 1.3.9 below.

3 For further details regarding the res tructuring in The Phoenix Agencies, see Section 1.3.10 below.

The capital market - during the reporting period, there was volatility in financial markets in Israel and across the world. These changes affected both on the Company's financial results, and on The Phoenix Insurance's solvency ratio.

Inflation - during the reporting period, the inflation rate increased by 2.2%. The increase in inflation rates has an adverse effect both on the Company's financial results, and on The Phoenix Insurance's solvency ratio.

In the period subsequent to the reporting date through immediately prior to the financial statements publication date, financial markets in Israel and across the world continued to be volatile, the Bank of Israel did not raise the interest rate, and inflation continued to rise concurrently with expectations of a decrease in inflation in Israel and globally in 2023.

For more information regarding the effects of changes in the interest rate curve, the capital market and inflation rates on the Company's financial results, see Section 4.4.5 in the Description of the Corporation's Business chapter, and Note 41 to the financial statements for 2022. As to the effect of the changes in the shekel yield curve and in capital markets on The Phoenix Insurance's solvency ratio, see Section 2.1.5 below, and Section 8 in The Phoenix Insurance's Economic Solvency Ratio Report as of December 31, 2022.

For the purpose if using its financial results, the Company uses a real return of 3% (see Section 5.4.1); in view of that, the changes in the CPI, as stated above, affects the classification of amounts between underwriting profits and investment profits.

1.3.2. The legal reform

In recent months, there has been uncertainty regarding the government's plans to promote changes in the judicial system, and the growing public controversy surrounding this move. During January 2023, the government began promoting a plan to make fundamental changes in the legal system in Israel, which led to controversy and widespread public protests. In July 2023, protesters intensified their protest against the legislation of the Basic Law: The Judiciary (Amendment No. 3) - Abolishing the Standard of Reasonableness, which was passed by the Knesset on July 24, 2023. Against the backdrop of promoting the changes in the judiciary, in April 2023, Moody's - the international rating agency - published Israel's credit rating, leaving the rating unchanged at A1, and changing the credit rating outlook from "positive" to "stable" following its assessments regarding developments that will arise from the implementation of the changes. In May 2023, S&P - the international rating agency published Israel's credit rating. S&P reiterated Israel's AA- rating with a stable outlook, based on the assumption that agreement will be reached regarding the reform in the legal system.

In July 2023, immediately prior to the revocation of the standard of reasonableness, Moody's and S&P published special reports in response to the legislation of the law for the abolishment of the standard of reasonableness, which emphasized the risks and the concerns regarding potential adverse effects on the Israeli economy, which might arise from further unilateral legislation. However, no changes were made to the rating of the State of Israel and/or its rating outlook. In addition, credit rating agency Fitch reiterated Israel's credit rating at A+ and the rating outlook at "stable", but also issued a warning regarding further future developments.

At this stage the Company is unable to assess future developments, or the effect of those events on the Israeli economy in general and the Company's activity in particular.

The insurance activity

1.3.3.Completing the listing of restricted Tier 1 capital of The Phoenix Insurance

In August 2021, The Phoenix Insurance issued - through The Phoenix Capital Raising (2009) Ltd. (hereinafter - "The Phoenix Capital Raising") subordinated bonds to institutional entities and to the Company. The subordinated bonds were recognized by the Commissioner as an Additional Tier 1 capital instrument of The Phoenix Insurance, and listed by The Phoenix Capital Raising for trade on the TACT Institutionals trading platform operated by the TASE.

In April 2023, The Phoenix Capital Raising fulfilled the conditions for listing the subordinated bonds on the main list of the TASE, and at the beginning of May 2023 trading of the subordinated bonds on the main list started. In accordance with the provisions of the deed of trust, the interest in respect of the subordinated bonds was reduced by 0.2% from 2.29% to 2.09%.

As part of the listing on the main list, The Phoenix Insurance undertook to publish data in connection with its economic solvency ratio on a quarterly basis in respect of the quarter preceding the reporting date. For further details, please see Section 2.1.3 below.

For more information in connection with the issuance of the subordinated bonds and their listing on the main list, see the Company's immediate reports dated August 2, 2021, August 3, 2021 August 8, 2021, April 24, 2023 and May 3, 2023 (Ref. Nos.: 2021-01-060658, 2021-01-061159, 2021-01-062515, 2023-01-038554 and 2023- 01-040573, respectively).

1.3.4.Completion of a study regarding costs in connection with long-term health insurance coverage

As of the report date, the Company completed a study regarding costs in connection with long-term health insurance coverage (hereinafter - the "Study"). Following the Study, the Company recorded in its financial statements as of June 30, 2023, a NIS 59 million pre-tax profit; for more information, see Note 8(a)4 to the financial statements.

1.3.5. FNX Private

As from 2011, The Phoenix Insurance and The Phoenix Pension and Provident (hereinafter - the "Companies") operate - together with Saifa Management Services (2013) Ltd. (hereinafter - "Saifa") - the "FNX Private" venture (hereinafter - "FNX Private"), which is engaged in the development, adaptation, marketing and direct marketing (rather than through external insurance agents) of The Phoenix's selfdirected policies and provident funds (IRA). These are customized services and products with unique characteristics, which are mainly suitable to wealthy customers (hereinafter - the "Venture"). Each of the companies' share in the Venture is 50%. In the first quarter of 2023, the Companies and Saifa, entered into an agreement for the incorporation of the Venture as separate legal entities, such that the Companies will continue holding 50% of the joint Venture. In accordance with the Circular on Allocation of Non-Marketable Assets, The Phoenix Insurance carried out a valuation of FNX Private's activity in relation to The Phoenix's self-directed insurance products; the valuation was conducted by an independent external appraiser. In accordance with the valuation, The Phoenix Insurance recognized, during the first quarter of

2023, a pre-tax earning of NIS 113 million from revaluation of excess fair value of the illiquid assets against the LAT reserve in the health insurance segment.

In June 2023, the companies signed an agreement for assuming control over the partnerships of the FNX Private venture; as a result of assuming control over the said venture's partnerships, in the second quarter, the companies recorded a post-tax one-off profit of NIS 129 million; on the other hand, The Phoenix Insurance deducted the profit from revaluation of excess fair value of illiquid assets, which was recognized against the LAT reserve in the first quarter of the reporting period, as stated above.

The asset management activity

1.3.6. Acquisition of assets under management from Psagot Investment House

A. In January 2023, an agreement was signed between KSM Mutual Funds Ltd. (hereinafter - "KSM") and Psagot Mutual Funds Ltd. (hereinafter - "Psagot Funds"), according to which KSM will acquire from Psagot Funds, in an asset transaction, part of its mutual funds activity, with assets under management of NIS 17.1 billion in consideration for NIS 260 million (hereinafter, respectively the "Funds Agreement" and the "Sold Funds").

In July 2023, following discussions regarding the Transaction held with the Israel Competition Authority, the parties received the Israel Competition Authority's position regarding the parties' suggestion to enter into an alternative transaction that includes changes to the sold assets and the consideration compared to the Funds Agreement (hereinafter - the "Alternative Transaction"), whereby the Israel Competition Authority will not demand the filing of merger notices in respect of the Alternative Transaction, and therefore the Competition Commissioner (hereinafter - the "Commissioner") or the Israel Competition Authority will not take enforcement measures in respect of its execution. The total assets under management that will be acquired in the Alternative Transaction shall stand at NIS 11.1 billion, in consideration for NIS 200 million, instead of the total assets under management and consideration under the Funds Agreement. For further information in connection with an agreed order pursuant to Section 50B to the Economic Competition Law, 1998, see immediate report of July 13, 2023 (Ref. No.: 2023-01-066511).

As of the report publication date, the parties completed the alternative transaction.For further details, please see the immediate report dated July 13, 2023 (Ref. No.: 2023-01-066511).

B. Furthermore, The Phoenix Investment House and Psagot Securities Ltd. (hereinafter - "Psagot Securities") signed an agreement, which is independent and unconditional of and separate from the Funds Agreement; under the said agreement, The Phoenix Investment House will acquire the entire portfolio management activity of Psagot Securities, comprising assets under management of approx. NIS 8.1 billion (hereinafter - the "Portfolio Agreement"), in consideration for NIS 50 million. As of the report publication date, the entire consideration in respect of the Portfolio Agreement was paid, and all economic rights and liabilities in respect of the activity were transferred to The Phoenix Investment House. The parties applied to the Israel Competition Authority for its approval of the transaction and filed a motion with the court in accordance with Section 350 to the Companies Law, 1999.

In June 2023, the parties agreed an amendment to the Portfolio Agreement whereby the Court's approval in accordance with Section 350 to the Companies Law, 1999, is not a condition precedent to the completion of the transaction. In view of the above, the Company announces that the conditions precedent set in the Portfolio Agreement were fulfilled and the transaction was completed. The actual transfer of the holding in the assets and liabilities sold under the Portfolio Agreement shall be carried out on the Court's approval date or on the date on which the holding thereof shall be transferred to The Phoenix Investment House by way of independent transfer of the portfolio management customers in accordance with the law.

The consideration in respect of the agreements was funded through a loan advanced by the Company to The Phoenix Investment House, further to the expansion of the Series 6 Bonds, that was carried out in January 2023, and the remaining amount will be funded through a loan KSM will take from a financial institution.

For further details regarding the above, please see immediate reports dated January 19, 2023 and July 2, 2023 (Ref. Nos.: 2023-01-009285 and 2023-01- 061972).

1.3.7. The Phoenix Pension and Provident Fund

A. Closing down of the retail unit

In May 2023, The Phoenix Insurance closed the activity of the retail unit, which employs 120 employees. This move is part of the promotion of the Company's strategy to cut costs on the one hand, and enhance and develop it distribution channels on the other hand.

B. Loan and credit facility guaranteed by the Company

As part of a strategy for efficient and effective management of the capital at the Group level, in June of 2023 The Phoenix Pension and Provident approved a NIS 330 million loan and a NIS 150 million credit facility from a financial institution in order to refinance an internal debt of The Phoenix Pension and Provident to The Phoenix Insurance and to the Company; the debt arises from the rapid growth in the activity of The Phoenix Pension and Provident. To secure the repayment of the loan and credit facility, the Company provided a guarantee to the financial institution.

1.3.8. The discontinuance of the operations of The Phoenix Value P2P Limited Partnership (formerly - Halman-Aldubi I2P1 Limited Partnership).

In July 2023, The Phoenix Value P2P Limited Partnership (hereinafter - the "Partnership") - a publicly-traded limited partnership, whose general partner is The Phoenix Value P2P General Partner Ltd. - which merged into The Phoenix as part of its merger with Halman Aldubi Investment House Ltd., in which the Company has an indirect stake of 47.5% (hereinafter - the "General Partner"), announced that the General Partner's Board of Directors decided that it is in the best interest of all holders of participation units in the Partnership (hereinafter - the "Investors") to take action to discontinue the Partnership's operations in accordance with the provisions of the partnership agreement, such that the Partnership will stop executing investments in

the form of acquisition of new loans, and other the other hand will take steps to distribute to investors the funds that will be received in respect of the existing loans included in the Partnership's portfolio of assets; the Partnership reported that during the said period no success fees will be collected, and the amount of management fees that will be collected will not exceed the actual amount of expenses incurred by the General Partner. The Partnership's decision was made in view of the macro-economic conditions, their worsening and their impact on the Partnership's activity. The General Partner's decision to discontinue the Partnership's operations in accordance with the provisions of the partnership agreement was made based on the assessment that in the foreseeable period there will be no substantial changes in the macroeconomic conditions in the capital and interest markets across the world, and therefore the Partnership will find it difficult in the future to meet the return targets it has set; this, among other things, taking into account the scope of the cumulative redemption requests received by the Partnership, as well as in view of the continued uncertainty regarding the ability to raise additional funds for the Partnership in order to make new investments.

Accordingly, as from the date on which the decision was made, no new transactions will be executed by the General Partner in connection with the Partnership's portfolio of assets, no further funds will be raised for investment in the Partnership, and the Partnership's assets will be used by the General Partner to make payments in an equitable manner. After the completion of the above process, the Partnership will be wound-up, and accordingly it will stop being a reporting corporation.

Credit activity

1.3.9. Full tender offer in respect of Gama shares

In August 2023, The Phoenix Investments and Finances Ltd., a wholly-owned subsidiary of the Company (hereinafter - "The Phoenix Investments") published a full tender offer (whose validity is conditional upon the acquisition of all of the offerees' shares) to acquire all shares of Gama Management and Clearing Ltd. (hereinafter - "Gama").

As of the report's publication date, The Phoenix Investments holds 76.87% of Gama's shares. If the full tender offer will come to fruition, the consideration which The Phoenix Investments is expected to pay will amount to NIS 221 million. It should be clarified that it is uncertain whether the tender offer will, indeed, be completed successfully. For further details, please see the immediate report dated August 10, 2023 (Ref. No. 2023-01-074644).

The distribution activity

1.3.10.Restructuring - The Phoenix Agencies

A. In December 2022, the competent organs of The Phoenix Agencies and Agam Leaderim Holdings (2001) Ltd. (hereinafter - "Agam Holdings"), a company in which The Phoenix Agencies has a 60% stake, approved a merger offer between the two aforesaid companies, in accordance with a merger agreement under which Agam Holdings will be wound up and merged with and into The Phoenix Agencies in consideration for allotment of ordinary shares of The Phoenix Agencies that will be issued to the other shareholders of Agam Holdings, such that after the execution of the merger the Company will hold 80% of the shares of The Phoenix Agencies, and the other shareholders will hold the remaining shares. The merger was completed in June 2023. For more information, see the immediate reports

dated June 11, 2023, and June 28, 2023 (Ref. Nos.: 2023-01-054346 and 2023- 01-060460).

  • B. Furthermore, in May 2023, the Company and the other shareholders of Agam Holdings signed an agreement whereby, subject to the provisions of any law, immediately after the completion of the merger, The Phoenix Agencies shall distribute a dividend at an amount equal to the distributable profits for tax purposes, in accordance with The Phoenix Agencies' financial statements as of March 31, 2023; such profits are estimated at NIS 675 million (hereinafter - the "Dividend Distribution"), of which, as of the publication date of the financial statements, NIS 250 million was paid. In addition, it was decided that if The Phoenix Agencies will require shareholder loans in order to execute the Dividend Distribution, the Company and the other shareholders shall advance shareholder loans at a total maximum amount of up to NIS 500 million, based on their proportionate share in The Phoenix Agencies' issued share capital.
  • C. As part of the Company's strategy to unlock value in the activities of the Group's subsidiaries, the Company entered into an agreement with an international investment bank in order to assess the introduction of an international strategic investor as a partner in The Phoenix Agencies. As of the report publication date, the Company is negotiating with several global entities that have expressed their interest in investing in The Phoenix Agencies. At this stage, there is no certainty that the said transaction will come to fruition.

1.3.11.Dividend distribution

Distribution from The Phoenix Insurance to the Company

In August 2023, concurrently with the approval of The Phoenix Insurance's Financial Statements as of June 30, 2023, The Phoenix Insurance's Board of Directors decided to distribute a NIS 350 million dividend, at a rate higher than that set in the distribution policy, without detracting from its long-term dividend policy, and given the amount of the distributable profits and the solvency ratio rate of The Phoenix Insurance, and after compliance with the solvency ratio targets and the distribution tests as per the Companies Law.

Furthermore, the Board of Directors of The Phoenix Insurance also passed a decision as to a change in the minimum solvency ratio target, net of the transitional provisions, for purposes of dividend distribution from a 111% rate to a 115% rate.

Distribution of dividend by the Company to its shareholders

In August 2023, concurrently with the approval of the Company's Financial Statements as of June 30, 2023, which are included in this report, the Company's Board of Directors decided to distribute a dividend in accordance with the Company's dividend distribution policy, which was revised in March 2022,10 totaling NIS 120 million and NIS 0.5 per share. It shall be clarified that to the extent that options are exercised by employees between the dividend declaration date and the record date, the per-share dividend amount shall be adjusted in accordance with the actual number of outstanding shares on the record date. The Company shall publish, as required, a supplementary report in respect of said adjustment on the record date.

The said distribution is based, among other things, on a dividend distribution from subsidiaries, including from The Phoenix Insurance, as detailed above.

10 Please see the immediate report dated March 29, 2022 (Ref. No. 2022 -01-037000).

1.3.12.Award of options to employees and officers

In December 2018, the Company adopted an option plan for employees and officers. Pursuant to the option plan, the Company grants, from time to time and without consideration, option warrants (hereinafter - "Options") to employees and officers of the Company and companies under its control.

In June 2023 and August 2023, the Company's Board of Directors approved the award of up to 3,211,588 options to employees and officers of the Company and its subsidiaries, exercisable into ordinary shares of the Company NIS 1.00 par value each, subject to adjustments, without cash consideration. In accordance with the Board of Directors' decision, out of the amount of 3,211,588 options allotted to offerees a total of 57,190 options were allotted to the Company's CEO. The award of options to the Company's CEO was approved in an extraordinary general meeting of the Company on August 2, 2023 (hereinafter - the "Meeting").

As part of the Meeting, the shareholders also approved the allocation of 78,771 (illiquid) options of The Phoenix Investment House Ltd. to the Company's CEO and 63,321 (illiquid) options to the Chairman of the Company's Board of Directors11 in respect of their service as directors in The Phoenix Investment House Ltd. In the Compensation Committee and Board of Directors' reasons for the award of the options to the CEO and the Chairman of the Board of Directors, it is noted, among other things, that the Compensation Committee and Board of Directors believe that the award of the options, which are exercisable into The Phoenix Investment House's shares, and whose vesting depends on the latter's performances, plays an important role in the strengthening of the link between the Company's CEO and Chairman of the Board of Directors in their capacity as directors in The Phoenix Investment House, and the performances of the latter, and constitutes a proper incentive for their continued work and the fulfillment of their role in the future to achieve the objectives, targets and business and strategic plans of The Phoenix Investment House (and consequently also those of the Company). The Board of Directors of The Phoenix Investment House also approved the award of options to other officers and employees of The Phoenix group, which influence and contribute to the activity of The Phoenix Investment House. For further details, please see the immediate reports dated June 28, 2023, July 26, 2023 and August 2, 2023 (Ref. Nos.: 2023-01-060307, 2023-01-060334, 2023-01-072205513 and 2023-01-088974, respectively).

1.3.13.The Company's preparation for the application of IFRS 17

The Company continues to prepare for applying IFRS 17, in the Financial Statements of the Company and The Phoenix Insurance. During the second quarter, the Capital Markets Authority published a revised roadmap - third revision (hereinafter - the "Revised Roadmap"). Among other things, the Revised Roadmap postponed the firsttime application to January 1 2025. Furthermore, the Revised Roadmap included a requirement for the Company to conduct several quantitative impact studies (hereinafter - "QIS"). Subsequent to the reporting date, the Company completed the first QIS regarding the calculation of the opening balances of selected portfolios on the transition date as of January 1, 2023.

For further details, please see Note 2(FF) to the 2022 Periodic Report. Regarding the deferral of the standard's application date, see Section 2.2.2 below.

11 The award of the options to the Chairman of the Company's Board of Directors as part of the Meeting was subjec t to the approval of an amendment to the Compensation Policy, which was also presented for the Meeting 's approval.

1.3.14.ESG

In July 2023, the Company published an ESG report for 2022. The report was published on the Company's website and on the websites of the TASE and the Israel Securities Authority. To view the full report, as published on the Company's website, see the Company's website at:

https://www.fnx.co.il/sites/docs/genery/for_new_site/esg/ESG_BOOK_2022_HEB_ Digital_new.pdf

1.3.15.Buyback of Bonds Series 6

In July 2023, the Company executed a buyback of NIS 124 million in bonds (Series 6). The Company's Board of Directors decided to execute the transaction due to its positive effect on the Company's capital structure and liquidity, and due to the fact that the buyback price reflects a bargain purchase. For further details, please see the immediate report dated July 2, 2023 (Ref. No.: 2023-01-061600).

1.3.16.Ratings

Maalot

On July 11, 2023, S&P Maalot announced the upgrading of the Company's rating from ilAA- to ilAA with a stable outlook, and the rating of The Phoenix Insurance Company from ilAA+ to ilAAA with a stable outlook.

Midroog

On August 23, 2023, Midroog announced it is reiterating the rating of The Phoenix Insurance at Aa1.il, and upgrading the outlook from stable to positive. Accordingly, the rating outlook of the subordinated bonds that were issued by The Phoenix Capital Raising (2009) Ltd. were upgraded from stable to positive.

Moody's - Global rating for The Phoenix Insurance

On May 23, 2023 Moody's - the international rating agency - announced the assignment of an A2 international credit rating with a stable outlook to The Phoenix Insurance.

2. Description of the Business Environment

2.1. Implementation of the Economic Solvency Regime provisions applicable to The Phoenix Insurance Company Ltd.

2.1.1. Provisions regarding the implementation of the Economic Solvency Regime The Phoenix Insurance is subject to the Solvency II-based Economic Solvency Regime in accordance with the provisions of Circular 2020-1-15 of the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner") - "Amendment to the Consolidated Circular concerning Implementation of a Solvency II-Based Economic Solvency Regime for Insurance Companies" (hereinafter - the "Economic Solvency Regime"), which was published on October 14, 2020. The Economic Solvency Regime is a regulatory directive that regulates capital requirements and risk management processes among insurance companies. The Economic Solvency Regime sets a standard model for calculating eligible capital and the regulatory solvency capital requirement, with the aim of bringing insurance companies to hold buffers to absorb losses arising from the materialization of unexpected risks to which they are exposed. The solvency ratio is the ratio between an insurance company's economic shareholders' equity recognized for solvency purposes and the required capital.

2.1.2. Increasing economic capital according to the transitional provisions

The Phoenix Insurance opted for the alternative provided by the Economic Solvency Regime regarding the transitional provisions, whereby the economic capital may be increased by gradually deducting from the insurance reserves until 2032 (hereinafter - the "Deduction during the Transitional Period"). The Deduction During the Transitional Period as of December 31, 2022, amounts to NIS 3,385 million after its linear amortization as at this date (compared with NIS 4,710 million as of December 31, 2021). This amount matches the expected increase rate in The Phoenix Insurance's capital surplus during the Transitional Period, and reflects, at the very least, the expected expiry of the solvency capital requirements (SCR) and the risk margin of the existing portfolio as of the calculation date. For more information, see Section 2A(2) to The Phoenix Insurance's Economic Solvency Ratio Report as of December 31, 2022.

2.1.3. Publication of Economic Solvency Ratio Report

The Economic Solvency Ratio Report as of December 31, 2022 was published at the same time as the Financial Statements as of the first quarter, on May 31, 2023 and was prepared and presented in accordance with the provisions of Chapter 1, Part 4, Section 5 of the Consolidated Circular, according to Circular 2020-1-17 (hereinafter the "Disclosure Provisions"). In accordance with the Consolidated Circular, the economic solvency ratio report in respect of the December 31 and June 30 data of each year shall be included in the first periodic report published after the calculation date.

Furthermore, in view of the listing of additional Tier 1 capital on the main list, and in accordance with The Phoenix Insurance's undertakings under the deed of trust, as from 2023 the Company will publish to the public an estimated quarterly solvency ratio as of March 31 and September 30, as part of the periodic report published following the calculation date. The calculation of the estimated quarterly solvency ratio is not audited or reviewed by the independent auditor, and the controls conducted by The Phoenix Insurance for the purpose of publishing the estimated ratio are less in scope compared to those executed for the purpose of publishing the

solvency ratio report, which is published in accordance with the Commissioner's directives.

2.1.4. Economic solvency ratio and minimum capital requirement (MCR) as of December 31, 2022:

Set forth below are details regarding the economic solvency ratio as published in the latest economic solvency ratio report published by The Phoenix Insurance. The meaning of the terms in this section is the same as in Appendix B to Chapter 2 in Part 2 of Section 5 of the Consolidated Circular - "Economic Solvency Regime".

Economic solvency ratio:

As of December 31
2022 2021
Audited*
NIS thousand
Shareholders equity in respect of SCR 14,711,664 14,212,110
Solvency capital requirement (SCR) 6,968,263 7,666,458
Surplus 7,773,401 6,545,652
Economic solvency ratio (in %) 211% 185%
Effect of material capital-related measures taken in the period
between the calculation date and the publication date of the
solvency ratio report:
Raising (redemption) of equity instruments** (410) 346,133
Shareholders equity in respect of SCR 14,711,254 14,558,243
Surplus 7,742,991 6,891,784
Economic solvency ratio (in %) 211% 190%
  • * The term "audited" refers to an independent audit held in accordance International Standard on Assurance Engagement (ISAE) 3400 – "The Examination of Prospective Financial Information".
  • ** Subsequent to December 31, 2022, NIS 411 million in Series F bonds were redeemed (immediate report dated January 15, 2023, Ref. No.: 2023-01-006268). The redemption referred to above does not have a material effect on the solvency ratio results as of December 31, 2022 in view of the unrecognized Tier 2 capital balances due to the quantitative limit on recognizing Tier 2 capital.

For details regarding the economic solvency ratio without applying the transitional provisions for the Transitional Period, and without adjusting the stock scenario, and regarding the target economic solvency ratio and restrictions applicable to the Company in connection with dividend distribution, see below.

For explanations about key changes in the capital surplus and in the economic solvency ratio as of December 31, 2022 compared with December 31, 2021, see Section 1(a) to The Phoenix Insurance's economic solvency ratio report as of December 31, 2022.

Below is a link to the Economic Solvency Ratio Report on The Phoenix Insurance's website.

https://www.fnx.co.il/investors-relations-hebrew/kosherpiraon/

Minimum capital requirement (MCR)

As of December 31
2022 2021
Audited
NIS thousand
Minimum capital requirement (MCR) 1,843,583 1,916,615
Shareholders equity for MCR 11,596,249 11,024,131

A. Limitations on dividend distribution and solvency ratio without the implementation of the transitional provisions

Dividend

According to the letter published by the Commissioner, in October 2017, (hereinafter - the "Dividend Distribution Letter") an insurance company shall be entitled to distribute a dividend only if, following the distribution, the company has a solvency ratio - according to the provisions of the Economic Solvency Regime - of at least 100%, calculated without taking into account the transitional provisions and subject to the solvency ratio target set by the Company's Board of Directors. The aforesaid ratio shall be calculated without the relief granted in respect of the original difference attributed to the acquisition of the provident funds and management companies. In addition, the letter set out provisions for reporting to the Commissioner.

The Phoenix Insurance's policy is to have a solid capital base to ensure its solvency and ability to meet its liabilities to policyholders, to preserve The Phoenix Insurance's ability to continue its business activity such that it is able to provide returns to its shareholders. The Phoenix Insurance is subject to capital requirements set by the Commissioner.

The Phoenix Insurance's Board of Directors has set a minimum economic solvency ratio target and target range based on Solvency II. The economic solvency ratio target range, within which The Phoenix Insurance seeks to be during and at the end of the Transitional Period, taking into account the Deduction during the Transitional Period and its gradual reduction is 150%-170%.

The minimum economic solvency ratio target, taking into account the transitional provisions, was set at 135%, and the minimum solvency ratio target without taking into account the provisions during the Transitional Period is set to reach 135% at the end of the Transitional Period according to the Company's capital plan. On August 23, 2023, the Board of Directors of The Phoenix Insurance increased the minimum economic solvency ratio target by 4 percentage points without taking into account the provisions during the Transitional Period - from a rate of 111% to a rate of 115%, beginning on June 30, 2023.

Therefore, based on the audited results as of December 31, 2022, and on the estimated solvency ratio as of March 31, 2023, which is not audited or reviewed, The Phoenix Insurance meets the minimum capital targets set by the Board of Directors. It is hereby clarified that the aforesaid does not guarantee that The Phoenix Insurance will meet the set capital targets at all times.

B. Solvency ratio without applying the transitional provisions for the Transitional Period, and without adjusting the shares scenario:

The following are data as published in the latest economic solvency ratio report published by The Phoenix Insurance, about the economic solvency ratio calculated without taking into account the transitional provisions and the solvency ratio target set by The Phoenix Insurance's Board of Directors, as required in the letter referred to above. As of December 31, 2022 and December 31, 2021, this ratio is higher than the target set by the Board of Directors.

As of December 31
2022 2021
Audited
NIS thousand
Shareholders equity in respect of SCR 12,301,691 11,112,151
Solvency capital requirement (SCR) 8,254,667 9,818,889
Surplus 4,047,024 1,293,262
Economic solvency ratio (in %) 149% 113%
Effect of material capital-related measures taken in
the period between the calculation date and the
publication date of the solvency ratio report:
Raising of capital instruments* - 354,205
Shareholders equity in respect of SCR 12,301,691 11,466,356
Surplus 4,047,024 1,647,467
Economic solvency ratio (in %) 149% 117%
Capital surplus after capital-related actions
in relation to the Board of Directors' target:
Minimum solvency ratio target without applying the Transitional
Provisions
111% 108%
Excess capital over target 3,139,011 861,956

* Subsequent to December 31, 2022, The Phoenix Insurance redeemed NIS 411 million in Series F bonds (immediate report dated January 15, 2023, Ref. No.: 2023-01-006268); the said redemption does not affect the solvency ratio without applying the transitional provisions to the transitional period, and without adjusting the stock scenario as of December 31, 2022, in view of the unrecognized Tier 2 capital balances due to the quantitative limit on the recognition of Tier 2 capital.

2.1.5. Estimation of solvency ratio as of March 31, 2023:

In accordance with the undertakings of The Phoenix Capital Raising (2009) Ltd. under the provisions of the deed of trust for Series L Subordinated Bonds which are part of Additional Tier 1 capital, and which it published on April 24, 2023, the Company made an estimate of its economic solvency ratio as of March 31, 2023 (hereinafter - the "Estimate"); the Estimate is not audited or reviewed by the independent auditor. The calculation (of the Estimate) was carried out in accordance with the guidelines of the Solvency II-based Economic Solvency Regime, and in accordance with the provisions of Circular 2020-1-15 of the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner") - "Amendment to the Consolidated Circular concerning Implementation of a Solvency II-Based Economic Solvency Regime for Insurance Companies" (hereinafter - the

"Provisions of the Economic Solvency Regime"), which was published on October 14, 2020. The Company carries out the Estimate and publishes this quarterly disclosure in addition to the publication of a mandatory solvency ratio reports as required under the Provisions of the Economic Solvency Regime. It should be noted that the scope of the controls executed by the Company for the purpose of publishing the Estimate is reduced compared to those executed for the purpose of publishing the economic solvency ratio report, which is published in accordance with the Commissioner's guidance.

In accordance with the Estimate, the Company's economic solvency ratio as of March 31, 2023, is 208% (with the implementation of the transitional provisions to the transitional period and adjustment of a stock scenario, and after the dividend distribution as outlined in Section 2.1.6 below.

The said Estimate of the solvency ratio as of March 31, 2023, does not include the changes and effects that took place since March 31, 2023, and through the publication date of this report, including the effect of the business activity of The Phoenix Insurance, changes in the mix and amounts of insurance investments and liabilities, exogenous effects, inter alia changes in the risk-free interest rate curve, and regulatory changes affecting the business environment.

The assessment is based, among other things, on forecasts and estimates of future events, the materialization of which is uncertain and is not under the Company's control, and which should be considered as "forward-looking information" as the term is defined in Section 32A to the Securities Law, 1968.

2.1.6. Capital-related measures and significant updates in 2023:

    1. On March 22, 2023, The Phoenix Insurance's Board of Directors approved a cash dividend distribution in the amount of NIS 205 million out of 2022's profits. This distribution was taken into account in the results of the solvency ratio as of December 31, 2022.
    1. Subsequent to the calculation date s of December 31, 2022, The Phoenix Insurance redeemed NIS 411 million in Series F bonds; this redemption did not have a material effect on the solvency ratio as of December 31, 2022, as stated above.
    1. On August 23, 2023, The Phoenix Insurance's Board of Directors approved a cash dividend distribution in the amount of NIS 350 million. This distribution was taken into account in the results of the solvency ratio estimate as of March 31, 2023 (for further details, see Section 1.3.11 above).

2.1.7. Sensitivity to changes in the interest curves:

Changes in the linked shekel risk-free yield curve affect the Company's economic solvency ratio, especially in the mid- to long-terms, affect The Phoenix Insurance's economic solvency ratio. During 2023, there was a substantial increase in the riskfree linked interest rate curve, has had a positive effect on The Phoenix Insurance's solvency ratio.

Range/years December 31, 2022 June 30, 2023 August 17, 2023
Short term 1-3 Between 0.68% and
0.86%
Between 1.86% and
1.20%
Between 1.91% and
1.31%
Mid-term 4-10 Between 0.88% and
0.86%
Between 1.12% and
1.03%
Between 1.27% and
1.31%
Mid-long term 11-15 Between 0.88% and
0.97%
Between 1.03% and
1.06%
Between 1.30% and
1.29%
Long term 16-25 Between 1.00% and
1.10%
Between 1.07% and
1.19%
Between 1.29% and
1.33%

The following table summarizes the positive (negative) risk-free linked interest ("spot") rates:4

The Phoenix Insurance estimated the sensitivity of the economic solvency ratio at a 50 bps decrease in the risk-free interest, after applying the transitional provisions, and including adjusting the stock scenario; the estimation was carried out based on the data and results of the calculation of the economic solvency ratio as of December 31, 2022. The estimation resulted in a 18% decrease in the economic solvency ratio (after applying the transitional provisions and adjusting the stock scenario).

It should be noted that the sensitivity is not necessarily linear; i.e., sensitivity at other rates is not necessarily a simple extrapolation of the sensitivity test presented. For the results of the sensitivity tests of the economic solvency ratio to various risk factors, see Section 8 to The Phoenix Insurance's Economic Solvency Ratio Report as of December 31, 2022.

2.2. Arrangements in force

Set forth below are material regulatory directives published during the reporting period and thereafter, and which are not included in the Report on the Corporation's Business for 2022 and the Report of the Board of Directors for the first quarter of 2023. For further details regarding material regulatory directives published during the reporting period, please see Section 4.1.1 to the 2022 Report on the Corporation's Business and Section 2.2 to the Report of the Board of Directors for the first quarter of 2023.

2.2.1. In June 2023, the Economic Plan Law (Legislative Amendments for Implementing Economic Policies for the Budget Years 2023 and 2024), 2023 (hereinafter - the "Economic Arrangements Law") was published; it included provisions on the following:

Insurance and pension saving brokering

The amendment prescribes that an institutional entity will not "unreasonably refuse" to engage with a pension advisor in an agreement for the execution of a transaction for a customer, and will not terminate an engagement in such an agreement with a pension advisor under the circumstances listed in the definition of "unreasonable refusal".

Health

The objective of the Amendment is to reduce the incidence of overlapping insurance in the surgical procedures subsegment between Supplementary Healthcare Services (hereinafter - the "SHABAN Plans") of health maintenance organizations and private health insurance policies; the aim is to reach a situation where most of private surgical procedures in Israel will be conducted by the health management organizations as

4 The risk-free linked interest rate curves were taken from Fair Spread Ltd. To calculate the solvency ratio, the Company takes into account other components in addition to the risk-free interest rate.

part of the SHABAN Plans. In effect, the Amendment implements the recommendations of the public committee for strengthening healthcare services in Israel and regulating the public and private health system (hereinafter - the "Ash Committee"), which were published in November 2022. According to the Amendment, where a policyholder has an health insurance policy that includes insurance coverage that is not dependent on the exercise of the policyholder's rights under the SHABAN Plan, and such policyholder filed a claim to cover a private surgical procedure in Israel under his/her rights by virtue of the SHABAN Plan, and this surgical procedure is covered by the policyholder's insurance policy, the insurer shall pay the health maintenance organization through which the surgical procedure was carried out a total equal to the price of the surgical procedure paid by the health maintenance organization as per the Ministry of Health's price list, or an amount equal to the price of the insurance arrangement as paid by the insurer - the lower of the two. It was also established that on the next renewal date of a first shekel individual surgical procedure policy that was taken out before the amendment came into force (hereinafter - the "Original Policy"), the insurer will be required to add the policyholders of the said policy, who also have SHABAN Plans in place, to a surgical procedures policy of the SHABAN Plan instead of the original policy. This will be the case unless the policyholders informed the insurer that he/she do not wish to be transferred to a SHABAN Plan, all in accordance with the provisions listed in the Amendment to the Law.

  • 2.2.2. Further to the Roadmap for the Adoption of International Financial Reporting Standard (IFRS) 17 - Insurance Contracts, that was published by the Capital Market, Insurance and Savings Authority in June 2020, and which lists the steps that will be required and the time tables to ensure Israeli insurance companies' preparedness for the application of IFRS 17 - Insurance Contracts (whose application date was postponed in April 2022 to January 1, 2024), a third draft revision to the Roadmap was published in June 2023, which postpones the standard's application date in Israel to January 1, 2025; accordingly, the milestones for the application of the standard were revised.
  • 2.2.3. Further to the health insurance reform, which was published in March 2022, amendments to the health insurance reform were published in June 2023, which postpone the reform's effective date from May 1, 2023 to December 15, 2023, due to the parallel reform regarding overlapping insurance, which was promoted as part of the Economic Arrangements Law (as detailed in this section above).
  • 2.2.4. The Circular regarding Directives to Financial Information which are Institutional Entities was published in June 2023. This circular sets the rules for institutional entities which are sources of information regarding obtaining access to financial information in accordance with the Financial Information Service Law, 2021 (the "Open Banking Reform"). The law requires from various financial institutions that hold information about customers (banks, credit companies, institutional entities) (hereinafter - the "Sources of Information") to allow entities holding the required license ("Financial Information Service Providers") to obtain, at the consent of the customer, online access to financial information about the customer. Based on this information, the Financial Information Service Providers will be able to offer services to the customer through an online system (such as: concentrating all the information in one place for the customer, comparing costs between different financial institutions, brokering, receiving offers for the customers, pension advice, etc.). It should be noted that in relation to institutional entities it was decided that they are only required to

give a service provider access to "financial information about credit"; it was also decided that the law will not apply to the transfer of financial information to the pension clearing system. The circular sets provisions that regulate the activities of institutional entities, which are "sources of information" in accordance with the law.

  • 2.2.5. In July 2023, the Income Tax Regulations (Rules for Approval and Management of Provident Funds) (Amendment), 2023, and Supervision of Financial Services Regulations (Provident Funds) (Transfer of Funds between Provident Funds) (Amendment No), 2023 were published in accordance with the government's resolution of February 24, 2023 dealing with "Increasing the Competition in the Insurance and Savings Brokering Industry", which was included in the economic plan for 2023-2024. According to the Amendment to the Income Tax Regulations, the contribution into an insurance fund will be capped to that portion of the wage that exceeds double the average wage in Israel, such that the portion up to double the average wage in Israel will be deposited with an annuity provident fund which is not an insurance fund. Furthermore, as a complementary step, the Transfer Regulations, were amended such that the transfer of funds to an insurance fund will be limited to that portion of the wage that exceeds double the average wage in Israel.
  • 2.2.6. In July 2023, the Insurance Contract Law (Amendment No. 12), 2023 was published. The amendment deals with a change of irrevocable beneficiary in a life insurance policy as part of a housing loan, in order to remove barriers from the process of transferring a housing loan from one lender to another ("mortgage recycling"). The amendment prescribes that where an institutional lender serves as an irrevocable beneficiary in a life insurance policy as part of a housing loan (hereinafter - the "First Beneficiary"), and the policyholder wishes to transfer beneficiaries between institutional lenders under the same insurance contract, the policyholder should be allowed to do so even without obtaining the consent of the First Beneficiary, and the change in beneficiaries will come into effect on the repayment date of the housing loan advanced by the First Beneficiary.
  • 2.2.7. The Manner of Presentation of Annual Expected Cost to Planholders or Policyholders Circular was published in July 2023. The Supervision of Financial Services Regulations (Provident Funds) (Direct Expenses Incurred as a Result of Execution of Transactions) (Amendment), 2022 stipulate that when planholders join a provident fund, as part of the periodic reports sent to savers and wherever it is required by law to present the management fees, the planholder or policyholder shall also be presented with the expected annual costs comprising the management fees and direct expenses, under the terms and in the manner prescribed by the Commissioner. Accordingly, the circular prescribes provisions that regulate the manner by which institutional entities should present to existing and new customers the expected annual cost in a uniform manner. The circular sets a fixed formula that is supposed to allow calculating the total expected cost, in a manner that will ensure uniformity between institutional entities, and as a result, according to the explanatory notes, the savers will be easily able to compare the rates of total expected costs of the investment alternative he/she assesses. It was also prescribes that the circular shall not apply to insurance policies with a saving component, which were marketed before 2004, or to old funds.

2.3. Draft laws, regulations and bills

Following are drafts of material regulatory provisions published during the reporting period and thereafter, which are not included in the 2022 Report on the Corporation's Business or in the Report of the Board of Directors for the first quarter of 2023. For further details regarding additional drafts of material regulatory provisions published during the reporting period, please see Section 4.1 to the 2022 Report on the Corporation's Business as well as Section 2.3 of the Report of the Board of Directors for the first quarter of 2023.

  • 2.3.1. In June 2023, the Commissioner published a Draft Decision in Principle on the Offsetting of Amounts Against Insurance Benefits in Motor (Property) Insurance in respect of a Difference in Spare Parts Prices Where the Vehicle was Repaired in a Garage which is not Included in an Arrangement. The draft decision deals with a practice implemented by insurance companies regarding motor property insurance policies, as part of which the insurance companies deduct some of the insurance benefits based on the difference between the price list of the spare parts' importer quoted by the appraiser in its appraisal, and the amount the insurance company would have paid for those parts had they been purchased from spare parts suppliers, with whom the insurance company entered into engagement. The draft suggests to set the following provisions: (1) An insurance company that operates in the said manner should display to the policyholder, in a prominent way, the way he/she is expected to conduct himself/herself upon the occurrence of an insured event, both at the stage of the insurance offer, and when the policyholder reports a claim; (2) regarding an existing policy, the insurance company may inform the policyholder if it did not do so when he/she purchased the insurance, so long as an insured event has not taken place, as stated in the draft; (3) an insurance company will not offset or deduct any amount from the insurance benefits in respect of the cost of spare parts without disclosing such deduction or offsetting to the policyholder; (4) an insurance company that deducted from the insurance benefits payable to the policyholder through the date on which this decision was made, is required to assess whether the deduction was made after the policyholder was informed in the manner set in this decision. If the insurance company made such an offset of insurance benefits without disclosing such offsetting to the policyholder, the insurance company will check whether the amount of insurance benefits it paid was lower than the repair amount paid by the policyholder, and any difference should be refunded to the policyholder. Should the Company be required to refund amounts following this draft (if it becomes a binding circular), it will not have a material effect on the Company.
  • 2.3.2. A Draft Amendment to the Consolidated Circular - Appendix 6.2.1 to Title 6, Part 2, Variables and Categories in Compulsory Motor Insurance was published in June 2023. The Capital Markets Authority has the power to set the variables, according to which insurance premiums in the compulsory motor insurance subsegment will be calculated, subject to the approval of a joint committee of the Knesset's Constitution, Law and Justice Committee and the Knesset's Finance Committee. According to the draft, based on the recommendations of the operator of the statistical database that operates in the segment, and is charged with the risk assessment, the Capital Markets Authority intends to request the joint committee's approval for the adding the following variables to the list of variables one will be allowed to use in order to determine the insurance premiums in the segment: distance traveled, driving course for motorcyclists, autonomous breaking system, and a support system assisting to keep the vehicle in the traveled lane.

  • 2.3.3. In July 2023, Draft Circular - Revision of the Consolidated Circular - The Independent Auditor Chapter was published. The draft suggests to implement in the Consolidated Circular various provisions of the Commissioner that formed a part of previous circulars, and to revise references to the various chapters of the Consolidated Circular following changes that were made therein. The revision of the Independent Auditor Chapter includes, among other things, the following issues: (1) Compromising the independent auditor's independence due to the provision of a related service; (2) the independent auditor's role in connection with Economic Solvency Ratio Reports; (3) revisions to the provisions regarding the issuance of a detailed annual report about annual financial statements; (4) revision to provisions regarding the independent assessment of the pension liabilities of a pension fund.
  • 2.3.4. A Draft Amendment to the Consolidated Circular Title 6, Part 3, Chapter 2 The Requirement to Offer Supplementary Healthcare Coverage was published in July 2023. The draft was published further to the publication of the provisions of the reform aiming to reduce the incidence of overlapping insurance in health insurances, which was approved as part of the Economic Arrangements Law (see Section 2.2.1 above). As part of the draft, it is suggested to amend Title 6, Part 3, Chapter 2 to the Consolidated Circular, such that a SHABAN policy shall offer only the coverages listed in the draft.
  • 2.3.5. In August 2023, the Commissioner published Draft Directives regarding Financial Services Supervision (Insurance) (Group Long-Term Care Insurance to Members of Health Maintenance Organizations) (Amendment), 2023. As part of the draft, it is suggested to revise the existing insurance coverage in order to stabilize the funds of policyholders insured under long-term care insurance for members of a health maintenance organization. The revisions to the coverage include the following changes: (1) extending the waiting period from 60 to 180 days; (2) revising the monthly insurance benefits such that they include linkage differences as from the known CPI as of those directives' effective date, instead of the current situation, where the insurance benefits are linked to the known CPI of July 1, 2016 (the effective date of the key directives). It is also suggested that those directives shall apply to long-term care insurance contracts that will be entered into or renewed as from the commencement date, and that they will also apply to contracts that were entered into prior to that date, if was determined therein that those directives shall apply to them. In addition, the draft suggests to postpone the effective date of the directives pertaining to the extended coverage as of January 1, 2028.

3. Developments in the Macroeconomic Environment

3.1. Key macroeconomic data

  • (1) Bank of Israel. The data include funds under the management of institutional entities. The decrease in 2022 stems from redemptions.
  • (2) The IMF, in accordance with the USD exchange rate in April 2023.
  • (3) Israel Central Bureau of Statistics, the Bank of Israel (GDP in accordance with adjusted annual return).
  • (4) Bloomberg and the IMF. The data refer to unemployment rates as of the end of the period.
  • (5) Bloomberg; returns on bonds are based on returns on 10-year bonds of the government of Israel (unlinked to the CPI), as of the last month at the end of the period.
  • (6) Bloomberg. The data are annual inflation data for the past 12 months.

3.2. Trends, events and developments in the macroeconomic environment

Set forth below is a summary description of trends, events and developments in the Group's macroeconomic environment, that have or are expected to have an effect on the Group.

3.2.1. Financial markets in Israel

Growth forecasts for the Israeli economy in 2023 were revised downwards; those of the Bank of Israel - from 2.8% to 2.5% and those of the International Monetary Fund's forecast - from 2.9% to 2.5%; however, S&P's downwards revision of its forecast was the sharpest - from 2.0% to 1.5%. On the other hand, the average of the economists' forecasts (according to Bloomberg) remained at 2.9%. The key revisions were global downwards revisions to growth and global trade, including by the IMF, further interest rate hikes, and concerns regarding the consequences of the judiciary reform. In connection with the judicial reform, the Bank of Israel described two scenarios: 1. A scenario in which the dispute around the changes to legislation pertaining to the judiciary is resolved in a manner that does not impact the economic activity from now on; 2. A scenario that presents an analysis of potential economic consequences if legislative and institutional changes shall involve an increase in Israel's risk premium, have an adverse effect on exports, and cause a decline in domestic investments and in private consumption. On a different subject - during the balance sheet period, the state budget was approved concurrently with the Economic Arrangements Law for 2023- 2024. In the geopolitical arena, Israel launched the "Shield and Arrow" military

operation in the Gaza Strip, during which hundreds of rockets were fired into the south and center regions of the country, which resulted in minor disruption to economic activity. S&P reiterated Israel's credit rating outlook at AA-. The unemployment rate was down to 3.6%. On the other hand, the Composite State-of-the-Economy Index of the Bank of Israel stopped deteriorating. Inflation "cooled down" in May more than expected, reaching a level of 4.6%, and the Bank of Israel increased its interest rate to 4.75%, and no longer signals that further hikes are expected. After significant underperformance in the first quarter, during the period subsequent to the balance sheet date the local share indexes recorded overperformance compared with other capital markets across the world:

The TA 125 Index increased by 2.9%, the yield on 10-year government bond was down to 3.66%, the Tel-Bond 60 Index was up by 2.5%, the NIS devalued against the USD and the EUR, reaching a rate of NIS 3.71 per USD 1, and NIS 4.05 per EUR 1.

Subsequent to the balance sheet date

The Bank of Israel upgraded its growth forecast for the Israeli economy for 2023 from 2.5% to 3.0%, apparently ignoring the risks of the judiciary reform and the reactions to it. The Bank of Israel claims that the upgrade stems mainly from the surprisingly positive trend in GDP data in the first quarter - 3.2% compared to an expected increase of 1.8% (according to forecasters' average). At a later date, the Central Bureau of Statistics revised the figure downwards to 2.9%, but on the other hand it published the estimated GDP figure for the second quarter, which was also surprisingly high, and increased by 3% compared with the expected 2.3%. As mentioned above, in May rating agency S&P cut Israel's growth forecast to 1.5%, mainly due to the risks arising from the judicial reform; on the other hand, Citi Bank reaffirmed Israel's growth forecast for 2023 at a relatively high level of 3.1%, arguing that the reform is not expected to have an immediate effect on GDP, since the increase in revenues remains strong and therefore the personal consumption will also remain strong. Citi's assessment of the situation was supported by the unemployment rate data, which was down in July from 3.6% to 3.5%. The Bank of Israel's semi-annual Financial Stability Report referred to the two scenarios regarding the effects of the judicial reform on the Israeli economy; those scenarios had already been presented by the Bank of Israel during the reporting period. Despite the legislation of the abolishment of the standard of reasonableness by the Knesset, Israel's debt risk premium (CDS) did not increase, and even decreased. Similarly, the two rating agencies - S&P and Fitch - affirmed Israel's credit rating and its rating outlook. Inflation rate in July was surprisingly low, for the third consecutive month, with an annual rate of 3.3%.

The TA 125 Index increased by 5.0%, the yield on 10-year government bond increased to 3.93%, the Tel-Bond 60 Index was up by 0.3%, the NIS devalued against the USD and the EUR, reaching a rate of NIS 3.77 per USD 1, and NIS 3.10 per EUR 1.

3.2.2. Capital markets abroad

Growth rate in the USA during the first quarter was in line with expectations - 2.0%, and in Europe growth was disappointing with a contraction of 0.1% (in quarterly terms), that is to say - two consecutive quarters in which the economy contracted. The International Monetary Fund (in its April quarterly update) slashed its 2023 growth forecasts for the USA to 1.6% (and 0.8% for the Eurozone). The banking crisis in the USA - which began in March - continued, which was manifested in further withdrawal of deposits and further declines in prices of small banks' shares; at the same time,

concerns increased about the possibility of the US administration hitting the debt ceiling; this was reflected in a sharp increase in the USA's debt risk premium (CDS). Those concerns were resolved in May, and the debt risk premium declined back to previous levels. The US Federal Reserve has, indeed, increased its interest rate to 5.25%, but in view of the concerns regarding the economy it hinted heavily that this interest rate hike campaign approaches its end, also due to the sharp decline in inflation rate in May leading to annual levels of 4.0%, and expectation that inflation will cool even further, but that core inflation will remain "sticky". In Europe, inflation continued cooling until May, declining to annual levels of 6.1%; the ECB increased the interest on deposits to 3.25% and signaled that there will be further hikes. The relative "hawkishness" of the ECB, together with a correction to the sharp declines in the euro's exchange rates since 2022 (against the backdrop of concerns of an impending energy crisis) led to a sharp increase in the currency's exchange rate. Equity markets were supported by extensive optimism regarding the Artificial Intelligence (AI) revolution, which was reflected - through May - in a sharp rise in rates of a very small number of mega-tech shares, which drove stock indexes up. In June, prices of other shares increased too. The optimism in the markets was also driven by the announcement regarding the resolution of the US debt ceiling crisis, as referred to above.

The yield on 10-year US bonds increased to 3.84%, the S&P 500 Index increased by 10.3%, the EURO-STOXX 50 Index increased by 5.0%; and the EUR strengthened against the USD, reaching an exchange rate of 1.10%.

Subsequent to the balance sheet date

Growth in the second quarter was surprisingly good, with a 2.4% increase in the USA compared with expected growth of 1.8%, and in Europe - growth of 0.3% compared with an expectation of 0.2% (QoQ). In addition, Europe's growth rate in the first quarter was upgraded from -0.1% to 0.0%. The global inflation environment cooled faster than expected; in the USA, annual inflation reached 3.0% and in Europe - 5.3%. However, central banks were careful not to sound complacent; interest rates were increased both in the USA and in Europe; in the USA, rates increased to 5.50%, and in Europe to 3.75%; central banks continued to estimate that there may be further interest rate hikes, although in the USA market expectations are that the likelihood of such hikes is lower than 50%, and in Europe only one to two further interest rate hikes are expected. Central banks implement a new approach - a "data dependent" policy based on incoming information. Economic data from across the world indicate a continued slowdown, but expectations are that it will be a "soft landing" change; in the USA, for example, this was reflected in retail sales data and in new positions data. The central bank of Japan, which is normally a staunch supporter of loose monetary policy, made an unexpected move by introducing larger flexibility to its yield on 10-year bonds; the move was initially perceived as a type of "tightening", but at a later stage the central bank clarified that this was not the intended result of this move. Across the world there were many indications that the drop in commodity prices and in prices of physical products has stopped, which was reflected in increases in the prices of most commodities and in some of the marine freight rate indexes. In stock indexes there were increases in other sectors besides those recorded in technology stocks. The Fitch rating agency surprised the markets when it downgraded the USA's perfect credit rating.

The yield on 10-year US bonds increased to 4.27%, the S&P 500 Index decreased by 0.9%, the EURO-STOXX 50 decreased by 2.5%; and the EUR devalued slightly against the USD, reaching an exchange rate of 1.088.

4. Business Targets and Strategy

The Group's business strategy and targets constitute forward-looking information, as defined in Section 32A of the Securities Law, and are based on the data and information available to the Group as of the report date, its plans as a result thereof, the market situation and the Group's position. The Group's business strategy and targets may change from time to time. In addition, the achievement of the Group's targets and strategy is uncertain and is not under the sole control of the Group. The Group's business strategy and targets may not materialize due to, among other things, changes in the Group's priorities, new needs of the Group, market developments, macro changes, other business opportunities, etc.

The multi-year strategic plan - which was approved in December 2020 - is based on four fundamental principles: yield-focused growth, technological innovation and efficiency, maximization of the portfolio's value and capital management, all of which are relevant to the group's key areas of activity: insurance, asset management, agencies and credit. Since the publication of the plan, the Company has acted consistently to implement and execute it. The Company reviews its targets from time to time in the light of its achievements and market conditions; accordingly, in March 2022, the Company's Board of Directors adopted an update to the strategic plan (hereinafter - the "Strategic Plan"), as part of which the Company's targets for the plan's period were updated as described in the chart below.

(*) For further details, please see Section 5.4.5 below.

The interim targets are based on (a) multi-year work plans for a 5-year period (from its approval date); (b) an assumption of net return on investment of 3%. Compared to the plan's objective, actual results are based on the actual returns in the financial markets in Israel and around the world, macroeconomic growth, the Company's results and other variables. For the Company's actual results taking into account a 3% return, see Sections 5.4-5.6.

5. The Board of Directors' Explanations for the State of the Corporation's Business

5.1. General

The Group's operations are affected by constant regulatory changes and reforms. In addition, as the controlling shareholder of institutional entities, the Group must also deal with the minimum capital requirements that apply to the activity of the institutional entities, which impose, among other things, restrictions on dividend distribution by the institutional entities.

The Group's operations and results are significantly affected by the capital markets, including, among other things, the low-interest environment that has implications for its insurance liabilities and on the returns embodied in the Group's financial asset portfolios, and consequently - on the management fees and financial margins from investments as well.

5.2. Summary of data from the Group's consolidated Financial Statements

Assets under management as of June 30, 2023

Premiums, gross, contributions towards benefits and proceeds in respect of investment contracts for 1-6/2023

Total assets under management by provident funds, excluding guaranteed return provident fund tracks, pension funds, ETFs, and customers' investment portfolios are not included in the Financial Statements. Proceeds in respect of investment contracts are not included in the premiums line item; rather, they are charged directly to liabilities in respect of insurance contracts and investment contracts.

For further details on the premiums in the various operating segments, please see Note 3 to the Financial Statements.

5.3. Description of the development of the Group's financial position

5.3.1. Set forth below are key data from the consolidated balance sheets (in NIS billion):

Assets:

Total financial assets in respect of yield-dependent contracts and cash and cash equivalents in respect of yield-dependent contracts as of June 30, 2023, amounted to approximately NIS 101.7 billion, compared to approximately NIS 95.2 billion as of June 30, 2022, and NIS 96.1 billion as of December 31, 2022. Other assets as of June 30, 2023 amounted to NIS 53.9 billion, compared with NIS 50.9 billion as of June 30, 2022 and NIS 51.4 billion as of December 31, 2022.

Liabilities:

Liabilities in respect of insurance contracts and yield-dependent investment contracts amounted to approximately NIS 98.3 billion as of June 30, 2023, compared to approximately NIS 93.1 billion as of June 30, 2022, and NIS 94 billion as of December 31, 2022. Other liabilities as of June 30, 2023 amounted to NIS 46.8 billion, compared with NIS 42.9 billion as of June 30, 2022 and NIS 43 billion as of December 31, 2022.

5.4. Description of the development of the Group's comprehensive income

5.4.1. General

  • 5.4.1.1. At each reporting period, the Company reviews its sources of income, according to the segments breakdown, as outlined in Section 5.4.2 below. The Company also reviews its profitability by separating operating profit which assumes a real return of 3% net (less bonuses to employees and managers from excess returns), and gain from capital market effects above or below a real return of 3%, effects of interest and other special items as described below.
  • 5.4.1.2. Special effects are considered by the Company as changes in profit or loss outside the Company's ordinary course of business, including actuarial changes as a result of studies, changes in actuarial models, exceptional effects due to structural changes and exceptional purchase expenses following the implementation of the strategy of increasing the market share in the (hereinafter - "Special Items").

  • 5.4.1.3. In the health insurance and in property and casualty insurance segments, the profitability analysis is based on a breakdown to underwriting profits, which assumes a real return of 3%, and earnings stemming from capital market effects (hereinafter - the "underwriting profits"), which include income from nostro investments above or below a real return of 3%, the effect of the interest rate curve and other Special Items.
  • 5.4.1.4. In the life insurance and savings segment, the profitability analysis is based on a breakdown to underwriting profits - which assumes a real return of 3%, including income from variable management fees in the profit participating portfolio based on said rate, fixed management fees and a financial margin in guaranteed return policies, which assumes said return both for the free portion and non-free portion of the portfolio, investment income after offsetting return credited to policyholders, and earnings stemming from capital market effects, which include income from nostro investments and management fees calculated above or below a real return of 3%, the effect of the interest rate curve, including changes in the K factor, and other Special Items.
  • 5.4.1.5. In order to separate the financial results between profits attributed to insurance and profits arising from other core activities, the Company splits the "other" segment. The split is made for convenience purposes and the Company views the capital and unattributed segment as a single operating segment.

5.4.2. Set forth below is the composition of the Company's financial performance by segment for the 6-month reporting period and their comparison to the corresponding period last year (in NIS million):

Set forth below is the composition of the Company's financial performance by segments in the second quarter of 2023 compared with the corresponding quarter last year (in NIS million):

For the effects on the results at the segment level, please see details in Sections 5.5- 5.6 below.

5.4.3. Set forth below are the payment balances and changes in insurance liabilities:

1-6/2023 1-6/2022 1-12/2022
In NIS million
Payments and change in liabilities in respect of insurance contracts
and investment contracts - retention in the income statement 9,899 (1,890) 1,965
Net of amounts included
in the above amounts:
Investment gains (losses) in respect of yield-dependent policies(*) 4,803 (5,903) (6,618)
Changes in interest 103 (1,120) (1,645)
Special items in the insurance segment (81) (154) (85)
Total investment income, changes in interest and special items 4,825 (7,177) (8,348)
Total payments and change in liabilities in respect
of yield-dependent policies, net of investment income,
changes in interest and special items 5,074 5,287 10,313

(*) Including health; for further details about the life insurance segment, see Section 5.5.3.5 below.

5.4.4. Set forth below is explanation regarding investment income in the insurance business:

1-6/2023 1-6/2022 1-12/2022
In NIS million
Items from the income statement
Investment income 5,289 (5,435) (5,555)
Equity profits 43 30 62
Other comprehensive income 297 (324) (231)
Tax effect on comprehensive income 141 (177) (133)
Total 5,770 (5,906) (5,858)
Less:
Investment gains (losses) in respect of yield-dependent policies 4,803 (5,903) (6,618)
Gains (losses) attributable to the credit and financial services segment 168 34 103
4,971 (5,869) (6,514)
Total investment income - nostro 799 (37) 657
Income from nostro investments, real return at 3% 1,365 1,483 2,661
Income from nostro investments, over or above real return at 3% (*) (566) (1,520) (2,004)

(*) See Section 5.4.5 below.

5.4.5. Set forth below is the composition of the sources of the Company's pre-tax income by profit per activity and profit from capital market effects, interest rate and Special Items for a period of 6 months in the reporting period (in NIS million):

  • (*) Please see Section 5.4.1.
  • (**) For further details about the Special Items at segment level, see Section 5.4.4, and results at segment level in Sections 5.5-5.6 below.

Operating profit after deducting effects of the capital market, Special Items and interest increased by NIS 57 million in the reporting period, compared with the corresponding period last year.

In the reporting period, the nominal return from nostro investments was an annualized 6.2%, and the real return in the reporting period was an annualized 1.2%. After transferring annual real return of 3%, and an amount in respect of variable management fees, which is calculated based on the real return, the negative effect of the capital market after the said deduction is NIS 566 million, see Section 5.4.1 regarding the review of sources of earnings.

The total positive change in investment income, in excess of a real return of 3% in the reporting period compared with the corresponding period last year totaled NIS 954 million, in view of the lower downturns in financial markets in Israel and across the world. As of June 30, 2023, the effect of the decline in planholders' portfolios will lead to non-collection of future variable management fees in the amount of approx. NIS 571 million, before tax (as of the report publication date - NIS 529 million before tax). The change as a result of the effect of the risk-free interest rate curve and the decline in the illiquidity premium in the reporting period compared with the corresponding period last year caused a NIS 1,223 million decrease in profit in the reporting period, compared with the corresponding period last year. The total net negative effect of the interest and capital market effects (in excess of a real return of 3%) in the reporting period amounted to NIS 669 million before tax, as reflected in the above chart.

During the reporting period, the special items line item decreased by NIS 161 million compared with the corresponding period last year; most of the decrease stemmed from the recognition of a higher one-off earning in the corresponding period last year as a result of the transfer of the Company's rights in Phoeniclass Ltd. to The Phoenix Insurance, and a one-off earning from assuming control over The Phoenix Capital net of studies compared with the recognition of one-off capital gain, during the reporting

period, from assuming control in FNX Private Partnerships (for more information, see Section 1.3.5 above), which was partially offset from a study on costs for disability coverage (for further details, see Section 1.3.4 above).

For information about the effects on the results at the segment level, please see details in Sections 5.5-5.6 below.

Set forth below is the composition of the sources of the Company's pre-tax income by operating profit and earnings from capital market effects, interest rate and Special Items in the second quarter of 2023 (in NIS million):

Operating profit after deducting effects of the capital market, Special Items and interest decreased by NIS 54 million in the second quarter of the reporting period, compared with the corresponding quarter last year.

After transferring annual real return of 3%, and an amount in respect of variable management fees, which is calculated based on the real return, the negative effect of the capital market after the said deduction is NIS 116 million, see Section 5.4.1 regarding the review of sources of earnings.

The total positive change in investment income, in excess of a real return of 3% in the second quarter of the reporting period compared with the corresponding quarter last year totaled NIS 730 million, in view of the lower downturns in financial markets in Israel and across the world.

As of June 30, 2023, the effect of the decline in planholders' portfolios will lead to non-collection of future variable management fees in the amount of approx. NIS 571 million, before tax (as of the report publication date - NIS 529 million before tax).

The change as a result of the effect of the risk-free interest rate curve and the decline in the illiquidity premium in the second quarter of the reporting period compared with the corresponding quarter last year is a reduction in profit of NIS 576 million. The total net negative effect of the interest and capital market effects (in excess of a real return of 3%) in the second quarter of the reporting period amounted to a pre-tax profit of NIS 369 million as reflected in the above chart.

During the second quarter of the reporting period, the special items line item decreased by NIS 76 million compared with the corresponding quarter last year; most of the decrease stemmed from the recognition of a higher one-off earning in the corresponding period last year as a result of the transfer of the Company's rights in Phoeniclass Ltd. to The Phoenix Insurance, and a one-off earning from assuming control, in the second quarter of the reporting period, in The Phoenix Capital compared with the recognition of one-off capital gain from assuming control over FNX Private partnerships (for more information, see Section 1.3.5 above), which was partially offset from a study on costs for disability coverage in the life insurance segment (for further details, see Section 1.3.4 above).

5.4.6. Set forth below is the composition of the differences between the interest rate effects and main special items on pre-tax insurance liabilities for the 6-month in the reporting period compared to the corresponding period last year (in NIS million):

5.4.7. Set forth below is the composition of the differences between the interest effects and main special items effects on pre-tax insurance liabilities in the second quarter of 2023 compared with the corresponding quarter last year (in NIS million):

5.4.8. Set forth below are data regarding the Company's return on equity:

1-6/2023 1-6/2022 4-6/2023 4-6/2022 1-12/2022
Return on shareholders' equity for the
period (based on comprehensive income 6.0% 11.4% 9.0% 7.9% 11.4%
for the period)(*)
Adjusted return on shareholders' equity for
the period (based on comprehensive 13.0% 12.3% 15.0% 15.4% 11.9%
income for the period)(**)
  • (*) Return on equity is calculated based on the comprehensive income for the period attributable to Company's shareholders, adjusted to reflect a one-year period and divided by the average equity for the period.
  • (**) Adjusted return on equity is calculated based on the comprehensive income for the period attributable to Company's shareholders, net of the effect of the capital market and special items (see Section 5.4.1 above), adjusted to reflect a one-year period and divided by the average adjusted equity for the period.

Following is a description of the developments in the Group's financial performance, by operating segment:

5.5. Description of developments in core areas - insurance

5.5.1. Property and casualty insurance

Set forth below is a composition of the main effects and changes on the results of the property and casualty insurance subsegment for the reporting period compared to the corresponding period last year (in NIS million, before tax):

The NIS 141 million increase in underwriting profits in the reporting period compared with the corresponding period last year stems mainly from the compulsory motor insurance subsegment, motor property insurance subsegment, and other liability subsegments; the said profit is offset against a decrease in profitability in other property subsegments.

The NIS 339 million increase in investment income in the reporting period compared with the corresponding period last year stemmed from a lower negative effect in financial markets in Israel and globally during the reporting period, compared with the corresponding period last year, in relation to the mix of the portfolio against the segment's liabilities. The NIS 73 million decrease in interest income in the reporting period compared with the corresponding period last year stems mainly from an increase in insurance liabilities in compulsory motor insurance and from a decrease in liability insurance as a result of a change in the discount rate.

Following is the composition of the main effects and changes on the results of the property and casualty insurance subsegment for the second quarter of 2023 compared to the corresponding quarter last year (in NIS million before tax):

5.5.1.1. Set forth below is the pre-tax comprehensive income in the various subsegments of property and casualty insurance (P&C) for the reporting period compared with the corresponding period last year (in NIS million):

Set forth below is the pre-tax underwriting profit in the various subsegments of property and casualty insurance (P&C) for the reporting period compared with the corresponding period last year (in NIS million):

The increase in underwriting profit in the reporting period compared with the corresponding period last year arises mainly from the motor property subsegment, mainly as a result of an improvement of the damage rate, and from the liability subsegment as a result of a NIS 40 million decrease in insurance liabilities in the Sales Law guarantees subsegment; for more information, see Note 8A(4) to the financial statements. The increase in the compulsory motor subsegment stems mainly from an increase in average premium. On the other hand, some of the increase in profitability was offset against a decrease in profitability of other property insurance subsegments as a result of an increase in the cost of claims in home and business insurance.

5.5.1.2. Following is the pre-tax comprehensive income (loss) in the various subsegments of property and casualty insurance for the second quarter of 2023 compared with the corresponding quarter last year (in NIS million):

Following is the pre-tax underwriting profit (loss) in the various subsegments of property and casualty insurance for the second quarter of 2023 compared with the corresponding quarter last year (in NIS million):

The increase in underwriting profit in the second quarter of the reporting period compared with the corresponding quarter last year arises mainly from the compulsory motor subsegment as a result of an increase in the average premium and an increase in the underwriting profit in the motor property subsegment, mainly as a result of an improvement in the damage rate from accidents, that was partially offset due to an increase in vehicle thefts.

The increase in profitability was partially offset against a decrease in profitability of other property insurance subsegments as a result of an increase in the cost of claims in home and business insurance, and in the liability subsegment - as a result of an increase in the cost of claims in third party insurance.

Motor property (*)
In NIS million
1-6/2023 1-6/2022 4-6/2023 4-6/2022 1-12/2022
Gross loss ratio 86.0% 86.0% 87.8% 69.8% 91.0%
Retention loss ratio 86.0% 86.1% 87.8% 69.9% 91.1%
Gross combined ratio 107.0% 110.7% 108.2% 96.0% 116.6%
Retention combined ratio 107.0% 110.7% 108.2% 96.0% 116.6%

5.5.1.3. Set forth below is the gross loss ratio and combined ratio, and retention loss ratio in the motor property and other property subsegments:

Property and other subsegments
In NIS million
1-6/2023 1-6/2022 4-6/2023 4-6/2022 1-12/2022
Gross loss ratio 63.5% 35.0% 45.8% 34.1% 31.4%
Retention loss ratio 37.0% 21.9% 38.1% 20.8% 22.5%
Gross combined ratio 90.0% 62.5% 71.6% 63.4% 58.9%
Retention combined ratio 68.7% 51.9% 69.4% 59.6% 53.3%

(*) Includes UGL (excess value of illiquid assets); for more information, see Section 5.5.1 above.

5.5.2. Health insurance

Earnings on investments affects the profitability of this segment, some of whose products (such as long-term care coverage) are characterized by accrual of significant reserves over long periods. Investment earnings are affected by financial market fluctuations, as well as changes in interest rates and the rate of change in the Israeli consumer price index, which affect the yields on liquid financial asset portfolios held against insurance and contingent claims reserves. It should be noted that at this stage, the Company has ceased to market long-term care insurance policies in view of the guaranteed return in long-term care insurance plans, and the complexity of the related reinsurance in this area.

The agreement and the group long-term health insurance policy for Maccabi members expire on December 31, 2023. The Company informed the policyholder - "Maccabi Healthcare Services" - and the Commissioner that it will not extend the agreement, and that it is making preparations for the expiry of the agreement in accordance with its provisions.

Set forth below is the composition of the main effects and changes on the results of the health insurance subsegment for the reporting period compared to the corresponding period last year (in NIS million):

The decrease in underwriting profits in the reporting period compared to the corresponding period last year in the amount of NIS 61 million is mainly due to longterm care insurance policies.

The NIS 41 million increase in investment income in the reporting period compared with the corresponding period last year stemmed mainly from more positive effects in financial markets in Israel and globally, compared with adverse effects in financial markets in Israel and globally in the corresponding period last year, in relation to the mix of the portfolio against the segment's liabilities.

The NIS 736 million decrease in interest income in the reporting period compared with the corresponding period last year stems mainly from an increase in insurance liabilities as a result of the decrease in the illiquidity premium in the reporting period compared to the decrease in insurance liability as a result of the effect of the increase in the discount rate in the corresponding period last year, and the change in excess value of illiquid assets, which was recognized in the LAT reserve.

In addition, the results in the reporting period compared with the corresponding period last year were affected from a NIS 14 million decrease in earnings in the Special Items

line item. In the reporting period, the Company recognized a NIS 113 million one-off capital gain from assuming control in the FNX Private partnerships (for more information, see Section 1.3.5 above); this gain was partially offset against changes in assumptions, model revisions, and others. In the corresponding period last year, the Company recorded a one-off earning of NIS 99 million as a result of the transfer of the Company's rights in Phoeniclass Ltd. to The Phoenix Insurance; this one-off earning was recognized in the LAT reserve as part of the excess value of illiquid assets.

Following is a composition of the main effects and changes on the results of the health insurance subsegment for the second quarter of 2023 compared to the corresponding quarter last year (in NIS million):

The NIS 30 million decrease in underwriting profit in the second quarter of the reporting period, compared to the corresponding quarter last year, is mainly due to a decrease in profit from long-term health insurance policies, which was partially offset against an increase in travel insurance policies.

The NIS 7 million increase in investment income in the second quarter of the reporting period compared with the corresponding quarter last year stemmed mainly from positive effects in financial markets in Israel and globally, compared with negative effects in financial markets in Israel and globally in the corresponding period last year, in relation to the mix of the portfolio against the segment's liabilities.

The NIS 321 million decrease in interest income in the second quarter of the reporting period compared with the corresponding quarter last year stems mainly from an increase in insurance liability as a result of the effect of the decrease in the illiquidity premium in the second quarter of the reporting period, compared to a decrease in insurance liability in the corresponding quarter last year, and the change in excess value of illiquid assets, which was recognized in LAT reserve (for further details, see Section 1.3.5 above).

Furthermore, the results in the reporting period compared with the corresponding period last year were impacted by the NIS 79 million increase in the special items line item mainly as a result of the recognition of a NIS 113 million one-off earning in the second quarter of the reporting period as a result of assuming control over the FNX Private partnerships (for further details, see Section 1.3.5 above); the profit was partially offset by changes in assumptions, model revisions, etc.

As of June 30, 2023, the LAT reserve balance amounts to NIS 358 million.

5.5.2.1. Set forth below is the (pre-tax) comprehensive income (loss) in the various subsegments of health insurance for the reporting period compared with the corresponding period last year (in NIS million):

5.5.2.2. Set forth below is the (pre-tax) comprehensive income (loss) in the various subsegments of health insurance in the second quarter of the reporting period compared with the corresponding quarter last year (in NIS million):

5.5.2.3. Set forth below is the pre-tax underwriting income (loss) in the various subsegments of health insurance for the reporting period compared with the corresponding period last year (in NIS million):

The decrease in underwriting profits in the reporting period compared to the corresponding period last year in the amount of NIS 61 million is mainly due to an increase in incidence of claims and a change in LAT reserve for LTC policies compared with last year.

Set forth below is the pre-tax underwriting income (loss) in the various subsegments of health insurance in the second quarter of the reporting period compared with the corresponding quarter last year (in NIS million):

The decrease in underwriting profits in the second quarter of the reporting period, compared to the corresponding quarter last year, in the amount of NIS 30 million is mainly due to an increase in incidence of claims and change in LAT reserve.

5.5.3. Life insurance and savings

5.5.3.1. Earnings on investments have a material effect on the profitability of this segment, which is characterized by accrual of significant reserves over long periods. Investment earnings are affected by financial market fluctuations, as well as changes in interest rates and the rate of change in the Israeli consumer price index, which affect the yields on liquid financial asset portfolios held against insurance and contingent claims reserves. It should be noted that a significant portion of the investment income was carried to participating policies and has no direct effect on the Company's results.

Set forth below is the composition of the main effects and changes on the results of the life insurance subsegment for the reporting period compared to the corresponding period last year (in NIS million):

The results in the reporting period were affected mainly by a NIS 414 million decrease in profit as a result of the change in the risk-free interest rate curve and illiquidity premium during the reporting period compared with the corresponding period last year. In addition, the results in the reporting period compared with the corresponding period last year were affected by a NIS 40 million decrease in underwriting profit, which stemmed mainly from the decrease in fixed management fees as a result of the negative yields.

Furthermore, in the reporting period, the results were affected - compared with the corresponding period last year - by a NIS 61 million decrease in investment income in excess of a real return of 3%, which mainly arose from lower revenues on nostro investments in the corresponding period last year. As of June 30, 2023, the effect of the decline in planholders' portfolios will lead to non-collection of future variable management fees in the amount of approx. NIS 571 million, before tax (as of the report publication date - NIS 529 million before tax).

The NIS 46 decrease in profit in the special items line item stems from a NIS 38 million profit in the reporting period, mainly as a result of the effects of the study regarding long-term health insurance (for more information, see Section 1.3.5 above), which was partially offset by model revisions and provisions for class actions, compared with a NIS 84 million profit in the corresponding period last year as a result of the effects of a study on retirement age and pension uptake rates, which was partially offset by the implementation of a circular regarding the revision to mortality assumptions, model revisions and provisions for class actions.

Following is a composition of the main effects and changes on the results of the life insurance subsegment for the second quarter of 2023 compared to the corresponding quarter last year (in NIS million):

The results in the second quarter of the reporting period compared with the corresponding quarter last year were affected mainly by a NIS 162 million decrease in profit as a result of the change in the risk-free interest rate curve and illiquidity premium. In addition, the results in the second quarter of the reporting period compared with the corresponding quarter last year were affected by a NIS 28 million decrease in underwriting profit, which stemmed

mainly from the decrease in fixed management fees as a result of the negative yields, and an increase in general and administrative expenses.

Furthermore, in the second quarter of the reporting period, the results were affected - compared with the corresponding quarter last year - by a NIS 76 million decrease in investment income in excess of a real return of 3%, which mainly arose from lower revenues on nostro investments in the corresponding period last year. As of June 30, 2023, the effect of the decline in planholders' portfolios will lead to non-collection of future variable management fees in the amount of approx. NIS 571 million, before tax (as of the report publication date - NIS 529 million before tax).

The NIS 54 decrease in profit in the special items line item stems from a NIS 49 million profit in the second quarter of the reporting period, mainly as a result of the effects of the study regarding long-term health insurance (for more information, see Section 1.3.5 above), which was partially offset by model revisions and provisions for class actions, compared with a NIS 103 million profit in the corresponding quarter last year as a result of the effects of a study on retirement age and pension uptake rates, which was partially offset by the implementation of a circular regarding the revision to mortality assumptions, model revisions and provisions for class actions.

5.5.3.2. Set forth below is the results of the (pre-tax) comprehensive income (loss) in the various subsegments of life insurance for the reporting period compared with the corresponding period last year (in NIS million):

5.5.3.3. Set forth below is the (pre-tax) comprehensive income (loss) in the various subsegments of life insurance in the second quarter of the reporting period compared with the corresponding quarter last year (in NIS million):

5.5.3.4. Set forth below is the pre-tax underwriting income (loss) in the various subsegments of life insurance for the reporting period compared with the corresponding period last year (in NIS million):

The NIS 40 million decrease in underwriting profits in the reporting period, compared with the corresponding period last year is attributed mainly to a decrease in underwriting profit in policies issued through 1990, as a result of a decrease in the financial margin, and the effect of the expenses, and in policies issued as from 2004 - as a result of the decline in fixed management fees and the effect of the expenses.

Set forth below is the pre-tax underwriting income (loss) in the various subsegments of life insurance in the second quarter of the reporting period compared with the corresponding quarter last year (in NIS million):

The NIS 28 million decrease in underwriting profits in the second quarter, compared with the corresponding quarter last year is attributed mainly to a decrease in underwriting profit in policies issued through 1990, as a result of a decrease in the financial margin, and the effect of the expenses, and in policies issued as from 2004 - as a result of the decline in fixed management fees and the effect of the expenses.

  • 5.5.3.5. The rate of redemptions out of the average reserve (in annual terms) was approximately 5.9% compared with 5.1% in the corresponding period last year. The increase stems mainly from increase in cancellations of investment policies due to changes in the capital market and from internal transfers to The Phoenix Pension and Provident's provident funds. It should be noted that the general state of the economy, transition from product to product, employment rates, employees' wages, and market competition all affect this rate.
  • 5.5.3.6. Set forth below are details concerning estimated net investment earnings attributed to policyholders of yield-dependent insurance policies and management fees calculated according to the Insurance Commissioner's guidelines, based on the return and the insurance reserves balances:
1-6/2023 1-6/2022 4-6/2023 4-6/2022 1-12/2022
In NIS million
Investment gains (losses)
credited to policyholders net of
management fees
4,118 (5,442) 3,447 (4,272) (6,325)
Management fees 296 300 147 149 591

(*) Excluding investment gains credited (debited) to policyholders in the health insurance segment.

5.5.3.7. Weighted returns on participating policies

Set forth below are the nominal returns on participating policies in respect of policies issued from 1992 to 2003:

Policies issued up to 2004 (Fund J)
1-6/2023 1-6/2022 4-6/2023 4-6/2022 1-12/2022
Nominal returns before payment
of management fees
4.21% (5.54%) 3.77% (4.68%) (5.69%)
Nominal returns after payment of
management fees
Real returns before payment of
management fees
Real returns after payment of
management fees
3.92% (5.84%) 3.63% (4.82%) (6.29%)
1.71% (8.41%) 2.38% (6.48%) (10.42%)
1.42% (8.70%) 2.24% (6.62%) (10.99%)

Fluctuations in these returns are a function of capital market returns in Israel and abroad, changes in the consumer price index, and changes in the exchange rate of the shekel against major currencies.

5.5.3.8. Set forth below are the nominal returns on yield-dependent insurance policies in respect of policies issued from 2004 and thereafter

Policies issued from 2004 and thereafter
1-6/2023 1-6/2022 4-6/2023 4-6/2022 1-12/2022
Nominal returns before payment
of management fees
4.56% (6.61%) 3.72% (5.44%) (6.64%)
Nominal returns after payment of
management fees
4.11% (7.05%) 3.50% (5.66%) (7.49%)
Real returns before payment of
management fees
2.05% (9.44%) 2.33% (7.23%) (11.32%)
Real returns after payment of
management fees
1.61% (9.87%) 2.11% (7.45%) (12.13%)

5.5.4. Capital gains - other

Set forth below is the composition of the main effects and changes in respect of other capital gains for the reporting period compared to the corresponding period last year (in NIS million):

Set forth below is the composition of the main effects and changes of other capital gains for the second quarter of 2023 compared to the corresponding quarter last year (in NIS million):

The decrease in loss of NIS 575 million and NIS 480 million, respectively, in other capital gains in the reporting period and the second quarter compared with the corresponding period last year stems mainly from lower declines in financial markets in Israel and globally compared with the corresponding period last year.

5.6. Description of developments in other core activities

5.6.1. The field of asset management - pension and provident

The Group manages various types of pension funds and provident funds through The Phoenix Pension and Provident Fund. In addition, the Group manages - through Halman-Aldubi IEC Gemel Ltd. - the central provident fund for annuity of Israel Electric Corporation employees. As of the report date, the Company holds - directly and indirectly - 100% of the shares of The Phoenix Pension and Provident, and 100% of the shares of Halman-Aldubi IEC Gemel Ltd.

Set forth below is the composition of the main effects and changes on the results of the investment management - pension and provident subsegment for the reporting period compared to the corresponding period last year (in NIS million):

Set forth below is the composition of the main effects and changes on the results of the asset management - pension and provident segment for the second quarter of 2023 compared to the corresponding quarter last year (in NIS million):

5.6.1.1. Provident funds subsegment

The Group manages provident and advanced education funds through The Phoenix Pension and Provident, a wholly owned subsidiary of the Company, which manages benefits and severance pay funds, advanced education funds, a central benefits and severance pay fund, a yield-guaranteed provident fund, an investment provident fund, a child long-term investment provident fund for savings, a self-directed benefits provident fund, and a personally managed advanced education fund.

The pre-tax comprehensive income in the reporting period amounted to approximately NIS 53 million compared to approximately NIS 54 million during the corresponding period last year.The pre-tax comprehensive income in the second quarter of the reporting period amounted to approximately NIS 36 million compared to approximately NIS 37 million during the corresponding quarter last year.

Based on Ministry of Finance data,5 aggregate contributions towards benefits in the provident funds subsegment in the first half of 2023 totaled approximately NIS 23.1 billion, compared to a total of approximately NIS 27.0 billion in the corresponding quarter last year, reflecting a decrease of approximately 14.14%. According to the Ministry of Finance data, as of June 30, 2023, total assets under management in the provident funds subsegment amounted to approximately NIS 685 billion, compared to approximately NIS 644 billion as of June 30, 2022, an increase of approximately 6.56%.

5.6.1.2. Pension funds subsegment

The Group's pension subsegment is conducted through The Phoenix Pension and Provident, a wholly-owned subsidiary of the Company.

The pre-tax earnings in the reporting period amounted to NIS 6 million compared with pre-tax earnings of NIS 5 million in the corresponding period last year. The pre-tax comprehensive income in the second quarter of the reporting period amounted to approximately NIS 3 million compared to approximately NIS 1 million during the corresponding quarter last year.

5 Based on Gemel Net data.

Set forth below are developments in contributions towards benefits and total assets under management:

Based on Ministry of Finance data,6 aggregate contributions towards benefits in the new comprehensive pension funds subsegment in the first half of 2023 totaled approximately NIS 32.2 billion, compared to a total of approximately NIS 27.7 billion in the corresponding quarter last year, reflecting an increase of approximately 16.1%.

According to Ministry of Finance data, as of June 30, 2023, total assets under management in the new comprehensive pension funds subsegment amounted to a total of approximately NIS 671 billion, compared to approximately NIS 574 billion on June 30, 2022, an increase of approximately 17.0%.

5.6.2. Investment management - financial services

The activity in this area is carried out mainly through The Phoenix Investment House (formerly - Excellence Investments), and as from June 30, 2022 partly through The Phoenix Advanced Investments. For more information about the completion of the merger of KSM ETN Holdings Ltd. with The Phoenix Investment House in January 2023, see Note 8G to the financial statements.

Set forth below is the composition of the main effects and changes on the results of the financial services subsegment for the reporting period compared to the corresponding period last year (in NIS million):

6 Based on Pension Net data.

The NIS 36 million decrease in profits in the reporting period compared with the corresponding period last year arises mainly from a NIS 48 million improvement in the profitability of the TASE Member, which was partially offset against a NIS 84 million decrease in profits, mainly as a result of the recognition of a one-off capital gain from assuming control in The Phoenix Capital in the corresponding period last year.

Following is the composition of the main effects and changes on the results of the financial services segment for the second quarter of 2023 compared to the corresponding quarter last year (in NIS million):

The NIS 64 million decrease in profits in the second quarter of the reporting period compared with the corresponding quarter last year arises mainly from a NIS 28 million improvement in the profitability of the TASE Member, which was offset against a NIS 83 million decrease in profits, mainly as a result of the recognition of a one-off capital gain from assuming control in The Phoenix Capital in the corresponding period last year.

5.6.3. The insurance agencies segment

Set forth below is the composition of the main effects and changes on the results of the insurance agencies subsegment for the reporting period compared to the corresponding period last year (in NIS million):

Following is the composition of the main effects and changes on the results of the insurance agencies segment for the second quarter of 2023 compared to the corresponding quarter last year (in NIS million):

In the reporting period, hiring of new employees in Israel was down, which led to a decline in commissions. In the reporting period, EBITDA increased to NIS 167 million compared with NIS 161 million in the corresponding period last year.

As to the option of introducing an international partner to The Phoenix Agencies, see Section 1.3.6(c) above.

5.6.4. The Credit Segment

Set forth below is the composition of the main effects and changes on the results of the credit segment subsegment for the reporting period compared to the corresponding period last year (in NIS million):

Set forth below is the composition of the main effects and changes on the results of the credit segment for the second quarter of 2023 compared to the corresponding quarter last year (in NIS million):

The increase in operating profit in the reporting period compared with the corresponding period last year stems mainly from an increase in activity turnovers and an increase in credit spreads in the reporting period compared with the corresponding period last year. Gama continued to consistently expand the credit card activity as well as the business credit portfolio and guarantee activity. As part of the Company's responsible growth strategy, and in view of the macroeconomic picture that is reflected in significant interest rate hikes in Israel, Gama reduced its checks factoring activity.

Gama's credit loss expenses in the reporting period amounted to NIS 7.7 million, of which NIS 3.5 million is recorded in respect of a general provision for debts in the credit portfolio, which are ordinary debts.

For more information regarding The Phoenix Investments' tender offer subsequent to the balance sheet date, see Section 1.3.9 above.

5.6.5. Other segments and operation not attributed to the operating segments

Set forth below is the composition of the main effects and changes on the results of "other" segment and activity that is not attributed to operating segments in the reporting period compared to the corresponding period last year (in NIS million, before tax):

Following is the composition of the main effects and changes on the results of "other" segment and activity that is not attributed to operating segments in the second quarter of 2023 compared to the corresponding quarter last year (in NIS million before tax):

The results in the reporting period and in the second quarter compared with the corresponding periods last year were mainly affected by a NIS 5 million decrease and a NIS 7 million decrease, respectively, in the financial margin, and from a NIS 16 million one-off capital gain as a result of buyback of bonds.

5.7. Analysis of cash flow development

5.7.1. Cash flow for the first half of 2023

The consolidated cash flows from operating activities in the reporting period amounted to approximately NIS 2.096 million. The consolidated cash flows used in investing activities in the reporting period amounted to approximately NIS 431 million and included mainly a total of NIS 169 million used to purchase property, plant, and equipment, NIS 200 million used to acquire and capitalize costs of intangible assets, and NIS 88 million used for investment in associates.

The consolidated cash flows used for financing activities in the reporting period amounted to approximately NIS 21 million; the cash flows included, among other things, a total of NIS 772 million arising from a REPO liability, a total of NIS 678 million used to repay financial liabilities, and a total of NIS 227 million arising from issuance of financial liabilities.

The Group's cash and cash-equivalent balances increased from a total of approximately NIS 19,798 million at the beginning of the reporting period to approximately NIS 21,442 million at the end of the reporting period.

5.7.2. Sources of financing and liquidity

For liquidity purposes, the Company relies, among other things, on net financial assets and on distribution of dividends by some of its investees. Set forth below is a breakdown of the material investees for liquidity purposes.

It is hereby clarified that some of the investees are subject to regulatory provisions in addition to the distribution restrictions set in the Companies Law, 1999:

A. The Phoenix Insurance - the dividends from The Phoenix Insurance depend on the solvency ratio target set by the Board of Directors, which is higher than the minimum target set by the Banking Supervision Department; the dividends also depend on the policy set by the Board of Directors of The Phoenix Insurance, see Section 2.1 above.

For the purpose of making a conservative assessment of the Company's future cash flows, the Company assumes a payment of dividend by The Phoenix Insurance to the Phoenix Holdings in accordance with the work plan.

The Company considers its holding in a Restricted Tier 1 capital instrument of The Phoenix Insurance as a source of liquidity, and classifies this holding as a financial investment (for more details, see Section 1.3.3 above).

B. The Phoenix Pension and Provident - the dividend paid by The Phoenix Pension and Provident depend on the capital requirements set by the Banking Supervision Department, and on The Phoenix Pension and Provident's dividend distribution policy. The Company does not expect payment of dividend by The Phoenix Pension and Provident in the next two years. However, for purposes of the future cash flow, the Company takes into account the repayment of the loan it extended to The Phoenix Pension and Provident.(For further details, please see Section 1.3.7 below).

Furthermore, the Company controls the following entities which are not subject to special Regulatory Restrictions in addition to the Companies Law:

  • A. The Phoenix Agencies for information about restructuring and dividend, see Section 1.3.10.
  • B. The Phoenix Investments the Company presents the net financial assets of The Phoenix Investments as part of its net financial assets. The Company assumes a payment of dividend by Excellence to The Phoenix Investments in accordance with the work plan.

It should be noted that such work plans are reflected in the Company's targets as stated in Section 4 above.

Set forth below is a table providing a breakdown of the net financial debt (the table includes the following companies: the Company, The Phoenix Investments and The Phoenix Agencies (for information regarding the restructuring in The Phoenix Agencies, see Section 1.3.6 above) and does not include The Phoenix Insurance and The Phoenix Pension and Provident, which are subject to Regulatory Restrictions in addition to the distribution restrictions set out in the Companies Law, 1999):

as of June 30, as of June 30, As of December
2023 2022
NIS thousand
31, 2022
Financial assets
Cash and cash equivalents 245 151 160
Other financial investments 1,094 1,087 1,158
Total assets 1,339 1,238 1,319
Less current maturities
Financial liabilities - current (*) 71 45 35
Current financial assets net of current maturities 1,268 1,193 1,284
Non-current financial liabilities
Non-current financial liabilities 1,473 1,429 1,496
Other liabilities - 5 10
Total liabilities 1,473 1,434 1,506
Net financial debt (205) (241) (222)
LTV 2% 2% 2%

(*) The other financial investments include an investment in a Restricted Tier 1 capital instrument of The Phoenix Insurance, which has been listed on the main list since April 2023, amounting to NIS 1,024 million (fair value as of June 30, 2023 - NIS 979 million). Stock exchange value as of August 22, 2023 is NIS 959 million.

(**) The Company LTV is calculated as net financial debt as described above, in relation to the Company's market value as of March 31, 2023. For the calculation of LTV in accordance with financial covenants, please see Section 9.2 below.

(***) The Phoenix Agencies declared a NIS 675 million dividend to the shareholders, of which NIS 250 million were paid as of the report publication date.

6. Disclosure on Exposure to, and Management of, Market Risks

Generally, during the reporting period there were no material changes in the exposure to market risks and the manner of management of those risks compared to what is described in the 2022 Periodic Report, except as follows:

In June 2023, the Company executed a buyback of NIS 124 million par value of bonds (Series 6). The bonds are not linked to the CPI (principal and interest), and bear unlinked annual interest, as stated above, at the rate of 1.94%, which is paid in two annual payments in 2023-2032. Following this acquisition, there has been a change in the exposure to shekel interest rates in relation to the data as of March 30, 2023.

The following table summarizes the results of the sensitivity tests to the non-linked shekel interest rate on profit before tax, as of in June 30, 2023. The results are presented in NIS million, and do not include the insurance company:

Profit (loss) from changes in the
risk factor
Profit (loss) from changes in the
risk factor
Type of instrument Absolute
increase
of 2%
10%
increase
5%
increase
Fair
value
5%
decrease
Decrease
of 10%
Absolute
decrease
of 2%
Government bonds (0.8) (0.2) (0.1) 39.8 0.1 0.2 1.1
Corporate bonds (2.1) (0.0) (0.0) 31.1 0.0 0.0 2.2
Capital note to the insurance
company
- - - - - - -
MAOF options - - - - - - -
Total assets (3.0) (0.2) (0.1) 70.8 0.1 0.2 3.2
Loans from banking corporations - - - - - - -
The Phoenix bonds 24.3 4.8 2.4 (683.1) (2.5) (5.0) (28.0)
Total liabilities 24.3 4.8 2.4 (683.1) (2.5) (5.0) (28.0)
Total 21.4 4.6 2.3 (612.2) (2.4) (4.7) (24.8)

(*) The value of The Phoenix's bonds under the model is 3.4% lower than their market value.

Assumptions underlying the calculations

Fair value: Fair value was calculated using the discounted cash flow model, using the suitable interest rate for the cash flow period. The discount rate was calculated based on the market interest rate for the cash flow period, plus the risk premium derived from the security's rating.

Scenarios: For the interest risk, the calculation was based on absolute increase/decrease of 2% during the course of a day. This scenario was selected after a study of the yield curve database found that in the past 10 years, no absolute change exceeding 2% was observed in any single day. Scenario outcomes were calculated at the single asset level, so as to avoid distorting results by aggregating different instruments.

s ind
ies
in
in I
el
No
n-l
ink
ed
CP
I-li
nke
d
For
eig
net
ite
ice
Tot
al
n c
urr
enc
mo
ary
ms
com
pan
sra
s
com
pan
y
y
Inta
ible
As
set
1,
830
,7
84
476
861
10,
618
1,
008
,1
91
3,
ng
s
-
-
-
-
,
Def
d ta
ts
80,
623
779
10,
036
6,4
48
erre
x a
sse
-
-
-
-
Def
d a
isiti
ts
034
619
991
2,
1,
,54
1
1,
erre
cqu
on
cos
-
-
-
-
-
-
,
lant
&
ipm
Pro
ty,
ent
147
634
2,1
00
10,
792
1,
077
,41
5
1,
per
p
equ
-
-
-
-
,
Inv
est
nts
in i
ste
23,
439
19,
929
140
995
1,4
56,
411
1,
me
nve
es
-
-
-
-
,
Inv
est
nt p
erty
in
t
me
rop
res
pec
of y
ield
-de
den
t co
ntra
cts
2,
206
935
2,
pen
-
-
-
-
-
-
-
,
Inv
est
nt p
erty
the
86,
334
1,1
1,1
me
rop
- o
r
-
-
-
-
-
-
-
Rei
ts
3,
604
340
3,
nsu
ran
ce a
sse
-
-
-
-
-
-
-
,
dit
for
cha
f se
Cre
ities
644
000
111
000
755
pur
se o
cur
-
-
-
-
-
-
,
,
Cur
t ta
ts
20,
815
2
6
226
,55
4
ren
x a
sse
-
-
-
-
bles
d d
ebit
ba
lanc
Rec
eiva
415
,7
25
8,
013
48,
818
7,5
74
446
,5
32
an
es
-
-
-
Pre
miu
coll
ect
ible
026
855
1,
1,
ms
-
-
-
-
-
-
-
,
l inv
Fina
ncia
est
nts
in r
ect
me
esp
of y
ield
-de
den
t co
ntra
cts
80,
603
,5
91
80,
pen
-
-
-
-
-
-
-
Fina
ncia
l inv
for
hold
of
bon
ds,
ETN
est
nts
me
ers
s,
sho
rt E
TNs
osit
e E
TNs
dep
osit
rtifi
cat
, co
mp
ce
es
,
and
str
uct
d b
ond
194
000
ure
s
-
-
-
-
-
-
-
,
dit
of f
Cre
in r
ect
act
orin
esp
g,
clea
d fi
ring
cing
3,4
88,
853
3,4
an
nan
-
-
-
-
-
-
-
Liqu
id d
ebt
9,
815
203
140
828
08
811
set
14,
417
5,
646
,1
5,
as
s
-
-
-
,
Illiq
uid
deb
t as
set
502
,51
1
529
,44
6
29,
000
937
,55
2
12,
003
15,
276
930
17,
s
-
-
,
Sha
293
821
14,
820
1,
909
806
2,
res
-
-
-
-
-
,
,
Oth
17,
149
55,
096
51,
722
5,5
12,
779
5,
er
-
-
-
-
Cas
h a
nd
h e
ival
s in
ent
cas
qu
t of
ield
-de
den
18,
728
67
18,
t co
ntra
cts
,4
res
pec
pen
y
-
-
-
-
-
-
-
Oth
ash
d c
ash
uiva
lent
460
,5
32
63,
000
90,
583
33,
191
2,
065
,75
2
2,7
er c
an
eq
s
-
-
-
-
-
Tot
al a
ts
2,
056
02
2
584
607
228
365
2,5
48,
953
2,7
98,
606
3,5
73,
073
194
000
143
609
,4
39
155
,5
sse
,
,
,
,
,
Liab
ilitie
t of
s in
ins
ntra
cts
res
pec
ura
nce
co
and
ield
-de
den
t in
tme
nt c
ont
ract
1,
045
054
26,
204
,45
3
27,
249
no
n-y
pen
ves
s
-
-
-
-
-
-
,
Liab
ilitie
s in
t of
ins
ntra
cts
res
pec
ura
nce
co
and
ield
-de
den
t in
tme
nt c
ont
ract
98,
348
,4
93
98,
348
y
pen
ves
s
-
-
-
-
-
-
-
Liab
ilitie
t of
de
ferr
ed
s in
tax
35,
623
85,
469
426
280
547
res
pec
es
-
-
-
-
-
,
Liab
ility
for
loye
e b
fits
t
24,
105
208
185
4,
47,
75,
em
p
ene
, ne
-
-
-
-
-
Liab
ility
in
t of
t ta
57,
186
4,7
98
9,4
91
5,
636
77,
res
pec
cu
rren
xes
-
-
-
-
abl
nd
dit
bala
Pay
482
,7
63
429
93,
776
42,
378
3,5
66,
793
4,1
86,
es a
cre
nce
s
-
-
-
Liab
ilitie
s fo
r bo
nds
sh
, ET
Ns,
ort
ETN
ite
s, c
om
pos
nd
red
bo
nds
ETN
stru
ctu
193
000
193
s a
-
-
-
-
-
-
-
,
Fina
ncia
l lia
bilit
ies
(
*)
2,
329
6
912
655
142
000
2,
817
3,
027
610
998
80
,57
7,
,4
14,
-
-
,
,
,
Tot
al l
iab
ilit
ies
2,
836
,44
4
969
84
1
142
,4
29
35,
623
1,
231
914
3,
083
687
193
000
136
,5
97,
320
145
090
,
,
,
,
,
NIS Oth
er
non
-
sio
pen
n
Cre
dit
co
mp
any
ETN
link
age
s -
to
iou
var
i ins
Isr
ael
ura
nce
326
,45
4
97,
886
654
32
,5
237
941
,
640
,77
4
206
935
,
86,
334
604
340
,
000
,
247
377
,
926
662
,
026
855
,
603
,5
91
194
000
,
88,
853
371
,
287
,44
2
218
,44
7
636
,74
6
728
67
,4
13,
058
93,
065
,5
07
,4
93
372
,
498
111
139
000
,
413
38
,1
258
,
,
al e
Tot
xpo
sur
e
(
22)
780
,4
(
)
385
234
85,
936
2,5
13,
330
1,5
66,
692
489
386
1,
000
7,
01
2,1
19
,
10,
502
807
,

Linkage bases of assets and liabilities in the consolidated balance sheet (in NIS thousand) as of June 30, 2023

85,936(*) Against CPI-linked financial liabilities, the Company holds The Phoenix Insurance's Bonds (Series L), which is CPI-linked

2,513,330 1,566,692 489,386

Linkage bases of assets and liabilities in the consolidated balance sheet (in NIS thousand) as of June 30, 2022

NIS ETN
lin
kag
e to
s -
li ins
Isr
ae
No
n-l
ink
ed
CP
I-l
ink
ed
For
eig
n c
en
cy
urr
Oth
er
no
n-
net
ite
mo
ary
ms
sio
pen
n
ies
in
com
pan
ies
in
com
pan
l
Isr
ae
rio
us ind
va
ice
s
ura
nce
com
pan
y
To
tal
Int
ible
As
set
ang
s
- - - 1,
707
983
442
768
5,
950
- 762
425
2,
919
126
Def
ed
tax
set
err
as
s
- - - ,
60,
747
,
63
6,
233
- ,
-
,
67,
043
Def
ed
uis
itio
ost
err
acq
n c
s
- - - 3,
535
700
677
- - 576
814
1,
2,
281
026
lan
t &
Pro
ty,
uip
nt
per
p
eq
me
- - - 178
256
,
8,
109
8,
461
- ,
751
439
,
946
265
Inv
est
nts
in
inv
est
me
ees
94,
367
17,
830
- ,
69,
467
- 59 - ,
1,
292
677
,
1,
400
474
Inv
est
nt p
erty
in
t
me
rop
res
pec
, ,
of y
ield
-de
den
t co
ntra
cts
pen
- - - - - - - 1,
903
600
1,
903
600
Inv
the
est
nt p
erty
me
rop
- o
r
- - - - - - - ,
1,
038
015
,
1,
038
015
Rei
ets
nsu
ran
ce
ass
- - - - - - - ,
3,
167
199
,
3,
167
199
Cre
dit
for
cha
of s
ritie
pur
se
ecu
s
695
630
- 58,
370
- - - - ,
-
,
000
754
Cur
t ta
ts
ren
x a
sse
,
-
25,
757
- - - 5,
210
- 350 ,
31,
317
abl
and
de
bit
bal
Rec
eiv
es
anc
es
440
204
- - - 31,
195
14,
899
- 585
866
1,
072
164
Pre
miu
col
lect
ible
ms
,
-
- - - - - - ,
933
629
,
933
629
Hel
d-f
sale
f d
sal
set
ispo
or-
as
s o
gro
up
- - - - - - - ,
-
,
-
ial
Fin
inv
est
nts
in
t
anc
me
res
pec
of y
ield
-de
den
t co
ntra
cts
pen
fo
f bo
Fin
ial
inv
est
nts
r ho
lde
nds
anc
me
rs o
- - - - - - - 78,
267
921
,
78,
267
921
,
,
hor
dep
ETN
t ET
Ns,
osit
e E
TN
osit
s, s
co
mp
s,
tific
nd
red
bo
nds
ate
stru
ctu
cer
s a
- - - - - - 217
000
- 217
000
dit
of
fac
Cre
in r
ect
tor
ing
esp
, ,
,
clea
d fi
ring
cin
an
nan
g
- - - - - 3,
208
322
- - 3,
208
322
Liq
uid
de
bt a
ts
sse
10,
309
20,
328
847 - 742
57,
,
-
- 6,
312
247
,
6,
401
473
Illiq
uid
de
bt a
ts
sse
1,
588
980
422
019
87,
000
- 977
404
11,
508
- ,
14,
106
324
,
17,
193
235
Sha
res
,
-
,
-
- 344
823
,
24,
792
- - ,
2,
144
175
,
2,
513
790
Oth
er
1,
000
- 22,
309
,
63,
881
25,
961
- - ,
4,
358
036
,
4,
471
187
Cas
h a
nd
h e
iva
len
ts i
cas
qu
n
, ,
t of
ield
-de
den
t co
ntra
cts
res
pec
y
pen
- - - - - - - 789
357
14,
789
357
14,
Oth
ash
d c
ash
ale
uiv
nts
er c
an
eq
375
328
,
- 22,
000
- 69,
233
10,
909
- ,
1,
981
770
,
,
2,
459
240
,
To
tal
set
as
s
3,
20
5,
81
8
48
5,
93
4
190
52
6
,
2,
42
8,
69
2
2,
33
7,
94
4
3,
27
1,
55
1
21
7,
00
0
133
97
1,
84
4
,
146
109
30
9
,
,
Lia
bilit
ies
in r
of
ins
ect
ntra
cts
esp
ura
nce
co
and
ield
-de
den
t in
tme
nt c
ont
ts
no
n-y
pen
ves
rac
- - - - 989
995
,
- - 24,
325
518
,
25,
315
513
,
of
Lia
bilit
ies
in r
ect
ins
ntra
cts
esp
ura
nce
co
and
ield
-de
den
t in
tme
nt c
ont
ts
pen
ves
rac
y
- - - - - - - 93,
114
756
,
93,
114
756
,
Lia
bilit
ies
in r
of
def
ed
ect
tax
esp
err
es
- - - 60,
490
72,
634
- - 421
249
,
554
373
,
bilit
for
loy
ben
efit
Lia
et
y
em
p
ee
s, n
20,
648
- - - 881 6,
158
- 55,
833
83,
520
Lia
bilit
in r
of
ect
t ta
y
esp
cur
ren
xes
- 961
17,
- - 8,
859
2,
085
- 561
44,
73,
466
abl
and
dit
bal
Pay
es
cre
anc
es
536
572
,
- - - 252
697
,
26,
567
- 2,
442
802
,
3,
258
638
,
Lia
bilit
ies
for
bon
ds,
ET
Ns,
sh
ETN
ort
s,
ite
ETN
nd
red
bo
nds
stru
ctu
com
pos
s a
- - - - - - 215
058
,
- 215
058
,
ial
liab
ilitie
s (
*)
Fin
anc
3,
060
659
,
1,
172
337
,
177
000
,
- 3,
624
2,
926
171
,
- 6,
092
210
,
13,
432
001
,
To
tal
lia
bil
itie
s
3,
61
7,
87
9
1,
190
29
8
,
-
17
7,
00
0
60,
49
0
1,
32
8,
69
0
2,
96
0,
98
1
21
5,
05
8
126
49
6,
92
9
,
136
04
7,
32
5
,
tal
To
ex
pos
ure
(
2,
06
1)
41
(
70
36
4)
4,
13,
52
6
2,
36
8,
20
2
00
9,
254
1,
31
0,
0
57
94
2
1,
91
7,
47
4,
5
10,
06
98
1,
4

(*) Against CPI-linked financial liabilities, the Company holds The Phoenix Insurance's Bonds (Series L), which is CPI-linked.

NIS ETN
link
s -
age
i ins
Isr
ael
No
n-l
ink
ed
CP
I-li
nke
d
For
eig
n c
urr
enc
y
Oth
er
non
-
ite
net
mo
ary
ms
sio
pen
n
ies
in
com
pan
dit
Cre
co
mp
any
in I
el
sra
to
iou
s ind
var
ice
s
ura
nce
com
pan
y
Tot
al
ible
Inta
As
set
ng
s
-
-
- 1,7
18,
822
459
,1
86
8,
362
- 805
,15
6
2,
991
,5
26
Def
d ta
ts
erre
x a
sse
-
-
- 63,
261
1,
250
8,1
38
- - 72,
649
Def
d a
isiti
ts
erre
cqu
on
cos
-
-
- 3,5
98
897
824
- - 1,5
51,
961
2,4
53,
383
lant
Pro
ty,
&
ipm
ent
per
p
equ
-
-
- 180
965
,
2,
276
8,5
34
- 959
668
1,1
51,
443
Inv
est
nts
in i
ste
me
nve
es
014
15,
19,
409
- ,
124
838
- - - ,
34,
476
1,4
93,
737
1,5
Inv
est
nt p
erty
in
t
me
rop
res
pec
,
of y
ield
-de
den
t co
ntra
cts
pen
-
-
- - - - - 2,1
42,
074
2,1
42,
074
Inv
the
est
nt p
erty
me
rop
- o
r
-
-
- - - - - 1,1
47,
899
1,1
47,
899
Rei
ts
nsu
ran
ce a
sse
-
-
- - - - - 3,1
72,
249
3,1
72,
249
Cre
dit
for
cha
f se
ities
pur
se o
cur
673
90
,7
- 91,
210
- - - - - 765
000
,
Cur
t ta
ts
ren
x a
sse
33,
610
-
- - - - - 124
225
,
157
835
,
bles
d d
ebit
ba
lanc
Rec
eiva
an
es
138
963
,
- 5,
805
- 51,
000
12,
896
- 521
629
,
730
293
,
Hel
d-fo
le a
t
r-sa
sse
-
-
- 18,
387
- - - - 18,
387
coll
ible
Pre
miu
ect
ms
-
-
- - - - - 757
329
,
757
329
,
Fina
ncia
l inv
in r
est
nts
ect
me
esp
of y
ield
-de
den
t co
ntra
cts
pen
-
-
- - - - - 77,
394
271
,
77,
394
271
,
l inv
for
hold
of
bon
ds,
Fina
ncia
est
nts
ETN
me
ers
s,
sho
dep
rtifi
rt E
TNs
osit
e E
TNs
osit
cat
, co
mp
ce
es
,
and
d b
ond
str
uct
ure
s
-
-
- - - - 201
000
,
- 201
000
,
Cre
dit
in r
of f
orin
ect
act
esp
g,
clea
ring
d fi
cing
an
nan
-
-
- - - 3,4
43,
337
- - 3,4
43,
337
id d
ebt
Liqu
set
as
s
7,
888
6,4
18
552 - 118
687
,
- - 5,5
26,
350
5,
659
895
,
Illiq
uid
deb
t as
set
s
391
000
,
428
,5
06
40,
000
- 894
368
,
10,
711
- 14,
696
915
,
16,
461
,5
00
Sha
res
-
-
- 513
300
,
19,
364
- - 1,
869
608
,
2,4
02,
272
Oth
er
400 - 35,
439
27,
152
49,
650
- - 890
,1
82
4,
002
823
5,
,
h a
nd
h e
ival
Cas
ent
s in
t
cas
qu
res
pec
of y
ield
-de
den
t co
ntra
cts
pen
-
-
- - - - - 16,
358
,5
09
16,
358
,5
09
Oth
ash
d c
ash
uiva
lent
er c
an
eq
s
07
455
,5
- 000
14,
- 197
,17
7
20,
269
- 2,7
52,
813
3,4
39,
766
- -
Tot
al a
ts
sse
1,
68
2,5
62
48
7,
943
187
006
,
2,
650
323
,
2,
690
,7
82
3,5
12,
247
201
000
,
136
,1
05,
314
147
,51
7,1
77
Liab
ilitie
s in
t of
ins
ntra
cts
res
pec
ura
nce
co
and
ield
-de
den
t in
tme
nt c
ont
ract
no
n-y
pen
ves
s
-
-
- - 016
001
1,
- - 24,
442
95
,4
25,
458
96
,4
t of
Liab
ilitie
s in
ins
ntra
cts
res
pec
ura
nce
co
,
and
ield
-de
den
t in
tme
nt c
ont
ract
y
pen
ves
s
-
-
- - - - - 94,
042
093
94,
042
093
Liab
ilitie
s in
t of
de
ferr
ed
tax
res
pec
es
-
-
- 54,
652
75,
085
- - ,
460
,1
60
,
589
897
Liab
ility
for
loye
e b
fits
t
em
p
ene
, ne
19,
149
- - - - 5,4
78
- 42,
040
,
66,
667
Liab
ility
in
t of
t ta
res
pec
cu
rren
xes
32,
333
-
- - 23,
024
9,
251
- 185 64,
793
abl
nd
dit
bala
Pay
es a
cre
nce
s
392
948
- 739 - 443
,4
02
45,
095
- 2,5
73,
387
3,4
55,
571
Liab
ilitie
s fo
r bo
nds
, ET
Ns,
sh
ETN
ite
ort
s, c
om
pos
,
ETN
nd
red
bo
nds
stru
ctu
s a
-
-
- - - - 200
698
- 200
698
l lia
bilit
(
*)
Fina
ncia
ies
2,
043
986
,
1,1
98,
421
108
000
,
- 4,7
33
2,
986
,5
69
,
-
6,7
63,
855
,
13,
105
,5
64
Tot
al l
iab
ilit
ies
2,4
56,
083
1,
230
,75
4
108
,7
39
54,
652
1,5
62,
245
3,
046
393
,
200
698
,
128
324
215
,
,
136
983
,77
9
,

Linkage bases of assets and liabilities in the consolidated balance sheet (in NIS thousand) as of December 31, 2022

78,267(*) Against CPI-linked financial liabilities, the Company holds The Phoenix Insurance's Bonds (Series L), which is CPI-linked

2,595,671

1,128,537 465,854 7,781,099

302

10,533,398

(742,811)

(773,521) Total exposure

8. Corporate Governance Aspects

8.1. Effectiveness of Internal Control over Financial Reporting and Disclosure

8.1.1. The Securities Regulations

Amendment No. 3 to the Securities Regulations (Periodic and Immediate Reports), 2009 (hereinafter - "ISOX"), which deals with internal controls over financial reporting and the disclosure thereof (hereinafter - the "Regulations"), was published in December 2009. The amendment enacts a number of changes aimed at improving the quality of financial reporting and disclosure by reporting corporations.

As from the publication date of the ISOX amendment, and as set out in the Company's previous Reports of the Board of Directors, the Company has acted and is acting on an ongoing basis to implement the required procedure in The Phoenix group in accordance with the provisions of the ISOX amendment. In accordance with the provisions of the ISOX amendment, the Company opted to implement to the internal controls of all of its consolidated institutional entities the provisions of the circulars of the Commissioner of the Capital Market, Insurance and Savings applicable thereto the Institutional Entities Circular 2009-9-10, "Management's Responsibility for Internal Control over Financial Reporting"; Institutional Entities Circular 2010-9-6, "Management's Responsibility for Internal Control over Financial Reporting - Amendment"; Circular 2010-9-7 "Internal Control over Financial Reporting - Statements, Reports and Disclosures" (hereinafter - "Management's Responsibility Circulars").

The reports and statements required in accordance with the ISOX amendment are attached below to the periodic Financial Statements, please see Part 5 - Report on the Effectiveness of Internal Controls over Financial Reporting and Disclosure. The processes relating to the activities of institutional entities are also addressed in the Insurance Commissioner's Circulars, please see Section 8.1.2 below.

8.1.2. The Insurance Commissioner's Circulars

Alongside the process described in Section 8.1.1 above, The Phoenix group's institutional entities apply the provisions of Management's Responsibility Circulars pertaining to controls and procedures regarding disclosure and internal controls over financial reporting of an institutional entity, and implement the procedures required in connection therewith, as described below; this is done in accordance with the stages and dates set out in the above-mentioned circulars and in collaboration with external consultants engaged for that purpose. As part of this process, the Group's institutional entities adopted the internal control model of COSO - the Committee of Sponsoring Organization of the Treadway Commission - which is a generally accepted framework for assessment of internal controls.

Disclosure controls and procedures

Managements of the institutional entities, together with their CEOs and CFOs, assessed the effectiveness of the controls and procedures concerning the said institutional entities' disclosure in their Financial Statements as of the end of the period covered in this report. Based on this assessment, the CEOs and CFOs of the institutional entities in The Phoenix group concluded that, as of the end of this period, the controls and procedures as to the institutional entities' disclosure are sufficiently effective for recording, processing, summarizing, and reporting the information that the institutional entities are required to disclose in their quarterly report in accordance with the provisions of the law and the reporting provisions set by the Commissioner of the Capital Market, Insurance, and Savings and on the date set out in these provisions.

Internal control over financial reporting

During the quarter ending June 30, 2023, no changes took place in the internal control over financial reporting of the Group's institutional entities that had a material effect, or is expected to have a material effect, on the institutional entities' internal control over financial reporting. Furthermore, the Group's institutional entities are improving and streamlining processes and/or internal controls and/or customer service.

The reports and statements relating to the relevant processes are attached to the financial statements of The Phoenix Group's institutional entities, in accordance with the provisions of Management's Responsibility Circulars.

9. Disclosure Provisions Relating to the Corporation's Financial Reporting

9.1. Events subsequent to the balance sheet date

For further details regarding events subsequent to the balance sheet date, please see Note 9 to the Financial Statements.

9.2. Dedicated disclosure for the Company's bondholders

Series/issuance date Bonds Series 4 Bonds Series 5 Bonds Series 6
Rating agency Midroog / Maalot Midroog / Maalot Midroog / Maalot
Rating as of the report date Aa2.il ilAA /- Aa2.il ilAA /- Aa2.il ilAA /-
Par value on issuance date NIS 487,564,542 NIS 822,616,000 NIS 472,612,000 (*)
Interest type Unlinked CPI-linked Unlinked
Nominal interest The Bank of Israel's variable
quarterly interest rate plus a
1.28% spread
0.44% 1.94%
Effective interest rate on
issuance date
1.7% 0.55% 4.6% (*)
Listed on the TASE Yes Yes Yes
Principal payment dates 2 equal annual installments of
12% on July 31 of each of the
years 2020 and 2021 and 4
equal annual installments of
19% on July 31 of each of the
years 2025 through 2028.
3 equal annual installments
of 4% on July 1 of each of the
years 2022 through 2024,
one installment of 28% on
May 1, 2028, and 2 equal
annual installments of 30%
on May 1 of each of the years
2029 through 2030.
9 annual installments: 1 installment of
4% on December 31, 2024, 3 equal
installments of 12% on December 31
of each of the years 2025 through
2027, 3 equal installments of 10% on
December 31 of each of the years 2028
through 2030, and 2 installments of
15% in each of the years 2031 through
2032.
Interest payment dates Quarterly interest on January
31, April 30, July 31, and
October 31
Semi-annual interest on May
1 and November 1
Semi-annual interest on June 30 and
December 31
Nominal p.v. as of June 30,
2023
NIS 398 million NIS 756 million NIS 349 million
CPI-linked nominal p.v. as of
June 30, 2023
NIS 398 million NIS 834 million NIS 349 million
Carrying amount of bonds'
outstanding balances as of
June 30, 2023
NIS 397 million Approx. NIS 324 million
Carrying amount of interest
payable as of June 30, 2023
Approx. NIS 3.9 million Approx. NIS 0.6 million -
Market value as of
June 30, 2023 (*)
Approx. NIS 413 million Approx. NIS 749 million Approx. NIS 296 million
Series' materiality The series is material as this
term is defined in Regulation
10(b)13(a) of the Securities
Regulations
(Periodic
and
Immediate Reports), 1970
The series is material as this term is
defined in Regulation 10(b)13(a) of the
Securities Regulations (Periodic and
Immediate Reports), 1970

(*) Series 6 Bonds - in January 2023, an expansion of NIS 172 million par value was carried out; a buyback of NIS 124 million par value of the original number of Series 6 Bonds was carried out in June 2023.

(**) The market value includes interest accrued as of July 2, 2023.

Contractual restrictions and financial covenants

As part of the deed of trust of the Company's Series 4 bonds, the Company undertook not to place a general floating charge on its assets as long as the Series 4 bonds have not been repaid in full, unless it obtains the bondholders' consent in advance and placed on that date a charge of the same rank in favor of the Series 4 bondholders. Furthermore, with respect to Series 4 bonds, the Company assumed restrictions on distribution of dividends and expansion of the Bonds (Series 4); the Company also undertook to comply with financial covenants whereby its shareholders' equity will not fall below NIS 2.9 billion for two consecutive quarters, and that the Company's net financial debt to total assets ratio will not exceed 50% for two consecutive quarters. For further details, please see the Shelf Offering Report dated May 7, 2019.

As part of the deed of trust of the Company's Series 5 bonds, the Company undertook not to place a general floating charge on its assets as long as the Series 5 bonds have not been repaid in full, unless it obtains the bondholders' consent in advance and placed on that date a charge of the same rank in favor of the Series 5 bondholders.

Furthermore, with respect to Series 5 bonds, the Company assumed restrictions on dividend distribution; the Company also undertook to comply with financial covenants whereby its shareholders' equity will not fall below NIS 3.2 billion for two consecutive quarters, and that the Company's net financial debt to total assets ratio will not exceed 50% for two consecutive quarters. In addition, a mechanism for adjusting the rate of change in interest rate due to noncompliance with financial covenants was set: In the event that the Company's shareholders' equity falls below NIS 3.5 billion, the annual interest rate will increase by the rate set in Section 5.9 of the Deed of Trust. For further details, please see the shelf offering report dated February 20, 2020.

As part of the deed of trust of the Company's Series 6 Bonds, the Company undertook not to place a general floating charge on its assets as long as Series 6 bonds are not repaid in full, unless it has obtained the bondholders' consent in advance and placed on that date a lien of the same rank in favor of Series 6 bondholders. Furthermore, with respect to Series 6 bonds, the Company assumed restrictions on distribution of dividends and expansion of the Bonds (Series 6); the Company also undertook to comply with financial covenants whereby its shareholders' equity will not fall below NIS 3.6 billion for two consecutive quarters, and that the Company's net financial debt to total assets ratio will not exceed 48% for two consecutive quarters. For further details, please see the Shelf Offering Report dated January 5, 2022.

As of balance sheet date, the Company complies with the financial covenants described above. The net financial debt ratio as of June 30, 2023 was approximately 4.17% (including Restricted Tier 1 capital instrument issued by The Phoenix Insurance through The Phoenix Capital Raising), and the Company's shareholders' equity as per its separate financial statements as of June 30, 2023, was approximately NIS 10,055 million, which is higher than the above required shareholders' equity.

For further details – please see Note 5 to the Company's financial statements as of June 30, 2023.

The members of the Board of Directors thank the Company's management, employees and agents for their contribution to the Company.

Benjamin Gabbay Chairman of the Board of Directors

Eyal Ben Simon Chief Executive Officer

August 23, 2023

Part 2

Consolidated Interim Financial Statements

Table of Contents

Page
Review Report of the Independent Auditors………………………………………………………2
Condensed Consolidated Interim Statements of Financial Position……………………3-4
Condensed Consolidated Interim Income Statements…………………………………………5
Condensed Consolidated interim Statements of Comprehensive Income………………6
Condensed Consolidated Interim Statements of Changes in Equity…………………7-11
Condensed Consolidated Interim Statements of Cash Flow…………………………12-14
Notes to the Condensed Consolidated Interim Financial Statements…………….15-112
Appendix to the Condensed Consolidated Interim Financial Statements……113-116

Kost Forer Gabbay & Kasierer Menachem Begin Road 144A, Tel Aviv 6492102 Tel. +972-3-6232525 Fax +972-3-5622555 ey.com

Auditors' Review Report to the Shareholders of The Phoenix Holdings Ltd.

Introduction

We have reviewed the accompanying financial information of The Phoenix Holdings Ltd. And subsidiaries (the "Company"), the condensed consolidated statement of financial position as of June 30, 2023, the related condensed consolidated statements of profit or loss, comprehensive income, changes in equity and cash flows for the six and three-months periods then ended. The Company's Board of Directors and management are responsible for the preparation and presentation of financial information for this interim periods in accordance with the Israel Securities Regulations (Periodic and Immediate Reports), 1970, which pertain to insurers' holding companies, as described in Note 2(a). Our responsibility is to express a conclusion regarding the financial information for this interim periods based on our review.

We did not review the condensed interim financial information of certain subsidiary, whose assets included in consolidation constitute approximately 2.3% of the total consolidated assets as of June 30, 2023 and whose revenues included in consolidation constitutes approximately 1.5% and 1.1% of total consolidated revenuesfor the six and three-month periodsthen ended, respectively. Furthermore, we did not review condensed financial information for the interim periods of companies presented on the basis of the equity method. the investment in which, at equity, amounted to approximately NIS 688,475 thousand as of June 30, 2023, and the Company's share in the earning (loss) amounted to approximately NIS 31,224 thousand and (183) thousand for the six and three-month periods then ended, respectively. The condensed interim financial information of those companies was reviewed by other auditors, whose review reports have been furnished to us, and our conclusion, insofar as it relates to financial information in respect of these companies, is based on the review reports of the other independent auditors.

Scope of the Review

We conducted our review in accordance with Review Standard (Israel) 2410 of the Institute of Certified Public Accountants in Israel, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and of applying analytical and other review procedures. A review is substantially lessin scope than an audit performed pursuant to Israeli GAAP and, as a result, does not enable us to obtain assurance that we would become aware of all significant matters that may be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review and the review reports of other auditors, nothing has come to our attention that causes us to believe that the above-mentioned financial information does not comply, in all material respects, with the Israel Securities Regulations (Periodic and Immediate Reports), 1970, which pertain to insurers' holding companies, as described in Note 2(a) to the financial information.

Emphasis of matter

Without qualifying the above conclusion, we draw attention to Note 7 to the financial statements regarding exposure to contingent liabilities.

Tel Aviv, Kost Forer Gabbay & Kasierer August 23, 2023 Certified Public Accountants

Condensed Consolidated Interim Statements of Financial Position

Condensed Cons olidat ed Int erim Statem ents of Financial Position

As of
June 30, June 30, December 31,
2023 2022 2022
Unaudited Audited
Note NIS thousand
Assets
Intangible assets 4 3,326,454 2,919,126 2,991,526
Deferred tax assets 97,886 67,043 72,649
Deferred acquisition costs 2,654,532 2,281,026 2,453,383
Property, plant & equipment 1,237,941 946,265 1,151,443
Investments in associates 1,640,774 1,474,400 1,593,737
Investment property in respect
of yield-dependent contracts 2,206,935 1,903,600 2,142,074
Investment property - other 1,186,334 1,038,015 1,147,899
Reinsurance assets 3,604,340 3,167,199 3,172,249
Credit for purchase of securities 755,000 754,000 765,000
Current tax assets 247,377 31,317 157,835
Receivables and debit balances 926,662 1,072,164 730,293
Held-for-sale asset - - 18,387
Premiums collectible 1,026,855 933,629 757,329
Financial investments in respect
of yield-dependent contracts 5A 80,603,591 78,267,921 77,394,271
Financial investments for holders of
deposit certificates and structured bonds 194,000 217,000 201,000
Credit assets in respect of
factoring, clearing and financing 5C 3,488,853 3,208,322 3,443,337
Other financial investments:
Liquid debt assets 5,811,371 6,401,473 5,659,895
Illiquid debt assets 17,287,442 17,193,235 16,461,500
Shares 2,218,447 2,513,790 2,402,272
Other 5,636,746 4,471,187 5,002,823
Total other financial investments 5B 30,954,006 30,579,685 29,526,490
Cash and cash equivalents in respect
of yield-dependent contracts 18,728,467 14,789,357 16,358,509
Other cash and cash equivalents 2,713,058 2,459,240 3,439,766
Total assets 155,593,065 146,109,309 147,517,177
Total assets for yield-dependent contracts 101,743,507 95,216,686 96,055,588

Condensed Consolidated Interim Statements of Financial Position

As of
June 30,
2023
June 30,
2022
December 31,
2022
Unaudited Audited
Note NIS thousand
Equity
Share capital 313,168 310,514 311,640
Premium and capital reserves
in respect of shares 858,022 845,296 851,918
Treasury shares 8F (167,733) (155,628) (155,628)
Capital reserves 1,210,070 934,615 1,123,705
Retained earnings 7,841,012 7,773,062 8,013,123
Total equity attributable to
the Company's shareholders 10,054,539 9,707,859 10,144,758
Non-controlling interests 448,268 354,125 388,640
Total equity 10,502,807 10,061,984 10,533,398
Liabilities
Liabilities in respect of insurance contracts
and non-yield-dependent investment contracts 27,249,507 25,315,513 25,458,496
Liabilities in respect of insurance contracts
and yield-dependent investment contracts 98,348,493 93,114,756 94,042,093
Liabilities in respect of deferred taxes 547,372 554,373 589,897
Liability for employee benefits, net 75,498 83,520 66,667
Liability in respect of current taxes 77,111 73,466 64,793
Payables and credit balances 4,186,139 3,258,638 3,455,571
Liabilities in respect of structured products 193,000 215,058 200,698
Financial liabilities 5D 14,413,138 13,432,001 13,105,564
Total liabilities 145,090,258 136,047,325 136,983,779
Total capital and liabilities 155,593,065 146,109,309 147,517,177
Benjamin Gabbay Eyal Ben Simon Eli Schwartz
Chairman of the Board CEO EVP, CFO

Date of approval of the financial statements - August 23, 2023

The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.

Condensed Cons olidat ed Int erim Statem ents of Incom e

For the six months
ended June 30
For the three months
ended June 30
For the year ended
December 31
2023 2022 2023 2022 2022
Unaudited Audited
NIS thousand
Premiums earned, gross
Premiums earned
5,939,588 6,032,809 2,987,989 3,018,421 12,137,231
by reinsurers 797,567 791,985 405,735 400,792 1,570,094
Premiums earned - retention 5,142,021 5,240,824 2,582,254 2,617,629 10,567,137
Investment income (losses),
net and finance income
Income from
5,289,458 (5,435,372) 4,371,716 (4,753,868) (5,554,831)
management fees
Income from fees
817,870 762,044 409,328 389,199 1,547,728
and commissions
Income from other
406,078 430,265 192,710 197,051 835,912
financial services 160,000 101,000 90,000 57,000 223,000
Income from factoring
and clearing
90,568 63,827 44,356 35,215 142,754
Other income (Note 4B) 142,083 136,787 137,539 132,104 144,780
Total income 12,048,078 1,299,375 7,827,903 (1,325,670) 7,906,480
Payments and change in
liabilities in respect of
insurance contracts and
investment contracts, gross 10,639,493 (1,282,558) 7,089,554 (2,217,378) 2,988,830
Reinsurers' share in
payments and in changes in
liabilities in respect of
insurance contracts 740,826 607,294 369,803 308,137 1,023,801
Payments and change in
liabilities in respect of
insurance contracts and
investment contracts -
retention 9,898,667 (1,889,852) 6,719,751 (2,525,515) 1,965,029
Fees and commissions,
marketing expenses and
other purchase expenses 1,009,544 922,167 501,784 458,682 1,933,805
General and
administrative expenses 1,003,194 877,458 511,566 444,592 1,805,284
Other expenses 59,846 31,509 39,191 14,926 91,096
Finance expenses 191,536 150,105 95,176 90,464 318,534
Total expenses 12,162,787 91,387 7,867,468 (1,516,851) 6,113,748
Share in profits of equity
accounted investees
43,073 30,274 37,037 26,355 61,548
Profit (loss) before
taxes on income (71,636) 1,238,262 (2,528) 217,536 1,854,280
Taxes on income
(tax benefit) (125,984) 336,902 (90,054) 6,367 504,336
Profit for the period 54,348 901,360 87,526 211,169 1,349,944
Attributed to:
Company's shareholders 1,594 859,963 58,642 184,866 1,257,124
Non-controlling interests 52,754 41,397 28,884 26,303 92,820
Profit for the period 54,348 901,360 87,526 211,169 1,349,944
Earnings per share
attributable to the
Company's shareholders
(in NIS):
Basic earnings per share
Earnings per ordinary share
of NIS 1 par value (in NIS) 0.01 3.42 0.24 0.74 5.00
Diluted earnings
per share
Earnings per ordinary share
of NIS 1 par value (in NIS) 0.01 3.34 0.23 0.71 4.91
Condensed Consolidated interim Statements of Comprehensive Income

Condensed Consolidated Interim Statements of Comprehensive Income

For the six months For the three months For the year ended
ended June 30 ended June 30 December 31
2023 2022 2023 2022 2022
Unaudited Unaudited Audited
NIS thousand
Profit for the period 54,348 901,360 87,526 211,169 1,349,944
Other comprehensive
income (loss):
Amounts that will
be or that have been
reclassified to profit
or loss when specific
conditions are met
Net change in fair value of
financial assets classified as
available for sale, carried to
capital reserves 203,942 (634,247) 191,480 (233,659) (685,971)
Net change in fair value of
financial assets classified as
available for sale, carried to
the income statement
(88,771) (300,044) (41,580) (102,476) (318,278)
Gain on impairment of
financial assets classified as
available for sale, carried to
the income statement 296,895 414,604 76,981 311,690 612,492
The Group's share in other
comprehensive income of
equity-accounted investees 25,734 18,823 9,904 16,416 27,511
Tax effect (140,886) 177,241 (78,052) 8,073 133,322
Total components of net
other comprehensive income
(loss) subsequently
reclassified to profit or loss 296,914 (323,623) 158,733 44 (230,924)
Amounts that shall not
be subsequently
reclassified to profit or
loss
Revaluation of property,
plant and equipment - - - - 124,168
Actuarial gain (loss)
in respect of defined
benefit plans - 1,110 - - 3,684
Company's share in other
comprehensive income
(loss), net of equity
accounted companies - - - - -
Tax effect - (255) - - (29,602)
Total net income
components that will not be
subsequently reclassified to
profit or loss
Total other
- 855 - - 98,250
comprehensive
income (loss), net 296,914 (322,768) 158,733 44 (132,674)
Total comprehensive
income for the period 351,262 578,592 246,259 211,213 1,217,270
Attributed to:
Company's shareholders 298,508 536,933 217,375 184,910 1,123,907
Non-controlling interests 52,754 41,659 28,884 26,303 93,363
Comprehensive 351,262 578,592 246,259 211,213 1,217,270
income for the period

Condensed Cons olidat ed Int erim Statem ents of Changes in Equity Attributed to Company's shareholders
Share
capital
Premium
and
capital
reserves
in
respect
of shares
Treasury
shares
Retained
earnings
Capital
reserve
from
transactions
with non
controlling
interests
Capital
reserve
from
transaction
with
controlling
shareholder
-
bonus
Capital
reserve
from
share
based
payment
NIS thousand
Revaluation
reserve
Reserve
from
translation
differences
Capital
reserve in
respect of
available
for-sale
assets
Total Non
controlling
interests
Total equity
Balance on January 1,
2023 (audited)
Effect of first-time
311,640 851,918 (155,628) 8,013,123 (56,503) 11,000 62,920 224,054 (14,435) 896,669 10,144,758 388,640 10,533,398
application of IFRS 9 (*)
Balance as of January 1,
2023 after first-time
- - - 1,522 - - - - - (1,522) - - -
application of IFRS 9
Net profit
311,640
-
851,918
-
(155,628)
-
8,014,645
1,594
(56,503)
-
11,000
-
62,920
-
224,054
-
(14,435)
-
895,147
-
10,144,758
1,594
388,640
52,754
10,533,398
54,348
Total other
comprehensive income
- - - - - - - - 25,734 271,180 296,914 - 296,914
Total comprehensive
income - - - 1,594 - - - - 25,734 271,180 298,508 52,754 351,262
Share-based payment
Dividend to non
- (216) - - - 9,489 - - - 9,273 - 9,273
controlling interests - - - - - - - - - - - (176,639) (176,639)
Acquisition of
treasury shares - - (12,105) - - - - - - - (12,105) - (12,105)
Exercise of
employee options
1,528 6,320 - - - - (7,848) - - - - - -
Transfer from
revaluation reserve in
respect of revaluation of
property, plant, and
equipment, at the
depreciation amount - - - 1,945 - - - (1,945) - - - - -
Dividend (Note 8H) - - - (177,172) - - - - - - (177,172) - (177,172)
Acquisition of minority
interests (see Note 1H)
- - - - (10,848) - - - - - (10,848) (43,089) (53,937)
Commencement of
consolidation (Note 4B) - - - - - - - - - - - 27,309 27,309
Allocation of shares of a
consolidated company to
minority interests
- - - - 1,730 - - - - - 1,730 2,781 4,511
Transaction with
minority interest
(see Note 1F and 8J) - - - - (199,605) - - - - - (199,605) 196,512 (3,093)
Balance as of June 30,
2023 (unaudited)
313,168 858,022 (167,733) 7,841,012 (265,226) 11,000 64,561 222,109 11,299 1,166,327 10,054,539 448,268 10,502,807

(*) See Note 2B regarding first-time application of IFRS 9 (Financial Instruments) regarding financial instruments that do not relate to The Phoenix Insurance, which falls within the scope of the definition of insurer. According to the transition method that was selected, the comparative figures were not restated.

The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.

Attributed to Company's shareholders
Share
capital
Premium
and
capital
reserves
in
respect
of shares
Treasury
shares
Retained
earnings
Capital
reserve from
transactions
with non
controlling
interests
Capital
reserve
from
transaction
with
controlling
shareholder
-
bonus
Capital
reserve
from
share
based
payment
NIS thousand
Revaluation
reserve
Reserve
from
translation
differences
Capital
reserve in
respect of
available
for-sale
assets
Total Non
controlling
interests
Total equity
Balance on January 1,
2022 (audited)
Net profit
310,323
-
849,309
-
(99,769)
-
7,331,992
859,963
(45,655)
-
11,000
-
51,652
-
131,354
-
(41,946)
-
1,155,104
-
9,653,364
859,963
269,725
41,397
9,923,089
901,360
Other comprehensive
income (loss)
- - - 593 - - - - 18,823 (342,446) (323,030) 262 (322,768)
Total comprehensive
income (loss)
Share-based payment
-
-
-
(4,993)
-
-
860,556
-
-
-
-
-
-
10,035
-
-
18,823
-
(342,446)
-
536,933
5,042
41,659
-
578,592
5,042
Dividend paid to non
controlling interests
- - - - - - - - - - - (8,716) (8,716)
Acquisition of
treasury shares
Dividend
Commencement
-
-
-
-
(55,859)
-
-
(421,000)
-
-
-
-
-
-
-
-
-
-
-
-
(55,859)
(421,000)
-
-
(55,859)
(421,000)
of consolidation - - - - - - - - - - - 50,624 50,624
Exercise of
employee options
Transfer from revaluation
reserve in respect of
revaluation of property,
plant and equipment, at
191 980 - - - - (1,171) - - - - - -
the depreciation amount
Acquisition of non
- - - 1,514 - - - (1,514) - - - - -
controlling interests
Allocation of shares of a
consolidated company to
(12,000) - - (12,000) - (12,000)
minority interests - - - - 1,379 - - - - - 1,379 833 2,212
Balance as of June 30,
2022 (unaudited)
310,514 845,296 (155,628) 7,773,062 (56,276) 11,000 60,516 129,840 (23,123) 812,658 9,707,859 354,125 10,061,984

The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.

Attributed to Company's shareholders
Share
capital
Premium
and
capital
reserves
in
respect
of shares
Treasury
shares
Retained
earnings
Capital
reserve from
transactions
with non
controlling
interests
Capital
reserve
from
transaction
with
controlling
shareholder
-
bonus
Capital
reserve
from
share
based
payment
NIS thousand
Revaluation
reserve
Reserve
from
translation
differences
Capital
reserve in
respect of
available-for
sale assets
Total Non
controlling
interests
Total equity
Balance as of
April 1, 2023
(unaudited)
Net profit
Total other
311,817
-
851,225
-
(161,926)
-
7,781,449
(*)
58,642
(135,725)
-
11,000
-
67,407
-
223,030
-
1,395
-
1,017,498 (*)
-
9,967,170
58,642
449,122
28,884
10,416,292
87,526
comprehensive
income
Total
- - - - - - - - 9,904 148,829 158,733 - 158,733
comprehensive
income
Share-based
- - - 58,642 - - - - 9,904 148,829 217,375 28,884 246,259
payment
Dividend to non
controlling
- 1,428 - - - - 3,874 - - - 5,302 - 5,302
interests (see
Note 1F)
- - - - - - - - - - - (148,818) (148,818)
Acquisition of
treasury shares
- - (5,807) - - - - - - - (5,807) - (5,807)
Exercise of
employee options
Transfer from
revaluation
reserve in respect
of revaluation of
property, plant,
and equipment,
at the
1,351 5,369 - - - - (6,720) - - - - - -
depreciation
amount
Acquisition of
- - - 921 - - - (921) - - - - -
minority interests
(see Note 1H)
Commencement
- - - - (9,985) - - - - - (9,985) (30,479) (40,464)
of consolidation
(Note 4B)
Allocation of
shares of a
consolidated
- - - - - - - - - - - 27,309 27,309
company to
minority interests
Transaction with
- - - - 896 - - - - - 896 1,838 2,734
minority interest
(see Note 1F)
Balance as of
- - - - (120,412) - - - - - (120,412) 120,412 -
June 30, 2023
(unaudited)
313,168 858,022 (167,733) 7,841,012 (265,226) 11,000 64,561 222,109 11,299 1,166,327 10,054,539 448,268 10,502,807

(*) Reclassified.

The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.

Attributed to Company's shareholders
Share
capital
Premium
and
capital
reserves
in respect
of shares
Treasury
shares
Retained
earnings
Capital
reserve from
transactions
with non
controlling
interests
Capital
reserve
from
transaction
with
controlling
shareholder
-
bonus
Capital
reserve
from
share
based
payment
NIS thousand
Revaluation
reserve
Reserve
from
translation
differences
Capital
reserve
in respect
of
available
for-sale
assets
Total Non
controlling
interests
Total equity
Balance as of April
1, 2022 (unaudited)
Net profit
310,366
-
851,131
-
(155,628)
-
7,587,379
184,866
(45,408)
-
11,000
-
56,835
-
130,657
-
(39,539)
-
829,030
-
9,535,823
184,866
278,224
26,303
9,814,047
211,169
Other
comprehensive
income (loss)
- - - - - - - - 16,416 (16,372) 44 - 44
Total
comprehensive
income (loss)
- - - 184,866 - - - - 16,416 (16,372) 184,910 26,303 211,213
Share-based
payment
- (6,568) - - - - 4,562 - - - (2,006) - (2,006)
Dividend to non
controlling interests
- - - - - - - - - - - (1,780) (1,780)
Commencement
of consolidation
Exercise of
- - - - - - - - - - - 50,624 50,624
employee options
Transaction with
148 733 - - - - (881) - - - - - -
minority interest
Transfer from
revaluation reserve
in respect of
revaluation of
property, plant and
- - - - - - - - - - 85 85
equipment, at the
depreciation
amount
Acquisition of non
- - - 817 - - - (817) - - - - -
controlling interests
Allocation of shares
of a consolidated
- - - - (12,000) - - - - - (12,000) - (12,000)
company to
minority interests
Balance as of June
- - - - 1,132 - - - - - 1,132 669 1,801
30, 2022
(unaudited)
310,514 845,296 (155,628) 7,773,062 (56,276) 11,000 60,516 129,840 (23,123) 812,658 9,707,859 354,125 10,061,984

The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.

Attributed to Company's shareholders
Share
capital
Premium
and
capital
reserves
in respect
of shares
Treasury
shares
Retained
earnings
Capital
reserve
from
transactions
with non
controlling
interests
Capital
reserve from
transactions
with
controlling
shareholders
Capital
reserve
from
share
based
payment
NIS thousand
Revaluation
reserve
Reserve
from
translation
differences
Capital
reserve in
respect of
available
for-sale
assets
Total Non
controlling
interests
Total equity
Balance on January
1, 2022 (audited)
Net profit
Total other
310,323
-
849,309
-
(99,769)
-
7,331,992
1,257,124
(45,655)
-
11,000
-
51,652
-
131,354
-
(41,946)
-
1,155,104
-
9,653,364
1,257,124
269,725
92,820
9,923,089
1,349,944
comprehensive
income (loss)
Total
- - - 2,097 - - - 95,610 27,511 (258,435) (133,217) 543 (132,674)
comprehensive
income (loss)
Share-based
- - - 1,259,221 - - - 95,610 27,511 (258,435) 1,123,907 93,363 1,217,270
payment
Exercise of
- (2,362) - - - - 17,556 - - - 15,194 - 15,194
employee options
Acquisition of
1,317 4,971 - - - - (6,288) - - - - - -
treasury shares
Dividend paid to
- - (55,859) - - - - - - - (55,859) - (55,859)
non-controlling
interests
- - - - - - - - - - - (74,665) (74,665)
Commencement
of consolidation
- - - - - - - - - - - 53,886 53,886
Dividend
Transfer from
revaluation reserve
in respect of
revaluation of
property, plant, and
equipment, at the
depreciation
- - - (581,000) - - - - - - (581,000) - (581,000)
amount
Allocation of shares
of a consolidated
company to
- - - 2,910 - - - (2,910) - - - - -
minority interests - - - - 3,587 3,587 49,713 53,300
Transaction with
minority interest
Balance on
- - - - (14,435) - - - - - (14,435) (3,382) (17,817)
December 31, 2022
(audited)
311,640 851,918 (155,628) 8,013,123 (56,503) 11,000 62,920 224,054 (14,435) 896,669 10,144,758 388,640 10,533,398

The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.

Condensed Consolidated Interim Statements of Cash Flow

Consolidated Int erim Statements of Cash Flow For the six months For the three months For the year ended
ended June 30
2023
2022 ended June 30
2023
2022 December 31
2022
Unaudited Audited
Appendix NIS thousand
Cash flows from
operating activities
Profit for the period
54,348 901,360 87,526 211,169 1,349,944
Adjustments required to
present cash flows from
operating activities (a) 1,694,335 (62,472) 2,527,725 47,255 1,379,463
Net cash from
operating activities 1,748,683 838,888 2,615,251 258,424 2,729,407
Cash flows from
investing activities
Purchase of property,
plant and equipment (168,618) (64,222) (85,146) (34,538) (190,135)
Proceeds from disposal of
property, plant and equipment 8 171 6 10 342
Investment in associates (88,032) (57,525) (64,212) (56,295) (160,281)
Dividend from associates 11,749 19,657 10,448 7,802 41,580
Change in loans
granted to associates
Acquisition of consolidated
530 705 1,056 355 (3,688)
companies consolidated
for the first time (b) (48,000) (6,407) - (6,949) (9,775)
Proceeds from the sale of
pension funds, provident
funds, and fees and
commissions portfolios 45 25,049 - 25,014 30,372
Acquisition of minority interest
in a consolidated company
(39,925) (12,000) (27,395) (12,000) (17,817)
Proceeds from disposal of
investment in associate 101,209 - 81,457 - 108,158
Acquisition and capitalization
of intangible assets costs (200,128) (146,623) (117,376) (76,936) (334,726)
Net cash used for
investing activities
Cash flows from
(431,162) (241,195) (201,162) (153,537) (535,970)
financing activities
Issuance of shares to non
controlling interests in a
consolidated company - - - - 49,713
Acquisition of Company shares (12,105) (55,859) (5,807) - (55,859)
Short-term credit
from banks, net
Repayment of financial liabilities
(93,000)
(661,079)
369,000
(452,150)
(129,000)
(181,719)
302,000
(37,782)
420,000
(651,637)
Dividend to shareholders (177,172) (421,000) (177,172) (421,000) (581,000)
Repayment of lease
liability principal (21,842) (26,028) (11,071) (17,652) (50,082)
Issuance/receipt
of financial liabilities 557,038 1,305,911 408,670 697,568 1,910,320
Change in liability for REPO, net
Dividend paid to non-controlling
771,559 - (273,461) - 708,302
interests (37,670) (8,716) (9,849) (1,780) (74,665)
Repayment of contingent liability
in respect of a put option to
non-controlling interests - - - - (10,000)
Net cash provided by
(used in) financing activities 325,729 711,158 (379,409) 521,354 1,665,092
Increase in cash
and cash equivalents
1,643,250 1,308,851 2,034,680 626,241 3,858,529
Balance of cash and
cash equivalents at
beginning of period (c) 19,798,275 15,939,746 19,406,845 16,622,356 15,939,746
Balance of cash and cash
equivalents at end of period (c) 21,441,525 17,248,597 21,441,525 17,248,597 19,798,275

Condensed Consolidated Interim Statements of Cash Flow

For the six months
ended June 30
ended June 30 For the three months For the year ended
December 31
2023 2022 2023 2022 2022
Unaudited Audited
Adjustments required to present NIS thousand
cash flows from operating activities:
Items not involving cash flows
Investment losses (income),
net on financial investments in
respect of insurance contracts and
yield-dependent investment contract
(4,317,567) 6,135,612 (3,480,401) 4,957,622 7,404,308
Change in fair value of investment property
in respect of yield-dependent contracts
8,571 - - - (199,182)
Losses (income), net on
other financial investments
Liquid debt assets 67,891 11,775 (46,459) (3,435) 137,976
Illiquid debt assets (886,428) (747,487) (448,521) (441,559) (1,449,128)
Shares 48,849 (199,548) 21 48,444 (155,913)
Other 362,726 622,718 91,722 544,721 691,349
Depreciation and amortization
Loss from disposal of
218,262 194,191 106,835 104,098 408,658
property, plant and equipment - (2) - - -
Profit from sale of provident funds
Change in fair value of investment property
-
4,676
(14,185)
6,286
-
-
(14,185)
-
(14,185)
(96,200)
Gain on notional disposal as a result
of gaining control of an investee
(129,096) (108,942) (129,096) (108,942) (109,586)
Change in financial liabilities 726,529 3,374,687 (201,922) 3,017,433 1,899,625
Expenses on income tax (tax benefit) (125,984) 336,902 (90,054) 6,367 504,336
Company's share in the
profits of associates, net (43,073) (30,274) (37,037) (26,355) (61,548)
Payroll expenses in respect
of share-based payment 9,489 10,035 3,874 4,562 17,556
Changes in other balance
sheet line items, net:
Change in liabilities in respect of
non-yield-dependent insurance contracts
Change in liabilities in respect
1,791,011 202,527 1,140,304 342,705 345,510
of yield-dependent contracts 4,306,400 (2,513,828) 3,741,443 (3,489,199) (1,586,491)
Change in liabilities for bonds, ETFs (7,698) 10,058 7,543 23,058 (4,302)
Change in financial investments for
holders of ETFs, certificates of deposit 7,000 (11,000) (9,000) (24,000) 5,000
Change in credit assets in respect of
factoring, clearing and financing (45,516) (657,930) (50,074) (497,151) (892,945)
Change in deferred acquisition costs (201,149) (270,378) (60,474) (124,758) (442,735)
Change in reinsurance assets (432,091) (360,653) (225,141) (204,172) (365,703)
Change in liabilities for
employee benefits, net
8,831 11,850 2,006 698 (2,469)
Change in accounts receivable
and collectible premiums (449,948) (623,726) 90,418 (401,776) (123,460)
Change in payables and credit balances 558,719 307,484 637,889 234,851 506,544
Change in credit for purchase of securities 10,000 (257,000) (46,000) (201,000) (268,000)
Revaluation of loans granted to associates 453 2,403 - 3,479 (1,100)
Financial investments and investment
property in respect of insurance contracts
and yield-dependent investment contracts:
Acquisition of real estate properties
Proceeds on sale of real estate properties
(73,432)
-
(60,582)
219,844
(65,455)
-
(34,422)
123,045
(99,874)
219,844
Sales (acquisitions), net
of financial investments 1,108,247 (3,304,874) 1,107,704 (1,239,699) (3,699,920)
Financial investments and other investment
property:
Sales (acquisitions), net
of financial investments (592,115) (2,064,056) 576,970 (2,337,427) (540,903)
Acquisition of real estate properties (42,130) (38,522) (37,470) (18,005) (58,419)
Proceeds on sale of real estate properties - 119,055 - 66,255 119,054
Cash paid and received
during the period for:
Taxes paid
Taxes received
(262,132)
65,040
(401,238)
36,326
(51,899)
(1)
(265,070)
1,072
(765,600)
57,366
Total cash flows provided by
(used for) operating activities 1,694,335 (62,472) 2,527,725 47,255 1,379,463

Condensed Consolidated Interim Statements of Cash Flow

For the six months For the three months For the year ended
ended June 30 ended June 30 December 31
2023 2022 2023 2022 2022
Unaudited NIS thousand Audited
Acquisition of consolidated companies
(b) consolidated for the first time
Assets and liabilities of the consolidated
companies as of acquisition date:
Working capital (excluding
cash and cash equivalents) (3,000) 22,346 - 21,879 27,944
Property, plant and equipment, net - (783) - (145) (877)
Goodwill arising from acquisition (149,793) (82,272) (113,793) (35,741) (79,216)
Intangible assets (115,277) (64,925) (103,277) (64,925) (111,217)
Deferred taxes 38,310 6,190 35,310 4,173 23,020
Minority interests 27,309 50,624 27,309 50,624 53,886
Investments in investees
Disposal of investment in an associate
-
129,096
(74,732)
114,983
-
129,096
(74,732)
114,983
(72,109)
115,627
Financial liabilities - 733 - 733 8,614
Liability for payment in respect
of acquisition of an investee - 21,050 - (23,950) 24,134
Liabilities for employee benefits - 379 - 152 419
Payables for acquisition of a subsidiary 25,355 - 25,355 - -
(48,000) (6,407) - (6,949) (9,775)
(c) Cash and cash equivalents
Balance of cash and cash
equivalents at beginning of period:
Cash and cash equivalents 3,439,766 2,154,153 2,267,523 3,380,462 2,154,153
Cash and cash equivalents in 16,358,509 13,785,593 17,139,322 13,241,894 13,785,593
respect of yield-dependent contracts 19,798,275 15,939,746 19,406,845 16,622,356 15,939,746
Balance of cash and cash
equivalents at end of period:
Cash and cash equivalents 2,713,058 2,459,240 2,713,058 2,459,240 3,439,766
Cash and cash equivalents in respect
of yield-dependent contracts 18,728,467 14,789,357 18,728,467 14,789,357 16,358,509
21,441,525 17,248,597 21,441,525 17,248,597 19,798,275
(d) Significant non-cash activities
Recognition of right-of-use
asset against a lease liability (17,147) (40,334) (9,317) (35,654) (52,319)
Dividend declared for
non-controlling interests (138,969) - (138,969) - -
Sale of a consolidated company
consolidated for the first time
(25,355) - (25,355) - -
Acquisition of minority interest
in a consolidated company (11,231) - (11,231) - -
Breakdown of amounts
(e) included in operating activities
Interest paid 135,581 75,514 63,261 27,690 178,990
Interest received 609,626 438,572 446,202 318,828 957,447
Dividend received 34,672 29,591 14,084 21,961 47,571

NOTE 1 - GENERAL

Notes to the Condensed Consolidated Int erim Financial Stat ements

  • A. The Phoenix Holdings Ltd. (hereinafter the "Company") is an Israeli resident company incorporated in Israel, whose official address is 53 Derech Hashalom St., Givatayim, Israel. These financial statements were prepared in condensed format as of June 30, 2023 and for the sixmonth and three-month periods then ended (hereinafter - the "Condensed Consolidated Interim Financial Statements"). These financial statements should be read in conjunction with the Company's Annual Financial Statements as of December 31, 2022 and for the year then ended and the accompanying notes (hereinafter - the "Consolidated Annual Financial Statements").
  • B. Definitions
The Company - The Phoenix Holdings Ltd.
The Group - The Phoenix Holdings Ltd. and its consolidated companies.
The Phoenix
Insurance
- The Phoenix Insurance Company Ltd., a wholly-owned subsidiary.
The Phoenix
Investments
- The Phoenix Investments and Finances Ltd., a wholly-owned
subsidiary.
The Phoenix
Investment
House
- The
Phoenix
Investment
House
Ltd.
(formerly
Excellence
Investments Ltd.), a subsidiary of The Phoenix Investments, is a
wholly-owned subsidiary of the Company.
The Phoenix
Advanced
Investments
- The Phoenix Advanced Investments Ltd., a wholly-owned
subsidiary of The Phoenix Investments.
Gama Gama Management and Clearing Ltd., a subsidiary in which The
Phoenix Investments is a controlling shareholder.
The Phoenix
Agencies
- The Phoenix Insurance Agencies 1989 Ltd. is held by the Company
at 80%. For further details, please see Note 1F.
The Phoenix Pension
and Provident Fund
- The Phoenix Pension and Provident Funds Ltd., a wholly-owned
subsidiary of the Company.
The Phoenix
Capital Raising
- The Phoenix Capital Raising (2009) Ltd., a wholly-owned
subsidiary of The Phoenix Insurance.
Belenus Lux S.a.r.l - The controlling shareholder, held indirectly by Centerbridge
Partners LP and Gallatin Point Capital LLC (hereinafter - the
"Funds"). Centerbridge Partners LP is controlled by CCP III
Cayman GP Ltd. and Gallatin Point Capital LLC is controlled by
Matthew Botein, Lewis (Lee) Sachs.
Phoeniclass - Phoeniclass Ltd., an investee of The Phoenix Insurance and The
Phoenix Investments.
The Commissioner The Commissioner of the Capital Market, Insurance and Savings.

NOTE 1 - GENERAL (cont.)

C. Control of The Phoenix Holdings

The controlling shareholder of the Company is Belenus Lux S.à.r.l. (hereinafter - "Belenus"), which is held indirectly, through a number of companies, by Centerbridge Partners LP and Gallatin Point Capital LLC. Centerbridge Partners LP is controlled by CCP III Cayman GP Ltd. and Gallatin Point Capital LLC is controlled by Matthew Botein, Lewis (Lee) Sachs.

In December 2022, the Company reported that a consortium of investors from the United Arab Emirates alongside other international investors are assessing the option of acquiring the control core in the Company from Belenus, and the parties' signing a memorandum of understanding. In July 2023, the Company reported that the parties reached a mutual understanding regarding the cancellation of the memorandum of understanding and concurrently, on the execution of a transaction for the sale of Belenus shares to the consortium, with Belenus retaining a stake of at least 30% of its shares, fully diluted. On August 14, a transaction for the sale of 2% of the Company's shares to a company controlled by an investor from the United Arab Emirates was completed, and as of the report's publication date Belenus holds 31.15% of the Company's shares. For further details, please see reports dated December 13, 2022, July 23, 2023 and August 15, 2023 (Ref. Nos.: 2022-01-150541, 2023-01-068953 and 2023-01-075799, respectively).

D. Effects of inflation and increase in interest rates

Further to global macroeconomic developments, which started in 2022 and continued through the report publication date, inflation rates in Israel and across the world have exceeded inflation targets of central banks. Further to steps taken to curb price increases, central banks across the world, including the Bank of Israel, continued to increase interest rates. Changes in inflation rates, interest rates and the illiquidity premium (which is calculated based on the average up-to-date and historical spreads of the bonds included in the Tel-Bond 60 Index) affect the Company's financial results, and mainly those of The Phoenix Insurance. For information about the effect of the change in interest rates in the reporting periods on the Company's financial results, see Note 8A. For information about the financial results' sensitivity to changes in interest and inflation rates, see Note 41 Section 3.2 to the Consolidated Annual Financial Statements.

E. The legal reform

In recent months, there has been uncertainty regarding the government's plans to promote changes in the judicial system, and the growing public controversy surrounding this move. During January 2023, the government began promoting a plan to make fundamental changes in the legal system in Israel, which led to controversy and widespread public protests. In July 2023, protesters intensified their protest against the legislation of the Basic Law: The Judiciary (Amendment No. 3) - Abolishing the Standard of Reasonableness, which was passed by the Knesset on July 24, 2023. Against the backdrop of promoting the changes in the judiciary, in April 2023, Moody's the international rating agency - published Israel's credit rating, leaving the rating unchanged at A1, and changing the credit rating outlook from "positive" to "stable" following its assessments regarding developments that will arise from the implementation of the changes. In May 2023, S&P - the international rating agency published Israel's credit rating. S&P reiterated Israel's AArating with a stable outlook, based on the assumption that agreement will be reached regarding the reform in the legal system.

In July 2023, immediately prior to the revocation of the standard of reasonableness, Moody's and S&P published special reports in response to the legislation of the law for the abolishment of the standard of reasonableness, which emphasized the risks and the concerns regarding potential adverse effects on the Israeli economy, which might arise from further unilateral legislation. However, no changes were made to the rating of the State of Israel and/or its rating outlook. In addition, credit rating agency Fitch reiterated Israel's credit rating at A+ and the rating outlook at "stable", but also issued a warning regarding further future developments.

At this stage the Company is unable to assess future developments, or the effect of those events on the Israeli economy in general and the Company's activity in particular.

NOTE 1 - GENERAL (cont.)

F. In December 2022, the competent organs of The Phoenix Agencies and Agam Leaderim Holdings (2001) Ltd. (hereinafter - "Agam Holdings"), a company in which The Phoenix Agencies has a 60% stake, approved a merger offer between the two aforesaid companies, in accordance with a merger agreement under which Agam Holdings will be wound up and merged with and into The Phoenix Agencies in consideration for allotment of ordinary shares of The Phoenix Agencies that will be issued to the other shareholders of Agam Holdings, such that after the execution of the merger the Company will hold 80% of the shares of The Phoenix Agencies, and the other shareholders will hold the remaining shares. Furthermore, the Company and the other shareholders signed an agreement whereby, subject to the provisions of any law, immediately after the completion of the merger, The Phoenix Agencies shall distribute a dividend at an amount equal to the distributable profits for tax purposes, in accordance with The Phoenix Agencies' financial statements as of March 31, 2023; the profit is estimated at NIS 670 million.

The merger was completed in June 2023 after the fulfillment of all conditions precedent; accordingly, The Phoenix Agencies declared a NIS 675 million cash dividend, of which NIS 250 million were paid as of the publication date of the financial statements. In addition, it was decided that if The Phoenix Agencies will require shareholder loans in order to execute the said Dividend Distribution, the Company and the other shareholders shall advance shareholder loans at a total maximum amount of up to NIS 500 million, based on their proportionate share in The Phoenix Agencies' issued share capital. As a result of the merger, the equity attributed to the Company's shareholders decreased by NIS 120 million. For further details, please see Note 8E(3) to the Annual Financial Statements.

G. Global rating for The Phoenix Insurance On May 23, 2023 Moody's - the international rating agency - announced the assignment of an A2 international credit rating with a stable outlook to The Phoenix Insurance.

H. Full tender offer in respect of Gama shares

During the reporting period, The Phoenix Investments purchased 4.2 million Gama shares for a total consideration of NIS 42 million. Subsequent to the reporting period, The Phoenix Investments purchased further 6.6 million Gama shares for a total consideration of NIS 73 million. As of June 30, 2023 and the report's publication date, The Phoenix Investments holds 67.15% and 76.87% of Gama's shares, respectively.

Subsequent to these acquisitions, in August 2023, The Phoenix Investments published a full tender offer (whose validity is conditional upon the acquisition of all of the offerees' shares) to acquire all of Gama's shares.

If the full tender offer will come to fruition, the consideration which The Phoenix Investments is expected to pay will amount to NIS 220 million. It should be clarified that it is uncertain whether the tender offer will, indeed, be completed successfully. For further details, please see the immediate report dated August 10, 2023 (Ref. No. 2023-01-074644).

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

A. Preparation format of the consolidated interim financial statements

The consolidated interim financial statements of the Company have been drawn up in accordance with the provisions of the Securities Regulations (Periodic and Immediate Reports), 1970. In accordance with these provisions, those financial statements data that relate to a consolidated subsidiary, which falls within the scope of the definition of insurer, as defined in the Securities Regulations (Preparation of Annual Financial Statements), 2010, are drawn up in accordance with the requirements set by the Commissioner in accordance with the Financial Services Supervision Law (Insurance), 1981.

In accordance with requirements set by the Commissioner, the first-time application date of IFRS 17 regarding Insurance Contracts and IFRS 9 regarding Financial Instruments was postponed to January 1, 2025 (instead of the first-time application date that was set in the standard itself - January 1, 2023). Consequently, during the periods through the date of first-time application in Israel, those data in the financial statements that relate to The Phoenix Insurance, as stated above, continue to be drawn up in accordance with IFRS 4 regarding Insurance Contracts, and IAS 39 (of 2017) regarding Financial Instruments.

In addition, data included in The Phoenix Insurance's consolidated financial statements, which do not relate to IFRS 17 and IFRS 9 as stated above, and the remaining data in the consolidated financial statements, are drawn up in accordance with IAS 34 - "Interim Financial Reporting". In addition, the financial statements were prepared in accordance with the disclosure provisions in Chapter D of the Securities Regulations (Periodic and Immediate Reports), 1970, insofar as these regulations apply to a corporation consolidating an insurance company.

In preparing the condensed financial statements in accordance with the above, the Company is required to exercise discretion in assessments, estimates and assumptions that affect the implementation of the policy and the amounts of assets and liabilities, income and expenses. It is clarified that the actual results may differ from those estimates. Management's discretion in applying the group's accounting policies and the key assumptions used in assessments involving uncertainty is consistent with that which is applied in the preparation of the Consolidated Annual Financial Statements. For further information regarding changes in critical estimates and assumptions used to calculate the insurance reserves, please see Note 8.A.

The accounting policies applied in the preparation of the Consolidated Interim Financial Statements are consistent with those implemented in the preparation of the Consolidated Annual Financial Statements, with the exception of what is stated below:

IFRS 9 - Financial Instruments:

As described in Note 2.B.1 below regarding the first-time application of IFRS 9 - Financial Instruments (hereinafter - the "Standard") in respect of the financial instruments that do not belong to a consolidated subsidiary, which falls within the scope of the definition of insurer, the Company opted to apply the provisions of the Standard retrospectively, without restating comparative figures.

For information regarding the accounting policy that was applied through December 31, 2022 in respect of all financial instruments, and for information regarding the accounting policy that is applied in respect of the financial instruments that belong to a consolidated subsidiary, which falls within the scope of the definition of insurer - see Note 2K - to the Company's Consolidated Annual Financial Statements.

The accounting policy applied as from January 1, 2023 regarding financial instruments that do not belong to a consolidated subsidiary, which falls within the scope of the definition of insurer, is as follows:

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (cont.)

A. Preparation format of the consolidated interim financial statements (cont.)

IFRS 9 - Financial Instruments (cont.)

1. Financial assets

Financial assets under the scope of the standard are measured on initial recognition at fair value plus transaction costs that are directly attributable to the purchase of the financial asset, except for financial assets that are measured at fair value through profit or loss, for which transaction costs are carried to profit or loss.

The Company classifies and measures the debt instruments in its financial statements based on the following criteria:

  • (a) The Company's business model for managing financial assets, and
  • (b) Contractual cash flow characteristics of the financial asset.

1a) Measurement of debt instruments at amortized cost

The Company's financial model is to hold the financial assets in order to collect contractual cash flows; furthermore, the contractual terms and conditions of the financial asset provide entitlement, at specified dates, to cash flows that are only principal and interest payments in respect of the outstanding principal amount.

Subsequent to initial recognition, instruments included in this group shall be presented according to their terms at cost, plus direct transaction costs, using the amortized cost method.

Furthermore, an entity may designate a financial instrument irrevocably on initial recognition as measured at fair value through profit or loss, if such designation eliminates or significantly reduces a measurement or recognition inconsistency. For example, where the relating financial liabilities are also measured at fair value through profit or loss.

1b) Measurement of debt instruments at fair value through other comprehensive income

The Company's business model is both to hold the financial assets in order to collect contractual cash flows and to sell the financial assets; furthermore, the contractual terms and conditions of the financial asset provide entitlement, at specified dates, to cash flows that are only principal and interest payments in respect of the outstanding principal amount. Subsequent to initial recognition, instruments in this group are measured at fair value. Gains or losses arising from fair value adjustments, except for interest and exchange rate differentials are recognized in other comprehensive income.

1c) Measurement of debt instruments at fair value through profit or loss

A financial asset that constitutes a debt instrument does not comply with the criteria for measurement at amortized cost or at fair value through other comprehensive income, including a financial asset that constitutes a debt instrument, which, under certain conditions, is designated to be subsequently measured at fair value through profit or loss. Subsequent to initial recognition, the financial asset is measured at fair value; gains or losses arising from fair value adjustments are charged to profit or loss.

A. Preparation format of the consolidated interim financial statements (cont.)

IFRS 9 - Financial Instruments (cont.)

    1. Financial assets (cont.)
  • 1d) Measurement of equity instruments

Financial assets that constitute investments in equity instruments do not comply with the said criteria and are therefore measured at fair value through profit or loss. In connection with equity instruments that are not held for trading the Company may, on initial recognition, irrevocably opt to present in other comprehensive income subsequent changes in fair value, which would have otherwise been measured at fair value through profit or loss. These changes will not be recognized in profit or loss in the future, even when the investment is derecognized.

  1. Impairment of financial assets

At each reporting date, the Company tests the provision for loss in respect of financial debt instruments that are not measured at fair value through profit or loss should be estimated. The Company differentiates between two situations of recognition of a provision for loss:

  • A) Debt instruments with no significant impairment in credit quality since initial recognition or with a low credit risk - the provision for loss recognized for this debt instrument will take into account expected credit losses in the 12 months period after the reporting date; or
  • B) Debt instruments with significant deterioration in credit quality since initial recognition and their credit risk is not low, the provision for loss recognized will take into account the expected credit losses - over the balance of the useful life of the instrument. The Company applies the expedient, according to which it assumes that the credit risk of a debt instrument has not increased significantly since its initial recognition, if it is determined, at the reporting date, that the instrument has low credit risk, for example

  • if the instrument has an external "investment grade" rating. The impairment in respect of debt instruments measured at amortized cost shall be recognized in profit or loss against a provision, whereas the impairment in respect of debt instruments measured at fair value through other comprehensive income shall be recognized against capital reserve, and will not reduce the carrying amount of the financial asset in the statement of financial position.

The Company has financial assets with short credit periods, to which it may apply the expedient set forth in the model, i.e., the Company measures the impairment provision at an amount equal to expected credit losses throughout the entire life of the instrument. The Company opted to apply the expedient available in respect of these financial assets.

A. Preparation format of the consolidated interim financial statements (cont.)

IFRS 9 - Financial Instruments (cont.)

  1. Derecognition of financial assets

The Company derecognizes a financial asset if and only if:

  • A. The contractual rights to the cash flows from the financial asset have expired, or
  • B. The Company transfers substantially all the risks and rewards arising from the contractual rights to receive the cash flows from the financial asset or when some of the risks and rewards upon the transfer of the financial asset remain in the hands of the entity but the Company can be said to have transferred control over the asset.
  • C. The Company retains the contractual rights to receive the cash flows arising from the financial asset, but assumes a contractual obligation to pay these cash flows in full to a third party, without any substantial delay.

Transactions for the sale of financial assets are accounted for as a derecognition when the conditions specified above are fulfilled.

If the Company transfers its rights to receive cash flows from an asset and neither transfers nor retains substantially all the risks and rewards of the asset or transfers control thereof, a new asset is recognized in accordance with the Company's continuing involvement therein. Continuing involvement by way of providing a guarantee for the transferred asset is measured at the lower of the original balance of the asset in the financial statements and the maximum amount of consideration that the Company may be required to repay (the guarantee amount).

When the Company continues to recognize an asset to the extent of its continuing involvement, the entity also recognizes an associated liability. The associated liability is measured in such a way that the net carrying amount of the transferred asset and the associated liability is:

  • (a) The amortized cost of the rights and obligations retained by the entity, if the transferred asset is measured at amortized cost; or
  • (b) Equal to the fair value of the rights and obligations retained by the company when measured on a stand-alone basis, if the transferred asset is measured at fair value.
    1. Financial liabilities

At initial recognition, the Company measures the financial liabilities that fall within the scope of the standard at fair value net of transaction costs that are directly attributable to the issue of the financial liability, except for financial liability measured at fair value through profit or loss, for which transaction costs are recognized in profit or loss.

Upon initial recognition, the Company designated a financial liability as a liability measured at fair value through profit or loss. Changes in the fair value of the financial liability that are attributable to changes in the Company's credit risk are presented in other comprehensive income.

A. Preparation format of the consolidated interim financial statements (cont.)

IFRS 9 - Financial Instruments (cont.)

  1. Financial Liabilities (cont.)

Subsequent to initial recognition, the Company measures all financial liabilities at amortized cost, except for:

  • (a) Financial liabilities measured at fair value through profit or loss, such as: derivatives;
  • (b) Financial liabilities that arise when a transfer of a financial asset does not qualify for derecognition or the continuing involvement approach applies;
  • (c) financial guarantee contracts;
  • (d) Commitment to advance a loan at an interest rate which is lower than the market interest rate;
  • (e) contingent consideration recognized by an acquirer in a business combination that falls within the scope of IFRS 3.

5. Derecognition of financial liabilities

The Company derecognizes a financial liability if and only if it is extinguished - that is to say, when the obligation established in a contract is repaid or canceled or expires.

A financial liability is extinguished when the debtor repays the liability by a cash payment, other financial assets, goods or services, or is legally released from the liability.

If the terms of an existing financial liability change, the Company assesses whether the terms of the liability are materially different than the existing terms.

When a material change has been made to the terms of an existing financial liability, the change is accounted for as a derecognition of the original liability and a recognition of a new liability. The difference between the balance of the two liabilities in the financial statements is carried to profit or loss.

In the event that the change is immaterial, the Company is required to update the liability amount, that is to say, to discount the new cash flows at the original effective interest rate, and the differences will be recognized in profit or loss.

When determining whether a change has occurred in the substantive terms and conditions of an existing liability, the Company takes qualitative and quantitative considerations into account.

6. Offsetting financial instruments

Financial assets and financial liabilities are offset and the net amount is presented in the statement of financial position if there is a legally enforceable right to set off the recognized amounts and there is an intent to dispose of the asset and liability on a net basis or realize the asset and dispose of the liability simultaneously. The right to offset must be legally enforceable not only in the ordinary course of business of the parties to the contract, but also in the event of bankruptcy or insolvency of one of the parties. In order for the offset right to be readily available, it must not be contingent on a future event, or have periods of time in which it is inapplicable, nor events that may cause it to expire.

A. Preparation format of the consolidated interim financial statements (cont.)

IFRS 9 - Financial Instruments (cont.)

7. Compound financial instruments

Convertible bonds, that include an equity conversion component and a liability component are split into two components. Such a split is calculated by first determining the value of the liability component based on the fair value of a similar liability without a conversion option; the value of the equity conversion component is determined as residual value. Direct transaction costs were allocated between the equity component and the liability component based on the allocation of the consideration between the equity component and the liability component.

8. Issuance of a package of securities

When a package of securities is issued, the consideration received (before issuance expenses) is allocated to the securities issued as part of the package in accordance with the following allocation order: financial derivatives and other financial instruments presented periodically at fair value. Thereafter, the fair value is determined for financial liabilities measured at amortized cost, and the consideration allocated to equity instruments is determined as residual value. Issuance costs are allocated to each component in accordance with the ratio of the amounts that was determined for each component of the package.

9. Put option granted to non-controlling interests

When the Group grants a put option to non-controlling interests, the option is classified as a financial liability and the non-controlling interests' share in the profits of the consolidated company is not conferred upon them. At each reporting date, the financial liability is measured at the present value of the estimated consideration to be transferred when the put option or is exercised based on the fair value of the consideration determined. Changes in the liabilities are recognized in profit or loss.

10. Settlement of financial liabilities through equity instruments

Equity instruments that were issued in order to replace debt are measured at the fair value of the equity instruments that were issued, if it may be reliably estimated. If the fair value of the issued equity instrument cannot be reliably measured, the equity instruments are measured in accordance with the fair value of the settled financial liability on its settlement date. The difference between the financial statement balance of the extinguished financial liability and the fair value of the issued equity instruments is recognized in profit or loss.

11. Embedded derivatives

In accordance with the provisions of the standard, derivatives embedded into financial assets shall not be separated from a host contract. These hybrid contracts shall be measured as a whole at amortized cost or at fair value, in accordance with the criteria of the business model and the contractual cash flows.

When a host contract does not falls within the scope of the definition of financial asset, an embedded derivative is separated from the host contract and is accounted for as a derivative, if the economic characteristics and risks of an embedded derivative are not closely related to the economic characteristics and risks of the host contract, the embedded instrument meets the definition of a derivative, and the hybrid contract is not measured at fair value with changes in fair value recognized in profit or loss.

The need to bifurcate an embedded derivative is only reassessed if there is a change in the terms and conditions of the contract that significantly modifies the cash flows from the contract.

B. First-time application of amendment to existing accounting standards

1. First-time application of IFRS 9 - Financial Instruments

In July 2014, the IASB published the full and final version of IFRS 9 - Financial Instruments, which replaces IAS 39 - Financial Instruments: Recognition and Measurement. IFRS 9 (hereinafter - the "New Standard") focuses mainly on the classification and measurement of financial assets and is applicable to all financial assets that fall within the scope of IAS 39.

The New Standard is applied for the first time in these financial statements to the financial instruments that are not owned by a consolidated subsidiary, which falls within the scope of the definition of insurer.

The New Standard is applied retrospectively without restating the comparative figures, as allowed under the provisions of the New Standard. The Company recognizes any difference between the previous carrying amount and the carrying amount on the first-time application date in the opening balance of retained earnings.

The New Standard's effect on the Company's financial statements, other than a consolidated subsidiary, which falls within the scope of the definition of insurer, is immaterial.

2. Amendment to IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors

In February 2021, the IASB issued an amendment to IAS 8: "Accounting Policies, Changes in Accounting Estimates and Errors" (hereinafter - the "Amendment). The purpose of the amendment is to introduce a new definition of the term "accounting estimates".

Accounting estimates are defined as "financial amounts in the financial statements subject to measurement uncertainty". The Amendment clarifies what changes in accounting estimates are and how they differ from changes in accounting policies and corrections of errors.

The Amendment was applied prospectively to annual periods beginning on January 1, 2023 and shall apply to changes in accounting policies and accounting estimates that occur at the beginning of that period or thereafter.

The above Amendment did not have a material effect on the Consolidated Interim Financial Statements of the Company.

3. Amendment to IAS 12 - Taxes on Income

In May 2021, the IASB issued an amendment to IAS 12, Taxes on Income (hereinafter - "IAS 12" or the "Standard"), which narrows the scope of the "initial recognition exemption" (hereinafter - the "Exemption") for deferred taxes set forth in Sections 15 and 24 to IAS 12 (hereinafter - the "Amendment").

Under the guidelines for recognition of deferred tax assets and liabilities, IAS 12 exempts recognition of deferred tax assets and liabilities in respect of certain temporary differences arising from initial recognition of assets and liabilities in certain transactions. The Amendment narrows the scope of the exemption and clarifies that it does not apply to the recognition of deferred tax assets and liabilities arising from a transaction that is not a business combination and for which equal temporary differences are generated in debit and credit, even if they meet the other terms and conditions of the IRE.

B. First-time application of amendment to existing accounting standards (cont.)

3. Amendment to IAS 12 - Taxes on Income (cont.)

The Amendment was applied as from annual periods beginning on January 1, 2023. The above Amendment did not have a material effect on the Consolidated Interim Financial Statements of the Company.

4. Amendment to IAS 1, Disclosure of Accounting Policies

In February 2021, the IASB issued an amendment to IAS 1: Presentation of Financial Statements (hereinafter - the "Amendment"). In accordance with the Amendment, companies are required to disclose their material accounting policies; this will replace the requirement to disclose companies' significant accounting policies. One of the main reasons for this amendment stems from the fact that the term "significant" is not defined in IFRS, whereas the term "material" is defined in various standards, and specifically in IAS 1. The Amendment was applied as from annual periods beginning on January 1, 2023.

The above Amendment did not have a material effect on the condensed consolidated interim financial statements of the Company; however, it is expected to affect the accounting policy in the Company's Consolidated Annual Financial Statements.

C. Disclosure of the new IFRSs in the period prior to their application

IFRS 17 - Insurance Contracts and IFRS 9 Financial Instruments

Further to what is stated in Note 2FF to the Company's Annual Financial Statements - disclosure of the new IFRSs in the period prior to their application - IFRS 17 - "Insurance Contracts" (hereinafter - "IFRS 17") and IFRS 9 - "Financial Instruments" (hereinafter - "IFRS 9"), on June 1, 2023, the Commissioner of the Capital Market, Insurance and Savings Authority published a third revision of the "Roadmap for the Adoption of International Accounting Standard (IFRS) 17 - Insurance Contracts" (hereinafter - the "Third Revision"), which includes a number of amendments compared with the "Roadmap - Second Revision", that was published on December 14, 2022.

As part of the Third Revision the first-time application date of IFRS 17 and IFRS 9 in Israel was postponed to the quarterly and annual periods beginning on January 1, 2025; (accordingly, the transition date shall be January 1, 2024).

In accordance with the Third Revision, in 2024, as part of the financial statements for the third quarter, the companies will be required to include, as part of a dedicated note in the financial statements, only a pro forma statement of financial position as of January 1, 2024 (opening balances data as of the transition date, without comparative figures), drawn up in accordance with the provisions of IFRS 17 and IFRS 9. In their 2024 Annual Financial Statements, companies will be required to include key proforma statements (statement of financial position as of January 1, 2024 and selected line items from the statement of comprehensive income for 2024 at the very least, and without comparative figures), that will be prepared in accordance with the provisions of IFRS 17 and IFRS 9 according to the disclosure format attached to the Third Revision. Furthermore, as part of the Third Revision, the milestones for the implementation of the standards in 2023 and 2024 were amended in line with the postponement of the first-time application date of IFRS 17 and IFRS 9, and in order to ensure the preparedness of Israeli insurance companies for a fair and reliable application of the standards. The key amendments pertain to the reporting requirements to the Capital Market, Insurance and Savings Authority before the first-time application date, the time table for adapting the IT systems, the completion of the formulation of the accounting policy, the preparations for the calculation of the risk adjustment for a non-financial risk, the involvement of the independent auditors, and the disclosure of high-quality supplementary information for the dedicated note as from the financial statements for the first quarter of 2024.

C. Disclosure of the new IFRSs in the period prior to their application (cont.)

IFRS 17 - Insurance Contracts and IFRS 9 Financial Instruments (cont.)

The Company continues to assess the effects of the adoption of the said standards on its financial statements, and is preparing for their implementation according to said schedule.

As part of the standard's adoption process, the Company is implementing and integrating IT systems that are necessary for the implementation of the standard's provisions. In addition, the Company is testing and mapping the required controls and the flow of information to the financial statements.

Furthermore, in accordance with the Third Revision, by August 31, 2023 the Company will report to the Capital Markets Authority the results of the first Quantitative Impact Study (hereinafter - "QIS") for assessing the effect of the first-time application of IFRS 17. As part of the first QIS, the Company conducted quantitative tests in order to check the methodology employed to calculate the opening balances, based on the opening balances as of January 1, 2023 of certain insurance contracts set in the Third Revision.

D. Reclassification

Reclassifications were made in the Condensed Consolidated Interim Financial Statements and in the notes to the financial statements. The reclassifications did not have an effect on the equity, profit and loss and comprehensive income.

E. Details of the change rates in the Consumer Price Index and US dollar representative exchange rate

CPI Representative
Known
CPI
%
In lieu
CPI
%
exchange rate of
US dollar
%
For the six months ended on:
June 30, 2023 2.5 2.2 5.1
June 30, 2022 3.1 3.2 12.5
For the three months ended on:
June 30, 2023 1.4 1.0 2.4
June 30, 2022 1.9 1.7 10.2
For the year ended December 31, 2022 5.3 5.3 13.2

NOTE 3 - OPERATING SEGMENTS

The Company operates in the following operating segments:

1. Life insurance and savings segment

The life insurance and savings segment includes the life insurance subsegments and related coverages. The segment includes various categories of insurance policies as well insurance coverages in respect of various risks such as: death, disability, permanent health insurance, and more.

2. Health insurance segment

The health insurance segment includes the Group's health insurance activity. The segment includes long-term care, medical expenses, surgery and transplants, dental, travel and foreign workers insurance and more.

3. Property and casualty insurance segment

The property and casualty insurance segment includes the liability and property subsegments. In accordance with the Commissioner's directives, the property and casualty insurance segment in Israel is broken down into compulsory motor insurance, motor property, other property and other liability subsegments:

▪ Compulsory motor subsegment

The compulsory motor subsegment focuses on coverage, the purchase of which by the vehicle owner or driver is mandatory, in respect of bodily injury caused as a result of the use of a motor vehicle (to the driver, passengers, or pedestrians).

▪ Motor property subsegment

The motor property subsegment focuses on coverage against property damage to the policyholder's vehicle and third-party property damage caused by the insured vehicle.

▪ Other liability subsegments

The liability subsegments provide coverage in respect of the policyholder's liability for any third-party damage he/she may cause. These subsegments include: third-party liability, employers' liability, professional liability, product liability and other subsegments.

▪ Property and other subsegments Property subsegments other than motor and liability as well as other insurance subsegments.

4. Pension and Provident segment

The pension and provident segment includes the management of pension funds and provident funds through The Phoenix Pension and Provident, which is a wholly-owned subsidiary of the Company.

In accordance with the Commissioner's directives, segment activity is described separately for the pension activity and the provident activity.

NOTE 3 - OPERATING SEGMENTS (cont.)

5. Financial services segment

The financial services segment includes the results of The Phoenix Investment House (formerly Excellence). The segment includes investment management activity, including mutual funds, ETFs, brokerage services, underwriting services, market making in various securities and other services.

In addition, the results of this segment include those of The Phoenix Investments including The Phoenix group's alternative investment funds.

6. Insurance agencies segment

The insurance agencies segment includes the activity of the pension arrangement agencies and other insurance agencies in the group.

7. Credit segment

The credit segment includes Gama. Gama is a credit aggregator providing financing against postdated checks (factoring), clearing, and management of credit vouchers services, financing against real estate properties, loans and credit, equipment financing and supplier financing.

8. The activity is not attributed to operating segments

This activity includes part of the group's HQ function that is not attributed to the operating segments, activities which are ancillary/overlapping with the group's activity and holding assets and liabilities against the Company's share capital in accordance with the Capital Regulations. Financial liabilities that serve the Company's equity requirements and finance expenses in respect thereof are not allocated to the operating segments.

It should be noted that the Company allocates the assets which are not measured at fair value in accordance with the provisions of the law and Company's procedures, and specifically the allocation in accordance with the consolidated circular on testing the appropriateness of the LAT reserve and the Commissioner's Position - Best Practice for Calculation of Reserves in Property and Casualty Insurance (for more information, see Note 41, Sections 5.1 and 5.2 to the Annual Financial Statements). This allocation may have an effect on investment income allocated to the different segments.

A. Reportable segment

For the 6-month period ended June 30, 2023
Life
insurance
and
savings (a)
Health (b) Property and
casualty
insurance (c)
Pension
and
provident
funds (d)
Financial
services
Insurance
agencies
Credit Not attributed
to operating
segments
Adjustments
and offsets
Total
Unaudited
NIS thousand
Premiums earned, gross 2,352,787 1,638,610 1,948,191 - - - - - - 5,939,588
Premiums earned by reinsurers 138,246 116,624 542,697 - - - - - - 797,567
Premiums earned -
retention
2,214,541 1,521,986 1,405,494 - - - - - - 5,142,021
Investment income (losses), net and finance income 4,750,212 464,406 89,425 55,835 16,521 11,525 74,461 (160,123) (12,804) 5,289,458
Income from management fees 294,599 - - 361,442 177,543 1,030 - 2,162 (18,906) 817,870
Income from fees and commissions (e) 17,474 21,243 117,841 - - 385,599 - - (136,079) 406,078
Income from financial services - - - - 160,000 - - - - 160,000
Income from factoring and clearing - - - - - - 90,568 - - 90,568
Other income (see Note 4B) 255 113,454 - 16,826 3,241 8,874 - 8 (575) 142,083
Total income 7,277,081 2,121,089 1,612,760 434,103 357,305 407,028 165,029 (157,953) (168,364) 12,048,078
Payments and change in liabilities in respect of
insurance contracts and investment contracts, gross 7,148,603 1,981,131 1,459,815 49,944 - - - - - 10,639,493
Reinsurers' share in payments and in changes in
liabilities in respect of insurance contracts 134,217 219,337 387,272 - - - - - - 740,826
Payments and change in liabilities in respect of
insurance contracts and investment contracts -
retention
7,014,386 1,761,794 1,072,543 49,944 - - - - - 9,898,667
Fees and commissions and other purchase expenses 301,480 253,314 356,182 181,637 29,468 - 2,822 63 (115,422) 1,009,544
General and administrative expenses 203,855 88,611 73,461 118,879 205,054 237,754 51,533 46,276 (22,229) 1,003,194
Other expenses (income) (662) - - 17,107 13,613 13,078 4,059 12,877 (226) 59,846
Finance expenses 13,854 - 8,400 7,183 3,944 2,231 51,761 115,638 (11,475) 191,536
Total expenses 7,532,913 2,103,719 1,510,586 374,750 252,079 253,063 110,175 174,854 (149,352) 12,162,787
Company's share in the net results of investees 10,413 26,984 747 362 5,396 1,289 - (2,118) - 43,073
Profit (loss) before taxes on income (245,419) 44,354 102,921 59,715 110,622 155,254 54,854 (334,925) (19,012) (71,636)
Other
comprehensive income before taxes on income
162,053 28,512 69,665 - - - - 177,570 - 437,800
Total comprehensive income
(loss) before taxes on income
(83,366) 72,866 172,586 59,715 110,622 155,254 54,854 (157,355) (19,012) 366,164
June 30, 2023
Unaudited
NIS thousand
Liabilities, gross in respect of insurance contracts
and yield-dependent investment contracts 92,392,142 5,956,351 - - - - - - - 98,348,493
Liabilities, gross in respect of insurance contracts
and non-yield-dependent investment contracts 12,806,395 5,560,457 7,837,601 1,045,054 - - - - - 27,249,507

(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.

(b) For additional data regarding the health insurance subsegments, please see Section C below.

(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.

(d) For more information regarding the pension and provident subsegments, please see Section E below.

A. Reportable segment (cont.)

For the 6-month period ended June 30, 2022
Life
insurance
and
savings (a)
Health (b) Property and
casualty
insurance (c)
Pension
and
provident
funds (d)
Financial
services
Insurance
agencies
Credit Not attributed
to operating
segments
Adjustments
and offsets
Total
Unaudited
NIS thousand
Premiums earned, gross 2,916,520 1,479,230 1,637,059 - - - - - - 6,032,809
Premiums earned by reinsurers 164,347 106,451 521,187 - - - - - - 791,985
Premiums earned -
retention
2,752,173 1,372,779 1,115,872 - - - - - - 5,240,824
Investment income (losses), net and finance income (4,652,642) (665,610) 79,815 50,829 4,417 4,498 29,851 (270,761) (15,769) (5,435,372)
Income from management fees 298,435 - - 328,313 155,826 1,589 - 2,055 (24,174) 762,044
Income from fees and commissions (e) 38,545 26,960 121,265 - - 353,652 - - (110,157) 430,265
Income from financial services - - - - 101,000 - - - - 101,000
Income from factoring and clearing - - - - - - 63,827 - - 63,827
Other income - - - 14,853 91,367 31,302 - 2 (737) 136,787
Total income (1,563,489) 734,129 1,316,952 393,995 352,610 391,041 93,678 (268,704) (150,837) 1,299,375
Payments and change in liabilities in respect of
insurance contracts and investment contracts, gross (2,346,987) (258,730) 1,269,744 53,415 - - - - - (1,282,558)
Reinsurers' share in payments and in changes 121,965 139,514 345,815 - - - - - - 607,294
in liabilities in respect of insurance contracts
Payments and change in liabilities in respect of insurance
contracts and investment contracts -
retention
Fees and commissions and other purchase expenses
(2,468,952)
277,629
(398,244)
227,294
923,929
319,029
53,415
150,384
-
36,500
-
8,854
-
2,410
-
-
-
(99,933)
(1,889,852)
922,167
General and administrative expenses 187,477 75,733 60,836 113,535 165,388 204,951 44,538 52,617 (27,617) 877,458
Other expenses (income) (353) - - 10,286 6,453 11,290 4,059 - (226) 31,509
Finance expenses (income) 1,044 - 19,777 7,627 (2,758) 1,344 19,205 118,306 (14,440) 150,105
Total expenses (2,003,155) (95,217) 1,323,571 335,247 205,583 226,439 70,212 170,923 (142,216) 91,387
Company's share in the net results of investees 16,899 12,456 (2,969) - 1,397 2,491 - - - 30,274
Profit (loss) before taxes on income 456,565 841,802 (9,588) 58,748 148,424 167,093 23,466 (439,627) (8,621) 1,238,262
Other comprehensive income
(loss) before taxes on income 20,934 1,249 (224,814) - (1,035) - 850 (296,938) - (499,754)
Total comprehensive income
(loss) before taxes on income 477,499 843,051 (234,402) 58,748 147,389 167,093 24,316 (736,565) (8,621) 738,508
June 30, 2022
Unaudited
NIS thousand
Liabilities, gross in respect of insurance contracts
and yield-dependent investment contracts 87,356,951 5,757,805 - - - - - - - 93,114,756
Liabilities, gross in respect of insurance contracts
and non-yield-dependent investment contracts 12,340,232 4,661,998 7,323,289 989,994 - - - - - 25,315,513

(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.

(b) For additional data regarding the health insurance subsegments, please see Section C below.

(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.

(d) For more information regarding the pension and provident subsegments, please see Section E below.

(e) Arises from fees and commissions income received from agencies owned by the group, mainly from activities in the life insurance and savings.

A. Reportable segment (cont.)

For the 3-month period ended June 30, 2023
Life
insurance
and
savings (a)
Health (b) Property and
casualty
insurance (c)
Pension
and
provident
funds (d)
Financial
services
Insurance
agencies
Credit Not attributed
to operating
segments
Adjustments
and offsets
Total
Unaudited
NIS thousand
Premiums earned, gross 1,145,188 830,869 1,011,932 - - - - - - 2,987,989
Premiums earned by reinsurers 69,676 58,727 277,332 - - - - - - 405,735
Premiums earned -
retention
1,075,512 772,142 734,600 - - - - - - 2,582,254
Investment income, net and finance income 3,842,791 366,709 65,665 34,084 5,524 5,938 39,117 19,698 (7,810) 4,371,716
Income from management fees 146,727 - - 183,154 89,512 595 - 1,167 (11,827) 409,328
Income from fees and commissions (e) 2,634 10,821 58,507 - - 194,314 - - (73,566) 192,710
Income from financial services - - - - 90,000 - - - - 90,000
Income from factoring and clearing - - - - - - 44,356 - - 44,356
Other income (see Note 4B) - 113,454 - 16,356 2,118 5,772 - 8 (169) 137,539
Total income 5,067,664 1,263,126 858,772 233,594 187,154 206,619 83,473 20,873 (93,372) 7,827,903
Payments and change in liabilities in respect of
insurance contracts and investment contracts, gross 5,002,336 1,321,485 739,092 26,641 - - - - - 7,089,554
Reinsurers' share in payments and in changes
in liabilities in respect of insurance contracts
87,656 136,440 145,707 - - - - - - 369,803
Payments and change in liabilities in respect of insurance
contracts and investment contracts -
retention
4,914,680 1,185,045 593,385 26,641 - - - - - 6,719,751
Fees and commissions and other purchase expenses 143,036 130,510 183,705 92,694 12,597 - 1,232 63 (62,053) 501,784
General and administrative expenses 105,413 43,599 37,551 61,685 107,287 116,524 25,591 27,240 (13,324) 511,566
Other expenses 404 - - 9,300 8,037 6,657 2,029 12,877 (113) 39,191
Finance expenses 8,785 - 3,851 4,227 1,593 1,468 27,803 54,594 (7,145) 95,176
Total expenses 5,172,318 1,359,154 818,492 194,547 129,514 124,649 56,655 94,774 (82,635) 7,867,468
Company's share in the net results of investees 7,325 2,358 25,009 362 2,120 388 - (525) - 37,037
Profit (loss) before taxes on income (97,329) (93,670) 65,289 39,409 59,760 82,358 26,818 (74,426) (10,737) (2,528)
Other comprehensive income before taxes on income 91,348 16,269 31,543 - - - - 97,625 - 236,785
Total comprehensive income
(loss) before taxes on income (5,981) (77,401) 96,832 39,409 59,760 82,358 26,818 23,199 (10,737) 234,257
June 30, 2023
Unaudited
NIS thousand
Liabilities, gross in respect of insurance contracts
and yield-dependent investment contracts 92,392,142 5,956,351 - - - - - - - 98,348,493
Liabilities, gross in respect of insurance contracts
and non-yield-dependent investment contracts 12,806,395 5,560,457 7,837,601 1,045,054 - - - - - 27,249,507

(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.

(b) For additional data regarding the health insurance subsegments, please see Section C below.

(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.

(d) For more information regarding the pension and provident subsegments, please see Section E below.

A. Reportable segment (cont.)

For the 3-month period ended June 30, 2022
Life Pension
insurance
and
savings (a)
Health (b) Property and
casualty
insurance (c)
and
provident
funds (d)
Financial
services
Insurance
agencies
Credit Not attributed
to operating
segments
Adjustments
and offsets
Total
Unaudited
NIS thousand
Premiums earned, gross 1,418,185 755,168 845,068 - - - - - - 3,018,421
Premiums earned by reinsurers 83,068 54,799 262,925 - - - - - - 400,792
Premiums earned -
retention
1,335,117 700,369 582,143 - - - - - - 2,617,629
Investment income (losses), net and finance income (3,884,676) (572,269) (21,967) 27,419 3,431 2,010 16,317 (314,114) (10,019) (4,753,868)
Income from management fees 148,360 - - 168,199 81,024 1,589 - 1,215 (11,188) 389,199
Income from fees and commissions (e) 20,646 12,041 59,286 - - 180,115 - - (75,037)(e) 197,051
Income from financial services - - - - 57,000 - - - - 57,000
Income from factoring and clearing - - - - - - 35,215 - - 35,215
Other income - - - 14,538 90,012 27,916 - - (362) 132,104
Total income (2,380,553) 140,141 619,462 210,156 231,467 211,630 51,532 (312,899) (96,606) (1,325,670)
Payments and change in liabilities in respect of
insurance contracts and investment contracts, gross (2,737,755) (87,124) 576,971 30,530 - - - - - (2,217,378)
Reinsurers' share in payments and in changes
in liabilities in respect of insurance contracts 66,076 85,437 156,624 - - - - - - 308,137
Payments and change in liabilities in respect of insurance
contracts and investment contracts -
retention
(2,803,831) (172,561) 420,347 30,530 - - - - - (2,525,515)
Fees and commissions and other purchase expenses 134,920 117,697 172,874 80,489 17,571 4,168 1,123 - (70,160) 458,682
General and administrative expenses 94,287 36,688 30,321 51,599 85,497 106,270 22,884 29,978 (12,932) 444,592
Other expenses (income) (1,503) - - 4,944 3,453 6,116 2,029 - (113) 14,926
Finance expenses (income) 425 - 16,175 4,532 (557) 752 13,392 65,099 (9,354) 90,464
Total expenses (2,575,702) (18,176) 639,717 172,094 105,964 117,306 39,428 95,077 (92,559) (1,516,851)
Company's share in the net results of investees 9,766 17,262 (2,221) - 641 907 - - - 26,355
Profit (loss) before taxes on income 204,915 175,579 (22,476) 38,062 126,144 95,231 12,104 (407,976) (4,047) 217,536
Other comprehensive income (loss) before taxes on
income 108,755 12,141 (69,459) - (1,269) (260) - (57,937) - (8,029)
Total comprehensive income
(loss) before taxes on income 313,670 187,720 (91,935) 38,062 124,875 94,971 12,104 (465,913) (4,047) 209,507
June 30, 2022
Unaudited
NIS thousand
Liabilities, gross in respect of insurance contracts
and yield-dependent investment contracts 87,356,951 5,757,805 - - - - - - - 93,114,756
Liabilities, gross in respect of insurance contracts
and non-yield-dependent investment contracts 12,340,232 4,661,998 7,323,289 989,994 - - - - - 25,315,513

(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.

(b) For additional data regarding the health insurance subsegments, please see Section C below.

(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.

(d) For more information regarding the pension and provident subsegments, please see Section E below.

A. Reportable segment (cont.)

For the year ended December 31, 2022
Life
insurance
and
savings (a)
Health (b) Property and
casualty
insurance (c)
Pension
and
provident
funds (d)
Financial
services
Insurance
agencies
Credit Not attributed
to operating
segments
Adjustments
and offsets
Total
Audited
NIS thousand
Premiums earned, gross 5,611,196 3,054,811 3,471,224 - - - - - - 12,137,231
Premiums earned by reinsurers 282,181 222,363 1,065,550 - - - - - - 1,570,094
Premiums earned -
retention
5,329,015 2,832,448 2,405,674 - - - - - - 10,567,137
Investment income (losses), net and finance income (4,716,483) (693,537) 105,630 90,823 14,526 10,632 87,879 (432,161) (22,140) (5,554,831)
Income from management fees 587,708 - - 670,387 337,279 469 - 3,868 (51,983) 1,547,728
Income from fees and commissions (e) 68,306 48,549 247,245 - - 723,577 - - (251,765) 835,912
Income from financial services - - - - 223,000 - - - - 223,000
Income from factoring and clearing -
4,204
-
-
-
-
-
15,864
-
90,919
-
35,228
142,754
-
-
2
-
(1,437)
142,754
144,780
Other income 1,272,750 2,187,460 2,758,549 777,074 665,724 769,906 230,633 (428,291) (327,325) 7,906,480
Total income
Increase in insurance liabilities and
payments in respect of insurance contracts
(73,812) 730,355 2,234,066 98,221 - - - - - 2,988,830
Reinsurers' share in payments and in changes
in liabilities in respect of insurance contracts 180,954 272,140 570,707 - - - - - - 1,023,801
Payments and change in liabilities in respect of insurance
contracts and investment contracts -
retention
(254,766) 458,215 1,663,359 98,221 - - - - - 1,965,029
Fees and commissions and other purchase expenses 573,176 481,619 701,452 315,325 71,433 8,854 5,696 - (223,750) 1,933,805
General and administrative expenses 379,479 152,882 122,715 229,351 345,900 423,455 92,667 117,618 (58,783) 1,805,284
Other expenses 1,187 - - 31,879 17,583 32,782 8,118 - (453) 91,096
Finance expenses (income) 8,483 - 24,161 13,315 (2,054) 7,472 52,907 233,734 (19,484) 318,534
Total expenses 707,559 1,092,716 2,511,687 688,091 432,862 472,563 159,388 351,352 (302,470) 6,113,748
Company's share in the net results of investees 26,648 26,017 4,213 - 2,494 2,735 (57) (502) - 61,548
Profit (loss) before taxes on income 591,839 1,120,761 251,075 88,983 235,356 300,078 71,188 (780,145) (24,855) 1,854,280
Other comprehensive income
(loss) before taxes on income 18,923 (860) (222,399) - (333) 70 1,593 (33,388) - (236,394)
Comprehensive income
(loss) before taxes on income 610,762 1,119,901 28,676 88,983 235,023 300,148 72,781 (813,533) (24,855) 1,617,886
As of December 31, 2022
Audited
NIS thousand
Liabilities, gross in respect of insurance contracts
and yield-dependent investment contracts 88,307,936 5,734,157 - - - - - - - 94,042,093
Liabilities, gross in respect of insurance contracts
and non-yield-dependent investment contracts 12,517,305 4,784,707 7,140,483 1,016,001 - - - - - 25,458,496

(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.

(b) For additional data regarding the health insurance subsegments, please see Section C below.

(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.

(d) For more information regarding the pension and provident subsegments, please see Section E below.

NOTE 3 - OPERATING SEGMENTS (cont.)

B. Additional information regarding the life insurance and long-term savings segment

Breakdown of results by type of policy

For the six-month period ended June, 2023:

Policies including a saving component
(including appendices) by policy issuance date
Policies without a
savings component sold as
From 2004 a single policy
Until Until Yield
1990 (1) 2003 dependent Individual Group Total
Unaudited
Gross premiums
Proceeds in respect
of investment
contracts credited
26,975 587,453 NIS thousand
1,334,485
340,843 63,031 2,352,787
directly to insurance
reserves
Financial margin
- - 2,506,919 - - 2,506,919
including
management fees (2)
Payments and
(32,941) 101,643 (3) 192,365 - - 261,067
change in liabilities in
respect of insurance
contracts, gross
Payments and
change in liabilities
549,754 2,083,421 (4) 3,097,176 (4) 168,950 44,881 5,944,182
for investment
contracts
Total payments and
change in liabilities
- - 1,204,421 (4) - - 1,204,421
from life insurance
and long-term
savings
Total comprehensive
income (loss) from
life insurance and
7,148,603
savings business (59,337) (5) (70,227) (5) (16,639) 42,495 (5) 20,342 (83,366)

(1) Products issued until 1990 (including increases in respect thereof) were mainly guaranteed return policies that were backed mainly by designated bonds.

  • (2) The financial margin does not include additional income of the Company collected as a percentage of the premium and is calculated before deducting investment management expenses. The financial margin in guaranteed return policies is based on actual investment income, for the reporting year, less the product of the annual guaranteed rate of return, multiplied by the average reserve per year in the various insurance reserves. In this matter, investment income also includes the change in the fair value of available-for-sale financial assets that is charged to the statement of comprehensive income. In yield-dependent contracts, the financial margin is the total fixed and variable management fees calculated on the basis of the yield and average balance of insurance reserves.
  • (3) As of June 30, 2023, the estimated management fees which were not collected due to negative yield in respect of participating policies amounted to approximately NIS 571 million. As of the report publication date, the estimated management fees which were not be collected amounted to approximately NIS 529 million.
  • (4) This amount includes investment income or losses carried to participating policies.
  • (5) Includes a profit in respect of the effect of the changes in the discount rate and in the assumptions regarding the cost of claims in longterm health insurance totaling approximately NIS 42 million, before tax. For further details, please see Note 8A.

NOTE 3 - OPERATING SEGMENTS (cont.)

B. Additional information regarding the life insurance and long-term savings segment (cont.)

Breakdown of results by type of policy (cont.)

For the six-month period ended June, 2022:

Policies including a saving component
(including appendices) by policy issuance date
From 2004
Policies without a
savings component sold as
a single policy
Until
1990 (1)
Until
2003
Yield
dependent
Unaudited
Individual Group Total
NIS thousand
Gross premiums
Proceeds in respect
of investment
contracts credited
29,109 584,954 1,938,463 302,978 61,016 2,916,520
directly to insurance
reserves
Financial margin
- - 4,522,230 - - 4,522,230
including
management fees (2)
Payments and
change in liabilities in
respect of insurance
(44,355) 100,044 (3) 197,942 - - 253,631
contracts, gross
Payments and
change in liabilities
for investment
127,077 (1,540,181) (4) 19,648 (4) 170,031 54,638 (1,168,787)
contracts
Total payments and
change in liabilities
from life insurance
and long-term
- - (1,178,200) (4) - - (1,178,200)
savings
Total comprehensive
income (loss) from
life insurance and
(2,346,987)
savings business 386,404 (5) 81,776 (5) (9,550) 13,365 5,504 477,499
  • (1) Products issued until 1990 (including increases in respect thereof) were mainly guaranteed return policies that were backed mainly by designated bonds.
  • (2) The financial margin does not include additional income of the Company collected as a percentage of the premium and is calculated before deducting investment management expenses. The financial margin in guaranteed return policies is based on actual investment income, for the reporting year, less the product of the annual guaranteed rate of return, multiplied by the average reserve per year in the various insurance reserves. In this matter, investment income also includes the change in the fair value of available-for-sale financial assets that is charged to the statement of comprehensive income. In yield-dependent contracts, the financial margin is the total fixed and variable management fees calculated on the basis of the yield and average balance of insurance reserves.
  • (3) As of June 30, 2022, the estimated management fees which were not collected due to negative yield in respect of participating policies amounted to approximately NIS 507 million.
  • (4) This amount includes investment income or losses carried to participating policies.
  • (5) Includes a profit in respect of the effect of the changes in assumptions and the effect of the change in the discount rate in the calculation of the supplementary retirement pension reserve and paid pensions totaling approximately NIS 495 million, before tax. For further details, please see Note 8A.

NOTE 3 - OPERATING SEGMENTS (cont.)

B. Additional information regarding the life insurance and long-term savings segment (cont.)

Breakdown of results by type of policy (cont.)

For the three-month period ended June 30, 2023:

Policies including a saving component
(including appendices) by policy issuance date
Policies without a
savings component sold as
From 2004 a single policy
Until
1990 (1)
Until
2003
Yield
dependent
Individual Group Total
Unaudited
NIS thousand
Gross premiums 13,237 288,280 637,098 174,576 31,997 1,145,188
Proceeds in respect of
investment contracts
credited directly to
insurance reserves - - 1,309,549 - - 1,309,549
Financial margin
including
management fees (2) 58,971 51,132 (3) 95,221 - - 205,324
Payments and change
in liabilities in respect
of insurance
contracts, gross 324,077 1,598,478 (4) 2,049,775 (4) 79,049 22,458 4,073,837
Payments and change
in liabilities for
investment contracts - - 928,499 (4) - - 928,499
Total payments and
change in liabilities
from life insurance
and long-term savings 5,002,336
Total comprehensive
income (loss) from life
insurance and savings
business
4,797 (5) (50,048) (5) (21,190) 46,520 (5) 13,940 (5,981)
  • (1) Products issued until 1990 (including increases in respect thereof) were mainly guaranteed return policies that were backed mainly by designated bonds.
  • (2) The financial margin does not include additional income of the Company collected as a percentage of the premium and is calculated before deducting investment management expenses. The financial margin in guaranteed return policies is based on actual investment income, for the reporting year, less the product of the annual guaranteed rate of return, multiplied by the average reserve per year in the various insurance reserves. In this matter, investment income also includes the change in the fair value of available-for-sale financial assets that is charged to the statement of comprehensive income. In yield-dependent contracts, the financial margin is the total fixed and variable management fees calculated on the basis of the yield and average balance of insurance reserves.
  • (3) As of June 30, 2023, the estimated management fees which were not collected due to negative yield in respect of participating policies amounted to approximately NIS 571 million. As of the report publication date, the estimated management fees which were not be collected amounted to approximately NIS 529 million.
  • (4) This amount includes investment income or losses carried to participating policies.
  • (5) Includes a profit in respect of the effect of the changes in the discount rate and in the assumptions regarding the cost of claims in longterm health insurance totaling approximately NIS 16 million, before tax. For further details, please see Note 8A.

NOTE 3 - OPERATING SEGMENTS (cont.)

B. Additional information regarding the life insurance and long-term savings segment (cont.)

Breakdown of results by type of policy (cont.)

For the three-month period ended June 30, 2022:

Policies including a saving component
(including appendices) by policy issuance date
Policies without a
savings component sold as
From 2004 a single policy
Until
1990 (1)
Until
2003
Yield
dependent
Individual Group Total
Unaudited
NIS thousand
Gross premiums 14,772 295,277 924,974 151,921 31,241 1,418,185
Proceeds in respect of
investment contracts
credited directly to
insurance reserves - - 1,829,247 - - 1,829,247
Financial margin
including management
fees (2) 31,183 49,005 (3) 99,134 - - 179,322
Payments and change
in liabilities in respect
of insurance contracts,
gross 88,918 (1,420,614) (4) (569,786) (4) 82,192 27,983 (1,791,307)
Payments and change
in liabilities for
investment contracts
Total payments and
- - (946,448) (4) - - (946,448)
change in liabilities
from life insurance
and long-term savings
Total comprehensive
(2,737,755)
income from the life
insurance and savings
businesses
248,349 (5) 44,286 (5) 317 15,492 5,226 313,670

(1) Products issued until 1990 (including increases in respect thereof) were mainly guaranteed return policies that were backed mainly by designated bonds.

(2) The financial margin does not include additional income of the Company collected as a percentage of the premium and is calculated before deducting investment management expenses. The financial margin in guaranteed return policies is based on actual investment income, for the reporting year, less the product of the annual guaranteed rate of return, multiplied by the average reserve per year in the various insurance reserves. In this matter, investment income also includes the change in the fair value of available-for-sale financial assets that is charged to the statement of comprehensive income. In yield-dependent contracts, the financial margin is the total fixed and variable management fees calculated on the basis of the yield and average balance of insurance reserves.

(3) As of June 30, 2022, management fees which were not collected due to negative yield in respect of participating policies amounted to approximately NIS 507 million.

  • (4) This amount includes investment income or losses carried to participating policies.
  • (5) Includes a profit in respect of the effect of the change in the calculation of the supplementary retirement pension reserve and paid pensions totaling approximately NIS 217 million, before tax. For further details, please see Note 8A.

NOTE 3 - OPERATING SEGMENTS (cont.)

B. Additional information regarding the life insurance and long-term savings segment (cont.)

Breakdown of results by type of policy (cont.)

Data for the year ended December 31, 2022:

Policies including a saving component
(including appendices) by policy issuance date
Policies without a
savings component sold as
a single policy
Until
1990 (1)
Until
2003
From 2004
Yield
dependent
Individual Group Total
Audited
Gross premiums
Proceeds in respect of
investment contracts
58,871 1,182,140 NIS thousand
3,630,606
617,400 122,179 5,611,196
credited directly to
insurance reserves
Financial margin
- - 7,335,455 - - 7,335,455
including management
fees (2)
Payments and change
in liabilities in respect
57,890 206,820 (3) 380,001 - - 644,711
of insurance contracts,
gross
Payments and change
465,040 (915,658) (4) 1,178,225 (4) 337,718 104,553 1,169,878
in liabilities for
investment contracts
Total payments and
change in liabilities
- - (1,243,690) (4) - - (1,243,690)
from life insurance
and long-term savings
Total comprehensive
income from the life
(73,812)
insurance and savings
businesses
585,610 (5) (11,979) (5) 9,058 13,341 14,732 610,762

(1) Products issued until 1990 (including increases in respect thereof) were mainly guaranteed return policies that were backed mainly by designated bonds.

(2) The financial margin does not include additional income of the Company collected as a percentage of the premium and is calculated before deducting investment management expenses. The financial margin in guaranteed return policies is based on actual investment income, for the reporting year, less the product of the annual guaranteed rate of return, multiplied by the average reserve per year in the various insurance reserves. In this matter, investment income also includes the change in the fair value of available-for-sale financial assets that is charged to the statement of comprehensive income. In yield-dependent contracts, the financial margin is the total fixed and variable management fees calculated on the basis of the yield and average balance of insurance reserves.

(3) As of December 31, 2022, the estimated management fees which were not collected due to negative yield in respect of participating policies amounted to approximately NIS 643 million.

  • (4) This amount includes investment income or losses carried to participating policies.
  • (5) Includes a profit in respect of the effect of the changes in assumptions and the effect of the change in the discount rate in the calculation of the supplementary retirement pension reserve and paid pensions totaling approximately NIS 671 million. For details, see Note 8A.

NOTE 3 - OPERATING SEGMENTS (cont.)

C. Additional data regarding the health insurance segment

For the 6-month period ended June 30, 2023
Long-term care Other (2)
Long Short
Individual (5) Group (6) term term Total
Unaudited
NIS thousand
Gross premiums
Payments and change in
139,891 613,328 826,336(1) 56,905(1) 1,636,460
liabilities in respect of
insurance contracts, gross
Total comprehensive income
337,211 1,089,391 534,174 20,355 1,981,131
(loss) from health insurance
business
5,293(3) (9,959)(3) 66,407 11,125 72,866

(1) Of this, individual premiums in the amount of NIS 570.651 thousand and collective premiums in the amount of NIS 312,590 thousand.

For the 6-month period ended June 30, 2022
Long-term care Other (2)
Long Short
Individual Group term term Total
Unaudited
NIS thousand
Gross premiums
Payments and change in
132,214 541,539 777,055(1) 54,804(1) 1,505,612
liabilities in respect of
insurance contracts, gross
Total comprehensive income
(614,889) (187,072) 511,768 31,463 (258,730)
(loss) from health insurance
business
762,668(3) 39,064(3) 41,952 (633) 843,051

(1) Of this, individual premiums in the amount of NIS 515.483 thousand and collective premiums in the amount of NIS 316,376 thousand.

For the 3-month period ended June 30, 2023
Long-term care Other (2)
Individual
Group (6)
Long
term
Short
term
Total
Unaudited
NIS thousand
Gross premiums
Payments and change in
70,017 309,372 423,456(1) 29,741(1) 832,586
liabilities in respect of
insurance contracts, gross
Total comprehensive income
350,671 695,294 266,053 9,467 1,321,485
(loss) from health insurance
business
(136,178)(4) (6,202)(4) 56,895 8,084 (77,401)

(1) Of this, individual premiums in the amount of NIS 289.523 thousand and collective premiums in the amount of NIS 163,674 thousand.

NOTE 3 - OPERATING SEGMENTS (cont.)

C. Additional data regarding the health insurance segment (cont.)

For the 3-month period ended June 30, 2022
Long-term care Other (2)
Long Short
Individual Group term term Total
Unaudited
NIS thousand
Gross premiums
Payments and change in
66,587 273,418 382,285(1) 35,932(1) 758,222
liabilities in respect of
insurance contracts, gross
(67,282) (316,064) 276,438 19,784 (87,124)
Total comprehensive income
from health insurance business
139,572(4) 28,888(4) 17,737 1,523 187,720

(1) Of this, individual premiums in the amount of NIS 269.033 thousand and collective premiums in the amount of NIS 149,184 thousand.

Long-term care For the year ended December 31, 2022
Other (2)
Individual Group Long-term
Audited
NIS thousand
Short
term
Total
Gross premiums
Payments and change in
268,396 1,107,617 1,545,413(1) 139,110(1) 3,060,536
liabilities in respect of
insurance contracts, gross
Total comprehensive
(660,586) 304,476 1,014,645 71,820 730,355
income (loss) from
health insurance business
966,680 46,978 90,821 15,422 1,119,901
  • (1) Of this, individual premiums in the amount of NIS 1084435 thousand and collective premiums in the amount of NIS 600,088 thousand.
  • (2) The most material coverage included in other long-term health insurance is medical expenses; in short-term health insurance - travel insurance.
  • (3) The loss in the six-month period ended June 30, 2023, includes an increase in the insurance reserves (LAT) in the amount of NIS 117 million, and the profit in the six-month period ended June 30, 2022 includes a decrease in LAT of NIS 761 million.
  • (4) The profit in the three-month period ended June 30, 2023, includes an increase in the insurance reserves (LAT) in the amount of NIS 222 million, and the profit in the three-month period ended June 30, 2022 includes a decrease in LAT of NIS 134 million.
  • (5) For information about gain from assuming control in the FNX Private, which was recognized in the 6- and 3-months periods ended on June 30, 2023, see Note 4B.
  • (6) The agreement and the collective long-term health insurance policy for Maccabi members expire on December 31, 2023. The Company informed the policyholder - "Maccabi Healthcare Services" - and the Commissioner of the Capital Market that it will not extend the agreement, and that it is making preparations for the expiry of the agreement in accordance with its provisions. In accordance with the provisions of the policy and the Capital Markets Authority, as from January 1, 2024 The Phoenix Insurance is required to add all policyholders that were insured under the said policy, to a mutual collective long-term health insurance policy, without an insurance risk component for The Phoenix Insurance.

NOTE 3 - OPERATING SEGMENTS (cont.)

D. Additional data regarding the property and casualty insurance segment

For the 6-month period ended June 30, 2023
Compulsory Property
motor Motor and other Other liability
insurance property subsegments (*) subsegments (**) Total
Unaudited
NIS thousand
Gross premiums 388,714 997,604 554,322 417,882 2,358,522
Reinsurance premiums 26,800 - 387,603 192,410 606,813
Premiums - retention 361,914 997,604 166,719 225,472 1,751,709
Change in unearned premium
balance, retention 63,772 219,119 22,175 41,149 346,215
Premiums earned - retention 298,142 778,485 144,544 184,323 1,405,494
Investment income, net
and finance income 37,636 16,490 3,659 31,640 89,425
Income from fees and commissions 15,689 9 78,547 23,596 117,841
Total income 351,467 794,984 226,750 239,559 1,612,760
Payments and change in liabilities in
respect of insurance contracts, gross 286,838 669,482 298,322 205,173 1,459,815
Reinsurers' share in payments
and in changes in liabilities in
respect of insurance contracts 33,674 (57) 244,856 108,799 387,272
Payments and change in liabilities
for insurance contracts - retention 253,164 669,539 53,466 96,374 1,072,543
Fees and commissions,
marketing expenses and
other purchase expenses 37,828 137,093 109,003 72,258 356,182
General and administrative expenses 15,568 26,183 15,310 16,400 73,461
Finance expenses 4,334 - 422 3,644 8,400
Total expenses 310,894 832,815 178,201 188,676 1,510,586
Company's share in the
net results of investees 307 152 30 258 747
Profit (loss) before taxes on income 40,880 (37,679) 48,579 51,141 102,921
Other comprehensive income
before taxes on income 28,633 14,178 2,783 24,071 69,665
Total comprehensive
income (loss) for the period
before taxes on income 69,513 (23,501) 51,362 75,212 172,586
Liabilities in respect of
insurance contracts, gross,
as of June 30, 2023 (unaudited) 3,140,226 1,262,198 894,524 2,540,653 7,837,601
Liabilities in respect of
insurance contracts - retention -
as at June 30, 2023 (unaudited) 2,083,847 1,262,186 229,278 1,712,529 5,287,840

(*) Property and other subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 82% of total premiums in these subsegments.

(**) Other liability insurance subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 79% of total premiums in these subsegments.

NOTE 3 - OPERATING SEGMENTS (cont.)

D. Additional data regarding the property and casualty insurance segment (cont.)

For the 6-month period ended June 30, 2022
Compulsory Property
motor Motor and other Other liability
insurance property subsegments (*) subsegments (**) Total
Unaudited
NIS thousand
Gross premiums 373,367 747,043 483,558 352,802 1,956,770
Reinsurance premiums 71,665 6 338,697 167,719 578,087
Premiums - retention 301,702 747,037 144,861 185,083 1,378,683
Change in unearned premium
balance, retention 79,415 133,658 21,374 28,364 262,811
Premiums earned - retention 222,287 613,379 123,487 156,719 1,115,872
Investment income, net and
finance income 34,101 10,281 3,511 31,922 79,815
Income from fees and commissions 32,325 153 69,628 19,159 121,265
Total income 288,713 623,813 196,626 207,800 1,316,952
Payments and change in
liabilities in respect of
insurance contracts, gross 329,391 528,245 140,223 271,885 1,269,744
Reinsurers' share in payments
and in changes in liabilities in
respect of insurance contracts 84,975 305 113,205 147,330 345,815
Payments and change in liabilities
for insurance contracts - retention 244,416 527,940 27,018 124,555 923,929
Fees and commissions,
marketing expenses and
other purchase expenses 37,693 128,637 93,562 59,137 319,029
General and
administrative expenses 13,573 22,828 13,130 11,305 60,836
Finance expenses 9,699 - 999 9,079 19,777
Total expenses 305,381 679,405 134,709 204,076 1,323,571
Company's share in the
net results of investees (1,207) (508) (124) (1,130) (2,969)
Profit (loss) before taxes on income (17,875) (56,100) 61,793 2,594 (9,588)
Other comprehensive
loss before taxes on income (91,373) (38,500) (9,407) (85,534) (224,814)
Total comprehensive income
(loss) for the period before
taxes on income (109,248) (94,600) 52,386 (82,940) (234,402)
Liabilities in respect of
insurance contracts, gross, as
of June 30, 2022 (unaudited) 3,134,450 1,008,282 739,820 2,440,737 7,323,289
Liabilities in respect of
insurance contracts - retention
- as of June 30, 2022
(unaudited) 1,951,790 1,007,889 201,962 1,797,629 4,959,270

(*) Property and other subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 83% of total premiums in these subsegments.

(**) Other liability subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 80% of total premiums in these subsegments.

NOTE 3 - OPERATING SEGMENTS (cont.)

D. Additional data regarding the property and casualty insurance segment (cont.)

For the 3-month period ended June 30, 2023
Compulsory Property
motor Motor and other Other liability
insurance property subsegments (*) subsegments (**) Total
Unaudited
NIS thousand
Gross premiums 187,934 469,401 270,637 199,008 1,126,980
Reinsurance premiums 13,248 - 199,255 99,548 312,051
Premiums - retention 174,686 469,401 71,382 99,460 814,929
Change in unearned premium
balance, retention 18,508 61,371 (3,429) 3,879 80,329
Premiums earned - retention 156,178 408,030 74,811 95,581 734,600
Investment income,
net and finance income 27,425 12,578 2,725 22,937 65,665
Income from fees and commissions 7,373 13 39,331 11,790 58,507
Total income 190,976 420,621 116,867 130,308 858,772
Payments and change in
liabilities in respect of
insurance contracts, gross 136,460 358,206 111,304 133,122 739,092
Reinsurers' share in payments
and in changes in liabilities in
respect of insurance contracts 7,782 (56) 82,783 55,198 145,707
Payments and change in liabilities
for insurance contracts - retention 128,678 358,262 28,521 77,924 593,385
Fees and commissions,
marketing expenses and
other purchase expenses 20,290 71,650 55,106 36,659 183,705
General and
administrative expenses 8,945 11,709 7,652 9,245 37,551
Finance expenses 1,994 - 208 1,649 3,851
Total expenses 159,907 441,621 91,487 125,477 818,492
Company's share in the
net results of investees 10,246 5,093 940 8,730 25,009
Profit (loss) before taxes on income 41,315 (15,907) 26,320 13,561 65,289
Other comprehensive income
before taxes on income 13,016 6,415 1,354 10,758 31,543
Total comprehensive income
(loss) for the period before
taxes on income 54,331 (9,492) 27,674 24,319 96,832
Liabilities in respect of
insurance contracts, gross, as
of June 30, 2023 (unaudited) 3,140,226 1,262,198 894,524 2,540,653 7,837,601
Liabilities in respect of
insurance contracts - retention
- as at June 30, 2023
(unaudited) 2,083,847 1,262,186 229,278 1,712,529 5,287,840

(*) Property and other subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 82% of total premiums in these subsegments.

(**) Other liability subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 77% of total premiums in these subsegments.

NOTE 3 - OPERATING SEGMENTS (cont.)

D. Additional data regarding the property and casualty insurance segment (cont.)

For the 3-month period ended June 30, 2022
Compulsory Property
motor Motor and other Other liability
insurance property subsegments (*) subsegments (**) Total
Unaudited
NIS thousand
Gross premiums 167,419 340,430 252,594 180,043 940,486
Reinsurance premiums 32,775 (12) 188,348 92,609 313,720
Premiums - retention 134,644 340,442 64,246 87,434 626,766
Change in unearned premium
balance, retention 14,413 21,513 1,191 7,506 44,623
Premiums earned - retention 120,231 318,929 63,055 79,928 582,143
Losses on investments, net and
finance income (7,373) (6,793) (529) (7,272) (21,967)
Income from fees and commissions 15,541 69 34,880 8,796 59,286
Total income 128,399 312,205 97,406 81,452 619,462
Payments and change in
liabilities in respect of
insurance contracts, gross 157,808 222,854 69,137 127,172 576,971
Reinsurers' share in payments
and in changes in liabilities in
respect of insurance contracts 31,643 74 56,039 68,868 156,624
Payments and change in liabilities
for insurance contracts - retention 126,165 222,780 13,098 58,304 420,347
Fees and commissions,
marketing expenses and
other purchase expenses 19,039 72,027 52,738 29,070 172,874
General and
administrative expenses 6,328 11,447 6,604 5,942 30,321
Finance expenses 7,936 - 827 7,412 16,175
Total expenses 159,468 306,254 73,267 100,728 639,717
Company's share in the
net results of investees (904) (378) (95) (844) (2,221)
Profit (loss) before taxes on income (31,973) 5,573 24,044 (20,120) (22,476)
Other comprehensive
loss before taxes on income (28,536) (11,484) (3,286) (26,153) (69,459)
Total comprehensive income
(loss) for the period
before taxes on income (60,509) (5,911) 20,758 (46,273) (91,935)
Liabilities in respect of
insurance contracts, gross, as
of June 30, 2022 (unaudited) 3,134,450 1,008,282 739,820 2,440,737 7,323,289
Liabilities in respect of
insurance contracts - retention
- as of June 30, 2022
(unaudited) 1,951,790 1,007,889 201,962 1,797,629 4,959,270

(*) Property and other subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 85% of total premiums in these subsegments.

(**) Other liability subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 80% of total premiums in these subsegments.

NOTE 3 - OPERATING SEGMENTS (cont.)

D. Additional data regarding the property and casualty insurance segment (cont.)

For the year ended December 31, 2022
Compulsory Property and
motor Motor other Other liability
insurance property subsegments (*) subsegments (**) Total
Audited
NIS thousand
Gross premiums 721,382 1,445,963 892,080 657,496 3,716,921
Reinsurance premiums 138,769 8 611,459 311,648 1,061,884
Premiums - retention 582,613 1,445,955 280,621 345,848 2,655,037
Change in unearned premium
balance, retention 85,034 132,141 18,905 13,283 249,363
Premiums earned - retention 497,579 1,313,814 261,716 332,565 2,405,674
Investment income,
net and finance income 45,588 12,991 5,192 41,859 105,630
Income from fees and commissions 55,428 209 149,590 42,018 247,245
Total income 598,595 1,327,014 416,498 416,442 2,758,549
Payments and change in
liabilities in respect of
insurance contracts, gross 443,736 1,196,545 263,456 330,329 2,234,066
Reinsurers' share in payments
and in changes in liabilities in
respect of insurance contracts 118,598 342 204,498 247,269 570,707
Payments and change in liabilities
for insurance contracts - retention 325,138 1,196,203 58,958 83,060 1,663,359
Fees and commissions,
marketing expenses and
other purchase expenses 80,481 288,221 203,887 128,863 701,452
General and administrative
expenses 26,755 47,818 26,314 21,828 122,715
Finance expenses 11,890 - 1,354 10,917 24,161
Total expenses 444,264 1,532,242 290,513 244,668 2,511,687
Company's share in the
net results of investees 1,743 672 198 1,600 4,213
Profit (loss) before taxes on income 156,074 (204,556) 126,183 173,374 251,075
Other comprehensive loss
before taxes on income (91,992) (35,462) (10,477) (84,468) (222,399)
Total comprehensive income
(loss) for the period
before taxes on income 64,082 (240,018) 115,706 88,906 28,676
Liabilities in respect of
insurance contracts, gross, as
of December 31, 2022 (audited) 3,025,588 1,061,880 670,253 2,382,762 7,140,483
Liabilities in respect of
insurance contracts - retention
- as of December 31, 2022
(audited) 1,902,667 1,061,809 196,571 1,663,974 4,825,021

(*) Property and other subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 80% of total premiums in these subsegments.

(**) Other liability subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 82% of total premiums in these subsegments.

NOTE 3 - OPERATING SEGMENTS (cont.)

E. Additional data regarding the pension and provident segment

For the 6-month period ended June 30, 2023
Provident funds Pension Total
Unaudited
NIS thousand
Investment income, net and finance income 51,865 3,970 55,835
Income from management fees 214,073 147,369 361,442
Other income (see Note 4B) 15,616 1,210 16,826
Total income 281,554 152,549 434,103
Change in liabilities for investment contracts 49,944 - 49,944
Fees and commissions, marketing
expenses and other purchase expenses 94,414 87,223 181,637
General and administrative expenses 69,698 49,181 118,879
Other expenses 9,823 7,284 17,107
Finance expenses 4,647 2,536 7,183
Total expenses 228,526 146,224 374,750
Company's share in the
net results of an investee 362 - 362
Total comprehensive income for
the period before taxes on income 53,390 6,325 59,715
For the 6-month period ended June 30, 2022
Provident funds Pension Total
54,848 (4,019) 50,829
208,152 120,161 328,313
14,192 661 14,853
277,192 116,803 393,995
53,415 - 53,415
81,795 68,589 150,384
72,608 40,927 113,535
9,370 916 10,286
5,728 1,899 7,627
222,916 112,331 335,247
54,276 4,472 58,748
Unaudited
NIS thousand

NOTE 3 - OPERATING SEGMENTS (cont.)

E. Additional data regarding the pension and provident segment (cont.)

For the 3-month period ended June 30, 2023
Provident funds Pension Total
Unaudited
NIS thousand
Investment income, net and finance income 30,719 3,365 34,084
Income from management fees 107,946 75,208 183,154
Other income (see Note 4B) 15,616 740 16,356
Total income 154,281 79,313 233,594
Change in liabilities for investment contracts 26,641 - 26,641
Fees and commissions, marketing
expenses and other purchase expenses 48,482 44,212 92,694
General and administrative expenses 35,442 26,243 61,685
Other expenses 5,240 4,060 9,300
Finance expenses 2,578 1,649 4,227
Total expenses 118,383 76,164 194,547
Company's share in the
net results of an investee 362 - 362
Total comprehensive income for
the period before taxes on income 36,260 3,149 39,409
For the 3-month period ended June 30, 2022
Provident funds Pension Total
Unaudited
NIS thousand
Investment income (losses), net and finance income 31,885 (4,466) 27,419
Income from management fees 103,955 64,244 168,199
Other income 14,186 352 14,538
Total income 150,026 60,130 210,156
Change in liabilities for investment contracts 30,530 - 30,530
Fees and commissions, marketing
expenses and other purchase expenses 42,936 37,553 80,489
General and administrative expenses 31,310 20,289 51,599
Other expenses 4,486 458 4,944
Finance expenses 3,408 1,124 4,532
Total expenses 112,670 59,424 172,094
Total comprehensive income for
the period before taxes on income 37,356 706 38,062

NOTE 3 - OPERATING SEGMENTS (cont.)

E. Additional data regarding the pension and provident segment (cont.)

For the year ended December 31, 2022
Provident funds Pension Total
Audited
NIS thousand
Investment income (losses),
net and finance income 95,052 (4,229) 90,823
Income from management fees 415,822 254,565 670,387
Other income 14,215 1,649 15,864
Total income 525,089 251,985 777,074
Change in liabilities for investment contracts 98,221 - 98,221
Fees and commissions, marketing
expenses and other purchase expenses 175,411 139,914 315,325
General and administrative expenses 143,534 85,817 229,351
Other expenses 20,344 11,535 31,879
Finance expenses 9,862 3,453 13,315
Total expenses 447,372 240,719 688,091
Total comprehensive income for
the period before taxes on income 77,717 11,266 88,983

NOTE 4 - BUSINESS COMBINATIONS

A. Acquisition of control in Epsilon Investment House Ltd.

In November 2022, The Phoenix Investment House signed an agreement with Mr. Shmuel Frenkel, Flaming Star Ltd. (a wholly-owned company of Mr. Frenkel) and Mr. Lior Aviani (hereinafter, jointly - the "Sellers"), for the acquisition of the entire issued share capital of Epsilon Investment House Ltd. (hereinafter - "Epsilon"), which holds, among other things, Epsilon Mutual Funds Management (1991) Ltd. (hereinafter - "Epsilon Funds") and Epsilon Investment Portfolio Management Ltd. (hereinafter - "Epsilon Portfolios") in consideration for NIS 44.5 million plus an amount equal to Epsilon's liquid capital amount (as this term was defined in the agreement), and net of dividends that will be distributed after the calculation date of the liquid capital and through the completion date (hereinafter - the "Transaction").

The Transaction was completed on February 13, 2023, after obtaining a permit to hold means of control in Epsilon Funds from the Israel Securities Authority, and after obtaining the approval of the Competition Commissioner. The consolidation commencement date is January 1, 2023.

As part of the completion of the Transaction, The Phoenix Investment House paid the Sellers a total of NIS 89 million.

For the purpose of the acquisition, the Company advanced a NIS 60 million loan to The Phoenix Investment House by way of expansion of the lender's Bonds (Series 4); for information regarding the terms of the bonds - see Note 27E to the Consolidated Annual Financial Statements.

Under agreements between the parties, The Phoenix Investment House intends to take steps to sell the funds owned by Epsilon Funds to KSM Mutual Funds; the activity of Epsilon Portfolio will continue to be conducted independently under the management of the Sellers, and management agreements for a period of 5 years from the completion date were signed with them for that purpose.

The Company recognized the fair value of the assets acquired and the liabilities assumed as part of the business combination according to a provisional measurement. As of the date of approval of the financial statements, an acquisition cost allocation work has not yet been received from an external appraiser in relation to the fair value of the identified assets acquired and the liabilities assumed. A final adjustment of the consideration for the acquisition as well as the fair value of the assets and liabilities purchased can be carried out up to 12 months from the date of purchase. At the final measurement date, the adjustments were made by way of a restating the comparative results previously reported according to the provisional measurement.

The fair value of Epsilon's identified assets and identified liabilities as of the consolidation commencement date (January 1, 2023) is as follows:

NIS
thousand
Intangible assets 12,000
Working capital, net (excluding cash and cash equivalents) 3,000
Cash and cash equivalents 41,000
Liabilities in respect of deferred taxes (3,000)
Total identifiable assets net of identifiable liabilities 53,000
Goodwill arising from the acquisition 36,000
Total acquisition cost 89,000

As stated above, the date on which control was assumed is January 1, 2023; therefore, Epsilon's financial results are included in the financial services segment as from January 1, 2023.

NOTE 4 - BUSINESS COMBINATIONS (cont.)

B. Assuming control of FNX Private

  1. General

As from 2011, The Phoenix Insurance and The Phoenix Pension and Provident (hereinafter - the "Companies") operate - together with Saifa Management Services (2013) Ltd. (hereinafter - "Saifa") - the "FNX Private" venture (hereinafter - "FNX Private"), which is engaged in the development, adaptation, marketing and direct marketing (rather than through external insurance agents) of The Phoenix's self-directed policies and provident funds (IRA). These are customized services and products with unique characteristics, which are mainly suitable to wealthy customers (hereinafter - the "Venture"). The Companies share in the Venture is 50%.

In the first quarter of 2023, the Companies and Saifa, entered into an agreement for the incorporation of the Venture as two separate legal entities (hereinafter - "FNX Private Partnerships"), such that the Companies will continue holding 50% of the joint Venture.

2. Assuming control

In the second quarter of 2023, the Group completed a transaction for the acquisition of further 10% in the joint Venture's partnerships in consideration for NIS 25 million, such that subsequent to the acquisition the Group holds (directly and indirectly) 60% of the venture. Subsequent to the completion of the transaction, and as a result of assuming control in the Venture, the Company recognized a pre- and post-tax profit of NIS 129 million, which is included in the other income line item (in the health insurance segment - NIS 114 million, and in the pension and provident segment - NIS 15 million).

As of the report date, the Company recognized the fair value of the assets acquired and the liabilities assumed as part of the business combination according to a provisional measurement. As of the date of approval of the financial statements, a final valuation has not yet been received by an external appraiser in relation to the fair value of the identified assets acquired and the liabilities assumed. A final adjustment of the consideration for the acquisition as well as the fair value of the assets and liabilities purchased can be carried out up to 12 months from the date of purchase. At the time of the final measurement, the adjustments are made by way of a restating the comparison results previously reported according to the provisional measurement.

The Company has opted to measure the non-controlling interests in the acquired company according to the proportionate share of the non-controlling interests in the fair value of the net identified assets of the acquiree.

The fair value of FNX Private Partnerships' identified assets and identified liabilities as of the consolidation commencement date (June 30, 2023) is as follows:

NIS
thousand
Intangible assets 103,277
Liabilities in respect of deferred taxes (35,310)
Total identifiable assets net of identifiable liabilities 67,967
Non-controlling interests (27,309)
Profit from assuming control (129,096)
Goodwill arising from the acquisition 113,793
Total acquisition cost 25,355

NOTE 4 - BUSINESS COMBINATIONS (cont.)

B. Assuming control of FNX Private (cont.)

  1. Assuming control (cont.)

According to the terms of the agreement, the total acquisition cost shall be paid by August 31, 2023. As stated above, the date on which control was assumed is June 30, 2023, and therefore the financial results of FNX Private Partnerships are included in the profits of investees accounted for by the equity method for the 3 months period ended on June 30, 2023.

3. Excess value of illiquid assets against the LAT reserve

In accordance with the Circular on Allocation of Non-Marketable Assets, in the first quarter of 2023, The Phoenix Insurance carried out a valuation of FNX Private's activity in relation to The Phoenix's self-directed insurance products; the valuation was conducted by an independent external appraiser. In accordance with the valuation, in the first quarter, The Phoenix Insurance recognized a pre-tax profit of NIS 114 million from revaluation of excess fair value of the illiquid assets against the LAT reserve in the health insurance segment. As a result of assuming control in the FNX Private, as stated above, the profit from revaluation of excess fair value in the second quarter was derecognized.

    1. As part of assuming control, The Phoenix Investments also acquired 18% of the shares of Tehuda Management Services and 9% of the shares of Safra Consultation and Investments Ltd.; the said acquisitions include an indirect acquisition of 6% of the shares of The Phoenix Capital, such that subsequent to the acquisition the Company holds - through The Phoenix Investments - 71% of The Phoenix Capital's shares. The consideration for the acquisition amounts to NIS 7 million.
  • C. For information regarding the acquisition of portfolio management activity from Psagot, see Note 8G.

NOTE 5 - FINANCIAL INSTRUMENTS

A. Assets for yield-dependent contracts

  1. Following is a breakdown of assets held against insurance contracts and investment contracts presented at fair value through profit and loss:
As of June 30 As of December 31
2023 2022 2022
Unaudited Audited
NIS thousand
Investment property 2,206,935 1,903,600 2,142,074
Financial investments:
Liquid debt assets 22,297,970 20,988,024 21,252,417
Illiquid debt assets 8,131,412 8,685,245 8,306,926
Shares 19,755,597 21,510,775 19,610,785
Other financial investments 30,418,612 27,083,877 28,224,143
Total financial investments 80,603,591 78,267,921 77,394,271
Cash and cash equivalents 18,728,467 14,789,357 16,358,509
Other 204,514 255,808 160,734
Total assets for yield-dependent contracts 101,743,507 95,216,686 96,055,588
  1. Fair value of financial assets by level:

The following table presents

an analysis of assets held against insurance contracts and investment contracts presented at fair value through profit and loss. The different levels were defined as follows:

Level 1 - fair value measured using quoted prices (unadjusted) in an active market for identical instruments.

Level 2 - fair value measured using observable inputs, either directly or indirectly, that are not included in Level 1 above.

Level 3 - fair value measured using inputs that are not based on observable market inputs.

For financial instruments periodically recognized at fair value, the Company estimates, at the end of each reporting period, whether transfers have been made between the various levels of the fair value hierarchy.

During the reporting periods there were no material transfers between Level 1 and Level 2.

The Company holds the financial instruments measured at fair value according to the following classifications:

June 30, 2023
Level 1 Level 2 Level 3 Total
Unaudited
NIS thousand
Financial investments:
Liquid debt assets 15,941,467 6,356,503 - 22,297,970
Illiquid debt assets - 5,484,598 2,646,814 8,131,412
Shares 17,267,570 339,715 2,148,312 19,755,597
Other financial investments 10,485,451 1,096,654 18,836,507 30,418,612
Total 43,694,488 13,277,470 23,631,633 80,603,591

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

A. Assets for yield-dependent contracts (cont.)

2. Fair value of financial assets by level: (cont.)

June 30, 2022
Level 1 Level 2 Level 3 Total
Unaudited
NIS thousand
Financial investments:
Liquid debt assets 15,640,223 5,347,801 - 20,988,024
Illiquid debt assets - 6,573,194 2,112,051 8,685,245
Shares 18,702,517 1,108,956 1,699,302 21,510,775
Other financial investments 9,241,380 1,695,516 16,146,981 27,083,877
Total 43,584,120 14,725,467 19,958,334 78,267,921
As of December 31, 2022
Level 1 Level 2 Level 3 Total
Audited
NIS thousand
Financial investments:
Liquid debt assets (*) 15,871,715 5,380,702 - 21,252,417
Illiquid debt assets - 6,390,528 1,916,398 8,306,926
Shares 17,047,803 686,686 1,876,296 19,610,785
Other financial investments 9,989,631 965,706 17,268,806 28,224,143
Total 42,909,149 13,423,622 21,061,500 77,394,271

(*) Reclassified

Assets measured at fair value - Level 3

Fair value measurement at the reporting date
Financial assets at fair value through profit and loss
Liquid Illiquid Other
debt debt financial
assets assets Shares investments Total
NIS thousand
Balance on January 1,
2023 (audited) - 1,916,398 1,876,296 17,268,806 21,061,500
Total gains recognized
in profit or loss (*) - 176,470 14,342 1,151,755 1,342,567
Purchases - 709,408 349,235 1,917,563 2,976,206
Proceeds from interest
and dividend - (46,434) (13,085) (448,352) (507,871)
Redemptions / sales - (574,341) (78,476) (1,053,265) (1,706,082)
Transfers into Level 3 (**) - 569,646 - - 569,646
Transfers from Level 3 (**) - (104,333) - - (104,333)
Balance as of June 30,
2023 (unaudited) - 2,646,814 2,148,312 18,836,507 23,631,633
(*) Of which: Total unrealized
gains
for
the
period
recognized in profit and
loss in respect of assets
held as of June 30, 2023 - 108,850 847 802,446 912,143
(**) Transfers into (from) Level 3 stem mainly from securities whose rating changed.

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

A. Assets for yield-dependent contracts (cont.)

  1. Fair value of financial assets by level: (cont.)

Assets measured at fair value - Level 3 (cont.)

Fair value measurement at the reporting date
Financial assets at fair value through profit and loss
Liquid
debt
assets
Illiquid
debt
assets
Shares Other
financial
investments
Total
NIS thousand
Balance on January 1,
2022 (audited) - 1,722,489 1,622,980 13,931,585 17,277,054
Total gains recognized
in profit or loss (*) - 15,268 144,922 1,766,457 1,926,647
Purchases - 945,560 256,614 1,730,951 2,933,125
Proceeds from
interest and dividend - (15,949) (11,330) (362,043) (389,322)
Redemptions / sales - (381,970) - (838,449) (1,220,419)
Transfers into Level 3 (**) - 85,126 - - 85,126
Transfers from Level 3 (**) - (258,473) (313,884) (81,520) (653,877)
Balance as of June 30,
2022 (unaudited) - 2,112,051 1,699,302 16,146,981 19,958,334
(*) Of which: Total unrealized
gains
for
the
period
recognized in profit and
loss in respect of assets
held as of June 30, 2022 - 4,523 61,625 1,426,085 1,492,233

(**) Transfers into (from) Level 3 stem mainly from securities whose rating changed and from securities issued for the first time.

Liquid
debt
Illiquid
debt
Fair value measurement at the reporting date
Financial assets at fair value through profit and loss
Other
financial
assets assets Shares
Unaudited
investments Total
NIS thousand
Balance as of April 1, 2023
Total gains recognized
- 2,251,160 1,798,085 17,973,706 22,022,951
in profit or loss (*) - 104,840 22,357 809,367 936,564
Purchases
Proceeds from
- 441,207 342,815 956,352 1,740,374
interest and dividend - (25,496) (5,553) (265,229) (296,278)
Redemptions / sales - (422,539) (9,392) (637,689) (1,069,620)
Transfers into Level 3 (**) - 297,642 - - 297,642
Balance on June 30, 2023
(*) Of which: Total unrealized
gains
for
the
period
recognized in profit and
loss in respect of assets
- 2,646,814 2,148,312 18,836,507 23,631,633
held as of June 30, 2023 - 65,623 16,338 592,169 674,130

(**) Transfers into (from) Level 3 stem mainly from securities whose rating changed.

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

A. Assets for yield-dependent contracts (cont.)

  1. Fair value of financial assets by level: (cont.)

Assets measured at fair value - Level 3 (cont.)

Fair value measurement at the reporting date Financial assets at fair value through profit and loss

Notes to the Condensed Consolidated Interim Financial Statements as of June 30, 2023

Liquid
debt
Illiquid
debt
Other
financial
assets assets Shares investments Total
Unaudited
NIS thousand
Balance as of April 1, 2022 - 1,909,722 1,474,869 14,455,133 17,839,724
Total gains recognized
in profit or loss (*) - 32,168 61,786 1,397,196 1,491,150
Purchases - 594,942 172,984 789,410 1,557,336
Proceeds from
interest and dividend - (11,337) (10,337) (151,389) (173,063)
Redemptions / sales - (240,097) - (343,369) (583,466)
Transfers into Level 3 (**) - 85,126 - - 85,126
Transfers from Level 3 (**) - (258,473) - - (258,473)
Balance on June 30, 2022 - 2,112,051 1,699,302 16,146,981 19,958,334
(*) Of which: Total unrealized
gains
for
the
period
recognized in profit and
loss in respect of assets
held as of June 30, 2022 - 6,052 51,949 1,258,529 1,316,530
(**) Transfers into (from) Level 3 stem mainly from securities whose rating changed.
Fair value measurement at the reporting date
Financial assets at fair value through profit and loss
Liquid
debt
assets
Illiquid
debt
assets
Shares Other
financial
investments
Total
2,262,904
Purchases - 1,538,352 283,383 4,239,798 6,061,533
Proceeds from interest
(782,653)
Transfers from Level 3 (**)
Balance as of
January 1, 2022
Total gains recognized
in profit or loss ()
and dividend
Redemptions / sales
Balance as of
December 31, 2022
(
) Of which: Total unrealized
gains
(losses)
for
the
period included in profit
and loss in respect of
assets - balance held as of
December 31, 2022
(**) Transfers into (from) Level 3 stem mainly from securities whose rating changed and from
-
-
-
-
-
-
-
1,722,489
59,255
(42,028)
(804,657)
(557,013)
1,916,398
(11,021)
Audited
NIS thousand
1,622,980
324,560
(36,666)
(4,077)
(313,884)
1,876,296
228,762
13,931,585
1,879,089
(703,959)
(1,982,255)
(95,452)
17,268,806
1,332,466
17,277,054
(2,790,989)
(966,349)
21,061,500
1,550,207

securities issued for the first time.

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

B. Other financial investments (cont.)

  1. Illiquid debt assets

Composition:

June 30, 2023
Carrying amount Fair value (**)
Unaudited
NIS thousand
Loans and receivables
Designated bonds and treasury deposits (*) 8,808,980 11,439,046
Other non-convertible debt assets, excluding deposits with banks 7,179,943 7,112,671
Deposits with banks 1,298,519 1,306,702
Total illiquid debt assets 17,287,442 19,858,419

June 30, 2023
Carrying amount Fair value (**)
Unaudited
NIS thousand
Impairments carried to profit and loss (cumulative)
(*) The fair value was calculated according
69,365

to the contractual repayment date.

(**) The change in fair value in the reporting period is mainly attributed to the increase in the risk-free interest rate. See also Note 1D above.

June 30, 2022
Carrying
amount Fair value (**)
Unaudited
NIS thousand
Loans and receivables
Designated bonds (*) 8,477,307 11,917,819
Other non-convertible debt assets, excluding deposits with banks 6,323,737 6,346,775
Deposits with banks 2,392,191 2,419,840
Total illiquid debt assets 17,193,235 20,684,434
Impairments carried to profit and loss (cumulative)
(*) The fair value was calculated according
53,108
  • to the contractual repayment date.
  • (**) The change in fair value in the reporting period is mainly attributed to the increase in the risk-free interest rate. See also Note 1D above.
As of December 31, 2022
Carrying
amount Fair value (**)
Audited
NIS thousand
Loans and receivables
Designated bonds (*) 8,562,862 11,336,672
Other non-convertible debt assets, excluding deposits with banks 6,783,963 6,640,304
Deposits with banks 1,114,675 1,128,407
Total illiquid debt assets 16,461,500 19,105,383
Impairments carried to profit and loss (cumulative) 50,454

(*) The fair value was calculated according

to the contractual repayment date.

(**) The change in fair value in the reporting period is mainly attributed to the increase in the risk-free interest rate. See also Note 1D above.

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

B. Other financial investments (cont.)

  1. Fair value of financial assets by level

The tables below depict an analysis of the financial instruments presented at fair value. During the reporting periods there were no material transfers between Level 1 and Level 2.

June 30, 2023
Level 1 Level 2 Level 3 Total
Unaudited
NIS thousand
Liquid debt assets 4,312,769 1,498,602 - 5,811,371
Shares 1,555,503 135,082 527,862 2,218,447
Other 506,941 377,009 4,752,796 5,636,746
Total 6,375,213 2,010,693 5,280,658 13,666,564

June 30, 2022
Level 1 Level 2 Level 3 Total
Unaudited
NIS thousand
Liquid debt assets 4,661,233 1,740,240 - 6,401,473
Shares 1,650,443 371,416 491,931 2,513,790
Other 670,203 347,871 3,453,113 4,471,187
Total 6,981,879 2,459,527 3,945,044 13,386,450
As of December 31, 2022
Level 1 Level 2
Level 3
Total
Audited
NIS thousand
Liquid debt assets (*) 3,930,950 1,728,945 - 5,659,895
Shares 1,662,972 252,507 486,793 2,402,272
Other 585,574 305,766 4,111,483 5,002,823
Total 6,179,496 2,287,218 4,598,276 13,064,990

(*) Reclassified

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

B. Other financial investments (cont.)

2. Fair value of financial assets by level (cont.)

Assets measured at fair value - Level 3

Fair value measurement at the reporting date
Financial assets at fair value through profit and loss and
available-for-sale financial assets
Liquid
debt
Illiquid
debt
Other
financial
assets assets Shares investments Total
NIS thousand
Balance on January 1, 2023 (audited) - - 486,793 4,111,483 4,598,276
Total profits recognized:
In profit and loss (*) - - 1,958 125,125 127,083
In other comprehensive income - - 17,470 201,771 219,241
Purchases - - 23,168 605,450 628,618
Proceeds from interest and dividend - - (1,527) (127,962) (129,489)
Redemptions / sales - - - (163,071) (163,071)
Balance as of June 30, 2023 (unaudited) - - 527,862 4,752,796 5,280,658
(*) Of which: Total unrealized gains (losses) for the
period recognized in profit and loss in respect of
assets held as of June 30, 2023 - - (1,000) (24,415) (25,415)
Fair value measurement at the reporting date
Financial assets at fair value through profit and loss and
available-for-sale financial assets
Liquid Illiquid Other
debt debt financial
assets assets Shares investments Total
NIS thousand
Balance on January 1, 2022 (audited) - - 498,033 2,863,064 3,361,097
Total gains (losses) recognized:
In profit and loss (*) - - (3,649) 37,612 33,963
In other comprehensive income - - 26,345 331,780 358,125
Purchases - - 87,481 463,217 550,698
Proceeds from interest and dividend - - (55) (71,305) (71,360)
Redemptions / sales - - - (153,902) (153,902)
Transfers from Level 3 (**) - - (116,224) (17,353) (133,577)
Balance as of June 30, 2022 (unaudited) - - 491,931 3,453,113 3,945,044
(*) Of which: Total unrealized gains (losses) for the
period recognized in profit and loss in respect of
assets held as of June 30, 2022 - - (3,699) (42,895) (46,594)

(**) Transfers from Level 3 stem primarily from securities issued for the first time.

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

B. Other financial investments (cont.)

  1. Fair value of financial assets by level (cont.)

Assets measured at fair value - Level 3 (cont.)

Fair value measurement at the reporting date
Financial assets at fair value through profit and loss and
available-for-sale financial assets
Liquid
debt
Illiquid
debt
Other
financial
assets assets Shares investments Total
Unaudited
NIS thousand
Balance as of April 1, 2023 - - 503,089 4,403,232 4,906,321
Total gains (losses) recognized:
In profit and loss (*) - - (973) 70,822 69,849
In other comprehensive income - - 7,660 127,554 135,214
Purchases - - 18,086 281,484 299,570
Proceeds from interest and dividend - - - (78,214) (78,214)
Redemptions / sales - - - (52,082) (52,082)
Balance on June 30, 2023 - - 527,862 4,752,796 5,280,658
(*) Of which: Total unrealized gains (losses) for the
period recognized in profit and loss in respect of
assets held as of June 30, 2023 - - (1,000) (7,930) (8,930)
Fair value measurement at the reporting date
Financial assets at fair value through profit and loss and
available-for-sale financial assets
Liquid
debt
Illiquid
debt
Other
financial
assets assets Shares investments Total
Unaudited
NIS thousand
Balance as of April 1, 2022 - - 438,387 2,917,650 3,356,037
Total gains (losses) recognized:
In profit and loss (*) - - (3,649) (13,938) (17,587)
In other comprehensive income - - 22,140 320,192 342,332
Purchases - - 35,108 296,611 331,719
Proceeds from interest and dividend - - (55) (22,981) (23,036)
Redemptions / sales - - - (44,421) (44,421)
Balance on June 30, 2022 - - 491,931 3,453,113 3,945,044
(*) Of which: Total unrealized gains (losses) for the
period recognized in profit and loss in respect of
assets held as of June 30, 2022 - - (3,699) (34,401) (38,100)

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

B. Other financial investments (cont.)

  1. Fair value of financial assets by level (cont.)

Assets measured at fair value - Level 3 (cont.)

Fair value measurement at the reporting date Financial assets at fair value through profit and loss and available-for-sale financial assets

Notes to the Condensed Consolidated Interim Financial Statements as of June 30, 2023

Liquid
debt
Illiquid
debt
Other
financial
assets assets Shares investments Total
Audited
NIS thousand
Balance as of January 1, 2022 - - 498,033 2,863,064 3,361,097
Total gains (losses) recognized:
In profit and loss (*) - - (804) 154,348 153,544
In other comprehensive income - - 47,457 500,197 547,654
Purchases - - 60,189 1,211,807 1,271,996
Proceeds from interest and dividend - - (1,858) (140,728) (142,586)
Redemptions / sales - - - (459,852) (459,852)
Transfers from Level 3 (**) - - (116,224) (17,353) (133,577)
Balance as of December 31, 2022 - - 486,793 4,111,483 4,598,276
(*) Of which: Total unrealized losses for the period
included in profit and loss in respect of assets -
balance held as of December 31, 2022 - - (8,321) (75,807) (84,128)

(**) Transfers from Level 3 stem primarily from securities issued for the first time.

C. Credit assets in respect of factoring, clearing and financing

As of June 30 As of December 31
2023 2022 2022
Unaudited Audited
NIS thousand
Trade receivables and checks for collection 1,024,287 1,096,544 1,105,547
Credit vouchers 18,866 19,601 17,064
Loans and checks for collection 1,023,219 830,736 1,010,058
Credit vouchers for sale 1,454,634 1,280,360 1,335,486
Provision for doubtful debts - (18,919) (24,818)
Loan loss provision (*) (32,153) - -
Total 3,488,853 3,208,322 3,443,337

(*) See Note 2A and B regarding first-time application of IFRS 9 (Financial Instruments) regarding financial instruments that do not relate to The Phoenix Insurance, which falls within the scope of the definition of insurer. According to the transition method that was selected, the comparative figures were not restated.

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

D. Financial liabilities

1. Breakdown of financial liabilities

June 30, 2023
Carrying
amount
Fair
value
Unaudited
NIS thousand
Financial liabilities presented at amortized cost:
Loans and credit from banking corporations (see Note 8K and 8O) 815,705 815,705
Loans from non-bank entities 797,806 797,806
Bonds (see Note 8C and 8N) 2,141,941 2,051,986
Subordinated bonds (1) 3,679,246 3,547,009
Additional Tier 1 capital subordinated bond (1) 215,044 190,731
Trade receivables for credit cards 1,637,003 1,637,003
Notes to the Condensed Consolidated Interim Financial Statements as of June 30, 2023
REPO in respect of non-yield-dependent contracts (2) 753,384 753,384
Other (3) 27,362 27,362
Total financial liabilities presented at amortized cost 10,067,491 9,820,986
Financial liabilities presented at fair value through profit and loss:
Derivatives held for yield-dependent contracts 1,501,978 1,501,978
Derivatives held for non-yield-dependent contracts 611,717 611,717
REPO in respect of yield-dependent contracts (2) 855,992 855,992
Liability for short sale of liquid securities 1,269,828 1,269,828
Total financial liabilities presented at fair value through profit and loss 4,239,515 4,239,515
Lease liabilities (4) 106,132
Total financial liabilities 14,413,138

(1) The bonds were issued for the purpose of complying with the capital requirements.

A. See Note 8E regarding full early redemption of Series F Bonds.

B. See Note 8I regarding listing for trading of Series L Bonds.

(2) During the present quarter, The Phoenix Insurance entered into repo and reverse repo agreements with foreign banks. The term of those transactions was up to one year, against liquid debt assets of the Government of Israel; they include a mechanism for the adjustment of the value of the collateral that will be provided against the consideration that was received in the transaction.

(3) Mainly provision in respect of an option to acquire an investee and an undertaking to acquire portfolios.

(4) Disclosure of fair value was not required.

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

D. Financial liabilities (cont.)

1. Breakdown of financial liabilities (cont.)

June 30, 2022
Carrying Fair
amount value
Unaudited
NIS thousand
Financial liabilities presented at amortized cost:
Short-term credit from banking corporations 530,921 530,921
Loans from non-bank entities 821,494 821,494
Bonds (see Note 8C) 2,079,078 2,016,153
Subordinated bonds (1) 3,675,910 3,693,530
Additional Tier 1 capital subordinated bond (1) 206,145 191,479
Trade receivables for credit cards 1,472,492 1,472,492
Other (2) 34,612 34,612
Total financial liabilities presented at amortized cost 8,820,652 8,760,681
Financial liabilities presented at fair value through profit and loss:
Derivatives held for yield-dependent contracts 1,635,376 1,635,376
Derivatives held for non-yield-dependent contracts 528,042 528,042
Liability for short sale of liquid securities 2,319,030 2,319,030
Total financial liabilities presented at fair value through profit and loss 4,482,448 4,482,448
Lease liabilities (3) 128,901
Total financial liabilities 13,432,001

(1) The bonds were issued for the purpose of complying with the capital requirements.

(2) Mainly provision in respect of an option to acquire an investee and an undertaking to acquire portfolios.

(3) Disclosure of fair value was not required.

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

D. Financial liabilities (cont.)

1. Breakdown of financial liabilities (cont.)

As of December 31, 2022
Carrying Fair
amount value
Audited
NIS thousand
Financial liabilities presented at amortized cost:
Short-term credit from banking corporations 577,658 577,658
Loans from non-bank entities 827,333 827,333
Bonds 2,128,984 2,004,364
Subordinated bonds (1) 4,074,461 3,946,156
Subordinated bonds - Additional Tier 1 capital (1) 210,536 174,768
Trade receivables for credit cards 1,571,513 1,571,513
REPO in respect of non-yield-dependent contracts (2) 477,606 477,606
Other (3) 35,477 35,477
Total financial liabilities presented at amortized cost 9,903,568 9,614,875
Financial liabilities presented at fair value through profit and loss:
Derivatives held for yield-dependent contracts 1,177,929 1,177,929
Derivatives held for non-yield-dependent contracts 479,909 479,909
REPO in respect of yield-dependent contracts (2) 244,764 244,764
Liability for short sale of liquid securities 1,189,653 1,189,653
Total financial liabilities presented at fair value through profit and loss 3,092,255 3,092,255
Lease liabilities (4) 109,741
Total financial liabilities 13,105,564

(1) The bonds were issued for the purpose of complying with the capital requirements.

(2) In 2022, The Phoenix Insurance entered into repo and reversed repo agreements with foreign banks. The term of those transactions was up to one year, against liquid debt assets of the Government of Israel; they include a mechanism for the adjustment of the value of the collateral that will be provided against the consideration that was received in the transaction.

(3) Mainly provision in respect of an option to acquire an investee and an undertaking to acquire portfolios.

(4) Disclosure of fair value was not required.

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

D. Financial liabilities (cont.)

2. Fair value of financial liabilities by level

June 30, 2023
Level 1 Level 2 Level 3 Total
Unaudited
NIS thousand
Liability for short sale of liquid securities 1,269,828 - - 1,269,828
REPO in respect of yield-dependent contracts 855,992 855,992
Derivatives 167,902 1,935,410 10,383 2,113,695
Financial liabilities presented at fair value 1,437,730 2,791,402 10,383 4,239,515
June 30, 2022
Level 1 Level 2 Level 3 Total
Unaudited
NIS thousand
Liability for short sale of liquid securities 2,319,030 - - 2,319,030
Derivatives 314,073 1,849,345 - 2,163,418
Financial liabilities presented at fair value 2,633,103 1,849,345 - 4,482,448
As of December 31, 2022
Level 1 Level 2 Level 3 Total
Audited
NIS thousand
Liability for short sale of liquid securities 1,189,653 - - 1,189,653
REPO in respect of yield-dependent contracts 244,764 244,764
Derivatives 313,204 1,333,978 10,656 1,657,838
Financial liabilities presented at fair value 1,502,857 1,578,742 10,656 3,092,255

3. Valuation techniques

The fair value of investments traded actively in regulated financial markets is determined based on market prices as of the reporting date. For investments where there is no active market, fair value is determined using valuation techniques. Such techniques include using transactions that were recently made at fair market value, reference to the current market value of another instrument which is substantially the same, discounting of cash flows, or other valuation methods.

A) Illiquid debt assets

The fair value of illiquid debt assets, which are measured at fair value through profit and loss, and the fair value of illiquid financial debt assets, for which fair value information is provided solely for disclosure purposes, is determined by discounting the estimated future cash flows from those assets. The discount rates are based primarily on yields on government bonds and spreads of corporate bonds as measured on the Tel Aviv Stock Exchange. The quoted prices and interest rates used for discounting purposes are determined by a company which won the tender, published by the Ministry of Finance, for the setting up and operating a database of quoted prices and interest rates for institutional entities.

NOTE 5 - FINANCIAL INSTRUMENTS (cont.)

D. Financial liabilities (cont.)

3. Valuation techniques (cont.)

B) Illiquid shares

The fair value of the investment in illiquid shares was estimated using the discounted cash flow model (DCF). The estimate requires management to make certain assumptions regarding the model's data, including expected cash flows, discount rates, credit risk and volatility. The probabilities in respect of the estimates in the range can be measured reliably, and management uses them to determine and evaluate the fair value of these investments in illiquid shares.

C) Derivatives

The Company enters into transactions involving derivative financial instruments with multiple parties, especially financial institutions. The derivatives were valued using valuation models with observable market inputs are mainly interest rate swap contracts and foreign currency forwards. The most frequently used valuation techniques include prices of forwards and swap models using present value calculations. The models combine a number of inputs, including the credit rating of the parties to the financial transaction, spot/forward exchange rates, prices of forward contracts and interest rate curves. All derivative contracts are fully back against cash; therefore, there is no counterparty credit risk and non-performance risk of the Company itself in respect thereof.

NOTE 6 - SHAREHOLDERS' EQUITY AND CAPITAL REQUIREMENTS

It is management's policy to maintain a strong capital base in order to retain Company's ability to continue its activities such that it will be able to generate returns to its shareholders and support future business activities. The Phoenix Insurance, The Phoenix Investment House group, pension and provident funds management company and other institutional entities consolidated in the financial statements are subject to capital requirements set by the Commissioner.

A. Principles of the Solvency II-based Economic Solvency Regime

The Phoenix Insurance is subject to the Solvency II-based Economic Solvency Regime in accordance with implementation provisions as published in June 2017 and revised in October 2020 (hereinafter the "Economic Solvency Regime").

Economic solvency ratio

The economic solvency ratio is calculated as the ratio between the insurance company's recognized economic equity and the capital required for solvency purposes.

The recognized economic equity is determined as the sum of the core tier 1 capital derived from the economic balance sheet and debt instruments that include loss absorption mechanisms (Additional Tier 1 capital and Tier 2 capital instrument).

Economic balance sheet items are calculated based on economic value, with insurance liabilities calculated on the basis of a best estimate of all expected future cash flows from existing businesses, without conservatism margins, and plus a risk margin.

The solvency capital requirement (SCR) is designed to estimate the economic equity's exposure to a series of scenarios set out in the Economic Solvency Regime provisions, and which reflect insurance risks, market risks and credit risks as well as operational risks.

The Economic Solvency Regime includes, among other things, transitional provisions in connection with compliance with capital requirements, and which allow increasing the economic capital by deducting from the insurance reserves an amount calculated in accordance with the Economic Solvency Regime provisions (hereinafter - the "Deduction"). The Deduction will decrease gradually until 2032 (hereinafter - the "Transitional Period"). In addition to a reduced capital requirements, that will increase gradually until 2023, in respect of certain investment types.

In accordance with the provisions of the Economic Solvency Regime, the economic solvency ratio report as of the December 31 and June 30 data of each year shall be included in the first periodic report published after the calculation date.

Furthermore, further to Note 8I, in view of the listing of Additional Tier 1 capital for trading on the Tel Aviv Stock Exchange's main list, and in accordance with The Phoenix Insurance's undertakings under the deed of trust, as from 2023 the Company will publish to the public, in the framework of the Report of the Board of Directors, the estimated quarterly solvency ratio as of March 31 and September 30, as part of the periodic report published following the calculation date. The calculation of the estimated quarterly solvency ratio is not audited or reviewed by the independent auditor, and the controls conducted by The Phoenix Insurance for the purpose of publishing the estimated ratio are less in scope compared to those executed for the purpose of publishing the solvency ratio report, which is published in accordance with the Commissioner's directives.

NOTE 6 - SHAREHOLDERS' EQUITY AND CAPITAL REQUIREMENTS (cont.)

A. Principles of the Solvency II-based Economic Solvency Regime (cont.)

According to the above, the Company made an estimate of its economic solvency ratio as of March 31, 2023 (hereinafter - the "Estimate"); the Estimate is not audited or reviewed by the independent auditor. The calculation (of the Estimate) was carried out in accordance with the guidelines of the Solvency IIbased Economic Solvency Regime, and in accordance with the provisions of Circular 2020-1-15 of the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner") - "Amendment to the Consolidated Circular concerning Implementation of a Solvency II-Based Economic Solvency Regime for Insurance Companies" (hereinafter - the "Provisions of the Economic Solvency Regime"), which was published on October 14, 2020. The Company carries out the Estimate and publishes the quarterly disclosure in addition to the publication of a mandatory solvency ratio reports as required under the Provisions of the Economic Solvency Regime.

In accordance with the Solvency Ratio Report as of December 31, 2022, and the estimated quarterly solvency ratio as of March 31, 2023 as stated above, The Phoenix Insurance has surplus capital, both when calculation is made having no regard to the transitional provisions and when it is made taking into account the transition provisions.

The calculation As at December 31, 2022 made by The Phoenix Insurance was reviewed by The Phoenix Insurance's independent auditors, in accordance with International Standard on Assurance Engagements (ISAE 3400) - The Examination of Prospective Financial Information. This standard is relevant to audits of solvency calculations and does not constitute part of the auditing standards that apply to financial statements.

It should be emphasized that the projections and assumptions on the basis of which the economic solvency ratio report was prepared are based mainly on past experience as arising from actuarial studies conducted from time to time. In view of the reforms in the capital market, insurance and savings, and the changes in the economic environment, past data do not necessarily reflect future results. The calculation is sometimes based on assumptions regarding future events, steps taken by management, and the pattern of the future development of the risk margin, that will not necessarily materialize or will materialize in a manner different than the assumptions used in the calculation. Furthermore, actual results may materially vary from the calculation, since the combined scenarios of events may materialize in a manner that is materially different than the assumptions made in the calculation.

In their special report, the independent auditors noted that they did not review the appropriateness of the Deduction During the Transitional Period as of December 31, 2022, except for verifying that the Deduction amount does not exceed the expected discounted amount of the risk margin and the capital required for solvency in respect of life and health insurance risks arising from existing businesses during the Transitional Period in accordance with the pattern of future development of the required capital, which affects both the calculation of the expected capital release and the release of the expected risk margin as described in the provisions on calculation of risk margin. Furthermore, attention is drawn to what is stated in the economic solvency ratio report regarding the uncertainty derived from regulatory changes and exposure to contingent liabilities, the effect of which on the solvency ratio cannot be estimated.

For further details, please see Section 2.1 to the Report of the Board of Directors, and the Economic Solvency Ratio Report as of December 31, 2022 published on The Phoenix Insurance's website.

NOTE 6 - SHAREHOLDERS' EQUITY AND CAPITAL REQUIREMENTS (cont.)

B. Dividend

According to the letter published by the Commissioner, in October 2017, (hereinafter - the "Dividend Distribution Letter") an insurance company shall be entitled to distribute a dividend only if, following the distribution, the company has a solvency ratio - according to the provisions of the Economic Solvency Regime - of at least 100%, calculated without taking into account the transitional provisions and subject to the economic solvency ratio target set by the Company's Board of Directors. The aforesaid ratio shall be calculated without the relief granted in respect of the original difference attributed to the acquisition of the provident funds and management companies. In addition, the letter set out provisions for reporting to the Commissioner.

The Phoenix Insurance's Board of Directors has set a minimum economic solvency ratio target and target range based on Solvency II. The economic solvency ratio target range, within which the Company seeks to be during and at the end of the Transitional Period, taking into account the Deduction during the Transitional Period and its gradual reduction is 150%-170%. In addition, the minimum economic solvency ratio target, taking into account the transitional provisions, is set at 135%. In addition, on August 23, 2023, the Company's Board of Directors increased the minimum economic solvency ratio target by 4 percentage points without taking into account the provisions during the Transitional Period - from a rate of 111% to a rate of 115% beginning on June 30, 2023. This minimum economic solvency ratio target is expected to reach 135% at the end of the transitional period, in accordance with the Company's capital plan.

On October 27, 2020, The Phoenix Insurance's Board of Directors approval of the dividend distribution whereby, as from 2021, The Phoenix Insurance shall distribute an annual dividend at a rate of 30% to 50% of its distributable comprehensive income as per its audited annual consolidated financial statements for the relevant year, so long as The Phoenix Insurance meets the minimum economic solvency ratio targets in accordance with Solvency II, as described above.

On March 28, 2022, The Phoenix Insurance's Board of Directors approved a revision of the dividend distribution policy that will apply to future dividend distributions to be made in connection with The Phoenix Insurance's financial results for 2022 and thereafter. According to the update, the rate of dividend will not change, but The Phoenix Insurance will take steps to distribute a dividend twice a year: Dividend at the discretion of the Board of Directors on the approval date of the Financial Statements for the second quarter of each calendar year.

Supplementary dividend in accordance with the policy on the annual report's approval date of each calendar year.

It is hereby clarified that this policy should not be viewed as an undertaking by The Phoenix Insurance to distribute dividends, and that any actual distribution shall be individually subject to the Board of Directors' approval, at its sole discretion; the Board of Directors of The Phoenix Insurance may decide on actual distribution at different (higher or lower) rates, or not to distribute any dividend. Furthermore, the execution of any actual distribution shall be subject to compliance with the provisions of the law applicable to any dividend distribution, including, among other things, the provisions of the Companies Law, 1999, and to compliance with the financial covenants The Phoenix Insurance has undertaken or/or will undertake to comply with, to The Phoenix Insurance's having sufficient distributable profits on the relevant dates, to the condition that the distribution shall not adversely affect the terms of The Phoenix Insurance's bonds and/or its cash flows, and to the extent to which The Phoenix Insurance needs cash to finance its activities, including future investments, as shall be from time to time, and/or its expected and/or planned future activities.

The Board of Directors of The Phoenix Insurance may review the dividend distribution policy from time to time and decide, at any given time, taking into account business considerations and the legal and regulatory provisions applicable to The Phoenix Insurance, to change the dividend distribution policy, including the rate of dividend to be distributed.

NOTE 6 - SHAREHOLDERS' EQUITY AND CAPITAL REQUIREMENTS (cont.)

B. Dividend (cont.)

On March 22, 2023, The Phoenix Insurance's Board of Directors approved a cash dividend distribution in the amount of NIS 205 million. This dividend distribution was taken into account in the results of the solvency ratio as of December 31, 2022.

In August 2023, concurrently with the approval of The Phoenix Insurance's Financial Statements as of June 30, 2023, The Phoenix Insurance's Board of Directors decided to distribute a NIS 350 million dividend, at a rate higher than that set in the distribution policy, without detracting from its long-term dividend policy, and given the amount of the distributable profits and the solvency ratio rate of The Phoenix Insurance, and after compliance with the solvency ratio targets and the distribution tests as per the Companies Law.

The dividend distributions described above were approved after the revision of the Company's capital management plan, and indicated that The Phoenix Insurance meets the minimum capital target set by the Board of Directors as of the distribution dates, net of the transitional provisions, and meet the 150%- 170% target range, in which The Phoenix Insurance seeks to be during and after the Transitional Period, given the Deduction During the Transitional Period and its gradual reduction. Therefore, The Phoenix Insurance was in compliance with the requirements of the letter regarding the restrictions on dividend distribution as published by the Commissioner.

The solvency ratio as of December 31, 2022 does not include the effect of the business activity of The Phoenix Insurance subsequent to December 31, 2022 until the report publication date, changes in the mix and amounts of insurance investments and liabilities, exogenous effects - including changes in the risk-free interest rate curve, and regulatory changes affecting the business environment.

C. Own Risk and Solvency Assessment of an Insurance Company (ORSA)

On January 5, 2022, the Commissioner published an Amendment to the Provisions of the Consolidated Circular - "Reporting to the Commissioner of Capital Market" - Own Risk and Solvency Assessment of an Insurance Company (ORSA) was published (hereinafter - the "Amendment"); the Amendment stipulates that an insurance company shall report to the Commissioner about Own Risk and Solvency Assessment of an Insurance Company (ORSA) once a year - in January. In accordance with the Amendment, the Company shall provide the Commissioner with a report that will include a summary of its results, status of its business and interactions, risk exposure, assessment of solvency and capital requirement, forwardlooking valuation, scenarios and sensitivity analyses. The circular's effective date is January 1, 2023. In January 2023, the Company reported its Own Risk and Solvency Assessment of an Insurance Company to the Commissioner for the first time, in accordance with the requirements of the Amendment.

  • D. The Company undertook to supplement, at any time, the own capital of The Phoenix Pension and Provident to the amount prescribed by the Income Tax Regulations (Rules for Approval and Management of Provident Funds), 1964.This undertaking will be fulfilled only when The Phoenix Pension and Provident's equity will be negative, provided that the supplement amount does not exceed the liabilities limit as aforesaid; the commitment will be in effect so long as the Company is the controlling shareholder of this entity.
  • E. The Phoenix Pension and Provident Funds Ltd. is required to maintain minimum equity in accordance with the Supervision of Financial Services Regulations (Provident Funds) (Minimum Equity Required from a Provident Fund or a Pension Fund's Management Company), 2012, and the Commissioner's directives, the directives of the Israel Securities Authority and/or the TASE Rules and Regulations. As of June 30, 2023, the Company complies with those requirements.
  • F. For information regarding the share buyback, see Note 8F.
  • G. For further details regarding the Company's dividend distribution, please see Notes 8G and 9B.
  • H. For information about The Phoenix Insurance's international rating, see Note 1G.

NOTE 7 - CONTINGENT LIABILITIES AND COMMITMENTS

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions

In recent years, there has been a significant increase in the number of motions to certify class actions filed against the group and in the number of lawsuits recognized as class actions. This is part of an overall increase in motions to certify class actions in general, including against companies engaged in the group's areas of activity, which stems mainly from the enactment of the Class Actions Law, 2006 (hereinafter - the "Class Actions Law"). This trend substantially increases the group's potential exposure to losses in the event of a ruling against the group companies in class actions.

Motions to certify class actions are filed through the hearing procedure mechanism set forth in the Class Actions Law. The hearings procedure for motions to certify class actions is divided into two main stages: The first stage is the motion to certify (hereinafter - the "motion to certify" or the "motion stage", respectively). Provided the motion to certify is rejected by the court, the hearing stage at the class action level ends. A ruling at the approval stage may be subject to a request for appeal to the appellate courts. In the second stage, if the motion to certify is accepted, the class action will be heard (hereinafter - the "class action stage"). A judgment at the class action stage can be appealed to the appellate courts. Within the mechanism of the Class Actions Law, there are, inter alia, specific settlement agreements, both in the approval stage and in the class action stage, as well as arrangements with regard to the plaintiff's withdrawal of the motion to certify or class action lawsuit.

In the State of Israel, filing class action lawsuits does not entail payment of a fee derived from the claim amount; therefore the amounts of such claims may be significantly higher than the actual exposure for that claim.

In Sections 1-9, 11-22, 24-29, 31-33, 35-41, 43-46, 48, 49, 56 to the following table; for such lawsuits, which, in management's opinion - that is based, inter alia, on legal opinions whereby the group's defense claims are more likely than not to be accepted and the petitions to approve the lawsuit as class actions will be rejected - no provision was included in the financial statements, except for petitions to approve class actions in which the group is willing to reach a settlement. For motions to certify lawsuits as class actions (including lawsuits certified as class actions and the approval of which is under appeal), in which the group's defense claims - in whole or in part - are more likely than not to be rejected, and in which the group is willing to reach a compromise, provisions were included in the financial statements to cover the exposure as assessed by the group or a provision in the amount for which the group is willing to settle, as the case may be.

Management's assessment, which is based, inter alia, on legal opinions received, is included in the financial statements under adequate provisions, where such provisions were required, to cover the exposure as assessed by the group or the amount for which the group is willing to settle, as the case may be.

Many of the motions to certify lawsuits as class actions have been filed against the group on various matters related to insurance contracts and the group's ordinary course of business, for which the group has allocated insurance reserves.

In petitions to approve lawsuits as class actions as set out in Sections 10, 23, 30, 34, 42, 47, 50-55, 57, 58 in the table below, at this preliminary stage, the chances of the petitions to approve lawsuits as class actions cannot be assessed and therefore no provision is included in respect thereof in the financial statements.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

Following is more information about the motions to certify class actions:

No. Date,1 court,2 defendants and
claim amount3
Main arguments Details
1. January 2008 Unlawful
collection
of
In May 2018, the Supreme Court granted the defendants' motion for leave to appeal and dismissed the
Tel Aviv District Court payments known as "sub plaintiffs' appeal, such that the District Court's judgment was quashed and the motion to certify of the
annuals" for life insurance
policies, in an amount that
claim as a class action was denied.
The Phoenix Insurance and other exceeds the permitted one. In July 2019, the Supreme Court upheld the plaintiffs' request for a further hearing on the question set
insurance companies forth in the Judgment regarding the regulator's position filed with the court regarding its instructions,
Approximately NIS 1.67 billion of all and on the question of de minimis defense in a monetary class action.
defendants, with about NIS 277 million In July 2021, the Supreme Court handed down its judgment in respect of the further hearing by the
Insurance.4
attributed to The Phoenix
Supreme Court (which was concluded at a 4 to 3 majority), whereby the Supreme Court's judgment will
be canceled and the District Court's judgment will be reinstated, the motion to certify will be allowed
and the class action will be heard by the District Court, excluding the specific claims that were raised
against The Phoenix Insurance (and another insurance company) regarding the collection of "sub
annuals" in an amount that exceeds the amount permitted by law -
claims which were rejected by the
court and therefore will not be discussed again by the District Court, and the legal proceedings in
respect thereof has ended.
The class action continues to be heard in the District Court.
The parties are in mediation.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

4 The amounts were assessed by the plaintiffs in the class action statement of claim. It should be noted that the amounts in the motion to certify the claim as a class action were different and higher; those amounts also referred to the claim of collecting handling fees on policies and interest on annual premium, which is paid in installments, at a rate higher than the rate permitted by law, which, as stated, has been rejected.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
2. February 2010
Central District Court
The Phoenix Insurance (and other insurance
companies in a parallel case, in light of filing a
consolidated class action statement of claim)
Approximately NIS 1.47 billion of all defendants
(including the defendants in the corresponding
case), of which approximately NIS 238 million is
attributed to The Phoenix Insurance.4
The cause of the lawsuit, as
approved by the District Court (in
the corresponding case) was
breach of insurance policies due to
unlawful collection of
"policy
factor" commission in a manner
that reduced the saving amount
accrued in favor of the policyholder
for a period starting seven years
before the claim was filed.
In November 2016, the District Court -
in a parallel case filed against several other
insurance companies -
partially certified motions to approve the claims as class
actions.
The class action -
both in the corresponding case and in the case heard against The
Phoenix Insurance -
continues to be heard jointly by the District Court.
In June 2023, the parties filed with the Court a motion to approve a settlement
agreement. According to the settlement agreement that was filed, the considerations
paid to the class members (as defined in the settlement agreement), are: Refund at
the rate of 42% in respect of the past for the "policy factor"; future discount of 50%
in respect of the "policy factor"; and payment of compensation and legal fees to the
class action plaintiff and his attorney (for more information, see immediate report of
June 21, 2023,
Ref No.: 2023-01-057877).
The settlement agreement is subject to the Court's approval.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

4 The amounts are the amounts assessed by the plaintiffs in the consolidated class action statement of claim filed in March 2019 against the defendant insurance companies sued in the corresponding case and against The Phoenix. It should be noted that the amounts in the motion to certify of the claim as a class action were different and higher.

No. Date,1 court,2 defendants and claim amount3 Main arguments Details 3. May 2013 Tel Aviv District Court The Phoenix Insurance Approximately NIS 220 million or alternatively NIS 90 million.4 Non-payment of interest in respect of insurance benefits from the date of the insured event, or alternatively from the end of 30 days from the date on which the claim was filed and until actual payment date. In February 2021, the District Court handed down a partial judgment, according to which it has certified the class action, in respect of any entitled party (policyholder, beneficiary or third party), who - during the period starting three years prior to the filing of the lawsuit and ending on judgment date - received insurance benefits from The Phoenix Insurance (not in accordance with a judgment rendered in his case) without being duly paid interest thereon. It was also established that, for the purpose of implementing the judgment, calculation and manner of restitution, an expert will be appointed and that the class plaintiffs will be awarded legal expenses and legal fees. In November 2022, the motion for leave to appeal filed by The Phoenix Insurance to the Supreme Court in connection with the partial judgment was rejected, noting that the appropriate instance to hear The Phoenix Insurance's claims is an appeal against the final judgment, should such an appeal be filed. The proceeding was returned to the District Court and continues to be heard there, and in accordance with what is stated above an expert was appointed on behalf of the courts, whose identity was agreed by the parties. 4. July 2014 Central District Court The Phoenix Pension and Provident Fund Ltd. and management companies of additional pension funds. NIS 48 million from all defendants. Acting in bad faith when using the right - under the pension fund's rules and regulations - to increase management fees paid by pensioners from the accrual to the maximum amount allowed, as from the date they become pensioners. In March 2022, the District Court certified the claim as a class action lawsuit. As part of the approval process it was determined that the group on behalf of which the class action will be conducted will include any person who is a planholder in a new comprehensive pension fund, which is among the defendants, where such planholder is entitled to receive old-age pension; it was also determined that the questions for discussion are whether the defendants should have given planholders advance notice regarding the management fees that will be collected from them during the pension period, and if so - what is the damage caused as a result of not issuing such notice. The class action continues to be heard in the District Court, and a pre-trial hearing was scheduled for December 6, 2023.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

4 The amounts are those amounts that were estimated by the plaintiff in the class action statement of claim - NIS 220 million (if it was ruled that interest should be calculated from the date of occurrence of the insured event) and NIS 90 million (if it is ruled that interest should be calculated starting 30 days from the delivery date of the claim). It should be noted that the amounts in the motion for approval of the class action lawsuit were different and higher and also related to the linkage claim, which was rejected.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and
claim amount3
Main arguments Details
5. June 2015
Beer Sheva District Court
The Phoenix Insurance
Approximately NIS 125 million.
The cause of action, as approved by the District Court, is
a violation of the provisions of the policy regarding
special compensation (reimbursement) for performing
surgery
in a private hospital funded by "additional
insurance services" (SHABAN) and the questions
common to the class members are: what is the value of
the commitment form on behalf of a health maintenance
organization in respect of a privately-owned hospital
(Form 17), according to which the amount to be
reimbursed to the policyholder is calculated; how The
Phoenix Insurance in effect calculated the amount
reimbursed to policyholders who underwent surgeries as
part of SHABAN; and whether The Phoenix Insurance
violated the provisions of the policy, and did not
reimburse the full amount to the policyholders.
In December 2019, the District Court certified the claim as a class action
lawsuit.
The group on whose behalf the class action will be conducted will include
all policyholders who were insured under a health insurance policy with
The Phoenix Insurance, which included a reimbursement arrangement for
performing surgery at a private hospital funded by SHABAN, based on a
commitment form/Form 17, and in respect of whom an insured event
occurred from June 25, 2012 through June 25, 2015.
In January 2023, the parties filed with the Court a settlement agreement
approval motion at amounts which are immaterial for The Phoenix
Insurance.
The settlement agreement is subject
to the Court's approval.
6. September 2015
Tel Aviv District Court
The Phoenix Pension (currently -
The
Phoenix Pension and Provident Fund
Ltd.) and management companies of
additional pension funds
Approximately NIS 300 million per year
since 2008 of all the defendants.
The claim is that the defendants pay agents fees and
commissions calculated as a percentage of the
management fees charged by them, thus allegedly
violating their fiduciary duties, and that, as a result, the
management fees that planholders are charged are
higher than the appropriate rate.
In November 2022, the Court rejected the motion to certify the claim as a
class action.
In January 2023, the plaintiffs filed an appeal to the Supreme Court. An
appeal hearing is scheduled for November 9, 2023.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
7. December 2015
Tel Aviv District Court
Alleged unlawful collection of "sub-annuals" in life
insurance at a rate that is higher than the permitted
one.
In May 2020, the court issued a ruling rejecting the motion
to certify of the claim as a class action, on the grounds that
the plaintiffs do not have a cause of action.
The Phoenix Insurance and another insurance
company
In September 2020, the plaintiff filed an appeal with the
Supreme Court.
Approximately NIS 100 million from all defendants, of
which NIS 50 million is attributed to The Phoenix
Insurance.
In July 2023, the position of the Capital Market, Insurance
and Savings Authority
was filed to the Supreme Court, which
is consistent with the position of The Phoenix Insurance.
The appeal continues to be heard in the Supreme Court.
8. February 2016 The plaintiffs argue that The Phoenix Insurance does In May 2023, the parties filed with the Court a settlement
Central District Court not link the payments it is required to pay policyholders
under life insurance policies (which it issued until July
agreement approval motion at amounts which are immaterial
for The Phoenix Insurance.
The Phoenix Insurance
NIS 100 million.
19 1984) to the base index due to an insured event or
due to the redemption of the policy, to the correct base
index in accordance with the linkage terms and
conditions set out in the policies; i.e., the latest CPI
published before the first of the month in which the
insurance term begins; the plaintiffs argue that this has
a significant effect on the benefits to which the
policyholders will be entitled.
The settlement agreement is subject to the Court's approval.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2
defendants and claim
amount3
Main arguments Details
The motions to approve the lawsuits as class actions that appear in Sections 9-12 below were submitted on the grounds of unlawful collection of investment management expenses
which are not sanctioned by the policies or bylaws.
9. November 2016
Jerusalem Regional Labor
Court
Excellence Nessuah Gemel
Ltd. (currently: The Phoenix
Pension and Provident Fund
Ltd.)
Approximately NIS 215
million.
The plaintiffs argue that under the rules
and regulations of the Excellence Gemel
provident fund, which were in effect until
January 1, 2016, and according to the
rules and regulations of the Excellence
Advanced Education fund, Excellence
Gemel may not collect investment
management expenses from planholders,
since collection of such expenses had to
stipulated clearly and expressly in the
rules and regulations of the funds.
The court approved the hearing arrangement filed by the parties, according to which the hearings
to certify the claim as a class action will be postponed until a decision has been made in connection
with the motion for leave to appeal against the May 2019 District Court decision to certify as class
actions claims filed for similar causes of action against The Phoenix Insurance, among others.
In June 2023, the Supreme Court handed down its judgment (hereinafter the "Judgment"), whereby
the motion for leave to appeal was allowed, and the motions to certify the claims as class actions
were dismissed (see Section B(2) below).
According to the Court's decision, The Phoenix announced its position, whereby the motion to certify
should be disallowed in view of the Judgment.
10. June 2019
Tel Aviv Regional Labor
Court
The Phoenix Insurance
Approximately NIS 351
million.
According to the plaintiff, The Phoenix
Insurance
charges
policyholders
of
insurance policies which combine a life
insurance component and a pension
saving component (executive insurance)
for investment management expenses
without such charges being included in
the terms and conditions of the policy.
The Phoenix Insurance has yet to submit its response to the motion to certify the class action
lawsuit.
In October 2022, the Court stayed the proceedings until after a judgment is rendered in the motion
to appeal described in Section B(2) below.
In June 2023, a judgment was rendered, as outlined in Section 9 above and in Section B(2) below.
The Phoenix informed the Court that the Judgment was handed down, and that its position is that
the motion to certify should be disallowed in view of the Judgment.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
11. June 2019
Jerusalem Regional Labor Court
Halman Aldubi Provident and Pension Funds Ltd.
(which was merged into The Phoenix Pension and
Provident Fund Ltd.)
NIS 17.5 million.
The statement of claim alleges that IBI Provident and
Study Fund Management Company Ltd. (which was
merged with Halman Aldubi on July 1, 2018) charged
the plaintiff and the other planholders of the advance
education fund under its management, investment
management expenses, in addition to the fund
management fees, contrary to the fund's by
laws.
Halman Aldubi has yet to submit its response to the motion
to certify the class action lawsuit.
In March 2022, the Court stayed the proceedings until after
a judgment is rendered in the motion to appeal described in
Section B(2) below.
In June 2023, a judgment was rendered, as outlined in
Section 9 above and in Section B(2) below.
12. July 2019
Jerusalem Regional Labor Court
Halman Aldubi Provident and Pension Funds Ltd.
(which was merged into The Phoenix Pension and
Provident Fund Ltd.)
No estimate was provided, but it was noted that the
damage to all class members exceeds NIS 3 million.
According to the statement of claim, Halman Aldubi
charged the plaintiff and the other planholders of the
Halman
Aldubi
comprehensive
pension
fund
(hereinafter -
the "Fund") investment management
expenses, in addition to the management fees charged
by the Fund, contrary to the Fund's bylaws; the
practice continued until May 2017, at which time the
Fund's bylaws were changed so as to include the
specific provision for charging direct investment
management expenses.
Halman Aldubi has yet to submit its response to the motion
to certify the class action lawsuit.
In March 2022, the Court
stayed the proceedings until after a judgment is rendered in
the motion to appeal described in Section B(2) below.
In June 2023, a judgment was rendered, as outlined in
Section 9 above and in Section B(2) below.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and
claim amount3
Main arguments Details
13. January 2017
Central District Court
The Phoenix Insurance and other
insurance companies
At least approximately NIS 12.25
million in respect of each of the
defendants.
According to the plaintiffs, insurance companies
overcharge insurance premiums since they do not
disclose to policyholders a "practice" in the motor
insurance subsegment that allows updating the age of
the young driver insured under the policy and/or the
years of driving experience when moving into another
age bracket and/or years of driving experience bracket
which can potentially result in a reduction of the
insurance premium.
On March 2022, the Court stayed the proceedings in this case until a
judgment is handed down in the appeal that has been filed in a similar class
action lawsuit against another insurance company that was rejected (to which
the plaintiffs referred in the certification motion).
It should be noted that the plaintiffs refer in their claim
to a decision approving a motion to certify of a claim as
a class action dealing with the same issue and filed
against another insurance company, in which the said
practice had allegedly been proven.
14. June 2017
Central District Court
The Phoenix Insurance
The amount of the claim was not
estimated.
The lawsuit is concerned with a claim that service level
agreements are marketed and sold, either directly or
through agents on behalf of The Phoenix Insurance, in
violation of the provisions of the law
regarding the
marketing and sale procedure of such agreements.
In August 2021, the District Court issued a ruling approving the motion to
certify the claim as a class action.
The group on behalf of which the class action will be conducted is anyone
who had purchased from The Phoenix Insurance, whether directly or through
its agents, service level agreements as part of the comprehensive car
insurance policy, with The Phoenix Insurance violating the law regarding the
marketing and sale of service level agreements, in the period ranging from
June 30, 2016 until the date of the ruling.
The class action continues to be heard in court.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim
amount3
Main arguments Details
15. June 2017
Tel Aviv Regional Labor Court (the hearing
was transferred from the Central District
Court due to substantive jurisdiction).
The National Insurance Institute (hereinafter
-
the "National Insurance Institute").
The Phoenix Insurance and additional
insurance companies (hereinafter, jointly:
the "Official Respondents")
The amount of the claim was not estimated.
According to the plaintiffs, the National Insurance Institute
collects national insurance contributions and health insurance
contributions illegally from the tax-exempt income of class
members as defined below, in addition to collecting the minimum
rate of
health insurance contributions from class members'
disability annuity. According to the plaintiffs, the National
Insurance Institute overcharges class members for these
contributions through the pension fund, the employer or any other
third party.
The plaintiffs point out that the Official Respondents are entities
through which the insurance premiums were collected from the
plaintiffs, and clarify that any employer and any entity paying an
early pension and any entity paying a PHI benefit in Israel may
be
in a similar position to that of the Official Respondents.
According to the plaintiffs, it is impossible to add all the parties as
respondents and the court is asked to consider the Official
Respondents that were added and which are related to the
The motions to certify the claim as a class action lawsuit
continues to be heard in court.
plaintiffs' case as class action defendants. The plaintiffs also
stated that no operative remedy is requested in the case of the
Official Respondents in the framework of the above claim.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
16. August 2017
Tel Aviv Regional Labor Court (the hearing was
transferred from the Central District Court due to
substantive jurisdiction)
Excellence Gemel & Hishtalmut Ltd. (currently: The
Phoenix Pension and Provident Fund Ltd.)
The claim amount was not estimated but it was stated
as more than NIS 2.5 million.
Increasing management fees in 2007 without
sending prior notice as required by law.
In March 2022, the court certified the claim as a class action.
As part of the certification decision, it is decided that the group on
behalf of which the class action will be conducted is as requested in
the certification motion.
In June 2022, Excellence Gemel filed a motion for leave to appeal
against the decision approving the lawsuit as class action to the
National Labor Court.
The hearing of the class action by the Regional Court was delayed
until a decision is made regarding the motion for leave to appeal.
At the same time, the parties conduct a mediation process.
17. January 2018
Central District Court
The Phoenix Insurance and other insurance companies
Approximately NIS 82.2 million per year from all the
defendants, of which approximately NIS 22.3 million per
year is attributed to The Phoenix Insurance.
According to the plaintiff, The Phoenix
Insurance unlawfully refrains from paying its
policyholders and third parties the VAT
component applicable to the cost of damages
when the damages have not been effectively
repaired.
In January 2022, the District Court issued a judgment rejecting the
motion to certify of the claim as a class action lawsuit.
In April 2022 the plaintiff filed an appeal to the Supreme Court. A
hearing was scheduled for September 27, 2023.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
18. May 2018
Haifa Regional Labor Court
The Phoenix Pension and Provident Fund Ltd.4
NIS 200 million.
According to the plaintiffs, contrary to that which
is stated in its rules and regulations, The Phoenix
Pension has refrained from paying or from paying
in full the partial contributions towards benefits to
anyone who does not receive a full disability
pension. In any case, The Phoenix Pension
refrained from reporting to policyholders -
either
in pay slips or in annual statements -
about the
payments it made, to the extent that it did,
indeed, make such payments.
In August 2021,
the Regional Labor Court issued a resolution
approving the motion to certify of the claim as a class lawsuit.
As part of the above resolution, the Court approved causes of action
in connection with the failure to pay contributions towards benefits in
respect of planholders receiving a partial disability pension during the
period from May 1, 2012 through May 1, 2019; the Court ordered a
remedy whereby the rules and regulations should be abided by and
the planholders' accumulated balance should be credited with current
monthly contributions towards benefits based on a value date as of
the original entitlement date, plus the yield accrued on the fund as
from the said date. The Court also ruled that no separate pecuniary
damages has been proven in addition to what is stated above, and
that no monetary damages should be paid.
The class action continues to be heard in court.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

4 The motion to certify the claim as a class action lawsuit was originally filed against The Phoenix Insurance. The plaintiffs filed an amended motion to certify the claim as a class action lawsuit, in which they changed the identity of the defendant and also added to their previous allegations and to the definition of the class they seek to represent.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
19. June 2018
Jerusalem District Court
The Phoenix Insurance and another insurance
company
The amount of the claim was not estimated.
According to
the plaintiff, the claim deals with the
defendants' unjustified refusal to recognize a
surgical procedure that had medical justification
as an insured event according to the health
policies issued, by claiming that it is a "preventive
surgical procedure".
In January 2022, the District Court issued a ruling approving the
motion to certify the claim as a class action.
As part of the certification decision it was determined that the group
on whose behalf the class action will be conducted will include any
person who engaged in an health insurance contract with the
defendants, including insurance coverage for surgical procedures,
whose claim to have such procedure done was rejected for the
reason that it is a preventative procedure which is not covered by
the policy (even if the reason was presented differently in the letter
rejecting the claim), and the joint questions for the class members
are: Did the defendants breach the insurance contracts when they
rejected the claims for insurance coverage by stating that the
surgical procedure is a "preventative" one, and the remedies to
which class members are entitled due to that.
In May 2022, The Phoenix Insurance filed a motion for leave to
appeal to the Supreme Court against the decision approving the
class action lawsuit. At the same time, the class action continues to
be heard in the District Court, and the parties are concurrently
conducting a mediation process.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
20. December 2018
Tel Aviv District Court
According to the plaintiffs, the claim deals with unlawful overcharging
of insurance premiums for unnecessary building insurance policies
issued to building owners (who took out a mortgage loan and were
The motion to certify the claim as a class action
lawsuit continues to be heard in court.
The Phoenix Insurance, other insurance companies
and banks
NIS 280 million from all defendants.
required to insure the building with a building policy in favor of the
lending bank), despite the fact that at the time of issuance of such
policies, there was already and insurance policy covering that building,
regardless of whether that policy was taken out with the same
insurance company or with another insurance company.
21. March 2019 According to the plaintiff, the claim deals with The Phoenix Insurance's
practice to delay the repayment of the relative portion of insurance
The motion to certify the claim as a class action
lawsuit continues to be heard in court.
A pre-trial
Central District Court premiums upon cancellation of compulsory motor and property
insurance policies rather than paying it within the period set by law;
hearing is scheduled for November 22, 2023.
The Phoenix Insurance the plaintiff also claims that The Phoenix Insurance repays the said
amount without adding linked interest. The defendant also claims that
Approximately NIS 2.6 million. The Phoenix Insurance refrains from repaying full linkage when
refunding the relative portion of the insurance premiums.
22. May 2019 According to the plaintiff, the claim deals with The Phoenix Insurance's
not paying policyholders in participating life insurance policies which
The motion to certify the claim as a class action
lawsuit continues to be heard in court.
Tel Aviv District Court include an Rm formula their full share of the profits and full payments
to which they are entitled under the insurance contracts; the plaintiff
It should be noted that the plaintiff stated that a
similar motion to certify of a claim as class
The Phoenix Insurance also claims that The Phoenix Insurance does not fulfill its reporting and
disclosure obligations towards policyholders regarding their policies and
action, which was filed against another
insurance
company,
had
recently
been
Approximately NIS 766.8 million. rights. approved.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
23. July 2019
Tel Aviv District Court
The Phoenix Insurance and other insurance
companies
Approximately NIS 264.5 million from all the
defendants, of which approximately NIS 67.5 million
is attributed to The Phoenix Insurance.
The plaintiffs claim that the defendants do not pay their
policyholders interest as required by law in respect of
insurance benefits for the period starting 30 days after
the date of delivery of the claim until the date of actual
payment.
The Phoenix Insurance has yet to submit its response to the
motion to certify the class action lawsuit.
It should be noted that according to the plaintiffs, this claim is
based on the same cause of action as the class action described
in Section 3 above in the table; however, it was nevertheless
decided to file this claim for the sake of caution only, given the
doubt as to whether the class of plaintiffs seeking the approval
of this motion is included in the previous class action. In light of
this, the proceedings in this claim were stayed until a judgment
24. August 2019
Central District Court
The Phoenix Insurance and other insurance
companies
The claim amount was not estimated, but it was
stated that it was in the tens of millions of shekels or
more.
The plaintiffs claim that in case of vehicle theft or total
loss as a result of an accident, the defendants refuse
to reimburse policyholders for the proportionate share
of the insurance premiums (the premium) paid for
service contracts (road recovery services, windscreen
repair, towing, etc.) in respect of the period
subsequent to the theft or total loss, despite the fact
that the service contract is canceled and the risk it
covers no longer exists.
is rendered in the previous claim.
The motion to certify the claim as a class action lawsuit
continues to be heard in court.
In February 2020, the position of the Capital Market, Insurance
and Savings Authority was submitted, which is not in line with
the plaintiffs' position.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
25. December 2019
Central District Court
PassportCard Israel General Insurance Agency (2014)
(hereinafter -
"PassportCard") and The Phoenix
Insurance
The amount of the claim was not estimated.
According to the plaintiff, the defendants sell travel
insurance without informing their customers -
at the
time of issuing the insurance policy -
about the fact that
the "search and rescue" component can be excluded if
it is not required by the customers;
the plaintiff also
claims that the defendants do not inform customers
about price changes they make in insurance policies'
components; furthermore, the defendants do not
inform customers in a clear manner about the right to
reimbursement of a proportionate share of the
insurance premiums in the event that the actual trip is
shorter than planned, and in the event that the
insurance period is shortened for any reason
whatsoever (including due to cancellation of the
insurance policy).
In April 2023, the Court approved a settlement agreement
between The Phoenix Insurance and the plaintiff in relation
with The Phoenix Insurance's travel insurance policy,
according to which The Phoenix Insurance will make a
donation to a dedicated fund set up pursuant to the Class
Actions Law; The Phoenix Insurance will regulate its future
conduct as set out in the settlement agreement and in the
judgment, and pay the lead plaintiff's compensation and his
counsels' legal fees at amounts which are immaterial to The
Phoenix Insurance.
The motion to certify of the claim as a class action lawsuit
against PassportCard in connection with its policies continues
to be heard by the Court.
The plaintiff also claims that even when the defendants
reimburse insurance premiums to policyholders who
shortened their travel period and at the same time also
shortened the insurance period for any reason
whatsoever, they do not reimburse the full insurance
premium for the shortened insurance period, contrary
to law and the insurance policy.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and
claim amount3
Main arguments Details
26. January
2020
Central District Court
The Phoenix Insurance, other
insurance companies and a road
recovery
and
towing
services
company.
The
claim
amount
was
not
estimated but it was stated that it
significantly
exceeds
NIS
2.5
million.
The plaintiff claims that, in cases where
vehicles'
windscreens
broke,
the
defendants had provided and still provide
alternative windscreens, which do not meet
Israeli standards and are not manufactured
by the same maker as the car; by doing so,
the defendants allegedly breach their
obligations under the insurance policies
and coverage contracts.
The motion to certify the claim as a class action lawsuit continues to be heard in court.
27. February 2020
Central District Court
The Phoenix Insurance
The
claim
amount
was
not
estimated, but it was stated that it
is in the millions of shekels or more.
The plaintiff claims that starting in early
2016
or
thereabouts,
The
Phoenix
Insurance ceased to fulfill its obligation in
health insurance policies marketed prior to
February 1, 2016, in which it undertook to
provide
insurance
coverage,
at
no
additional cost, to all children born to the
principal policyholder (starting with the
fourth child), until they reach the age of 21.
In January 2023, a decision was issued, granting the motion to certify the claim as a class
action.
Under the approval decision, the class on whose behalf the class action will be administered
is all The Phoenix Insurance policyholders who had joined the health insurance plan, as,
with respect to that plan, The Phoenix Insurance pledged that from the fourth child they
have, they will have insurance coverage for no extra charge, and The Phoenix Insurance
did not provide such a coverage or it provided it for a fee; it was also found that the issue
all class members have in common is whether The Phoenix Insurance is obligated to
continue to allow the primary policyholders to buy policies for children from their fourth
oldest child and after for free even after January 31, 2016, or if it could have canceled this
acquisition option for the primary policyholders' children, as it had, even though they had
entered into the insurance contract with it before the termination.
The class action continues to be heard in the District Court.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
28. February 2020
Tel Aviv Regional Labor Court (the hearing was
transferred from the Tel Aviv District Court)
Halman Aldubi Provident and Pension Funds Ltd.
(which was merged into The Phoenix Pension and
Provident Fund Ltd.)
NIS
335 million (alternatively NIS
58 million, and
alternatively 36 million).
The claim is that Halman Aldubi allegedly violated its duty to
the plaintiff and to all beneficiaries in the provident funds of
Halman Aldubi, of deceased planholders, and any planholder
of the Halman Aldubi provident funds with whom contact was
lost, to locate and inform the said beneficiaries, as well as the
planholders with whom contact was lost, that they are
entitled to funds in the Halman Aldubi funds, on the dates set
forth to that effect in the Supervision of Financial Services
Regulations (Provident Funds) (Locating Planholders and
Beneficiaries), 2012, in the period beginning on January 1,
2013 until the date of the ruling in the lawsuit.
The motion to certify the claim
as a class action lawsuit
continues to be heard in court.
29. April 2020
Tel Aviv District Court
The Phoenix Insurance, other insurance companies
and the managing corporation of the Compulsory
Motor Insurance Pool (the "Pool") Ltd.
Approximately NIS 1.2
billion of all the defendants, of
which NIS 145 million is attributed to The Phoenix
Insurance or, alternatively, NIS 719 million of all the
defendants, of which NIS 113 million is attributed to
The Phoenix Insurance.
The subject matter of the lawsuit4
is that the defendants
unjustly profited, allegedly, by failing to reduce car insurance
premiums (for compulsory and/or comprehensive and/or
third-party
policies) during the mobility restrictions imposed
due to the Covid-19 pandemic. This was done, argued
the
plaintiffs, despite a decrease in mileage traveled and the level
of risk to which the defendants are exposed.
The motion to certify the claim as a class action lawsuit
continues to be heard in court. A pre-trial hearing is
scheduled for January 10, 2024.
It should be noted that a motion to certify a similar
claim as a class action, which was filed against The
Phoenix Insurance and other insurance companies was
rejected in August 2021, and another motion to certify
a similar claim as a class action, which was filed against
The Phoenix Insurance and other insurance companies
was concluded by its withdrawal by the plaintiffs in
February 2023.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

4 The motion to certify the claim as a class action includes two motions to certify claims as class actions filed against The Phoenix Insurance and other defendants, which were merged into a single claim in February 2021 by the Tel Aviv District Court (see Note 42(a)(1) in Sections 42 and 44 of the class actions table in the Company's financial statements as of December 31, 2020, published on March 25, 2021 (Ref. No. 2021-01-044709).

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
30. May 2020
Tel Aviv District Court
Phoenix Excellence Pension and Provident Funds Ltd.
(currently -
The Phoenix Pension and Provident Fund
Ltd.), Halman Aldubi Provident and Pension Funds
Ltd. (which was merged into The Phoenix Pension
and Provident Fund Ltd.) and additional management
companies
The claim amount was not estimated, but it was stated
that it is estimated, at a minimum, in the hundreds of
millions of shekels.
According to the plaintiffs, the claim deals with the
defendants' classifying some of the contributions
transferred to an advanced education fund on behalf
of their customers as taxable provisions, even though
they are not taxable.
In accordance with the Court ruling, the government -
the
Israel Tax Authority, was added as a further defendant to the
motion to certify the lawsuit as a class action.
The motion to certify the claim as a class action
lawsuit
continues to be heard in court. A pre-trial hearing is scheduled
for January 21, 2024. At the same time, the parties agreed to
conduct a mediation procedure.
31. June 2020
Tel Aviv District Court
PassportCard Israel General Insurance Agency
(2014) (hereinafter -
"PassportCard") and The
Phoenix Insurance
At least NIS 10 million.
According to the plaintiff, the claim deals with non
payment of insurance benefits in respect of
cancellation of a trip due to a pandemic (the Covid-19
pandemic) under
travel insurance that the plaintiff
purchased through PassportCard.
In September 2022, the Court handed down a ruling approving
the agreed motion for the plaintiff's withdrawing the motion to
certify the lawsuit as a class action lawsuit in relation to The
Phoenix Insurance's travel insurance policies.
The motion to certify of the claim as a class action lawsuit
against PassportCard in connection with its policies continues
to be heard by the Court.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
32. June 2020
Tel Aviv Regional Labor Court
The Phoenix Insurance
The amount of the claim was not estimated.
According to the claim, after a policyholder passes away, The
Phoenix Insurance links the funds accrued in the policy to the
consumer price index, instead of linking them to the
investment track selected by the policyholder, as it previously
did.
In March 2023, the parties
filed with the Court a
settlement agreement approval motion at amounts
which are immaterial for The Phoenix Insurance.
The settlement agreement is subject to the Court's
approval.
33. June 2020
Tel Aviv Regional Labor Court (the hearing was
transferred from the Central District Court due to
substantive jurisdiction)
The Phoenix Insurance and another insurance company
Approximately NIS 10.5 million for each defendant.
According to the claim, the defendants overcharge customers
in loan agreements they enter into with their customers;
overcharging takes place due to a one-way linkage
mechanism, which is in place under those agreements,
whereby if the CPI increases above the base index, the
defendants collect the linkage differences due to the increase;
however, if the CPI decreases below the base index, the
defendants do not credit their customers for the said
decrease.
The motion to certify the claim as a class action
lawsuit continues to be heard in court.
34. July 2020
Haifa Magistrate Court
PassportCard Israel General Insurance Agency (2014)
(hereinafter -
"PassportCard") and The Phoenix
Insurance
NIS 1.84 million.
According to the claim, when travel insurance benefits are
paid late, the defendants do not pay interest in respect of the
delay; the plaintiff also claims that the defendants usually pay
the insurance benefits according to the exchange rate on the
day of the insured event rather than the exchange rate on
repayment date. In addition, it was argued that the disclosure
duty regarding the deductible and the limitation of the
insurer's liability with regard to the "winter sports" component
is violated as part of a representation made prior to entering
into the insurance contract.
The Phoenix Insurance has yet to submit its
response to the motion to certify the class action
lawsuit.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
35. July 2020
Central District Court
The Phoenix Insurance and other insurance companies
According to the claim, the defendants must charge
reduced insurance premiums in cases of insurance
policies with exclusions due to an existing medical
condition compared to policies in which no such
exclusion is present, since exclusions mitigate the
defendants' insurance risk.
The motion to certify the claim as a class action lawsuit
continues to be heard in court. A pre-trial hearing is scheduled
for September 13,
2023.
About 1.9 billion of all defendants, with the share of
each of the defendants being in accordance with its
market segment; according to the plaintiffs, The
Phoenix's share is approximately 19%.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
36. September 2020 According to the claim, The Phoenix Insurance In September 2022, the District Court partially certified the
Tel Aviv District Court does not pay policyholders insured under a
As part of the approval
long-term care policies the full amount due to
them under their policies, since it offsets these
motion to approve the action as a class action lawsuit.
ruling, the Court dismissed the class
The Phoenix Insurance action approval motion in connection with the claim that The
Phoenix Insurance does not indemnify policyholders under their
NIS 92.7 million. amounts against proceeds received from the
National Insurance Institute; it is also claimed
long-term care policies for certain medical treatments, and
that The Phoenix Insurance does not indemnify
policyholders for certain medical treatments.
allowed
the class action approval
motion in connection with
offsetting of funds the policyholders receive from the National
Insurance Institute.
The group in whose name the class action shall be conducted
comprises all policyholders holding long-term care insurance
policies of The Phoenix
Insurance (or their successors for that
purpose), who did not receive the compensation payable to them
due to offsetting of National Insurance proceeds they received
due to their long-term care needs; that the limitation period is 7
years; and that the joint question raised by class members is
whether, under the terms of the policy, one may take into
account the funds the policyholder receives from the National
Insurance Institute and deduct them from the proceeds The
Phoenix Insurance pays the policyholder.
The class action continues to be heard in the District Court.
The parties agreed to refer the proceeding to mediation.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
37. September 2020
Central District Court
The Phoenix Insurance and another insurance
company
NIS 84 million from all the defendants, of which NIS
67.2 million is attributed to The Phoenix Insurance
(a total of NIS 16.8 million in respect of critical
illness insurance and a total of NIS 50.4 million in
respect of permanent health insurance).
According to the claim, the defendants acted in violation of
the provisions of critical illness insurance policies when they
continued to charge policyholders the full amount of the
monthly premium even after the first insured event had
occurred.
It was also alleged against The Phoenix Insurance that
contrary to its obligations, it charges its policyholders a
monthly PHI insurance premium, even after the period of
insurance coverage has ended.
In October 2022, the parties filed with the Court a motion
to certify a settlement agreement at amounts which are
immaterial for The Phoenix Insurance.
In view of the clarifications and supplementary information
requested by the court in connection with the settlement
agreement, the parties are considering the amendment of
the settlement agreement.
38. December 2020
Central District Court
The Phoenix Insurance
The aggregate claim amount was not estimated but
it was stated that it exceeds NIS 2.5 million.
According to the plaintiff, The Phoenix Insurance allegedly
does not indemnify its policyholders in motor insurance
policies relating to vehicles other than private and
commercial cars weighing up to 3.5 tons (such as trucks,
taxis, etc.), in respect of the damage caused to their vehicle
due to the insured event -
which, the plaintiff claims, is in
breach of the policy and the law. It is further claimed that
The Phoenix Insurance does not provide its policyholders
with an appraiser's report, which includes an estimate of the
impairment to the vehicle's value due to the insured event
nor its manner of calculation.
The motion to certify the claim as a class action lawsuit
continues to be heard in court.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and
claim amount3
Main arguments Details
39. March 2021
Tel Aviv District Court
The subject matter of the claim, according to the plaintiffs, is that the defendants refuse to pay
for the policyholders' expenses for the purchase of medical cannabis, contrary to the provisions
of the policy to cover drugs excluded from the Healthcare Services Basket, and since medical
The parties are in a mediation
procedure.
The Phoenix Insurance and other
insurance companies
cannabis is recognized for medical use in Western countries.
Approximately NIS
79 million from all
defendants.
40. March 2021
Central District Court
The Phoenix Insurance
No estimate was provided for the
claim amount, but it was stated that
the damage exceeds NIS 2.5 million.
The subject matter of the claim, according to the plaintiff, is that The Phoenix Insurance
allegedly unlawfully rejects claims by its policyholders in "personal accident" policies to pay for
hospitalization at a "non-general hospital", claiming that a "hospital", as defined in the policy,
is a medical institution whose underlying meaning is a "general hospital only".
The parties are in a mediation
procedure.
41. April 2021
Central District Court
The Phoenix Insurance, banks,
investment houses, credit card
companies and other insurance
companies
The claim amount was not estimated
but it was stated that it amounts to
millions of shekels.
According to the plaintiffs, when using
the defendants' digital services (while browsing their
personal accounts), customers' private, personal and confidential information is transferred to
third parties without the customers' consent, violating their privacy.
The motion to certify the claim as a
class action lawsuit continues to be
heard in court.
A
hearing
was
scheduled
for
September 14, 2023. At the same
time, the parties conduct a mediation
process.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
42. July 2021
Tel Aviv District Court
The Phoenix Insurance
The claim amount was not estimated, but it was
stated that it exceeds NIS 2.5 million.
According to the plaintiffs, the subject matter of the claim is that
the defendants deduct interest at the rate of 2.5% (or any other
rate) from the monthly yield accrued for policyholders to whom a
monthly benefit is paid under participating life insurance policies
issued in 1991-2004; according to the plaintiffs, such a deduction
is not established in the contractual terms of the relevant
insurance policies.
The motion to certify the claim as a class action
lawsuit continues to be heard in court.
43. December 2021
Tel Aviv District Court
The Phoenix Insurance
The claim amount was not estimated, but it was
stated that it was in the millions of shekels or more.
The plaintiff argues that in claims pertaining to damages caused
to vehicles (of a policyholder or a third party), The Phoenix
Insurance allegedly reduces the insurance benefits unlawfully due
to failure to fix the vehicles or transfer the damaged parts to
The
Phoenix Insurance.
The parties agreed to conduct a mediation procedure.
44. January 2022
Central District Court
The Phoenix Insurance
The claim amount was not estimated but it was
stated as being more than NIS 2.5 million.
The plaintiff claims that in 2019 The Phoenix Insurance renewed
a group health insurance policy to members of the Secondary
Schools and Colleges Teachers Union and their families, while
making changes, reducing the scope of the insurance coverage
and increasing the premium, allegedly without informing
policyholders and obtaining their consent.
The motion to certify the claim as a class action
lawsuit continues to be heard in court. A hearing is
scheduled for December 10, 2023.
At the same time, the parties agreed to subject the
proceeding to mediation.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim
amount3
Main arguments Details
45. January 2022
Central District Court
According to the plaintiffs, the defendants renewed a home insurance
policy automatically while increasing the premium, allegedly without
obtaining policyholders' consent.
The parties are in a mediation procedure.
The Phoenix Insurance and another insurance
company
The claim amount was not estimated but it was
stated that it exceeds NIS 3 million.
46. April 2022 The lawsuit deals with the claim that The Phoenix Insurance has
collected and is still collecting from policyholders an additional premium
The Phoenix Insurance has yet to submit its
response to the motion to certify the class action
Tel Aviv District Court for the expansion of insurance coverage in respect of preventative
surgical procedures, despite the fact that those procedures are
lawsuit. A pre-trial hearing is scheduled for
December 28 2023.
The Phoenix Insurance allegedly covered by the basic tier of The Phoenix Insurance's health
insurance policies.
The motion filed by The Phoenix Insurance to
The claim amount was not estimated but it was
stated as being (much) more than NIS 2.5 million.
According to the lawsuit, the plaintiff's claim is based on a decision of
the Jerusalem District Court, to approve a lawsuit against The Phoenix
Insurance and another insurance company as a class action (see
Section 19 in the table above).
stay the proceeding until a decision is made
regarding the class action against The Phoenix
Insurance and another insurance company (see
Section 19 to the table) has not been allowed by
the Court.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
47. May 2022
Tel Aviv Regional Labor Court (the hearing was transferred from the
Central District Court due to substantive jurisdiction)
The Phoenix Pension and Provident (formerly -
"The Phoenix
Excellence Pension and Provident Funds Ltd.") and another
management company
The claim amount was not estimated but it was stated that it exceeds
NIS 3 million.
The lawsuit deals with the claim that with regard to
CPI-linked
loans, the defendants adopted a practice of a one-way linkage
mechanism, whereby when the CPI increases compared with the
base index, the customer's monthly payment is increased
accordingly, and when the CPI decreases, the monthly payment
does not change; the plaintiffs claim that this practice was adopted
despite the fact that this is not mentioned in the provisions of the
agreement.
The plaintiffs noted that three motions to certify lawsuits as class
actions are pending, which they claim give rise to joint issues
against three other companies, including The Phoenix Insurance
(see Section 33 in the table above).
The
Phoenix
Pension
and
Provident has yet to submit its
response to the motion to certify
the class action lawsuit.
48. June 2022
Haifa Regional Labor Court
The Phoenix Insurance
NIS 5 million.
The subject matter of the lawsuit is the claim that The Phoenix
Insurance breached its contractual obligation with regard to
the
insurance period in a permanent health insurance, as reflected in
the insurance offer, in contrast to the policy's provisions regarding
"age for insurance purposes"; the lawsuit also deals with the claim
that as part of the engagement, The Phoenix Insurance did not
provide fair disclosure regarding the insurance end date.
The motion to certify the claim as
a class action lawsuit continues to
be heard in court.
49. September 2022
Tel Aviv District Court
Excellence Nessuah Brokerage Services Ltd.
(Currently: Excellence Investment Management and Securities Ltd.)
NIS 26.5 million.
The lawsuit deals with a claim of overcharging 2 agorot above the
conversion rate in respect of conversion of shekels into foreign
currency, and without such overcharging being set in an agreement
between the parties.
The motion to certify the claim as
a class action lawsuit continues to
be heard in court. A pre-trial
hearing
is
scheduled
for
November 1, 2023.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
50. October 2022
Tel Aviv District Court
The Phoenix Insurance and other insurance companies
The lawsuit deals with alleged discrimination of the defendants against male
policyholders, who have a health insurance policy, based solely
on their sex.
According to the plaintiffs, the defendants prevent men who pay an additional
premium for the ambulatory insurance appendix from receiving reimbursement in
connection with amounts they expensed in connection with their babies, claiming
The Phoenix Insurance has yet to
submit its response to the motion
to certify the class action lawsuit.
A pre-trial hearing is scheduled
for November 15, 2023.
The claim amount was not estimated but it was stated
as being more than NIS 2.5 million.
that only women are entitled to reimbursement of expenses in connection with
babies.
51. November 2022
Haifa District Court
According to the plaintiff, The Phoenix Insurance rejected a claim filed by a
policyholder with a "Long-Term Care Gift" long-term care policy, under which
insurance benefits are payable upon the occurrence of a long-term care event,
with the reason for rejecting the claim being that the policy is an "indemnity"
The parties agreed to conduct a
mediation procedure.
The Phoenix Insurance policy rather than a "compensation" policy; the plaintiff
also claimed that The
Phoenix Insurance allegedly made the payment of the insurance benefits
The claim amount was not estimated but it was stated
as being more than NIS 2.5 million.
conditional on the presentation of receipts in respect of actual payments made.
52. April 2023 The lawsuit concerns the claim that when a policyholder of a comprehensive motor
insurance policy has an insured event, due to which they file insurance claims
The Phoenix Insurance has yet to
submit its response to the motion
Central District Court and/or demands and/or request for insurance benefits, and decides to repair
his/her car at an auto-repair shop that is not among the auto-repair shops that
to certify the class action lawsuit.
A pre-trial hearing is scheduled
The Phoenix Insurance "participate" in The Phoenix Insurance's arrangement, The Phoenix Insurance
offsets various amounts from the insurance benefits even though it had authorized
for January 8, 2024.
The claim amount was not estimated but it was stated
as being more than NIS 2.5 million.
the appraiser's assessment, claiming that the auto-repair shop can purchase spare
parts from its own vendors for a lower price than these spare parts' consumer
prices, and thus, the policyholder allegedly ends up receiving insurance
compensation that does not cover the true cost of the damage they incurred as
determined in the appraiser's assessment.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
53. April 2023
Central District Court
The lawsuit concerns the claim that in an insured event in which the
policyholder's and/or a third party's vehicle is damaged, The Phoenix
Insurance underpays the appraiser's fees, as paid by the policyholder
and/or the third party.
The Phoenix Insurance has yet to submit its
response to the motion to certify the class action
lawsuit. A hearing date has not yet been
scheduled.
The Phoenix Insurance
The claim amount was not estimated but it was
stated as being more than NIS 2.5 million.
54. April 2023 The lawsuit concerns the claim that in work disability policies, the
defendants collected monthly insurance fees immediately prior to the
The Phoenix Insurance has yet to submit its
response to the motion to certify the class action
Haifa District Court stipulated insurance end date, for the last several months that overlap
with the duration of the last possible waiting period stipulated in every
lawsuit. A pre-trial hearing is scheduled for
October 23, 2023.
The Phoenix Insurance and another insurance
company
work disability insurance contract, a period in which, allegedly,
according to the insurance contracts, the defendants are under no
obligation to pay any insurance benefit.
No estimate was provided for the claim amount,
but it was stated that the damage amounts to
millions of shekels.
55. July 2023 The lawsuit concerns the plaintiffs' claim, whereby starting on January
1, 2012, when Amendment 190 to the Income Tax Ordinance [New
The Phoenix Insurance and The Phoenix Pension
and Provident have yet to submit their response
Tel Aviv District Court Version] came into effect, as alleged, the defendants did not ensure
that the recipients of annuities from one of the new pension funds
to the motion to certify the class action lawsuit. A
pre-trial hearing is scheduled for March 17, 2024.
The Phoenix Insurance, The Phoenix Pension and and/or provident funds and/or insurance funds they manage would
Provident and additional companies receive the tax exemption for those entitled due to the component
known as a "recognized annuity," as defined in the Income Tax
NIS 297 million from all defendants Ordinance.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

A. Class actions - motions to certify lawsuits as class actions and lawsuits certified as class actions (cont.)

No. Date,1 court,2 defendants and claim
amount3
Main arguments Details
56. July 2023
Tel Aviv District Court
The Phoenix Insurance
NIS 3.18 million
The lawsuit concerns the claim that callers to The Phoenix Insurance's call center
to purchase comprehensive motor / third party insurance were allegedly treated
differently than other callers due to their ethnic background, in that they had
been asked to submit a no claims confirmation, while other callers allegedly had
the option to present the confirmation retroactively, after entering into the
insurance policy.
On July 16, 2023, concurrently with the filing of
the motion to certify the claim as a class
action,
the parties filed with the Court a motion to certify
a settlement agreement at amounts which are
immaterial for The Phoenix Insurance.
The settlement agreement is subject to the Court's
approval.
57. August 2023
Tel Aviv Regional Labor Court
The Phoenix Insurance and The Phoenix
Pension and Provident
The claim amount was not estimated but
it was stated as being more than NIS 2.5
million.
The lawsuit concerns the claim that the defendants allegedly act contrary to the
provisions of the law by
transferring the redemption funds of their policyholders
or planholders under a pension fund and/or executive insurance and/or annuity
provident fund to an annuity after the stipulated date for this purpose under the
law. Thus, the defendants are unjustly
enriched, overcharge management fees,
and do not compensate their policyholders / planholders with the interest on
arrears plus the returns with respect to the alleged delay.
The Phoenix Insurance and The Phoenix Pension
and Provident have yet to submit their response
to the motion to certify the class action lawsuit.
A pre-trial hearing is scheduled for February 18,
2024.
58. August 2023 The claim deals with a claim that in cases where customers had a credit balance, The Phoenix Insurance's response to the motion
Central District Court The Phoenix Insurance has allegedly acted unlawfully by not transferring those
funds to the customers -
whether by transferring the funds to the customers by
way of a check that was not paid-in, rather than by way of bank transfer or by
to certify the claim as a class action has yet to be
filed. A hearing date has not yet been scheduled.
The Phoenix Insurance crediting the amount to the customer's credit card, or due to any other reason;
by not informing the customers of the funds they are entitled to; and by not
The claim amount was not estimated but acting to recover those funds. It was further claimed that damage was allegedly
it was stated that it is higher than NIS
3
caused to customers to whom The Phoenix Insurance transferred funds in
million (potentially tens of millions of
NIS).
respect of a
credit balance through checks that were paid-in, rather than by way
of bank transfer or by crediting the amount to the customer's credit card.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

B. Concluded claims*

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
1. June 2021
Tel Aviv District Court
The Phoenix Holdings, The Phoenix Insurance, the
Chairman of the Board of Directors of The Phoenix
Holdings and The Phoenix Insurance, serving board
members of The Phoenix Holdings and The Phoenix
Insurance and a long-serving manager in The Phoenix
Insurance (hereinafter -
the "Defendants").
NIS 137 million.
This lawsuit relies on the facts as presented in a motion to certify
a derivative lawsuit that was filed against the Defendants and
which deals with events that took place at the beginning of the
1990s and was concluded with
the plaintiff's withdrawal (see
Section 3 in Chapter C below under Legal and Other Proceedings).
According to the plaintiffs, the subject matter of the claim is an
alleged misleading report and non-disclosure by the Company of
material facts that caused damage to buyers of the share.
According to the plaintiffs, at the beginning of the 1990s, the
Company took steps, in which it managers were involved, to
recruit customers and help them to benefit from guaranteed
return policies; such steps were allegedly carried out in breach of
guidance.
On May 15, 2023, the Court handed down a
judgment approving the plaintiffs' withdrawal from
the motion to certify the claim as a class action.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

* For additional claims concluded between January 1, 2023 and March 23, 2023, please see Note 43A.2, Sections 11-13 of the table of concluded claims in the Company's financial statements as of December 31, 2022, published on March 23 (Ref. No. 2023-01-026428).

B. Concluded claims* (cont.)

No. Date,1 court,2 defendants and claim amount3 Main arguments Details
2. September 2016 Collecting
investment
In May 2019, the District Court certified the motion to certify as a class action the
Central District Court management expenses in the
individual saving policy Excellence
Invest in addition to collecting
management fees, without a
provision in the policy expressly
permitting to do so.
claim filed against The Phoenix Insurance and three other insurance companies
(hereinafter -
the "Defendants"), for breaching the provisions of the insurance
The Phoenix Insurance policy due to unlawful collection of investment management expenses. The class
NIS 14.7 million. on whose behalf the class action lawsuit against The Phoenix Insurance will be
conducted includes all policyholders of the individual savings policy Excellence
Invest issued by The Phoenix Insurance at present and in the seven years prior to
the date of submission of the motion to certify as class action. The remedies
claimed are the reimbursement of the investment management expenses that were
overcharged in addition to interest differentials; and an order directing the
defendants to stop collecting such fees.
In September 2019, The Phoenix Insurance (along with the other defendants) filed
a motion for leave to appeal to the Supreme Court against the decision approving
the class action lawsuit.
In June 2023, the Supreme Court allowed the defendants' motion for leave to
appeal and dismissed the motions to certify the claims as class actions.
It should be noted that requests for approval of class actions regarding investment
management expenses are also pending against Excellence Gemel (please see
Section A(9) above in the table), The Phoenix Insurance (see Section A(10) above
in the table) and Halman Aldubi Provident and Pension Funds Ltd. (see Sections
A(11-12) above in the table).

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

* For additional claims concluded between January 1, 2023 and March 23, 2023, please see Note 43A.2, Sections 11-13 of the table of concluded claims in the Company's financial statements as of December 31, 2022, published on March 23 (Ref. No. 2023-01-026428).

B. Concluded claims* (cont.)

Date,1 court,2 defendants and claim amount3
No.
Main arguments
Details
3.
April 2017
According to the plaintiffs, until the regulator intervened and
legislative changes were made in connection with this issue,
Tel Aviv Regional Labor Court (the hearing was
managers of pension arrangements in general and the defendants
transferred from the Tel Aviv District Court due to
in particular, provided employers with operating services involving
substantive jurisdiction)
preparing and managing pension insurance for employees
without the employers paying any consideration in respect thereof
Shekel Insurance Agency (2008) Ltd. (hereinafter -
to the pension arrangement managers, and that all costs
"Shekel"), Agam Leaderim (Israel) Insurance Agency
pertaining to the operating services are paid by the employees
(2003) Ltd. (hereinafter -
" Agam Leaderim"), second
through management fees they pay for the products marketed to
tier companies of The Phoenix Holdings, and other
them by the managers of the pension arrangement.
insurance agencies.
Approximately NIS 357 million of all defendants, of
which NIS 47.81 million is attributed to Agam
Leaderim and NIS 89.64 million to Shekel.
In August 2020, the Regional Court issued a ruling
rejecting the motion to certify of the claim as a class
action.
In September 2022, the National Court dismissed
the plaintiffs' appeal.
In December 2022, the plaintiffs filed a petition to
the Supreme Court, in its capacity as the High Court
of Justice, requesting the reversal of the judgment
that dismissed the appeal.
In June 2023, the Supreme Court, sitting as the High
Court of Justice, denied the plaintiffs' petition to
reverse the judgment.

1 The date on which the motion to certify the claim as a class action was originally filed.

2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.

3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

* For additional claims concluded between January 1, 2023 and March 23, 2023, please see Note 43A.2, Sections 11-13 of the table of concluded claims in the Company's financial statements as of December 31, 2022, published on March 23 (Ref. No. 2023-01-026428).

NOTE 7 - CONTINGENT LIABILITIES (cont.)

C. Legal and other proceedings

Set forth below is a description of legal and other proceedings against the group. For proceedings where, in the opinion of management - which is based, among other things, on the legal opinion it has received - it is more likely than not that the group's defense claims will be allowed and the proceeding will be dismissed, no provision was included in the financial statements.

For proceedings where it is more likely than not that the group's defense claims will be dismissed, in whole or in part, the financial statements include provisions to cover the exposure estimated by the group. In management's opinion, which is based, among other things, on legal opinions it received, the financial statements include adequate provisions, where provisions were required, to cover the exposure estimated by the group.

    1. On November 11, 2020, an insurance agency filed a lawsuit in the amount of approximately NIS 17.6 million against The Phoenix Insurance and nine other defendants, including an agency which consolidated in The Phoenix group's financial statements, alleging misuse of the plaintiff's trade secrets and list of customers. It should be noted that the plaintiff had previously filed a motion for a temporary injunction in respect of the subject matter of the claim - and the motion was dismissed. The lawsuit continues to be heard in court.
    1. On January 29, 2017, Pilat Group Ltd. (hereinafter "Pilat Group") and Pilat Holdings (1986) Ltd. (hereinafter, jointly, - "Pilat Group" and/or the "Plaintiffs") filed a lawsuit with the District Court, against Halman Aldubi Provident and Pension Funds Ltd. (by virtue of its merger with Hadas Arazim Provident Funds Ltd. on April 30, 2013) (hereinafter - "Halman Aldubi" and "Hadas Provident", respectively) - which was merged into The Phoenix Pension and Provident on October 1, 2021 - and against 17 other defendants, including Oracle Solutions Ltd. (hereinafter - "Oracle"). The main arguments of the claim was that some of the defendants joined Oracle in purchasing shares of the Pilat Group, constituting approximately 17.9% of the voting rights in Pilat Group (hereinafter - the "Oracle Group"), and that Hadas Provident joined forces with the Oracle Group to acquire control of Pilat Group, such that Oracle would hold 20% of the voting rights, and Hadas Provident - approximately 17%, while obtaining the approval of the Israel Securities Authority (ISA) that the Oracle Group and Hadas Provident not be considered "joint holders" under the Securities Law, 1968, which concealing from the ISA data and documents reflecting cooperation between the parties. In addition, allegations were made regarding a series of appointments and interested party transactions made in Pilat Group in violation of the law, which allegedly contributed significantly to the collapse of Pilat Group.

In the statement of claim, the Court is requested to order the defendants, jointly and severally, to compensate the plaintiffs for the damage caused to them, according to the claim, due to the impairment of Pilat Group's value, in the total amount of NIS 35.9 million; in addition, declaratory reliefs are requested against Oracle Group and Hadas Provident. In June 2023, the Court approved a mediation agreement between the plaintiffs and all of the other defendants other than Halman Aldubi. The lawsuit against Halman Aldubi continues to be heard in court. A hearing is scheduled for October 24 2023.

  1. In December 2021, The Phoenix Insurance received a letter from the Capital Market, Insurance and Savings Authority in connection with the restriction of insurance coverages in accordance with Regulation 45 to the Income Tax Regulations (Rules for Approval and Management of Provident Funds), 1964. As part of the said letter, The Phoenix Insurance was requested to transfer information and check whether it acted in accordance with provisions of the law referred to in the letter, and should it failed to act in accordance with the said provisions, to repay the cost of insurance coverage allegedly collected not in accordance with the relevant provisions.

NOTE 7 - CONTINGENT LIABILITIES (cont.)

C. Legal and other proceedings (cont.)

  1. (cont.)

The letter states that it was sent, among other things, against the backdrop of a legal proceeding currently being conducted against another insurance company in connection with this issue. On April 28, 2022, The Phoenix Insurance responded in writing to this letter. The Authority's decision has yet to be issued.

  1. In April 2023, a letter was received from the Capital Markets Authority, along with a draft audit report regarding the collective long-term care insurance plan administered by The Phoenix Insurance for members of the Meuhedet HMO. The draft audit report focuses on the adequacy of the management of the money held in the fund between 2017 and 2019, and mainly concerns the manner in which contingent claims funds were managed.

In June 2023, The Phoenix Insurance responded to the letter and to the draft audit report. In July 2023, The Phoenix Insurance added upon its response. The Authority's decision has yet to be issued.

  1. The group is a party to legal and other proceedings, which are not insurance claims, including, among other things, claims made by customers, former customers, agents and various third parties in immaterial amounts and for a total amount of approximately NIS 24.7 million. The causes of action against the Group in these proceedings are different.

D. Complaints

Complaints are filed against the group from time to time, including complaints to the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner") in relation to policyholders' rights under insurance policies and/or the law. These complaints are handled on an ongoing basis by the group's Public Complaints Department. The Commissioner's decisions with regard to these complaints, to the extent that a decision has been made in respect thereof, are sometimes issued as sweeping decisions relating to a group of policyholders. Before issuing a final version of his decisions, the Commissioner usually issues a draft decision.

Furthermore, as part of the Commissioner's inquiries with the group, following complaints and/or audits on his behalf, demands are made from time to time to receive various data regarding the group's handling of insurance policies in the past and/or a demand to reimburse funds to groups of policyholders and/or other guidelines. In addition, the Commissioner has the power, among other things, to impose monetary sanctions on the group in accordance with the data that was and/or will be transferred thereto following inquiries as described above. In addition to the motions to certify lawsuits filed against the group as class actions.

and the legal and other proceedings, there is a general exposure, which cannot be assessed and/or quantified, due to, among other things, the complexity of the services provided by the group to its policyholders. The complexity of these services inevitably leads to interpretive claims and other claims due to information gaps between the group and third parties to the insurance contracts in connection with a long list of commercial and regulatory terms. This exposure is reflected, among other things, in the areas of pension savings and long-term insurance, including health and long-term care insurance, in which the group operates. Insurance policies in these areas of activity are assessed over many years in which policies, regulation and legislation change and new court rulings are issued. These changes are implemented by automated systems that undergo frequent changes and adjustments. The complexity of these changes and the application of the changes over many years lead to an increased operational exposure. In addition, allowing new interpretations for the provisions of insurance policies and long-term pension products sometimes affects the group's future profits in respect of its existing portfolio, in addition to the exposure embodied in claims for compensation for customers in respect of past activity.

NOTE 7 - CONTINGENT LIABILITIES (cont.)

D. Complaints (cont.)

It is impossible to anticipate the types of claims that will be raised in this area or the exposure arising from these and other claims in connection with insurance contracts - claims which are raised through, among other things, the procedural mechanism set forth in the Class Actions Law.

In addition, some of the group's products have long terms and are particularly complex in light of the various legislative arrangements both in the field of product management and in the field of taxation, attribution of contributions, investment management, the policyholder's employment status, his contributions and more.

The Wage Protection Law, 1958 imposes a liability on the group's institutional entities, in accordance with the circumstances specified in the law, in respect of employers' debts to the institutional entities, where such debts have not been repaid on time. The group is in the process of improving the data on employers' debts and policyholders' rights, during the course of which lawsuits were filed against employers and the debts of other employers were rescheduled. Once this process is completed, the group will complete the handling of employers' debts in accordance with the provisions of the law.

E. Summary table

The following table summarizes the amounts claimed in pending motions to certify claims as class actions, claims certified as class actions and other material claims against the group, as noted by the plaintiffs in the statements of claim filed on their behalf. It is hereby clarified that the amount claimed does not necessarily constitute a quantification of the exposure amount assessed by the group, since these are assessments on behalf of the plaintiffs which will be resolved as part of the legal proceedings. It is further clarified that the table below does not include proceedings that have been concluded, including proceedings that concluded after a compromise agreement was approved in respect thereof.

Type No. of
claims
The amount
claimed in
NIS thousand
Claims certified as a class actions:
A specific amount was attributed to the Company 6 1,152,743
The claim pertains to several companies and
no specific amount was attributed to the Company 1 48,000
The amount of the claim was not specified 4 -
Pending motions to certify lawsuits as class actions:
A specific amount was attributed to the Company
The claim pertains to several companies and no
specific amount was attributed to the Company
The amount of the claim was not specified
18
6
23
2,691,892
3,067,875
-
Other material claims:
A specific amount was attributed to the Company
The claim pertains to several companies and
- -
no specific amount was attributed to the Company 1 35,900
The amount of the claim was not specified - -
Claims and other demands 20 24,725

The total provision amount in respect of class actions, legal proceedings and others, filed against the Group as specified above as of June 30, 2023 and December 31, 2022, amounted to approximately NIS 380,596 thousand (of which a total of approximately NIS 2,370 thousand is for concluded class actions) and approximately NIS 354,703 thousand, respectively.

NOTE 8 - SIGNIFICANT EVENTS DURING THE REPORTING PERIOD

  • A. Changes in estimates and principal assumptions used to calculate the insurance reserves:
      1. Effect of interest rate on pension reserves

A decrease (increase) in long-term interest rates may increase (decrease) the paid pension reserve and the supplementary retirement pension reserve is deferred due to the use of a lower (higher) discount rate, to the extent that a change in the discount rate is required due to changes in market interest rates.

In addition, the supplementary retirement pension reserve for deferred pensions is affected by future income expectations (using K factor), so that the decrease (increase) in interest rates may decrease (increase) the expected future income, and if according to the new projection it will be impossible to continue funding the provisions to the reserve, the Company will increase the reserve in order to reduce future provision amounts (or vice versa).

2. K factor values used by the Company

June 30,
2023
2022
Unaudited
%
December 31,
2022
Audited
In respect of guaranteed return insurance policies - - -
In respect of yield-dependent insurance policies 0.85 0.85 0.85

3. Reserve in respect of liability adequacy test (LAT)

The Company tests the adequacy of the reserves for life insurance and LTC and where necessary, increases the reserves. Testing is performed according to the regulatory guidelines and on the basis of actuarial assumptions and a risk-free yield curve plus an illiquidity premium. To the extent that there are changes in these assumptions, the supplement required according to the test will change.

A decrease (increase) in the risk-free interest rate curve and/or in the rate of illiquidity premium will increase (decrease) the supplement for the reserves required according to the LAT test (to the extent that a supplement is required).

NOTE 8 - SIGNIFICANT EVENTS DURING THE REPORTING PERIOD (cont.)

  • A. Changes in estimates and principal assumptions used to calculate the insurance reserves: (cont.)
      1. Set forth below is the effect of the changes in the interest rate curve and the main changes described above on the insurance liabilities:
For the 6 months
ended June 30
For the 3 months
ended June 30
For the year ended
December 31
2023 2022 2023 2022 2022
Unaudited Audited
Life insurance segment:
Effect of updating assumption
regarding rates of annuity uptake
- (462) - NIS million
(462)
(462)
Effect of updating other assumptions
on the supplementary retirement
pension reserve and paid pensions
- - - - (12)
The effect of the changes in the assumptions regarding
the cost of claims in long-term health insurance
(59) - (59) - -
Effect of updating assumptions on the expense rates - - - - (1)
Effect of updating assumptions on the mortality rates - 364 - 364 364
Change in the discount rate used in the
calculation of the supplementary retirement
pension reserve and paid pensions
17 (397) 43 (119) (560)
Total decrease in liabilities on
retention in life insurance segment
(42) (495) (16) (217) (671)
Health insurance segment:
Effect of updating of assumptions
on the cancellation rates:
LAT
Other
-
-
-
-
-
-
-
-
(16)
25
Effect of updating assumptions on the expense rates:
LAT
Other
-
-
-
-
-
-
-
-
(21)
(63)
Effect of updating assumptions on
the mortality and morbidity rates:
Other
- - - - 38
Change in LAT reserve following
a change in the discount rate (*)
81 (753) 187 (133) (919)
Total increase (decrease) in liabilities
on retention in health insurance segment
81 (753) 187 (133) (956)
P&C insurance segment:
Change in discount rate (*)
5 (68) 23 (70) (264)
Total decrease in liabilities on
retention in P&C insurance segment
5 (68) 23 (70) (264)
Total decrease in liabilities on retention before tax 44 (1,316) 194 (420) (1,891)

Total decrease in liabilities on retention, after tax 29 (869) 128 (277) (1,244) (*) This effect includes the change in the excess of value of illiquid assets, and the effect of the classification of excess value illiquid assets. For further details, please see Note 41 (5.2.2.5) A to the Consolidated Annual Financial Statements, and Note 4B(3).

Furthermore, in the first quarter of 2023, the Company revised the estimate of the insurance liabilities in the guarantees under the Sale Law line of business under the property and casualty insurance subsegment, such that the liabilities shall reflect the policyholders' weighted credit risks. As a result of the said revision, the pre-tax profit from property and casualty insurance increased by NIS 40 million, and post-tax comprehensive income increased by NIS 26 million.

NOTE 8 - SIGNIFICANT EVENTS DURING THE REPORTING PERIOD (cont.)

  • B. Transfer of the construction projects' financing activity to a separate company wholly-owned by The Phoenix Insurance - As from January 1, 2023, the construction projects' financing activity, which is funded solely by nostro funds, was separated from the activity of The Phoenix Insurance and transferred to a separate company wholly-owned by The Phoenix Insurance - The Phoenix Construction Finance Ltd. (hereinafter - the "The Phoenix Construction Financing"). In this framework, in the reporting period, the NIS 2.25 billion credit portfolio was transferred from The Phoenix Insurance to The Phoenix Construction Financing. The transfer of the credit portfolio was carried out against an investment in the share capital of The Phoenix Construction Financing (approx. 10%), and the remaining share was transferred against a shareholder loan. It should be noted that all exposure limits and regulatory provisions shall continue to apply in relation to The Phoenix Construction Financing, and that the Company's policy and procedures, as approved by the organs of The Phoenix Insurance shall continue to apply to The Phoenix Construction Financing, mutatis mutandis.
  • C. In January 2023, the Company issued, by way of expansion, NIS 172,612 thousand par value in Series 6 registered bonds of NIS 1 par value each; the bonds were issued according to the Company's shelf offering report dated January 26, 2023 (Ref. No.: 2023-01-003042) in consideration for NIS 148,391 thousand. The Bonds (Series 6) are rated ilAA- with a stable outlook by Ma'alot, and Aa2.il with a stable outlook by Midroog Ltd. The consideration from the said expansion of the series of bonds was used as a loan advanced to The Phoenix Investment House for the acquisition of the portfolio management activity and mutual funds from Psagot. For more information, see Section G below.
  • D. On January 19, 2023, Midroog announced it assigns the Company an issuer rating of Aa2.il with a stable outlook, and upgrades the rating of the Company's bonds from Aa3.il with a stable outlook to Aa2.il with a table outlook.
  • E. On January 31, 2023, The Phoenix Capital Raising executed a full early redemption of the principal of the Series F Bonds and the interest accrued thereon at the total amount of NIS 410 million, in accordance with the conditions precedent of the deed of trust, and the approval of the Capital Market, Insurance and Savings Authority. In view of the early redemption, the Series F bonds were delisted from trade on the TASE.
  • F. On January 31, 2023, the Company's Board of Directors approved a share buyback plan of Company shares, totaling up to NIS 100 million. During the reporting period, the Company purchased approximately 333,141 shares at a total cost of approximately NIS 12.1 million. Subsequent to the purchase, the Company holds 5,729 thousand Company shares.

NOTE 8 - SIGNIFICANT EVENTS DURING THE REPORTING PERIOD (cont.)

  • G. Acquisition of the portfolio management activity and mutual funds from Psagot by The Phoenix Investment House
      1. In January 2023, KSM Mutual Funds Ltd. (hereinafter "KSM") and Psagot Mutual Funds Ltd. (hereinafter - "Psagot Funds") signed an agreement where under KSM will acquire from Psagot Funds part of its mutual funds activity as part of an assets' transaction comprising assets under management of NIS 17.1 billion in consideration for NIS 260 million (hereinafter, respectively - the "Funds Agreement" and the "Sold Funds"). In July 2023, following discussions regarding the Transaction held with the Israel Competition Authority, the parties received the Israel Competition Authority's position regarding the parties' suggestion to enter into an alternative transaction that includes changes to the sold assets and the consideration compared to the Funds Agreement (hereinafter - the "Alternative Transaction"), whereby the Israel Competition Authority will not demand the filing of merger notices in respect of the Alternative Transaction, and therefore the Competition Commissioner (hereinafter - the "Commissioner") or the Israel Competition Authority will not take enforcement measures in respect of its execution. The total assets under management that will be acquired in the Alternative Transaction shall stand at NIS 11.1 billion, in consideration for NIS 200 million, instead of the total assets under management and consideration under the Funds Agreement. For further information in connection with an agreed order pursuant to Section 50B to the Economic Competition Law, 1998, see immediate report of July 13, 2023 (Ref. No.: 2023-01-066511). As of the report publication date, the parties completed the alternative transaction. For further details, please see the immediate report dated July 13, 2023 (Ref. No.: 2023-01- 066511).
      1. Furthermore, The Phoenix Investment House and Psagot Securities Ltd. (hereinafter "Psagot Securities") signed an agreement, which is independent and unconditional of and separate from the Funds Agreement; under the said agreement, The Phoenix Investment House will acquire the entire portfolio management activity of Psagot Securities, comprising assets under management of approx. NIS 8.1 billion (hereinafter - the "Portfolio Agreement"), in consideration for NIS 50 million. As of the report publication date, the entire consideration in respect of the Portfolio Agreement was paid, and all economic rights and liabilities in respect of the activity were transferred to The Phoenix Investment House. The parties applied to the Israel Competition Authority for its approval of the transaction and filed a motion with the court in accordance with Section 350 to the Companies Law, 1999. In June 2023, the parties agreed an amendment to the Portfolio Agreement whereby the Court's approval in accordance with Section 350 to the Companies Law, 1999, is not a condition precedent to the completion of the transaction. In view of the above, the conditions precedent set in the Portfolio Agreement were fulfilled and the transaction was completed. As of the date of approval of the financial statements, a final valuation has not yet been received by an external appraiser in relation to the fair value of the identified assets acquired and the liabilities assumed. A final adjustment of the consideration for the acquisition as well as the fair value of the assets and liabilities purchased can be carried out up to 12 months from the date of purchase.

For further details regarding the above, please see immediate reports dated January 19, 2023 and July 2, 2023 (Ref. Nos.: 2023-01-009285 and 2023-01-061972).

As of June 30, 2023, The Phoenix Investment House paid the entire consideration amount to Psagot Securities, and paid a NIS 160 million advance to Psagot Funds; this advance was recorded under the receivables line item in the Company's balance sheet. For said acquisitions, the Company advanced a NIS 149 million loan to The Phoenix Investment House for the acquisition of the activities as stated above. This loan was advanced against the expansion of the Company's Series 6 bonds. For further details regarding the above, please see immediate report dated January 19, 2023 (Ref. No.: 2023-01-009285). In addition, KSM and a bank entered into a loan agreement for the purpose of paying the outstanding consideration amount.

NOTE 8 - SIGNIFICANT EVENTS DURING THE REPORTING PERIOD (cont.)

  • H. On March 22, 2023, the Company's Board of Directors approved a dividend distribution in the amount of NIS 177 million. The dividend per share of NIS 1 par value is NIS 0.7. The record date for the distribution is March 30, 2023; the dividend was paid on April 10, 2023.
  • I. In August 2021, The Phoenix Insurance issued through The Phoenix Capital Raising subordinated bonds to institutional entities and to the Company. The subordinated bonds were recognized by the Commissioner of the Capital Market, Insurance and Savings as an Additional Tier 1 capital instrument of The Phoenix Insurance, and listed by The Phoenix Capital Raising for trade on the TACT Institutionals trading platform operated by the TASE. In April 2023, The Phoenix Capital Raising fulfilled the conditions for listing the subordinated

bonds on the main list of the TASE, such that in May 2023, trading of the subordinated bonds on the main list started. In accordance with the provisions of the deed of trust, the interest in respect of the subordinated bonds was reduced by 0.2%. As part of the listing on the main list, The Phoenix Insurance undertook to publish data in connection with its economic solvency ratio on a quarterly basis in respect of the quarter preceding the reporting date.

For further details in connection with the issuance of the subordinated bonds and their listing on the main list, see the Company's immediate reports dated August 2, 2021, August 3, 2021 August 8, 2021, April 24, 2023 and May 3, 2023 (Ref. Nos.: 2021-01-060658, 2021-01-061159, 2021- 01-062515, 2023-01-038554 and 2023-01-040573, respectively).

  • J. Further to what is stated in Note 8E(6) to the Consolidated Annual Financial Statements regarding the merger of KSM ETN Holdings Ltd. (hereinafter - "KSM Holdings") with The Phoenix Investment House, in January 2023, all of the required approvals were obtained and the merger was completed. As a result of the merger, the equity attributed to the Company's shareholders decreased by NIS 79 million.
  • K. On May 9, 2023, the Board of Directors of The Phoenix Pension and Provident approved the taking of a two-year bank loan at the total amount of NIS 330 million; most of the loan amount is to be used to repay the outstanding debt to The Phoenix Insurance; the Board of Directors also approved a one-year bank credit facility at the total amount of NIS 150 million; this amount will be used in operating activities. Furthermore, the Board of Directors of The Phoenix Pension and Provident passed a resolution whereby The Phoenix Pension and Provident will undertake not to pledge its assets in order to secure the repayment of the loan and the credit facility. The loan and the credit facility include a guarantee provided by the Company. The loan agreement with the bank was signed in June 2023.
  • L. In May 2023, The Phoenix Insurance closed the activity of the retail unit, which employs 120 employees. As part of the costs incurred due to the closure of the said unit, The Phoenix Insurance recognized a one-off expense of NIS 13 million in the other expenses line item.

NOTE 8 - SIGNIFICANT EVENTS DURING THE REPORTING PERIOD (cont.)

M. On June 27, 2023, the Company's Board of Directors approved - after obtaining the approval of the Compensation Committee - the allocation to employees of the Company and its subsidiaries, some of whom are Company officers (including the Company's CEO), and to service providers of the Company (hereinafter- the "Offerees") of up to 3,211,588 unlisted options (including options that were awarded in a private placement that was approved by the Board of Directors on August 1, 2023), which are offered without cash consideration (but in consideration of work or services provided to the Company by the Offerees), under the theoretical assumption of all allocatable options being exercised taking into consideration the cap price and the cashless exercise mechanism under the outline, immediately after exercise thereof and taking into account the issued and paid-up capital of the Company, the shares arising from the exercise of the options as of the Board of Directors' approval, shall constitute approximately 0.37% of the issued and paid-up capital of the Company and approximately 0.37% of its voting rights (and approximately 0.36% and 0.36%, respectively, fully diluted). The fair value at the Award Date is calculated based on an appraisal received from an external appraiser who used the binomial model. The average value of one option was estimated at approximately NIS 6.1, and the total value of the options allotted was estimated at that date at approximately NIS 20 million.

In accordance with the Board of Directors' decision, out of the amount of 3,211,588 options allotted to offerees a total of 57,190 options were allotted to the Company's CEO. The award of options to the Company's CEO was approved in an extraordinary general meeting of the Company held on August 2, 2023 (hereinafter - the "Meeting").

For further details regarding the vesting terms and conditions, see Note 37B to the Consolidated Annual Financial Statements. In addition, please see the immediate reports dated June 28, 2023, July 26, 2023 and August 2, 2023 (Ref. Nos.: 2023-01-060307, 2023-01-060334, 2023-01- 072205513 and 2023-01-088974, respectively).

  • N. In June 2023, the Company executed a buyback of NIS 124 million par value of bonds (Series 6). The bonds are not linked to the CPI (principal and interest), and bear unlinked annual interest, as stated above, at the rate of 1.94%, which is paid in two annual payments in 2023-2032. Following this buyback, the Company recorded in the second quarter a NIS 16 million gain from early redemption.
  • O. In April 2023, Gama and a banking corporation (which is not an interested party in the Company) entered into a loan agreement, whereby Gama will receive a NIS 75 million loan, that will be repaid in a single installment on April 30, 2026. The interest on the outstanding balance of the loan's principal shall be repaid in quarterly installments as from July 30, 2023 through April 30, 2026, and its effective rate will range between Prime minus 1.5% and Prime plus 1.5%.
  • P. In connection with class actions filed and developments in lawsuits in the reporting period, please see Note 7.

NOTE 9 - SIGNIFICANT EVENTS SUBSEQUENT TO THE BALANCE SHEET DATE

  • A. During the reporting period, the profit-participating policies marketed through 2004 achieved positive real returns. After the achievement of those returns, the estimated management fees which were not collected due to negative real yield immediately prior to the publication date of the financial statements, amounted to approximately NIS 529 million (pre-tax).
  • B. On August 23, 2023, the company's Board of Directors approved a dividend distribution in the amount of NIS 120 million in respect of the Company's profits for the 6-month period ended June 30, 2023. The dividend per share of NIS 1 par value is NIS 0.47. The record date is August 31, 2023, and the payment date is September 7, 2023.
  • C. On July 11, 2023, S&P Maalot announced the upgrading of the Company's rating from ilAA- to ilAA with a stable outlook, and the upgrading of The Phoenix Insurance Company's rating from ilAA+ to ilAAA with a stable outlook.
  • D. On August 23, 2023, Midroog announced it is affirming the rating of The Phoenix Insurance Company at Aa1.il, and upgrading the rating outlook from stable to positive. Accordingly, the rating outlook of the subordinated bonds that were issued by The Phoenix Capital Raising were upgraded from stable to positive.
  • E. In August 2023, after approval by the Board of Directors of The Phoenix Investment House, the Company's Board of Directors and their respective Compensation Committees, (illiquid) options were allocated to employees of The Phoenix Investment House and other Company subsidiaries, some of whom are Company officers (including the Company's Chairman of the Board of Directors and CEO) and to service providers of the Company (hereinafter - the "Offerees"); the total number of options that were allocated did not exceed 1,471,716 (each option is convertible into one ordinary share), which constitute approx. 7.2% of the fully diluted issued capital of The Phoenix Investment House.

The fair value at the Award Date is calculated based on an appraisal received from an external appraiser, which amounted to approximately NIS 23 million. The vesting period shall be spread over 4 years.

Out of the total number of options allocated as described above, 63,321 options were allocated to the Chairman of the Company's Board of Directors, and 78,771 options were allocated to the Company's CEO. The award of options to the Company's Chairman and CEO was approved in an extraordinary general meeting of the Company held on August 2, 2023. For further details, please see the immediate reports dated June 28, 2023 and August 2, 2023 (Ref. Nos.: 2023-01-060334 and 2023-01-088974, respectively).

F. In connection with class actions filed and developments in lawsuits subsequent to the balance sheet date, please see Note 7 above.

Details of assets for assets and other financial investments

A. Details of other financial investments

June 30, 2023
Presented at
fair value
through profit
and loss
Available
for-sale
Loans and
receivables
Total
Unaudited
NIS thousand
Liquid debt assets (a1) 220,947 5,425,161 - 5,646,108
Illiquid debt assets - - 15,276,930 15,276,930
Shares (a2) 18,086 1,891,720 - 1,909,806
Other (a3) 298,160 5,214,619 - 5,512,779
June 30, 2022
Presented at
fair value
through profit
and loss
Available
for-sale
Loans and
receivables
Total
Unaudited
NIS thousand
Liquid debt assets (a1) 380,954 5,931,293 - 6,312,247
Illiquid debt assets - - 14,106,324 14,106,324
Shares (a2) - 2,144,175 - 2,144,175
Other (a3) 433,597 3,924,439 - 4,358,036
Total 814,551 11,999,907 14,106,324 26,920,782
As of December 31, 2022
Presented at
fair value
through profit Available Loans and
and loss for-sale
Audited
receivables Total
NIS thousand
Liquid debt assets (a1) 394,299 5,132,051 - 5,526,350
Illiquid debt assets - - 14,696,915 14,696,915
Shares (a2) - 1,869,608 - 1,869,608
Other (a3) 311,906 4,578,276 - 4,890,182
Total 706,205 11,579,935 14,696,915 26,983,055

Details of assets for assets and other financial investments (cont.)

A1. Liquid debt assets

June 30, 2023
Carrying amount Amortized cost
Unaudited
NIS thousand
Government bonds 2,242,513 2,406,740
Other debt assets:
Other non-convertible debt assets 3,182,648 3,436,603
Other convertible debt assets 220,947 239,606
Total liquid debt assets 5,646,108 6,082,949
Impairments carried to profit and loss (cumulative) 499,998
June 30, 2022
Carrying amount Amortized cost
Unaudited
NIS thousand
Government bonds 2,717,777 2,805,869
Other debt assets:
Other non-convertible debt assets 3,213,516 3,230,546
Other convertible debt assets 380,954 410,952
Total liquid debt assets 6,312,247 6,447,367
Impairments carried to profit and loss (cumulative) 356,873
As of December 31, 2022
Carrying amount
Amortized cost
Audited
NIS thousand
Government bonds 1,814,653 1,628,926
Other debt assets:
Other non-convertible debt assets 3,317,398 3,367,254
Other convertible debt assets 394,299 441,759
Total liquid debt assets 5,526,350 5,437,939
Impairments carried to profit and loss (cumulative) 357,288

Details of assets for assets and other financial investments (cont.)

A2. Shares

Appendix A - Breakdown of Other Financial Investments of Consolidated Insurance Company

June 30, 2023
Carrying amount Cost
Unaudited
NIS thousand
Liquid shares 1,410,317 1,500,481
Illiquid shares 499,489 333,657
Total shares 1,909,806 1,834,138
Impairments carried to profit and loss (cumulative) 338,101
June 30, 2022
Carrying amount Cost
Unaudited
NIS thousand
Liquid shares 1,671,274 1,365,837
Illiquid shares 472,901 288,885
Total shares 2,144,175 1,654,722
Impairments carried to profit and loss (cumulative) 280,643
As of December 31, 2022
Carrying amount Cost
Audited
NIS thousand
Liquid shares 1,407,424 1,173,073
Illiquid shares 462,184 289,471
Total shares 1,869,608 1,462,544
Impairments carried to profit and loss (cumulative) 345,963

Details of assets for assets and other financial investments (cont.)

A3. Other financial investments

June 30, 2023
Carrying amount Cost
Unaudited
NIS thousand
Total liquid financial investments 550,952 509,214
Total illiquid financial investments 4,961,827 3,841,533
Total other financial investments 5,512,779 4,350,747
Impairments carried to profit and loss (cumulative) 255,228
June 30, 2022
Carrying amount Cost
Unaudited
NIS thousand
Total liquid financial investments 572,658 514,615
Total illiquid financial investments 3,785,378 2,651,937
Total other financial investments 4,358,036 3,166,552
Impairments carried to profit and loss (cumulative) 205,570
As of December 31, 2022
Carrying amount Cost
Audited
NIS thousand
Total liquid financial investments 511,235 443,876
Total illiquid financial investments 4,378,947 3,172,645
Total other financial investments 4,890,182 3,616,521
Impairments carried to profit and loss (cumulative) 245,426

Part 3

Standalone Financial Data from the Consolidated Interim Financial Statements Attributed to the Company

Page

Table of Contents

Independent Auditors' Review Report .......................................................................2 Condensed Interim Data on Financial Position ............................................................3 Condensed Interim Data about Profit and Loss ..........................................................4 Condensed Interim Data about Comprehensive Income ..............................................5 Condensed Interim Data about Changes in Equity .................................................6-10 Condensed Interim Data about Changes in Cash Flows ........................................11-12 Additional Information to the Condensed Interim Separate Financial Information....13-14

Kost Forer Gabbay & Kasierer Menachem Begin Road 144A, Tel Aviv 6492102

Tel. +972-3-6232525 Fax +972-3-5622555 ey.com

To The Shareholders of The Phoenix Holdings Ltd.

Dear Madam/Sir,

Re: Special Report on the Separate Interim Financial Information pursuant in accordance with Regulation 38D of the Securities Regulations (Periodic and Immediate Reports), 1970

Introduction

We have reviewed the separate interim financial information disclosed in accordance with Regulation 38D to the Securities Regulations (Periodic and Immediate Reports), 1970 of The Phoenix Holdings Ltd. ( "the Company") as of June 30, 2023 and for the six and three-months periods then ended. The company's board of directors and management are responsible for the separate interim financial information. Our responsibility is to express a conclusion regarding the separate interim financial information based on our review.

We did not review the separate interim financial information taken from the interim information of investees, in which the total amounted to approximately NIS 951,675 thousand as of June 30, 2023, and the Company's share in of their earnings amounted to approximately NIS 60,082 thousand and NIS 14,240 thousand for the six and three-months periods then ended, respectively. The separate interim financial statements of these companies were reviewed by other auditors, whose review reports have been furnished to us, and our conclusion, insofar as it relates to financial statements in respect of these companies, is based on the review reports of the other auditors.

Scope of the Review

We conducted our review in accordance with Review Standard (Israel) 2410 of the Institute of Certified Public Accountants in Israel, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and of applying analytical and other review procedures. A review is substantially less in scope than an audit performed pursuant to Israeli GAAP and, as a result, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we are not express an audit opinion.

Conclusion

Based on our review and the review reports of other auditors, nothing has come to our attention that causes us to believe that the accompanying separate interim financial information is not prepared, in all material respects, in accordance with Regulations 38D to the Securities Regulations (Periodic and Immediate Reports), 1970.

Tel Aviv, Kost Forer Gabbay & Kasierer August 23, 2023 Certified Public Accountants

As of
June 30, 2023 June 30, 2022 December 31, 2022
Unaudited Audited
NIS thousand
Assets
Investments in investees 9,162,290 9,381,481 9,842,459
Loans and capital notes to investees 881,387 689,681 (*) 805,201 (*)
Total non-current assets 10,043,677 10,071,162 10,647,660
Investments and capital notes for investees 1,038,168 985,155 (*) 1,009,673 (*)
Other financial investments 10,610 11,194 (*) 10,603 (*)
Receivables and debit balances 10,452 10,565 10,791
Dividend receivable (see Note 2F) 486,031 - -
Current tax assets - 31 31
Deferred tax assets 11,511 - -
Cash and cash equivalents 15,174 105,710 16,959
Total current assets 1,571,946 1,112,656 1,048,057
Total assets 11,615,623 11,183,818 11,695,717
Equity attributable to Company's shareholders
Share capital 313,168 310,514 311,640
Premium on shares and capital reserves 858,022 845,296 851,918
Treasury shares (167,733) (155,628) (155,628)
Capital reserves 1,210,070 934,615 1,123,705
Surplus 7,841,012 7,773,062 8,013,123
Total equity 10,054,539 9,707,859 10,144,758
Liabilities
Non-current liabilities - - -
Bonds 1,506,993 1,417,883 1,495,505
Current liabilities
Liability in respect of current taxes 5,556 - -
Payables and credit balances 12,262 4,796 10,362
Liability in respect of deferred taxes - 18,600 9,689
Short-term bonds 36,273 34,680 35,403
Total current liabilities 54,091 58,076 55,454
Total liabilities 1,561,084 1,475,959 1,550,959
Total equity and liabilities 11,615,623 11,183,818 11,695,717

(*) Reclassified.

Benjamin Gabbay Eyal Ben Simon Eli Schwartz
Chairman of the Board CEO EVP, CFO

Date of approval of the financial statements - August 23, 2023

Condensed Separate Interim Financial Information of Income as of June 30, 2023

For the six months
ended June 30
For the three months
ended June 30
For the year ended
December 31
2023 2022 2023 2022 2022
Unaudited Unaudited Audited
NIS thousand
Company's share in the profits
(losses) of investees, net of tax (38,264) 840,839 28,917 172,613 1,216,360
Investment income, net and finance income 53,199 55,302 28,573 31,351 101,271
Income from management fees of investees 1,500 1,500 750 750 3,000
Total income 16,435 897,641 58,240 204,714 1,320,631
General and administrative expenses 6,654 5,437 2,770 2,415 9,897
Finance expenses 23,787 32,241 5,628 17,433 62,710
Total expenses 30,441 37,678 8,398 19,848 72,607
Profit (loss) before taxes on income (14,006) 859,963 49,842 184,866 1,248,024
Income tax expenses (15,600) - (8,800) - (9,100)
Profit for the period attributable
to the Company's owners 1,594 859,963 58,642 184,866 1,257,124

Condensed Separate Interim Financial Information of Comprehensive Income as of June 30, 2023

ended June 30 For the six months ended June 30 For the three months For the year ended
December 31
2023 2022 2023 2022 2022
Unaudited Audited
NIS thousand
Profit for the period 1,594 859,963 58,642 184,866 1,257,124
Other comprehensive income:
Amounts that will be or that have
been reclassified to profit or loss
when specific conditions are met
Net change in fair value of financial
assets classified as available for sale,
carried to capital reserves - (673) - (710) (754)
Net gains from disposal of financial
assets classified as available for sale,
carried to the income statement - 87 - 9 (111)
Gain on impairment of financial
assets classified as available for sale,
carried to the income statement - 110 - 110 208
The Group's share in other comprehensive
income (loss) of investees 296,914 (323,030) 158,733 (323,623) (230,419)
Taxes on income relating to components
of other comprehensive income - (121) - 137 152
Total components of income
(loss) items, subsequently
reclassified to profit or loss 296,914 (323,627) 158,733 (324,077) (230,924)
Amount that will not be subsequently
reclassified to profit or loss
The Group's share in other comprehensive
income of equity-accounted investees - 597 - 324,121 97,707
Other comprehensive income
(loss) for the period, net 296,914 (323,030) 158,733 44 (133,217)
Total comprehensive
income for the period 298,508 536,933 217,375 184,910 1,123,907

Share
capital
Premium
and
capital
reserves
in
respect
of
shares
Treasury
shares
Retained
earnings
Capital
reserve
from
transactions
with non
controlling
interests
Capital
reserve
from
transaction
with
controlling
shareholder
NIS thousand
Capital
reserve
from
share
based
payment
Revaluation
reserve
Reserve
from
translation
differences
Capital
reserve in
respect of
available
for-sale
financial
assets
Total
equity
Balance on January 1, 2023 (audited) 311,640 851,918 (155,628) 8,013,123 (56,503) 11,000 62,920 224,054 (14,435) 896,669 10,144,758
Effect of first-time application of IFRS 9 (*) - - - 1,522 - - - - - (1,522) -
Balance as of January 1, 2023 after
first-time application of IFRS 9 311,640 851,918 (155,628) 8,014,645 (56,503) 11,000 62,920 224,054 (14,435) 895,147 10,144,758
Net profit - - - 1,594 - - - - - - 1,594
Other comprehensive income (loss) - - - - - - - - 25,734 271,180 296,914
Total comprehensive income (loss) - - - 1,594 - - - - 25,734 271,180 298,508
Share-based payment - (216) - - - - 9,489 - - - 9,273
Acquisition of treasury shares - - (12,105) - - - - - - - (12,105)
Exercise of employee options 1,528 6,320 - - - - (7,848) - - - -
Transfer from revaluation reserve in
respect of revaluation of property,
plant, and equipment, at the
depreciation
amount
- - - 1,945 - - - (1,945) - - -
Dividend
Acquisition of minority interests
-
-
-
-
-
-
(177,172)
-
-
(10,848)
-
-
-
-
-
-
-
-
-
-
(177,172)
(10,848)
Allocation of shares of a consolidated
company to minority interests - - - - 1,730 - - - - - 1,730
Transaction with minority interest - - - - (199,605) - - - - - (199,605)
Balance as of June 30, 2023 (unaudited) 313,168 858,022 (167,733) 7,841,012 (265,226) 11,000 64,561 222,109 11,299 1,166,327 10,054,539

(*) See Note 2B to the condensed consolidated financial statements regarding first-time application of IFRS 9 (Financial Instruments) regarding financial instruments that do not relate to The Phoenix Insurance, which falls within the scope of the definition of insurer. According to the transition method that was selected, the comparative figures were not restated.

Condensed Separate Interim Financial Information of Changes in Equity as of June 30, 2023

Share
capital
Premium
and
capital
reserves
in
respect
of shares
Treasury
shares
Retained
earnings
Capital
reserve from
transactions
with non
controlling
interests
Capital
reserve from
transaction
with
controlling
shareholder
NIS thousand
Capital
reserve
from
share
based
payment
Revaluation
reserve
Reserve
from
translation
differences
Capital
reserve in
respect of
available
for-sale
financial
assets
Total
equity
Balance on January 1, 2022 (audited) 310,323 849,309 (99,769) 7,331,992 (45,655) 11,000 51,652 131,354 (41,946) 1,155,104 9,653,364
Profit for the period - - - 859,963 - - - - - - 859,963
Other comprehensive income (loss) - - - 593 - - - - 18,823 (342,446) (323,030)
Total comprehensive income (loss) - - - 860,556 - - - - 18,823 (342,446) 536,933
Share-based payment (4,993) - - - - 10,035 - - - 5,042
Acquisition of treasury shares - - (55,859) - - - - - - - (55,859)
Dividend - - - (421,000) - - - - - - (421,000)
Exercise of employee options
Transfer from revaluation reserve in
respect of revaluation of property,
plant, and equipment, at the
191 980 - - - - (1,171) - - - -
depreciation amount
Allocation of shares of a consolidated
- - - 1,514 - - - (1,514) - - -
company to minority interests - - - - 1,379 - - - - - 1,379
Acquisition of non-controlling interests
Balance as of June 30, 2022
- - - - (12,000) - - - - - (12,000)
(unaudited) 310,514 845,296 (155,628) 7,773,062 (56,276) 11,000 60,516 129,840 (23,123) 812,658 9,707,859

Condensed Separate Interim Financial Information of Changes in Equity as of June 30, 2023

Share
capital
Premium
and
capital
reserves
in respect
of shares
Treasury
shares
Retained
earnings
Capital reserve
from
transactions
with non
controlling
interests
Capital
reserve
from
transaction
with
controlling
shareholder
NIS thousand
Capital
reserve
from
share
based
payment
Revaluation
reserve
Reserve
from
translation
differences
Capital
reserve in
respect of
available-for
sale financial
assets
Total
equity
Balance as of April 1, 2023
(unaudited)
Net profit
311,817
-
851,225
-
(161,926)
-
7,781,449 (*)
58,642
(135,725)
-
11,000
-
67,407
-
223,030
-
1,395
-
1,017,498 (*)
-
9,967,170
58,642
Other comprehensive
income (loss) - - - - - - - - 9,904 148,829 158,733
Comprehensive
income (loss) - - - 58,642 - - - - 9,904 148,829 217,375
Share-based payment
Treasury shares
-
-
1,428
-
-
(5,807)
-
-
-
-
-
-
3,874
-
-
-
-
-
-
-
5,302
(5,807)
Exercise of
employee options 1,351 5,369 - - - - (6,720) - - - -
Transfer from revaluation
reserve in respect of
revaluation of property,
plant, and equipment, at
the depreciation amount - - - 921 - - - (921) - - -
Acquisition of
minority interests - - - - (9,985) - - - - - (9,985)
Allocation of shares of a
consolidated company to
minority interests
Transaction with
- - - - 896 - - - - - 896
minority interest - - - - (120,412) - - - - - (120,412)
Balance as of June 30, 2023
(unaudited) 313,168 858,022 (167,733) 7,841,012 (265,226) 11,000 64,561 222,109 11,299 1,166,327 10,054,539

(*) Reclassified.

Share
capital
Premium
and
capital
reserves
in respect
of shares
Treasury
shares
Retained
earnings
Capital
reserve from
transactions
with non
controlling
interests
Capital reserve
from
transaction
with controlling
shareholder
NIS thousand
Capital
reserve
from
share
based
payment
Revaluation
reserve
Reserve
from
translation
differences
Capital
reserve
in
respect
of
available
for-sale
financial
assets
Total
equity
Balance as of April 1, 2022 (unaudited) 310,366 851,131 (155,628) 7,587,379 (45,408) 11,000 56,835 130,657 (39,539) 829,030 9,535,823
Profit for the period - - - 184,866 - - - - - - 184,866
Other comprehensive income (loss) - - - - - - - - 16,416 (16,372) 44
Total comprehensive income (loss)
Transfer from revaluation reserve in
respect of revaluation of property,
- - - 184,866 - - - - 16,416 (16,372) 184,910
plant and equipment, at the
depreciation amount - - - 817 - - - (817) - - -
Share-based payment - (6,568) - - - - 4,562 - - - (2,006)
Acquisition of non-controlling interests - - - - (12,000) - - - - - (12,000)
Exercise of employee options 148 733 - - - - (881) - - - -
Allocation of shares of a consolidated
company to minority interests - - - - 1,132 - - - - - 1,132
Balance as of June 30, 2022
(unaudited)
310,514 845,296 (155,628) 7,773,062 (56,276) 11,000 60,516 129,840 (23,123) 812,658 9,707,859

Share
capital
Premium
and
capital
reserves
in
respect
of
shares
Treasury
shares
Retained
earnings
Capital
reserve
from
transactions
with non
controlling
interests
Capital
reserve
from
transaction
with
controlling
shareholder
NIS thousand
Capital
reserve
from
share
based
payment
Revaluation
reserve
Reserve
from
translation
differences
Capital
reserve
in
respect
of
available
for-sale
financial
assets
Total
equity
Balance on January 1, 2022 (audited) 310,323 849,309 (99,769) 7,331,992 (45,655) 11,000 51,652 131,354 (41,946) 1,155,104 9,653,364
Profit for the year - - - 1,257,124 - - - - - - 1,257,124
Other comprehensive income (loss) - - - 2,097 - - - 95,610 27,511 (258,435) (133,217)
Total comprehensive income (loss) - - - 1,259,221 - - - 95,610 27,511 (258,435) 1,123,907
Share-based payment - (2,362) - - - - 17,556 - - - 15,194
Acquisition of treasury shares - - (55,859) - - - - - - - (55,859)
Exercise of employee options 1,317 4,971 - - - - (6,288) - - - -
Dividend - - - (581,000) - - - - - - (581,000)
Transfer from revaluation reserve in respect of
revaluation of property, plant, and equipment,
at the depreciation amount - - - 2,910 - - - (2,910) - - -
Transaction with minority interest - - - - (14,435) - - - - - (14,435)
Allocation of shares of a consolidated
company to minority interests
- - - - 3,587 - - - - - 3,587
Balance on December 31, 2022 (audited) 311,640 851,918 (155,628) 8,013,123 (56,503) 11,000 62,920 224,054 (14,435) 896,669 10,144,758

Condensed Separate Interim Financial Information of Cash Flows of the Company as of June 30, 2023

Condensed Separate Interim Financial Inform ation of Cash Flows of the Com pany as of June 30, 2022 For the six months
ended June 30
For the three months
ended June 30
For the year ended
December 31
2023
2022
Unaudited
2023
2022
2022
Appendix Unaudited Audited
NIS thousand
Cash flows for
operating activities
Profit 1,594 859,963 58,642 184,866 1,257,124
Adjustments required to
present cash flows for
operating activities (a) 14,409 (869,932) (42,331) (199,048) (1,271,235)
Net cash used for operating
activities of the Company 16,003 (9,969) 16,311 (14,182) (14,111)
Cash flows from investing
activities:
Loans and capital notes repaid
by subsidiaries 61,922 5,125 18,708 5,125 5,125
Dividend from investees 255,000 500,000 255,000 500,000 615,000
Sales (acquisitions) of
financial investments by
the Company, net 346 10,627 (5,588) 3,622 22,652
Investment in investees (1,750) (14,925) (1,750) (14,925) (16,675)
Loans and capital notes
provided to subsidiaries (149,405) - - - (109,500)
Net cash from investing
activities 166,113 500,827 266,371 493,822 516,602
Cash flows from
financing activities
Dividend paid to shareholders (177,172) (421,000) (177,172) (421,000) (581,000)
Acquisition of Company shares (12,105) (55,859) (5,807) - (55,859)
Repayment of bonds (143,015) (315,159) (143,015) (34,220) (356,564)
Issuance of bonds (less
issuance expenses) 148,391 296,948 - - 397,968
Net cash used in financing
activities (183,901) (495,070) (325,994) (455,220) (595,455)
Increase (decrease) in
cash and cash equivalents (1,785) (4,212) (43,312) 24,420 (92,963)
Balance of cash and
cash equivalents at
beginning of period 16,959 109,922 58,486 81,290 109,922
Balance of cash and
cash equivalents at
end of period 15,174 105,710 15,174 105,710 16,959

Condensed Separate Interim Financial Information of Cash Flows of the Company as of June 30, 2023

For the six months
ended June 30
For the three months
ended June 30
For the year ended
December 31
2023 2022 2023 2022 2022
Unaudited Audited
NIS thousand
Adjustments required to present
cash flows (for) from operating
(a) activities:
Items not involving cash flows:
Profits from financial investments, net (353) (695) (477) 268 367
Income and expenses not
involving cash flows:
Accrued interest and
appreciation of bonds 6,982 25,263 (3,513) 12,534 43,992
Tax expenses (income) (15,600) - (8,800) - (9,100)
Company's share in the losses
(profits) of investees, net 38,264 (840,839) (28,917) (172,613) (1,216,361)
Changes in other balance
sheet line items, net:
Change in receivables
and debit balances 245 6,318 (5,348) (6,647) 7,948
Change in payables
and credit balances 2,070 (6,652) (72) (1,658) (1,086)
Change in loans to investees (17,199) (53,327) 4,796 (30,932) (96,995)
Total cash flows for
operating activities 14,409 (869,932) (42,331) (199,048) (1,271,235)
Significant non-cash activities:
Dividend receivable from subsidiaries 486,031 - - - -

NOTE 1 - GENERAL

Additiona l Informa tion to the Condense d Interim F inancia l Informa tion

The Interim Separate Financial Information is presented in accordance with Regulation 38D of the Securities Regulations (Periodic and Immediate Reports), 1970 and does not include all the information required under Regulation 9C and the Tenth Addendum to the Securities Regulation (Periodic and Immediate Reports), 1970, "Separate Financial Information of the Corporation".

This separate financial information should be read in conjunction with the separate financial information as of the date and year ended December 31, 2022 and in conjunction with the Condensed Consolidated Interim Financial Statements as of June 30, 2023 (hereinafter - the "Consolidated Financial Statements").

Further to that detailed in Note 2 to the condensed consolidated financial statements, as of January 1, 2023, the Company applies to the condensed interim separate financial information IFRS 9, Financial Instruments (hereinafter - "IFRS 9") excluding the financial data related to The Phoenix Insurance, which meets the definition of an insurer.

Definitions

The "Company" - The Phoenix Holdings Ltd.

"Investee companies"- Consolidated companies and companies the Company's investment in which is included, whether directly or indirectly, in the financial statements based on the equity method.

NOTE 2 - SIGNIFICANT EVENTS DURING THE REPORTING PERIOD

  • A. On March 22, 2023, the Company's Board of Directors approved a dividend distribution in the amount of NIS 177 million. The dividend per share of NIS 1 par value is NIS 0.7. The record date for the distribution is March 30, 2023; the dividend was paid on April 10, 2023.
  • B. On March 22, 2023, The Phoenix Insurance's Board of Directors approved a dividend distribution in the amount of NIS 205 million. The dividend per NIS 1 p.v. share and per NIS 5 p.v. share was NIS 1.3 and NIS 6.5, respectively. The dividend was paid in April 2023. The dividend distribution is with respect to the 2022 profits.
  • C. On January 30, 2023, The Phoenix repaid NIS 43 million in capital notes to the Company.
  • D. In January 2023, the Company issued, by way of expansion, NIS 172,612 thousand par value in Series 6 registered bonds of NIS 1 par value each; the bonds were issued according to the Company's shelf offering report dated January 26, 2023 (Ref. No.: 2023-01-003042) in consideration for NIS 148,391 thousand. See Note 8C to the consolidated financial statements.
  • E. On February 9, 2023, the Company gave KSM Mutual Funds Ltd., a subsidiary of The Phoenix Investment House, a loan of NIS 149 million, repayable in 9 unequal installments and bearing an annual interest rate of 1.94%. This loan was advanced against the expansion of the Company's Series 6 bonds. See Note 8G2 to the consolidated financial statements.
  • F. In June 2023, as part of the merger of Agam Leaderim Holdings (2001) Ltd. with and into The Phoenix Agencies, The Phoenix Agencies declared a cash dividend of NIS 675 million. The Phoenix Holdings' share of the dividend is approximately NIS 536 million; as of June 30, 2023, NIS 50 million has been paid. Subsequent to the balance sheet date, the Company was paid an additional NIS 150 million; in addition, it was decided that if The Phoenix Agencies will require shareholder loans in order to execute the Dividend Distribution, the Company and the other shareholders shall advance shareholder loans at a total maximum amount of up to NIS 500 million, based on their proportionate share in The Phoenix Agencies' issued share capital. For further details, please see Note 4F to the Consolidated Financial Statements.
  • G. In June 2023, the Company executed a buyback of NIS 124 million par value of bonds (Series 6). The bonds are not linked to the CPI (principal and interest), and bear unlinked annual interest, as stated above, at the rate of 1.94%, which is paid in two annual payments in 2023-2032. Following this buyback, the Company recorded in the second quarter a NIS 16 million gain from early redemption.

NOTE 2 - SIGNIFICANT EVENTS DURING THE REPORTING PERIOD (cont.)

  • H. On May 9, 2023, the Board of Directors of The Phoenix Pension and Provident approved the taking of a twoyear bank loan at the total amount of NIS 330 million; most of the loan amount is to be used to repay the outstanding debt to The Phoenix Insurance; the Board of Directors also approved a one-year bank credit facility at the total amount of NIS 150 million; this amount will be used in operating activities. Furthermore, the Board of Directors of The Phoenix Pension and Provident passed a resolution whereby the said company will undertake not to pledge its assets in order to secure the repayment of the loan and the credit facility. The loan and the credit facility include a guarantee provided by the Company. The loan agreement with the bank was signed in June 2023.
  • I. For other significant events during the reporting period, please see Note 8 to the Consolidated Financial Statements.

NOTE 3 - SUBSEQUENT EVENTS

  • A. On August 23, 2023, the company's Board of Directors approved a dividend distribution in the amount of NIS 120 million in respect of the Company's profits for the 6-month period ended June 30, 2023. The dividend per share of NIS 1 par value is NIS 0.47. The record date for the distribution is August 31, 2023, and the payment date is September 7, 2023.
  • B. In August 2023, concurrently with the approval of The Phoenix Insurance's Financial Statements as of June 30, 2023, The Phoenix Insurance's Board of Directors decided to distribute a NIS 350 million dividend, at a rate higher than that set in the distribution policy, without detracting from its long-term dividend policy, and given the amount of the distributable profits and the solvency ratio rate of The Phoenix Insurance, and after compliance with the solvency ratio targets and the distribution tests as per the Companies Law.
  • C. For other significant events subsequent to the reporting period, see Note 9 to the consolidated financial statements.

Tel. +972-3-6232525 Fax +972-3-5622555 ey.com

To The Board of The Phoenix Holdings Ltd. (Hereinafter: the "Company")

Dear Madam/Sir,

Subject: Shelf Prospectus of The Phoenix Holdings Ltd. (hereinafter - the "Shelf Prospectus") published on August 24, 2022

We hereby inform you that we agree to the inclusion (including by way of reference) of our reports, as listed below, in a shelf offering based on the Shelf Prospectus in the subject:

    1. The Review Report dated August 23, 2023 on the Condensed Consolidated Financial Information of The Phoenix Holdings Ltd. as of June 30, 2023 and for the six-month and three-month periods then ended.
    1. Special report dated August 23, 2023 on the Standalone Interim Financial Information in accordance with Regulation 38D to the Securities Regulations (Periodic and Immediate Reports), 1970 of The Phoenix Holdings Ltd. of The Phoenix Holdings Ltd. as of June 30, 2023 and for the six-month and three-month periods then ended.

Kost Forer Gabbay & Kasierer Certified Public Accountants

Part 4

Report on the Effectiveness of Internal Control over Financial Reporting and Disclosure

Quarterly Report on the Effectiveness of the Internal Control over Financial Reporting and Disclosure in accordance with Regulation 38C(a):

Management, under the supervision of the Board of Directors of The Phoenix Holdings Ltd. (hereinafter the "Corporation") is responsible for establishing and maintaining adequate internal control over financial reporting and disclosure in the Corporation.

For this matter, the members of management are as follows:

    1. Eyal Ben Simon, CEO of the Company and The Phoenix Insurance.
    1. Eli Schwartz, EVP, CFO of the Company and The Phoenix Insurance.
    1. Haggai Schreiber, EVP, Chief Investment Manager, CEO of The Phoenix Investments Ltd.
    1. Meni Neeman, EVP, Chief Legal Counsel and Corporate Secretary and The Phoenix Insurance.
    1. Michal Leshem, EVP, Chief Internal Auditor of the Company and The Phoenix Insurance.
    1. David Alexander, EVP, Head of Business Development of the Company and The Phoenix Insurance.
    1. Eilon Dachbash, EVP, Head of Retail Credit of the Company.
    1. Amit Netanel, EVP, Chief Risk Officer of the Company and The Phoenix Insurance.

The internal control over financial reporting and disclosure consists of the Corporation's existing controls and procedures that have been planned by the chief executive officer and the most senior financial officer or under their supervision, or by the equivalent acting officers, under the supervision of the Corporation's Board of Directors, designed to provide reasonable assurance about the reliability of financial reporting and the preparation of the financial statements in compliance with applicable laws, and ensure that all information that the Company is required to disclose in the financial statements its publishes pursuant to law is collected, processed, summarized and reported in a timely manner and according to the format prescribed by law.

Among other things, internal controls include controls and procedures planned to ensure that all information that the Corporation is required to disclose as aforesaid is collected and transferred to the Corporation's management, including the chief executive officer and the most senior financial officer, or the equivalent acting officers, in order to allow decision making on a timely basis with respect to the disclosure requirements.

Due to its inherent limitations, internal control over financial reporting and disclosure is not designed to provide absolute assurance that misstatements or omissions of information in the financial statements shall be prevented or detected.

The Phoenix Insurance Ltd., a subsidiary of the Corporation, is an institutional entity which is subject to the directives of the Commissioner of the Capital Market, Insurance and Savings in the Ministry of Finance regarding the assessment of the effectiveness of internal controls over financial reporting.

With respect to the internal control of the said subsidiary, the Corporation implements the following provisions:

Institutional Entities Circular 2009-9-10, "Management's Responsibility for Internal Controls over Financial Reporting"; Institutional Entities Circular 2010-9-6, "Management's Responsibility for internal control over financial reporting - Amendment"; Circular 2010-9-7, "internal control over financial reporting - Statements, Reports and Disclosures"; and Circular 2015-9-15, "internal control over financial reporting - Statements, Reports, Disclosures and Management's Responsibility for internal control over financial reporting - Amendments".

In the quarterly report on the effectiveness of internal control over financial reporting and the disclosure attached to the quarterly report for the period ended March 31, 2023 (hereinafter - the "Last Quarterly Internal Control Report"), the internal control was found to be effective.

As of the report date, the Board of Directors and management have not been informed of any event or matter that may alter the assessment of the effectiveness of internal control, as presented in the Most Recent Annual Report Over Internal Control.

As of the report date, based on the Most Recent Quarterly Report over Internal Control and based on information brought to the attention of management and the Board of Directors as stated above, the internal control is effective.

Certification

Statement of the CEO

  • I, Eyal Ben Simon, hereby certify that:
  • (1) I have reviewed the periodic report of The Phoenix Holdings Ltd. (hereinafter the "Corporation") for the second quarter of 2023 (hereinafter – the "Reports");
  • (2) To my knowledge, the Reports do not contain any misrepresentation of a material fact, or omit a representation of a material fact that is necessary in order for the representations included therein - under the circumstances in which such representations were included - to be misleading as to the reporting period;
  • (3) To my knowledge, the financial statements and other financial information included in the Reports fairly represent, in all material aspects, the Company's financial position, financial performance and cash flows of the Corporation as of the dates and for the periods covered by the Reports;
  • (4) I have disclosed to the independent auditor of the Corporation, the Board of Directors, and the Board of Directors' audit committee, based on my most recent evaluation of the internal control over financial reporting and disclosure, the following:
    • (a) All significant deficiencies and material weaknesses in the establishment or implementation of the internal controls over financial reporting and disclosure that may adversely affect, in a reasonable manner, the Corporation's ability to collect, process, summate or report financial information in a manner that may give rise to doubt as to the reliability of financial reporting and preparation of the financial statements in accordance with the provisions of the law; and -
    • (b) Any fraud, whether material or not, involving the chief executive officer or anyone directly reporting thereto or involving other employees who have a significant role in the internal control over financial reporting and disclosure;
  • (5) I, alone or together with others in the Corporation, state that:
    • (a) I have established such controls and procedures, or ensured that such controls and procedures under my supervision be established and in place, designed to ensure that material information relating to the Corporation, including its consolidated companies as defined in the Securities Regulations (Preparation of Annual Financial Statements), 2010, is brought to my attention by others in the Corporation and the consolidated companies, particularly during the Reports' preparation period; and -
    • (b) I have established controls and procedures, or ensured that such controls and provisions under my supervision be established and in place, designed to ensure, in a reasonable manner, the reliability of financial reporting and preparation of financial statements in accordance with the provisions of the law, including in accordance with generally accepted accounting principles;
    • (c) I have not been informed of any event or matter that occurred in the period between the most recent report date (quarterly or periodic, as the case may be) and the date of this Report, which may change the conclusion of the Board of Directors and management regarding the effectiveness of internal controls over the corporation's financial reporting and disclosure.

Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.

August 23, 2023 ___________________________________________

Eyal Ben Simon, CEO

Certification

Statement of the Most Senior Financial Officer

I, Eli Schwartz, hereby certify that:

  • (1) I have reviewed interim financial statements and other financial information included in the interim report of The Phoenix Holdings Ltd. (hereinafter - the "Corporation") for the second quarter of 2023 (hereinafter – the "Reports" or "Interim Reports");
  • (2) To my knowledge, the interim financial statements and other financial information included in the Interim Reports do not contain any misrepresentation of a material fact, nor omit a representation of a material fact that is necessary in order for the representations included therein - under the circumstances in which such representations were included - to be misleading as to the reporting period;
  • (3) To my knowledge, the Interim Financial Statements and other financial information included in the Interim Reports present fairly, in all material aspects, the Company's financial position, financial performance and cash flows of the Corporation as of the dates and for the periods covered by the Reports;
  • (4) I have disclosed to the independent auditor of the Corporation, the Board of Directors, and the Board of Directors' audit committee, based on my most recent evaluation of the internal control over financial reporting and disclosure, the following:
    • (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting and disclosure insofar as it relates to the Interim Financial Statements and other financial information included in the Interim Reports, that could reasonably adversely affect the Corporation's ability to collect, process, summarize or report financial information so as to cast doubt on the reliability of financial reporting and the preparation of the financial statements in accordance with law; and -
    • (b) Any fraud, whether material or not, involving the chief executive officer or anyone directly reporting thereto or involving other employees who have a significant role in the internal control over financial reporting and disclosure;
  • (5) I, alone or together with others in the Corporation, state that:
    • (a) I have established such controls and procedures, or ensured that such controls and procedures under my supervision be established and in place, designed to ensure that material information relating to the Corporation, including its consolidated companies as defined in the Securities Regulations (Preparation of Annual Financial Statements), 2010, is brought to my attention by others in the Corporation and the consolidated companies, particularly during the Reports' preparation period; and -
    • (b) I have established controls and procedures, or ensured that such controls and provisions under my supervision be established and in place, designed to ensure, in a reasonable manner, the reliability of financial reporting and preparation of financial statements in accordance with the provisions of the law, including in accordance with generally accepted accounting principles.
    • (c) I have not been informed of any event or matter that occurred in the period between the most recent report date (quarterly or periodic, as the case may be) and the date of this Report, which may change the conclusion of the Board of Directors and management regarding the effectiveness of internal controls over the corporation's financial reporting and disclosure.

Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.

August 23, 2023 ___________________________________________

Part 5

Statements Regarding Controls and Procedures in respect of Disclosure in the Financial Statements of The Phoenix Insurance Company Ltd.

The Phoenix Insurance Company Ltd. Certification

I, Eyal Ben Simon, hereby certify that:

    1. I have reviewed the quarterly report of The Phoenix Insurance Company Ltd. (hereinafter the "Company") for the quarter ended June 30, 2023 (hereinafter - the "Report").
    1. To my knowledge, the Report does not contain any misrepresentation of a material fact, or omit a representation of a material fact, that is necessary in order for the representations included in it - under the circumstances in which such representations were included - to be misleading as to the reporting period.
    1. To my knowledge, the quarterly financial statements and other financial information included in the Report present fairly, in all material aspects, the Company's financial position, financial performance and changes in equity and cash flows as at the dates and for the periods covered by the report.
    1. I and others at the Company signing this certification are responsible for the establishment and implementation of controls and procedures regarding the Company's disclosure and internal control over financial reporting of the Company; and
    2. (a) We have established such controls and procedures, or caused such controls and procedures to be established under our oversight, with the aim of ensuring that material information about the Company and its consolidated companies is brought to our attention by others in the Company and these companies, especially during the preparation of the Report;
    3. (b) We have established such internal controls over the financial reporting or have overseen the establishment of such controls over financial reporting, with the aim of providing reasonable assurance as to the reliability of the financial reporting and that the financial statements have been prepared in accordance with the International Financial Reporting Standards (IFRS) and the directives of the Commissioner of the Capital Market, Insurance and Savings;
    4. (c) We have evaluated the effectiveness of the Company's disclosure controls and procedures and presented in the Report our conclusions regarding the effectiveness of the disclosure controls and procedures as of the end of the reporting period according to our evaluation; and -
    5. (d) The Report discloses any change in the Company's internal control over financial reporting which occurred during the fourth quarter and has materially affected, or is reasonably expected to affect, the Company's internal control over financial reporting; and -
    1. I and others at the Company signing this certification have disclosed to the joint independent auditors, the Board of Directors, and the Board of Directors' audit committee, based on our most recent evaluation of the internal control over financial reporting, the following:
    2. (a) All significant deficiencies and material weaknesses in the establishment or implementation of the internal controls over financial reporting that may harm the Company's ability to record, process, summarize and report financial information; and -
    3. (b) Any fraud, whether or not material, involving management or other employees who have a significant role in the Company's internal control over financial reporting.

Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.

August 23, 2023

______________________________________ Eyal Ben Simon, Chief Executive Officer

The Phoenix Insurance Company Ltd. Certification

I, Eli Schwartz, hereby certify that:

    1. I have reviewed the quarterly report of The Phoenix Insurance Company Ltd. (hereinafter the "Company") for the quarter ended June 30, 2023 (hereinafter - the "Report").
    1. To my knowledge, the Report does not contain any misrepresentation of a material fact, or omit a representation of a material fact, that is necessary in order for the representations included in it - under the circumstances in which such representations were included - to be misleading as to the reporting period.
    1. To my knowledge, the quarterly financial statements and other financial information included in the Report present fairly, in all material aspects, the Company's financial position, financial performance and changes in equity and cash flows as at the dates and for the periods covered by the report.
    1. I and others at the Company signing this certification are responsible for the establishment and implementation of controls and procedures regarding the Company's disclosure and internal control over financial reporting1 of the Company; and
    2. (a) We have established such controls and procedures, or caused such controls and procedures to be established under our oversight, with the aim of ensuring that material information about the Company and its consolidated companies is brought to our attention by others in the Company and these companies, especially during the preparation of the Report;
    3. (b) We have established such internal controls over the financial reporting or have overseen the establishment of such controls over financial reporting, with the aim of providing reasonable assurance as to the reliability of the financial reporting and that the financial statements have been prepared in accordance with the International Financial Reporting Standards (IFRS) and the directives of the Commissioner of the Capital Market, Insurance and Savings;
    4. (c) We have evaluated the effectiveness of the Company's disclosure controls and procedures and presented in the Report our conclusions regarding the effectiveness of the disclosure controls and procedures as of the end of the reporting period according to our evaluation; and -
    5. (d) The Report discloses any change in the Company's internal control over financial reporting which occurred during the fourth quarter and has materially affected, or is reasonably expected to affect, the Company's internal control over financial reporting; and -
    1. I and others at the Company signing this certification have disclosed to the joint independent auditors, the Board of Directors, and the Board of Directors' audit committee, based on our most recent evaluation of the internal control over financial reporting, the following:
    2. (a) All significant deficiencies and material weaknesses in the establishment or implementation of the internal controls over financial reporting that may harm the Company's ability to record, process, summarize and report financial information; and -
    3. (b) Any fraud, whether or not material, involving management or other employees who have a significant role in the Company's internal control over financial reporting.

Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.

August 23, 2023

______________________________________________ Eli Schwartz, EVP, CFO

1 As defined in the provisions of the institutional entities circular titled "Internal Controls over Financial Reporting - Statements, Reports and Disclosures".

Talk to a Data Expert

Have a question? We'll get back to you promptly.